<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="pmc-domain-id">2622</journal-id><journal-id journal-id-type="pmc-domain">pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11858194</article-id><article-id pub-id-type="pmcid-ver">PMC11858194.1</article-id><article-id pub-id-type="pmcaid">11858194</article-id><article-id pub-id-type="pmcaiid">11858194</article-id><article-id pub-id-type="pmid">40005560</article-id><article-id pub-id-type="doi">10.3390/pathogens14020185</article-id><article-id pub-id-type="publisher-id">pathogens-14-00185</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> in Inflammation and Pain: Update on Pathologic Mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9210-9764</contrib-id><name name-style="western"><surname>Rasquel-Oliveira</surname><given-names initials="FS">Fernanda S.</given-names></name><xref rid="af1-pathogens-14-00185" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ribeiro</surname><given-names initials="JM">Jhonatan Macedo</given-names></name><xref rid="af2-pathogens-14-00185" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6751-950X</contrib-id><name name-style="western"><surname>Martelossi-Cebinelli</surname><given-names initials="G">Geovana</given-names></name><xref rid="af1-pathogens-14-00185" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Costa</surname><given-names initials="FB">Fernanda Barbosa</given-names></name><xref rid="af1-pathogens-14-00185" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nakazato</surname><given-names initials="G">Gerson</given-names></name><xref rid="af2-pathogens-14-00185" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2296-1668</contrib-id><name name-style="western"><surname>Casagrande</surname><given-names initials="R">Rubia</given-names></name><xref rid="af3-pathogens-14-00185" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2756-9283</contrib-id><name name-style="western"><surname>Verri</surname><given-names initials="WA">Waldiceu A.</given-names></name><xref rid="af1-pathogens-14-00185" ref-type="aff">1</xref><xref rid="c1-pathogens-14-00185" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Guzzo</surname><given-names initials="CR">Cristiane Rodrigues</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>de Souza</surname><given-names initials="RF">Robson Francisco</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pathogens-14-00185"><label>1</label>Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Immunology, Parasitology and General Pathology, Center of Biological Sciences, Londrina State University, Londrina 86057-970, PR, Brazil; <email>fernandarasquel@uel.br</email> (F.S.R.-O.); </aff><aff id="af2-pathogens-14-00185"><label>2</label>Department of Microbiology, Center of Biological Sciences, Londrina State University, Londrina 86057-970, PR, Brazil<email>gnakazato@uel.br</email> (G.N.)</aff><aff id="af3-pathogens-14-00185"><label>3</label>Department of Pharmaceutical Sciences, Center of Health Science, Londrina State University, Londrina 86038-440, PR, Brazil</aff><author-notes><corresp id="c1-pathogens-14-00185"><label>*</label>Correspondence: <email>waverri@uel.br</email> or <email>waldiceujr@yahoo.com.br</email>; Tel.: +55-43-3371-4979; Fax: +55-43-3371-4387</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>14</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">482921</issue-id><elocation-id>185</elocation-id><history><date date-type="received"><day>03</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>23</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>26</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-02 21:25:18.277"><day>02</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pathogens-14-00185.pdf"/><abstract><p><italic toggle="yes">Staphylococcus aureus (S. aureus</italic>) is a Gram-positive bacterium of significant clinical importance, known for its versatility and ability to cause a wide array of infections, such as osteoarticular, pulmonary, cardiovascular, device-related, and hospital-acquired infections. This review describes the most recent evidence of the pathogenic potential of <italic toggle="yes">S. aureus</italic>, which is commonly part of the human microbiota but can lead to severe infections. The prevalence of pathogenic <italic toggle="yes">S. aureus</italic> in hospital and community settings contributes to substantial morbidity and mortality, particularly in individuals with compromised immune systems. The immunopathogenesis of <italic toggle="yes">S. aureus</italic> infections involves intricate interactions with the host immune and non-immune cells, characterized by various virulence factors that facilitate adherence, invasion, and evasion of the host&#8217;s defenses. This review highlights the complexity of <italic toggle="yes">S. aureus</italic> infections, ranging from mild to life-threatening conditions, and underscores the growing public health concern posed by multidrug-resistant strains, including methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA). This article aims to provide an updated perspective on <italic toggle="yes">S. aureus</italic>-related infections, highlighting the main diseases linked to this pathogen, how the different cell types, virulence factors, and signaling molecules are involved in the immunopathogenesis, and the future perspectives to overcome the current challenges to treat the affected individuals.</p></abstract><kwd-group><kwd>immunopathogenesis</kwd><kwd>infections</kwd><kwd>virulence factors</kwd><kwd>MRSA</kwd></kwd-group><funding-group><award-group><funding-source>CNPq</funding-source><award-id>#309633/2021-4</award-id><award-id>#307852/2019-9</award-id><award-id>#405027/2021-4</award-id><award-id>#427946/2018-2</award-id></award-group><award-group><funding-source>CAPES</funding-source><award-id>#001</award-id></award-group><award-group><funding-source>FINEP</funding-source><award-id>#01.12.0294.00</award-id><award-id>#01.13.0049.00</award-id></award-group><award-group><funding-source>SETI/Funda&#231;&#227;o Arauc&#225;ria and MCTI/CNPq, and Governo do Estado do Paran&#225;</funding-source><award-id>#014/2017</award-id></award-group><award-group><funding-source>Funda&#231;&#227;o Arauc&#225;ria</funding-source><award-id>#276/2022-PBA</award-id><award-id>#250/2022-PBA</award-id></award-group><award-group><funding-source>Governo do Estado do Paran&#225;, Conselho Paranaense de Ci&#234;ncia e Tecnologia, and SETI</funding-source><award-id>#4560.19.571.06.6153</award-id></award-group><funding-statement>This research was funded by Brazilian grants from CNPq (#309633/2021-4; #307852/2019-9; #405027/2021-4; #427946/2018-2); CAPES (finance code #001), FINEP (#01.12.0294.00 and #01.13.0049.00); PRONEX grant (agreement #014/2017) supported by SETI/Funda&#231;&#227;o Arauc&#225;ria and MCTI/CNPq, and Governo do Estado do Paran&#225;; Funda&#231;&#227;o Arauc&#225;ria (PBA/PROPPG 13/2021 agreement #276/2022-PBA and #250/2022-PBA); and Governo do Estado do Paran&#225;, Conselho Paranaense de Ci&#234;ncia e Tecnologia, and SETI (agreement #4560.19.571.06.6153).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-pathogens-14-00185"><title>1. Introduction</title><p><italic toggle="yes">Staphylococcus aureus</italic> (<italic toggle="yes">S. aureus</italic>) is a Gram-positive bacterium belonging to the <italic toggle="yes">Firmicutes</italic> phylum [<xref rid="B1-pathogens-14-00185" ref-type="bibr">1</xref>,<xref rid="B2-pathogens-14-00185" ref-type="bibr">2</xref>] and is recognized as one of the most relevant pathogens in medical practice due to its high versatility and ability to cause a wide variety of infections [<xref rid="B3-pathogens-14-00185" ref-type="bibr">3</xref>,<xref rid="B4-pathogens-14-00185" ref-type="bibr">4</xref>,<xref rid="B5-pathogens-14-00185" ref-type="bibr">5</xref>]. The importance of <italic toggle="yes">S. aureus</italic> as a clinical pathogen is evidenced by its association with hospital and community-acquired infections [<xref rid="B1-pathogens-14-00185" ref-type="bibr">1</xref>], being responsible for a significant burden of morbidity and mortality worldwide. In particular, this is due to its broad repertoire of virulence factors and forms of infection [<xref rid="B6-pathogens-14-00185" ref-type="bibr">6</xref>,<xref rid="B7-pathogens-14-00185" ref-type="bibr">7</xref>,<xref rid="B8-pathogens-14-00185" ref-type="bibr">8</xref>].</p><p>Under normal conditions, <italic toggle="yes">S. aureus</italic> is commonly found in the microbiota of the skin and mucous membranes of humans, with a colonization rate ranging from 20 to 40% in healthy individuals [<xref rid="B2-pathogens-14-00185" ref-type="bibr">2</xref>,<xref rid="B9-pathogens-14-00185" ref-type="bibr">9</xref>,<xref rid="B10-pathogens-14-00185" ref-type="bibr">10</xref>,<xref rid="B11-pathogens-14-00185" ref-type="bibr">11</xref>]. Although often harmless, <italic toggle="yes">S. aureus</italic> can become pathogenic when the skin and mucosal barriers are compromised (e.g., in cases of deep wounds, chronic skin conditions, or surgical interventions) [<xref rid="B12-pathogens-14-00185" ref-type="bibr">12</xref>,<xref rid="B13-pathogens-14-00185" ref-type="bibr">13</xref>].</p><p>Furthermore, colonization by <italic toggle="yes">S. aureus</italic> often precedes the development of infections, especially in individuals using invasive medical equipment (e.g., venous catheters) or in individuals with compromised immune systems [<xref rid="B2-pathogens-14-00185" ref-type="bibr">2</xref>,<xref rid="B13-pathogens-14-00185" ref-type="bibr">13</xref>,<xref rid="B14-pathogens-14-00185" ref-type="bibr">14</xref>]. These factors increase vulnerability to infections and the disease&#8217;s development by allowing <italic toggle="yes">S. aureus</italic> to invade the underlying tissues and bloodstream [<xref rid="B12-pathogens-14-00185" ref-type="bibr">12</xref>].</p><p>Infections caused by <italic toggle="yes">S. aureus</italic> range from mild to severe and potentially fatal diseases, such as bacteremia [<xref rid="B5-pathogens-14-00185" ref-type="bibr">5</xref>], sepsis [<xref rid="B5-pathogens-14-00185" ref-type="bibr">5</xref>,<xref rid="B15-pathogens-14-00185" ref-type="bibr">15</xref>], infective endocarditis [<xref rid="B16-pathogens-14-00185" ref-type="bibr">16</xref>], and osteomyelitis [<xref rid="B17-pathogens-14-00185" ref-type="bibr">17</xref>,<xref rid="B18-pathogens-14-00185" ref-type="bibr">18</xref>] (<xref rid="pathogens-14-00185-f001" ref-type="fig">Figure 1</xref>). In addition, the significant increase in the prevalence of multidrug-resistant strains of antibiotics, such as methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA), has raised major public health concerns [<xref rid="B19-pathogens-14-00185" ref-type="bibr">19</xref>]. These concerns stem from the difficulty in finding effective treatments against these strains and the increase in associated mortality and morbidity [<xref rid="B12-pathogens-14-00185" ref-type="bibr">12</xref>,<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>,<xref rid="B21-pathogens-14-00185" ref-type="bibr">21</xref>]. Previous studies have reported that mortality from diseases caused by antibiotic-resistant strains has already exceeded 10 million and will possibly surpass cancer death rates by 2050 [<xref rid="B19-pathogens-14-00185" ref-type="bibr">19</xref>].</p><p>The immunopathogenesis of infections and diseases caused by <italic toggle="yes">S. aureus</italic> is complex and involves interactions between the pathogen and the host immune system [<xref rid="B12-pathogens-14-00185" ref-type="bibr">12</xref>]. These interactions are mediated by innate and adaptive immune cells (e.g., neutrophils, macrophages, and lymphocytes) [<xref rid="B15-pathogens-14-00185" ref-type="bibr">15</xref>] and by a surprising range of virulence factors (e.g., toxins, enzymes, and cell surface-associated antigens) that are produced by <italic toggle="yes">S. aureus</italic> [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>,<xref rid="B22-pathogens-14-00185" ref-type="bibr">22</xref>] (<xref rid="pathogens-14-00185-f001" ref-type="fig">Figure 1</xref>). Successful infection is closely linked to the ability of <italic toggle="yes">S. aureus</italic> to adhere to and invade cells and tissues, as well as evade the host&#8217;s defense mechanisms [<xref rid="B5-pathogens-14-00185" ref-type="bibr">5</xref>,<xref rid="B6-pathogens-14-00185" ref-type="bibr">6</xref>,<xref rid="B13-pathogens-14-00185" ref-type="bibr">13</xref>], resulting in exacerbated inflammatory responses, tissue damage, and worsening of infections [<xref rid="B5-pathogens-14-00185" ref-type="bibr">5</xref>] (<xref rid="pathogens-14-00185-f001" ref-type="fig">Figure 1</xref>).</p><p>Given this scenario, it is evident that there is a need for research aimed at developing new treatment strategies and deepening the understanding of the mechanisms involved in the immunopathogenesis of <italic toggle="yes">S. aureus</italic> [<xref rid="B19-pathogens-14-00185" ref-type="bibr">19</xref>,<xref rid="B21-pathogens-14-00185" ref-type="bibr">21</xref>]. Thus, this review article aims to explore the interactions between <italic toggle="yes">S. aureus</italic> and the diseases generated by it, offering an updated and comprehensive view on the complexity of infections caused by this pathogen and its implications for public health, as well as the future perspectives behind the subject.</p></sec><sec id="sec2-pathogens-14-00185"><title>2. <italic toggle="yes">S. aureus</italic>: Inflammatory Diseases, Current Challenges, and Incidence</title><p>It is largely known that humans are natural reservoirs of <italic toggle="yes">S. aureus</italic>, which colonizes the skin and mucous membranes [<xref rid="B23-pathogens-14-00185" ref-type="bibr">23</xref>]. However, <italic toggle="yes">S. aureus</italic> can be an opportunistic pathogen [<xref rid="B24-pathogens-14-00185" ref-type="bibr">24</xref>], being the cause of bacteremia, infective endocarditis, osteoarticular infection [<xref rid="B3-pathogens-14-00185" ref-type="bibr">3</xref>], atopic dermatitis (AD) [<xref rid="B25-pathogens-14-00185" ref-type="bibr">25</xref>], asthma [<xref rid="B26-pathogens-14-00185" ref-type="bibr">26</xref>,<xref rid="B27-pathogens-14-00185" ref-type="bibr">27</xref>], and sepsis [<xref rid="B28-pathogens-14-00185" ref-type="bibr">28</xref>] (<xref rid="pathogens-14-00185-f002" ref-type="fig">Figure 2</xref>).</p><p>In this section, we will approach the contribution of <italic toggle="yes">S. aureus</italic> in varied disease contexts, which is the base for the relevance of the mechanisms that will be discussed in the following sections.</p><sec id="sec2dot1-pathogens-14-00185"><title>2.1. Asthma</title><p>According to the National Institutes of Health Guidelines on Asthma 2007 (The EPR 3 Guidelines on Asthma), asthma is a common and chronic inflammatory disease of the airways. It is characterized by airflow obstruction, recurrent symptoms such as cough, wheezing, shortness of breath, chest tightness, sputum production, bronchial hyperresponsiveness, and underlying inflammation [<xref rid="B29-pathogens-14-00185" ref-type="bibr">29</xref>]. There are multiple risk factors that lead to the development of asthma, including environmental factors, genetic factors, and physical and psychological conditions [<xref rid="B30-pathogens-14-00185" ref-type="bibr">30</xref>,<xref rid="B31-pathogens-14-00185" ref-type="bibr">31</xref>,<xref rid="B32-pathogens-14-00185" ref-type="bibr">32</xref>,<xref rid="B33-pathogens-14-00185" ref-type="bibr">33</xref>].</p><p>Epidemiological data indicate that this disease affects more than 300 million people worldwide [<xref rid="B34-pathogens-14-00185" ref-type="bibr">34</xref>]. In 2019, the global prevalence of asthma was 5.42% [<xref rid="B35-pathogens-14-00185" ref-type="bibr">35</xref>]. However, asthma is also responsible for numerous cases of death, which are influenced by differences in socioeconomic and environmental conditions, mainly in underdeveloped and developing countries, places where it is underdiagnosed and undertreated [<xref rid="B36-pathogens-14-00185" ref-type="bibr">36</xref>].</p><p>However, in recent years, the involvement of <italic toggle="yes">S. aureus</italic> in the development of asthma has gained prominence. One study shows a significant association between nasal colonization of <italic toggle="yes">S. aureus</italic> and asthma prevalence [<xref rid="B37-pathogens-14-00185" ref-type="bibr">37</xref>]. Another study indicates that environmental exposures to staphylococcal enterotoxins (SE) in houses have the potential to elicit asthma symptoms [<xref rid="B38-pathogens-14-00185" ref-type="bibr">38</xref>]. Furthermore, it has been demonstrated that specific IgE to <italic toggle="yes">S. aureus</italic> enterotoxins (SE-IgE) is associated with the development of asthma [<xref rid="B39-pathogens-14-00185" ref-type="bibr">39</xref>]. It was also identified that staphylococcal serine protease&#8211;like proteins (Spls) released by <italic toggle="yes">S. aureus</italic> have allergenic properties in humans, as they can induce IgG 4 /IgE antibodies and provoke an immunological response with a type 2 cytokine profile in airway tissues [<xref rid="B40-pathogens-14-00185" ref-type="bibr">40</xref>]. In addition, it was shown that enterotoxins of <italic toggle="yes">S. aureus</italic>, in addition to acting as conventional antigens leading to a specific IgE response, can act as superantigens leading to polyclonal activation of T cells [<xref rid="B41-pathogens-14-00185" ref-type="bibr">41</xref>].</p><p>Therefore, a possible therapeutic approach for asthma concomitant with <italic toggle="yes">S. aureus</italic> infection is based on anti-IgE, such as omalizumab. This anti-IgE monoclonal antibody has been shown to be effective in decreasing IgE levels, providing improvement in symptoms and quality of life, and reducing the use of concomitant and rescue medications [<xref rid="B42-pathogens-14-00185" ref-type="bibr">42</xref>].</p><p>Although there are several treatments currently available for asthma, the outcomes of interactions of <italic toggle="yes">S. aureus</italic> infection, asthma, and drug sensitivity must be better investigated to provide tailored treatments.</p></sec><sec id="sec2dot2-pathogens-14-00185"><title>2.2. Atopic Dermatitis</title><p>Atopic dermatitis (AD), also known as eczema and atopic eczema, is a chronic inflammatory skin disease that is recurrent and multifactorial, affecting thousands of people around the world [<xref rid="B43-pathogens-14-00185" ref-type="bibr">43</xref>]. The main symptoms associated with this disorder are recurrent eczematous lesions, intense itch, and a diverse clinical presentation, being heterogeneous in terms of severity, clinical signs, and development [<xref rid="B44-pathogens-14-00185" ref-type="bibr">44</xref>]. The pathophysiology of AD is complex and includes skin barrier dysfunction, dysregulation of the immune system with a more exacerbated Th2 response, and genetic predisposition [<xref rid="B44-pathogens-14-00185" ref-type="bibr">44</xref>]. Studies have demonstrated significant dysbiosis in the skin microbiome in patients with AD, as shown in <xref rid="pathogens-14-00185-t001" ref-type="table">Table 1</xref>, with greater colonization by <italic toggle="yes">S. aureus</italic>, and this correlated with worsened disease severity [<xref rid="B45-pathogens-14-00185" ref-type="bibr">45</xref>,<xref rid="B46-pathogens-14-00185" ref-type="bibr">46</xref>,<xref rid="B47-pathogens-14-00185" ref-type="bibr">47</xref>,<xref rid="B48-pathogens-14-00185" ref-type="bibr">48</xref>,<xref rid="B49-pathogens-14-00185" ref-type="bibr">49</xref>].</p><p>Therefore, with changes in the epidermal barrier, infection by opportunistic <italic toggle="yes">S. aureus</italic> can occur, which produces several virulence factors such as toxins, enzymes, and proteins, resulting in inflammation and exacerbation of AD [<xref rid="B37-pathogens-14-00185" ref-type="bibr">37</xref>]. It has been demonstrated that the &#948;-toxin is a mast cell degranulation-inducing factor produced by <italic toggle="yes">S. aureus</italic>, while phenol-soluble modulins (PSMs) from <italic toggle="yes">S. aureus</italic> stimulate the release of proinflammatory cytokines, such as IL-18 and IL-1&#946; from keratinocytes, exacerbating skin inflammation [<xref rid="B51-pathogens-14-00185" ref-type="bibr">51</xref>,<xref rid="B52-pathogens-14-00185" ref-type="bibr">52</xref>].</p><p>Epidemiological data show that AD has a global prevalence of 2.6% and affects approximately 204 million people. Of these, the most affected are children, with a prevalence rate of 4.0% [<xref rid="B53-pathogens-14-00185" ref-type="bibr">53</xref>]. Therefore, it is more common in childhood, generally appearing in the first five years of life in 85% of cases and disappearing in about 40% of them upon growth [<xref rid="B54-pathogens-14-00185" ref-type="bibr">54</xref>]. Data also show that colonization by <italic toggle="yes">S. aureus</italic> in AD occurs in more than 90% of cases [<xref rid="B54-pathogens-14-00185" ref-type="bibr">54</xref>]. However, AD can manifest at any age, and this generates numerous socioeconomic impacts. These impacts can be direct, indirect, or intangible, but they all generate substantial costs, and thus, AD represents a public health problem [<xref rid="B55-pathogens-14-00185" ref-type="bibr">55</xref>].</p></sec><sec id="sec2dot3-pathogens-14-00185"><title>2.3. Bacteremia</title><p>Bacteremia is defined as the presence of pathogenic bacteria in the bloodstream [<xref rid="B56-pathogens-14-00185" ref-type="bibr">56</xref>]. Examples of bacteria that can cause bacteremia are shown in <xref rid="pathogens-14-00185-t002" ref-type="table">Table 2</xref>.</p><p><italic toggle="yes">S. aureus</italic> stands out as a leading cause of community-acquired and healthcare-associated bacteremia [<xref rid="B61-pathogens-14-00185" ref-type="bibr">61</xref>]. There are numerous risk factors for <italic toggle="yes">S. aureus</italic> bacteremia, such as age (high rates in the first year of life and in the elderly), underlying medical conditions, ethnicity, intravenous drug abuse, frequent skin and soft tissue infections, and the presence of intravascular catheters, in addition to pulmonary and osteoarticular infections [<xref rid="B3-pathogens-14-00185" ref-type="bibr">3</xref>,<xref rid="B62-pathogens-14-00185" ref-type="bibr">62</xref>].</p><p><italic toggle="yes">S. aureus</italic> has several mechanisms to resist and escape the host&#8217;s immune response in the bloodstream. The secretion of coagulases is capable of leading to prothrombin activation, and the presence of agglutinins on the surface of <italic toggle="yes">S. aureus</italic> makes them capable of binding to fibrin, forming large bacterial aggregates covered with fibrin. This mechanism allows the bacteria to escape phagocytosis and culminates in the formation of abscess lesions [<xref rid="B16-pathogens-14-00185" ref-type="bibr">16</xref>]. These lesions eventually rupture, releasing purulent exudate and staphylococci, which disseminate and produce new infectious lesions or infect new hosts [<xref rid="B16-pathogens-14-00185" ref-type="bibr">16</xref>]. </p><p>Currently, the gold standard for the diagnosis and treatment of bacteremia is to obtain blood cultures as early as possible [<xref rid="B63-pathogens-14-00185" ref-type="bibr">63</xref>], although there are other less-used molecular-based tests that provide faster results [<xref rid="B64-pathogens-14-00185" ref-type="bibr">64</xref>,<xref rid="B65-pathogens-14-00185" ref-type="bibr">65</xref>]. In addition, some principles are also used, including defining if the patient has a complicated or uncomplicated infection, identifying and removing infected foci, and finally, administering appropriate antimicrobial therapy in relation to the causative agent, dose, and duration [<xref rid="B3-pathogens-14-00185" ref-type="bibr">3</xref>]. For bacteremia caused by methicillin-susceptible <italic toggle="yes">S. aureus</italic> (MSSA), &#946;-lactams are used as treatment, such as isoxazolic penicillins (cloxacillin) and first-generation cephalosporins (cefazolin), due to their faster and more intense bactericidal activity against MSSA, while for bacteremia caused by methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA), vancomycin and daptomycin are used, the activity of the latter being more intense and faster [<xref rid="B66-pathogens-14-00185" ref-type="bibr">66</xref>].</p><p>Research shows that the global incidence of <italic toggle="yes">S. aureus</italic> bacteremia is approximately 30 cases per 100,000 people per year [<xref rid="B61-pathogens-14-00185" ref-type="bibr">61</xref>,<xref rid="B67-pathogens-14-00185" ref-type="bibr">67</xref>]. Meanwhile, mortality rates have decreased over the years with the introduction of antibiotics, resulting in approximately 2 to 10 deaths annually per 100,000 population [<xref rid="B68-pathogens-14-00185" ref-type="bibr">68</xref>]. However, data show a high mortality rate related to MRSA bacteremia and infective endocarditis, from 17% to 50% [<xref rid="B61-pathogens-14-00185" ref-type="bibr">61</xref>]. </p></sec><sec id="sec2dot4-pathogens-14-00185"><title>2.4. Infective Endocarditis</title><p>Infective endocarditis (IE) is an inflammatory disease that results from infection of the endocardium, affecting the inner lining of the heart and heart valves [<xref rid="B69-pathogens-14-00185" ref-type="bibr">69</xref>]. IE has a variable clinical presentation, which can be acute, subacute, or chronic, as it can be caused by different microorganisms (as shown in <xref rid="pathogens-14-00185-t003" ref-type="table">Table 3</xref>) and reflects underlying cardiac conditions or pre-existing comorbidities [<xref rid="B70-pathogens-14-00185" ref-type="bibr">70</xref>].</p><p>Studies show that the most common causative agent of IE is <italic toggle="yes">S. aureus</italic> [<xref rid="B73-pathogens-14-00185" ref-type="bibr">73</xref>,<xref rid="B74-pathogens-14-00185" ref-type="bibr">74</xref>]. The pathophysiology of IE begins with damage to the cardiac endothelium, which leads to exposure of subendothelial cells, resulting in the production of extracellular matrix proteins, tissue factors, and the deposition of fibrin and platelets, forming sterile vegetations [<xref rid="B3-pathogens-14-00185" ref-type="bibr">3</xref>]. Therefore, bacteria in the bloodstream can adhere to these vegetations, leading to additional deposition of fibrin and bacterial proliferation, causing IE [<xref rid="B69-pathogens-14-00185" ref-type="bibr">69</xref>]. It has been demonstrated that superantigens secreted by <italic toggle="yes">S. aureus</italic>, in addition to evading the host immune response, are critical virulence factors in IE, as they result in the formation of vegetations through superantigenicity and direct toxic effects on aortic endothelial cells [<xref rid="B75-pathogens-14-00185" ref-type="bibr">75</xref>].</p><p>The global incidence of IE is estimated at 3&#8211;7 cases per 100,000 people per year, and the hospital mortality rate ranges from 15 to 30% [<xref rid="B76-pathogens-14-00185" ref-type="bibr">76</xref>]. Furthermore, the incidence of hospitalizations increased in recent years, which led to an increase in medical and hospital expenses [<xref rid="B77-pathogens-14-00185" ref-type="bibr">77</xref>]. Therefore, IE is a disease that generates high socioeconomic impact, mainly related to hospitalization and treatment costs.</p></sec><sec id="sec2dot5-pathogens-14-00185"><title>2.5. Osteomyelitis</title><p>Osteomyelitis is an inflammatory disease in the bones that is caused by infection [<xref rid="B78-pathogens-14-00185" ref-type="bibr">78</xref>]. It is characterized by intense inflammation, vascular damage, and localized bone loss [<xref rid="B79-pathogens-14-00185" ref-type="bibr">79</xref>]. Bone infections may be secondary to a contiguous focus of infection or by direct inoculation (for example, after trauma or surgery), result from vascular insufficiency and infection of surrounding soft tissues with the bone (e.g., diabetic foot), or occur through hematogenous routes (more common in children) [<xref rid="B78-pathogens-14-00185" ref-type="bibr">78</xref>,<xref rid="B80-pathogens-14-00185" ref-type="bibr">80</xref>]. Several microorganisms can cause osteomyelitis, as shown in <xref rid="pathogens-14-00185-t004" ref-type="table">Table 4</xref>.</p><p>The most common microorganism causing osteomyelitis is <italic toggle="yes">S. aureus</italic> [<xref rid="B17-pathogens-14-00185" ref-type="bibr">17</xref>]. It is responsible for both acute and chronic osteomyelitis through biofilm formation, antimicrobial resistance, and expression of virulence factors [<xref rid="B80-pathogens-14-00185" ref-type="bibr">80</xref>]. Several studies have reported the role of <italic toggle="yes">S. aureus</italic> in osteomyelitis [<xref rid="B83-pathogens-14-00185" ref-type="bibr">83</xref>]. <italic toggle="yes">S. aureus</italic> is capable of mediating bone destruction, either by promoting the activation of osteoclasts, leading to an increase in the release of pro-inflammatory cytokines and activation of the transcription factor NF-&#312;B, or by inducing osteoblast apoptosis [<xref rid="B84-pathogens-14-00185" ref-type="bibr">84</xref>,<xref rid="B85-pathogens-14-00185" ref-type="bibr">85</xref>].</p><p>Previous data show that the annual incidence of osteomyelitis was 21.8 cases per 100,000 persons, with the incidence being higher for men and increasing with age [<xref rid="B86-pathogens-14-00185" ref-type="bibr">86</xref>]. More recent data show that osteomyelitis significantly affects children aged 10 to 15 years with an incidence of 15.3/100,000 [<xref rid="B87-pathogens-14-00185" ref-type="bibr">87</xref>].</p></sec><sec id="sec2dot6-pathogens-14-00185"><title>2.6. Sepsis</title><p>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) defined sepsis as &#8220;life-threatening organ dysfunction caused by a dysregulated host response to infection&#8221;. Therefore, sepsis is characterized by both physiological, pathological, and biochemical abnormalities resulting from an infection [<xref rid="B88-pathogens-14-00185" ref-type="bibr">88</xref>]. Several microorganisms can cause sepsis, as can be seen in <xref rid="pathogens-14-00185-t002" ref-type="table">Table 2</xref>, but <italic toggle="yes">S. aureus</italic> stands out.</p><p>Several studies have demonstrated the incidence of sepsis caused by <italic toggle="yes">S. aureus</italic>. A study involving 74 patients with SAB and IE in Finland showed that 50% had severe sepsis [<xref rid="B89-pathogens-14-00185" ref-type="bibr">89</xref>]. Meanwhile, another study with 373 patients with <italic toggle="yes">S. aureus</italic> bloodstream infection in Norway showed that 57.4% of patients had sepsis without organ failure and 29.8% had severe sepsis [<xref rid="B90-pathogens-14-00185" ref-type="bibr">90</xref>]. Other studies show that <italic toggle="yes">S. aureus</italic> is able to up-regulate virulence factors under stress and thus persist in the bloodstream, and that high-level superantigens (SAgs) are critical in lethal sepsis [<xref rid="B91-pathogens-14-00185" ref-type="bibr">91</xref>]. Because of this, the presence of <italic toggle="yes">S. aureus</italic> in the bloodstream can lead to sepsis [<xref rid="B92-pathogens-14-00185" ref-type="bibr">92</xref>].</p><p>The pathophysiology of <italic toggle="yes">S. aureus</italic> sepsis involves several factors and is mediated by inflammation and immunosuppression, which may occur concurrently [<xref rid="B93-pathogens-14-00185" ref-type="bibr">93</xref>]. Initially, the host response to pathogens occurs through the production and release of proinflammatory and immunomodulating cytokines [<xref rid="B94-pathogens-14-00185" ref-type="bibr">94</xref>]. Monocytes/macrophages are cells of the monocytic lineage that are critical in bacterial sepsis, as they are the main source of inflammatory cytokines that are responsible for septic shock, such as tumor necrosis factor alpha (TNF-&#945;), IL-1&#946;, and IL-6 [<xref rid="B94-pathogens-14-00185" ref-type="bibr">94</xref>]. However, disorders in innate and acquired immunity can occur, leading to immunosuppression, with the release of anti-inflammatory cytokines, death of immune cells, T-cell exhaustion, and expansion of regulatory immune cells [<xref rid="B93-pathogens-14-00185" ref-type="bibr">93</xref>]. Thus, this uncontrolled inflammatory response in sepsis can lead to disseminated intravascular coagulation, organ failure, and tissue damage, leading to septic shock, rendering it as one of the causes of high mortality [<xref rid="B93-pathogens-14-00185" ref-type="bibr">93</xref>].</p><p>Therefore, because sepsis is complex, more recent recommendations and guidelines for the treatment of sepsis have been published through the Surviving Sepsis Campaign (SSC) [<xref rid="B95-pathogens-14-00185" ref-type="bibr">95</xref>]. They include screening and early treatment, diagnosis of infection and treatment, hemodynamic management, ventilation, and additional therapies [<xref rid="B95-pathogens-14-00185" ref-type="bibr">95</xref>]. Some of these treatments include hemodynamic resuscitation with the use of crystalloids, antimicrobial therapy, and corticosteroids, considering the physiological parameters of each patient [<xref rid="B96-pathogens-14-00185" ref-type="bibr">96</xref>].</p><p>With improvements in treatments over the last two decades, mortality from sepsis has reduced [<xref rid="B93-pathogens-14-00185" ref-type="bibr">93</xref>]. However, there are still significant mortality rates, as a study showed that in 2017, 48.9 million cases of sepsis were recorded worldwide and that 11 million sepsis-related deaths were related, a fact that is associated with diverse underlying conditions and varying immune responses among patients [<xref rid="B97-pathogens-14-00185" ref-type="bibr">97</xref>,<xref rid="B98-pathogens-14-00185" ref-type="bibr">98</xref>]. A recent study showed that the global annual sepsis incidence was 276&#8211;678/100,000 people, while lethality ranged from 22.5 to 26.7% [<xref rid="B99-pathogens-14-00185" ref-type="bibr">99</xref>]. Furthermore, a study in Japan showed that medical costs to treat sepsis amounted to US $4.38 billion in 2017 [<xref rid="B100-pathogens-14-00185" ref-type="bibr">100</xref>]. Therefore, sepsis still causes many deaths, in addition to a high cost related to treatment, which represents a major health and socioeconomic problem for the world [<xref rid="B101-pathogens-14-00185" ref-type="bibr">101</xref>].</p></sec><sec id="sec2dot7-pathogens-14-00185"><title>2.7. Septic Arthritis</title><p>Septic arthritis is an inflammatory disease caused by an infectious agent, which mainly affects large joints, such as the knee or hip [<xref rid="B102-pathogens-14-00185" ref-type="bibr">102</xref>]. Among the causative agents, as shown in <xref rid="pathogens-14-00185-t005" ref-type="table">Table 5</xref>, the most common is <italic toggle="yes">S. aureus</italic>, which presents a pronounced role in patients with rheumatoid arthritis or diabetes [<xref rid="B103-pathogens-14-00185" ref-type="bibr">103</xref>].</p><p>Generally, septic arthritis is considered a secondary infection due to bacterial dissemination from the bloodstream to surrounding tissues, significantly increasing morbidity and mortality [<xref rid="B106-pathogens-14-00185" ref-type="bibr">106</xref>]. However, in addition to the hematogenous route, there are other routes through which pathogens can enter the synovial membrane, infecting the joint, which are infected contiguous foci, neighboring soft-tissue sepsis, or direct inoculation due to trauma or an iatrogenic event such as intra-articular administration of medicine [<xref rid="B107-pathogens-14-00185" ref-type="bibr">107</xref>].</p><p>Therefore, once inside the synovial space, bacteria will adhere to the synovial cells, multiply rapidly, and bacterial products and toxins will initiate the inflammatory response [<xref rid="B108-pathogens-14-00185" ref-type="bibr">108</xref>]. There is the release of IL-1&#946; and IL-6 into the synovial fluid, which leads to the release of acute-phase proteins from the liver, promoting opsonization and activation of the complement system [<xref rid="B103-pathogens-14-00185" ref-type="bibr">103</xref>]. There is also an influx of immune cells that leads to the release of TNF-&#945;, IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF) [<xref rid="B103-pathogens-14-00185" ref-type="bibr">103</xref>]. TNF-&#945;, IL-1&#946;, and IL-6 have been indicated as being the main cytokines that lead to severe inflammation that precedes cartilage and bone destruction in septic arthritis [<xref rid="B102-pathogens-14-00185" ref-type="bibr">102</xref>]. Other cytokines such as IL-33 limit the immune response in septic arthritis; thus, inhibiting its signaling through ST2 receptors enhances Th1 lymphocytes and IFN&#947; production, resulting in optimized nitric oxide production and bacterial killing [<xref rid="B109-pathogens-14-00185" ref-type="bibr">109</xref>].</p><p>Furthermore, Toll-like receptors (TLRs) will act by recognizing bacterial pathogen-associated molecular pattern molecules (PAMPs) and activating the transcription factor kappa B (NF-&#954;B). The continuous phagocytosis of bacteria will culminate in a greater release of pro-inflammatory cytokines in an attempt to eliminate the infection [<xref rid="B108-pathogens-14-00185" ref-type="bibr">108</xref>,<xref rid="B110-pathogens-14-00185" ref-type="bibr">110</xref>]. If the infection is not eliminated, there is a large influx of T-cells and macrophages, causing a thickening of the synovial membrane [<xref rid="B108-pathogens-14-00185" ref-type="bibr">108</xref>]. In addition, due to high levels of cytokines, matrix metalloproteinases (MMPs) will be released from the host&#8217;s cells, contributing to the progressive destruction of joints in septic arthritis mediated by <italic toggle="yes">S. aureus</italic> [<xref rid="B111-pathogens-14-00185" ref-type="bibr">111</xref>].</p><p>Therefore, the standard treatment for septic arthritis consists of irrigation and debridement of the affected joint through arthroscopy, in addition to the administration of intravenous antibiotics [<xref rid="B105-pathogens-14-00185" ref-type="bibr">105</xref>]. Studies in animal models have demonstrated that combined antibiotic therapy with nonsteroidal anti-inflammatory drugs or corticosteroids is capable of reducing cartilage damage in staphylococcal septic arthritis and decreasing the prevalence, severity, and mortality of the disease, respectively [<xref rid="B112-pathogens-14-00185" ref-type="bibr">112</xref>,<xref rid="B113-pathogens-14-00185" ref-type="bibr">113</xref>]. However, in humans, there are still more clinical trials needed to provide other treatment alternatives, as this standard treatment has been used for more than two decades [<xref rid="B28-pathogens-14-00185" ref-type="bibr">28</xref>].</p><p>Recent epidemiological data indicate that the annual incidence of septic arthritis varies from 1 to 35 cases/100,000 people [<xref rid="B105-pathogens-14-00185" ref-type="bibr">105</xref>]. People over 80 years and young children are the most affected [<xref rid="B107-pathogens-14-00185" ref-type="bibr">107</xref>]. However, a study showed that the incidence may vary according to ethnicity and increase with socioeconomic deprivation and age [<xref rid="B114-pathogens-14-00185" ref-type="bibr">114</xref>]. Therefore, being a rapidly progressing disease that causes significant joint damage, people with low socioeconomic conditions, children, and the elderly are directly impacted, representing a clinical emergency.</p><p>In summary, <xref rid="sec2-pathogens-14-00185" ref-type="sec">Section 2</xref> brought an overview of diseases with the involvement of <italic toggle="yes">S. aureus</italic> in their etiology (<xref rid="pathogens-14-00185-f002" ref-type="fig">Figure 2</xref>).</p><p>Hence, as <italic toggle="yes">S. aureus</italic> is associated with several diseases with significant inflammatory components that commonly dictate severity, we discuss below the immunopathogenesis and how virulence factors and other evasion mechanisms put staphylococci infections in the spotlight.</p><fig position="anchor" id="pathogens-14-00185-f002" orientation="portrait"><label>Figure 2</label><caption><p>Main microorganisms and symptoms of inflammatory diseases. Several microorganisms are involved in the development and exacerbation of inflammatory diseases, such as asthma, atopic dermatitis, bacteremia, infective endocarditis, osteomyelitis, sepsis, and septic arthritis, resulting in a variety of symptoms [<xref rid="B17-pathogens-14-00185" ref-type="bibr">17</xref>,<xref rid="B29-pathogens-14-00185" ref-type="bibr">29</xref>,<xref rid="B44-pathogens-14-00185" ref-type="bibr">44</xref>,<xref rid="B70-pathogens-14-00185" ref-type="bibr">70</xref>,<xref rid="B107-pathogens-14-00185" ref-type="bibr">107</xref>,<xref rid="B115-pathogens-14-00185" ref-type="bibr">115</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pathogens-14-00185-g002.jpg"/></fig></sec></sec><sec id="sec3-pathogens-14-00185"><title>3. Immunopathogenesis: Host Reactivity During <italic toggle="yes">S. aureus</italic> Infections</title><p>Upon host invasion and bacterial colonization by <italic toggle="yes">S. aureus</italic>, an intense immune response is established, and several pro-inflammatory mediators are produced by immune cells such as neutrophils, macrophages, and B and T lymphocytes, as well as by non-immune cells. Besides cytokines and chemokines as potent leukocyte chemoattractants, it was previously described that bacterial products can directly impact neutrophil recruitment [<xref rid="B116-pathogens-14-00185" ref-type="bibr">116</xref>,<xref rid="B117-pathogens-14-00185" ref-type="bibr">117</xref>]. The interplay between pathogen-derived virulence factors and host immune reaction directly dictates the severity and/or resolution of the infection. Pre-clinical septic arthritis models show that chronic disease leads to histopathological changes that include local edema, pannus formation, synovitis, cartilage destruction, and bone loss [<xref rid="B109-pathogens-14-00185" ref-type="bibr">109</xref>,<xref rid="B118-pathogens-14-00185" ref-type="bibr">118</xref>], and a higher number of complications are seen among immunosuppressed sepsis patients [<xref rid="B119-pathogens-14-00185" ref-type="bibr">119</xref>].</p><p>This section was divided into three main topics: innate immune response, adaptive immune response, and the role of non-immune cells contributing to response against <italic toggle="yes">S. aureus</italic> infection.</p><sec id="sec3dot1-pathogens-14-00185"><title>3.1. Innate Immune Response</title><p>As a first line of defense, the innate immune response produces mediators to recruit more cells to the infection foci; at the same time, it induces microbial killing by triggering immune cell and complement system activation. When and where microorganisms invade, various cell types such as epithelial cells sense and recognize <italic toggle="yes">S. aureus</italic> components, including lipoteichoic acid (LTA), phenol-soluble modulins, lipoproteins, protein A, and peptidoglycans (PGN), and start an immune response [<xref rid="B94-pathogens-14-00185" ref-type="bibr">94</xref>]. This recognition occurs via pattern recognition receptors (PRRs), (e.g., TLRs). Following PRR activation, cytokines, chemokines, and growth factors, for example, IL-6, chemokine (C-X-C motif) ligand 8 (CXCL8), monocyte chemotactic protein-1 (MCP-1), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF), are released to guide the recruitment and sustain leukocyte survival in the infection site [<xref rid="B120-pathogens-14-00185" ref-type="bibr">120</xref>,<xref rid="B121-pathogens-14-00185" ref-type="bibr">121</xref>,<xref rid="B122-pathogens-14-00185" ref-type="bibr">122</xref>,<xref rid="B123-pathogens-14-00185" ref-type="bibr">123</xref>]. In this section, we discuss the main cell types participating in the innate immune response against <italic toggle="yes">S. aureus</italic>.</p><sec id="sec3dot1dot1-pathogens-14-00185"><title>3.1.1. Macrophages</title><p>As professional phagocytes, macrophages have essential roles during host response against <italic toggle="yes">S. aureus</italic>. Their activities and signaling can be beneficial or detrimental depending on the context. Tissue-resident macrophages originate from prenatal precursors and are immune sentinels transcriptionally programmed for rapid pathogen recognition and further immune system activation [<xref rid="B124-pathogens-14-00185" ref-type="bibr">124</xref>]. Furthermore, macrophages can originate from circulating monocytes that are recruited from the bloodstream to the site of the inflammation for effective infection control but can also contribute to the pathogenesis of several inflammatory diseases [<xref rid="B125-pathogens-14-00185" ref-type="bibr">125</xref>]. Monocytes comprise around 10% of leukocytes in humans, while tissue-resident macrophages are about 15% of total leukocytes (in quiescent conditions) [<xref rid="B126-pathogens-14-00185" ref-type="bibr">126</xref>,<xref rid="B127-pathogens-14-00185" ref-type="bibr">127</xref>]. The importance of macrophage activity during <italic toggle="yes">S. aureus</italic> infections is highlighted by studies in which depletion of this cell type has increased bacterial burden and mortality in sepsis [<xref rid="B128-pathogens-14-00185" ref-type="bibr">128</xref>] and airway infections [<xref rid="B129-pathogens-14-00185" ref-type="bibr">129</xref>,<xref rid="B130-pathogens-14-00185" ref-type="bibr">130</xref>,<xref rid="B131-pathogens-14-00185" ref-type="bibr">131</xref>].</p><p>Macrophage chemotaxis is mediated by molecules produced by both host cells and bacteria. The chemokines CCL9 [<xref rid="B132-pathogens-14-00185" ref-type="bibr">132</xref>] and CCL2/MCP-1 [<xref rid="B123-pathogens-14-00185" ref-type="bibr">123</xref>,<xref rid="B133-pathogens-14-00185" ref-type="bibr">133</xref>], the bioactive lipid leukotriene B4 (LTB4) [<xref rid="B134-pathogens-14-00185" ref-type="bibr">134</xref>], and complement cascade activation [<xref rid="B135-pathogens-14-00185" ref-type="bibr">135</xref>,<xref rid="B136-pathogens-14-00185" ref-type="bibr">136</xref>] promote phagocyte infiltration during <italic toggle="yes">S. aureus</italic> infection. Formylated peptides (fMLP) produced by <italic toggle="yes">S. aureus</italic> account for monocyte and neutrophil chemoattraction as well since these phagocytes express formyl-peptide receptors [<xref rid="B137-pathogens-14-00185" ref-type="bibr">137</xref>,<xref rid="B138-pathogens-14-00185" ref-type="bibr">138</xref>].</p><p>Upon bacterial encounter, macrophages get activated and are polarized to express genes that will favor leukocyte survival and microbial clearance [<xref rid="B139-pathogens-14-00185" ref-type="bibr">139</xref>]. The nomenclature M1 and M2 macrophage polarization are commonly used to refer to pro-inflammatory and anti-inflammatory phenotypes, respectively. However, M1 and M2 terminologies seem to be an oversimplification&#8212;due to the great plasticity of those cells, macrophages are able to express a variety of phenotypes [<xref rid="B140-pathogens-14-00185" ref-type="bibr">140</xref>]&#8212;therefore, this article will refer to inflammatory and anti-inflammatory macrophages for better understanding.</p><p>Inflammatory macrophages, as expected, elicit a pro-inflammatory response that enhances bacterial sensing, phagocytosis, ROS and NO generation, and the release of inflammatory cytokines and can express class II major histocompatibility complex molecules (MHC-II) [<xref rid="B141-pathogens-14-00185" ref-type="bibr">141</xref>]. <italic toggle="yes">S. aureus</italic> peptidoglycan and lipoproteins are recognized by TLR2, leading to downstream MyD88 activation and NF-&#954;B signaling [<xref rid="B142-pathogens-14-00185" ref-type="bibr">142</xref>,<xref rid="B143-pathogens-14-00185" ref-type="bibr">143</xref>], a pathway known to elicit pro-inflammatory cytokine production. Inhibition of TLR2 or MyD88 activity significantly impacts cytokine release [<xref rid="B144-pathogens-14-00185" ref-type="bibr">144</xref>,<xref rid="B145-pathogens-14-00185" ref-type="bibr">145</xref>], and TLR2 deficiency results in susceptibility to <italic toggle="yes">S. aureus</italic> infection [<xref rid="B146-pathogens-14-00185" ref-type="bibr">146</xref>]. Furthermore, previous reports state that NF-&#954;B activation is required for phagocytosis by macrophages [<xref rid="B147-pathogens-14-00185" ref-type="bibr">147</xref>]. This macrophage polarization towards an inflammatory profile via TLR2 is critically dependent on forkhead box O1 (FoxO1) overexpression [<xref rid="B148-pathogens-14-00185" ref-type="bibr">148</xref>]. In addition to TLR2, TLR4 can also be activated by <italic toggle="yes">S. aureus</italic>: the bacterial component iron-regulated surface determinant protein B (IsdB) promotes IL-6 and IL-1&#946; production by monocytes via the TLR4-MyD88-NF-&#954;B pathway, which also requires activation of the NLRP3 inflammasome [<xref rid="B149-pathogens-14-00185" ref-type="bibr">149</xref>].</p><p>In contrast, anti-inflammatory macrophages have limited phagocytic activity and are associated with chronic inflammation in <italic toggle="yes">S. aureus</italic>-colonized rhinosinusitis patients [<xref rid="B150-pathogens-14-00185" ref-type="bibr">150</xref>]. In fact, in some <italic toggle="yes">S. aureus</italic> infections, such as the ones affecting catheters or prosthetic joints, bacteria induce biofilm formation to avoid phagocytosis, attenuating traditional host pro-inflammatory response and further stimulating the anti-inflammatory phenotype in monocytes [<xref rid="B151-pathogens-14-00185" ref-type="bibr">151</xref>,<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>]. It was previously described that biofilms promote immune response evasion by different mechanisms: responding to host-derived IL-1&#946;, facilitating microbial growth, diminishing pro-inflammatory cytokine expression, and increasing anti-inflammatory macrophages [<xref rid="B153-pathogens-14-00185" ref-type="bibr">153</xref>,<xref rid="B154-pathogens-14-00185" ref-type="bibr">154</xref>]. Reprogramming the biofilm-associated monocytes from an anti-inflammatory to an inflammatory profile aids in biofilm clearance, suggesting an interesting therapeutic approach [<xref rid="B155-pathogens-14-00185" ref-type="bibr">155</xref>]. Moreover, the neuropeptide CGRP seems to promote macrophage polarization towards an anti-inflammatory phenotype during skin infections [<xref rid="B156-pathogens-14-00185" ref-type="bibr">156</xref>], when <italic toggle="yes">S. aureus</italic> virulence factors (e.g., formyl peptides or HL&#945;, a pore-forming toxin) activate TRPV1<sup>+</sup> neurons [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>].</p><p>As in regard to mechanisms employed by macrophages to kill <italic toggle="yes">S. aureus</italic>, phagocytosis is accompanied by several processes to degrade the microorganism: acidification of the phagolysosome, ROS and reactive nitrogen species (RNS) generation, antimicrobial peptides and lysozyme action, and macrophage extracellular traps (mETs) (for more detailed reviews, see [<xref rid="B139-pathogens-14-00185" ref-type="bibr">139</xref>,<xref rid="B158-pathogens-14-00185" ref-type="bibr">158</xref>]. The acidification of bacteria-containing phagolysosomes is made by ATPase, an H<sup>+</sup> pump that expels hydron (H<sup>+</sup>) from the cytosol into the vesicle, lowering the pH to 5.0 or less [<xref rid="B159-pathogens-14-00185" ref-type="bibr">159</xref>] and creating a hostile environment for bacterial growth [<xref rid="B160-pathogens-14-00185" ref-type="bibr">160</xref>] and favoring the activity of cathepsins, enzymes with optimal efficacy at lower pH [<xref rid="B161-pathogens-14-00185" ref-type="bibr">161</xref>]. ROS production depends on NADPH oxidase (NOX) assembly, an enzyme that catalyzes superoxide production and noxious ROS that damage DNA, proteins, and lipids [<xref rid="B162-pathogens-14-00185" ref-type="bibr">162</xref>], being an important mechanism of action against <italic toggle="yes">S. aureus</italic> [<xref rid="B163-pathogens-14-00185" ref-type="bibr">163</xref>]. Patients with mutations in one of the subunits of NOX2 are susceptible to <italic toggle="yes">S. aureus</italic> infection [<xref rid="B164-pathogens-14-00185" ref-type="bibr">164</xref>]. Production of RNS, in turn, is catalyzed by inducible nitric oxide synthase (iNOS) [<xref rid="B165-pathogens-14-00185" ref-type="bibr">165</xref>], which also contributes to <italic toggle="yes">S. aureus</italic> killing [<xref rid="B109-pathogens-14-00185" ref-type="bibr">109</xref>]. An inflammatory stimulus (e.g., interferon-gamma [IFN-&#947;]) is necessary for iNOS expression induction [<xref rid="B166-pathogens-14-00185" ref-type="bibr">166</xref>]. Antimicrobial peptides and enzymes are additional tools of macrophage-killing machinery. Some examples are cathepsins, proteases known to promote proteolytic attack and influence the production of pro-inflammatory cytokines [<xref rid="B167-pathogens-14-00185" ref-type="bibr">167</xref>], and lysozymes, able to interfere with peptidoglycan integrity and cause bacterial lysis [<xref rid="B168-pathogens-14-00185" ref-type="bibr">168</xref>], despite the fact that <italic toggle="yes">S. aureus</italic> seems to be highly resistant to lysozyme activity [<xref rid="B169-pathogens-14-00185" ref-type="bibr">169</xref>,<xref rid="B170-pathogens-14-00185" ref-type="bibr">170</xref>]. In addition to neutrophils (discussed in more detail in <xref rid="sec3dot1dot3-pathogens-14-00185" ref-type="sec">Section 3.1.3</xref>), extracellular traps can be released by other cell types, including macrophages&#8212;when they are called mETs&#8212;which facilitate bacterial immobilization and killing [<xref rid="B171-pathogens-14-00185" ref-type="bibr">171</xref>,<xref rid="B172-pathogens-14-00185" ref-type="bibr">172</xref>,<xref rid="B173-pathogens-14-00185" ref-type="bibr">173</xref>].</p><p>As discussed in <xref rid="sec2dot7-pathogens-14-00185" ref-type="sec">Section 2.7</xref>, septic arthritis is a debilitating disease characterized by colonization of articular space, and <italic toggle="yes">S. aureus</italic> is the most commonly identified organism in the synovial fluid of these patients [<xref rid="B174-pathogens-14-00185" ref-type="bibr">174</xref>]. Synovial cavity macrophages, after phagocytosis, act as antigen-presenting cells (APCs) to activate the adaptive immune system [<xref rid="B139-pathogens-14-00185" ref-type="bibr">139</xref>]. During septic arthritis pathogenesis, macrophages secrete transforming growth factor-beta (TGF-&#946;), IL-6, TNF-&#945;, and IL-1&#946; [<xref rid="B175-pathogens-14-00185" ref-type="bibr">175</xref>], cytokines with significant roles in NF-&#954;B activation and osteoclast differentiation, perpetuating the inflammatory milieu and bone resorption [<xref rid="B176-pathogens-14-00185" ref-type="bibr">176</xref>,<xref rid="B177-pathogens-14-00185" ref-type="bibr">177</xref>]. Ghosh and colleagues [<xref rid="B178-pathogens-14-00185" ref-type="bibr">178</xref>] described that neutralization of TGF-&#946; and IL-6 ameliorated septic arthritis by modulating tissue-resident macrophages; RANKL/OPG interaction (preventing bone loss); and enhancing the antioxidant activity of superoxide dismutase and catalase [<xref rid="B178-pathogens-14-00185" ref-type="bibr">178</xref>]. Similarly, by blocking TLR2 activation and consequent TNF-&#945; and IL-1&#946; production, disease severity was mitigated [<xref rid="B179-pathogens-14-00185" ref-type="bibr">179</xref>]. Moreover, after depleting monocytes with etoposide, lower levels of TNF-&#945;, IL-1&#946;, O<sub>2</sub><sup>&#8722;</sup>, H<sub>2</sub>O<sub>2</sub>, NO, metalloproteinase-2 (MMP-2), RANKL, and osteoprotegerin were detected, attenuating <italic toggle="yes">S. aureus</italic>-induced tissue destruction during septic arthritis in mice [<xref rid="B180-pathogens-14-00185" ref-type="bibr">180</xref>].</p><p>Lipoproteins are components of the <italic toggle="yes">S. aureus</italic> cell wall known for inducing a strong macrophage response, and variants lacking lipoproteins escape immune recognition [<xref rid="B181-pathogens-14-00185" ref-type="bibr">181</xref>]. As PAMPs, lipoproteins are recognized by macrophages and promote major NO production [<xref rid="B182-pathogens-14-00185" ref-type="bibr">182</xref>], TNF release [<xref rid="B183-pathogens-14-00185" ref-type="bibr">183</xref>], and bone resorption due to their lipid-moiety effect through monocytes/macrophages [<xref rid="B184-pathogens-14-00185" ref-type="bibr">184</xref>], and by shifting cellular metabolism to glycolysis, as lactate accumulation leads to bone erosion [<xref rid="B185-pathogens-14-00185" ref-type="bibr">185</xref>]. One study conducted by Mohammad and colleagues [<xref rid="B183-pathogens-14-00185" ref-type="bibr">183</xref>] showed that, in a murine model of septic arthritis, intra-articular injection of lipoproteins resulted in chronic inflammation and joint tissue degradation, while <italic toggle="yes">S. aureus</italic> mutant lacking lipoprotein diacylglyceryl transferase resulted in a more severe outcome with uncontrolled bacterial burden, suggesting the importance of lipoproteins for proper recognition by leukocytes. Co-injection of lipoproteins and viable <italic toggle="yes">S. aureus</italic> boosted neutrophil and macrophage activation, abrogating the severity of the disease, therefore implying an interesting action of lipoproteins as adjuvants of host defenses [<xref rid="B183-pathogens-14-00185" ref-type="bibr">183</xref>].</p><p>In conclusion, macrophages are professional phagocytes chemoattracted to the infection site by molecules produced both by other immune cells and by bacteria and are further activated and polarized to favor leukocyte survival and enhance microbial killing activity. Macrophage machinery includes phagolysosome formation, antimicrobial peptide production, and release of mETs. During septic arthritis pathogenesis, macrophages exert an important role.</p></sec><sec id="sec3dot1dot2-pathogens-14-00185"><title>3.1.2. Natural Killers (NKs)</title><p>Natural killers (NKs) are a subset of innate lymphoid cells (ILCs) important during the innate immune response against tissue injury, microbes, tumors, and the initial phase of inflammation [<xref rid="B186-pathogens-14-00185" ref-type="bibr">186</xref>,<xref rid="B187-pathogens-14-00185" ref-type="bibr">187</xref>,<xref rid="B188-pathogens-14-00185" ref-type="bibr">188</xref>]. During bacterial infections, NKs recognize microorganisms via TLRs and produce IFN-&#947; to activate macrophages, which in turn produce cytokines and ROS for a robust antimicrobial response [<xref rid="B189-pathogens-14-00185" ref-type="bibr">189</xref>]. Interestingly, at the same time, NK-derived IFN-&#947; induces macrophage priming. NKs activation by enterotoxins derived from <italic toggle="yes">S. aureus</italic> is thoroughly dependent on the presence of both monocytes and &#945;&#946; T cells [<xref rid="B190-pathogens-14-00185" ref-type="bibr">190</xref>].</p><p>The relevance of NKs during <italic toggle="yes">S. aureus</italic> host response is highlighted by studies that demonstrate their protective role during <italic toggle="yes">S. aureus</italic>-induced arthritis [<xref rid="B191-pathogens-14-00185" ref-type="bibr">191</xref>] and that NK-deficient mice are susceptible to pulmonary staphylococcal infection despite a great influx of macrophages and neutrophils. This process seems to be dependent on NK-derived IL-15 [<xref rid="B192-pathogens-14-00185" ref-type="bibr">192</xref>]. In addition, type II natural killer T cells are crucial for lowering bacterial burden prior to conventional T cell activation, exerting effector functions against <italic toggle="yes">S. aureus</italic> [<xref rid="B193-pathogens-14-00185" ref-type="bibr">193</xref>]. Furthermore, after a skin infection, circulating NKs turn into long-lived tissue-resident NKs to respond to secondary infections more quickly, acting as memory-like NK cells [<xref rid="B194-pathogens-14-00185" ref-type="bibr">194</xref>].</p><p>On the other hand, some studies point to the controversial aspect of IFN-&#947;: while boosting immune response, especially by activating macrophages for phagocytosis, higher survival rates were observed when neutralizing [<xref rid="B195-pathogens-14-00185" ref-type="bibr">195</xref>] or using IFN-&#947;-deficient mice [<xref rid="B196-pathogens-14-00185" ref-type="bibr">196</xref>] infected with <italic toggle="yes">S. aureus</italic>. Bacterial &#946;-hemolysin induces IFN-&#947; in human CD56<sup>bright</sup> NK cells, contributing to infection pathogenesis [<xref rid="B197-pathogens-14-00185" ref-type="bibr">197</xref>]. This dual role may be disease-dependent and multifactorial [<xref rid="B198-pathogens-14-00185" ref-type="bibr">198</xref>,<xref rid="B199-pathogens-14-00185" ref-type="bibr">199</xref>].</p><p>Therefore, NKs are important players during <italic toggle="yes">S. aureus</italic> infections as they recognize bacteria and activate other cells, such as macrophages via IFN-&#947;; despite other leukocytes&#8217; presence, animals that lack NKs show defense impairment, and also this cell type can act as memory-like cells. However, NK-derived IFN-&#947; can have ambiguous roles and may be detrimental by over-boosting inflammation, leading to poor survival rates.</p></sec><sec id="sec3dot1dot3-pathogens-14-00185"><title>3.1.3. Neutrophils</title><p>Human neutrophils, or polymorphonuclear (PMN) leukocytes, comprise 50&#8211;70% of the total circulating leukocytes [<xref rid="B200-pathogens-14-00185" ref-type="bibr">200</xref>] and are professional phagocytes that possess important microbicidal machinery [<xref rid="B201-pathogens-14-00185" ref-type="bibr">201</xref>]. Proper regulation of the recruitment and activation of these cells is essential because immune suppression can lead to impaired microbial clearance and higher mortality [<xref rid="B202-pathogens-14-00185" ref-type="bibr">202</xref>,<xref rid="B203-pathogens-14-00185" ref-type="bibr">203</xref>,<xref rid="B204-pathogens-14-00185" ref-type="bibr">204</xref>,<xref rid="B205-pathogens-14-00185" ref-type="bibr">205</xref>], but excessive and prolonged neutrophil infiltration can lead to tissue destruction and organ dysfunction [<xref rid="B206-pathogens-14-00185" ref-type="bibr">206</xref>].</p><p>Upon <italic toggle="yes">S. aureus</italic> invasion, signaling molecules that function as chemoattractants are released by tissue-resident cells, neurons, and bacteria, resulting in the recruitment of inflammatory cells to the site of the infection. <italic toggle="yes">S. aureus</italic>-derived chemotactic molecules, such as LTA and polysaccharides, induce IL-8 production, which promotes transmigration of neutrophils [<xref rid="B207-pathogens-14-00185" ref-type="bibr">207</xref>,<xref rid="B208-pathogens-14-00185" ref-type="bibr">208</xref>,<xref rid="B209-pathogens-14-00185" ref-type="bibr">209</xref>]. In a mouse model of osteomyelitis, <italic toggle="yes">S. aureus</italic> elevated the expression of neutrophil chemoattractants CXCL1, CXCL2, CXCL3, CXCL5, CC chemokine ligand 3 (CCL3), and CCL7 [<xref rid="B210-pathogens-14-00185" ref-type="bibr">210</xref>]. Evidence suggests that the pro-inflammatory cytokine TNF-&#945; promotes neutrophil recruitment via the intrinsic TNF receptor TNFR1, while TNFR2 directs neutrophil antimicrobial functions against <italic toggle="yes">S. aureus</italic> [<xref rid="B211-pathogens-14-00185" ref-type="bibr">211</xref>]. Formylated peptides present in <italic toggle="yes">S. aureus</italic> structure also are potent chemoattractants [<xref rid="B212-pathogens-14-00185" ref-type="bibr">212</xref>]. In fact, combining antibiotics with formylated peptides is an approach proposed by some authors to boost immune response and help combat the infection [<xref rid="B213-pathogens-14-00185" ref-type="bibr">213</xref>]. In addition, neutrophils are essential for the clearance of <italic toggle="yes">S. aureus</italic> aggregates that form on medical implants [<xref rid="B214-pathogens-14-00185" ref-type="bibr">214</xref>], and delayed neutrophil recruitment to a contaminated implant site allows <italic toggle="yes">S. aureus</italic> to establish a nascent biofilm and avoid host defenses [<xref rid="B215-pathogens-14-00185" ref-type="bibr">215</xref>].</p><p>Interestingly, neurons are also able to affect neutrophil recruitment (for a more detailed discussion on the role of neurons in <italic toggle="yes">S. aureus</italic> infections, see <xref rid="sec3dot3dot2-pathogens-14-00185" ref-type="sec">Section 3.3.2</xref>). Transient receptor potential cation channel subfamily V member 1 (TRPV1)+ neurons release calcitonin gene-related peptide (CGRP) during <italic toggle="yes">S. aureus</italic>-induced skin infections, which inhibits local neutrophil infiltration, decreases IL-1&#946; and TNF&#945; while enhancing IL-10 levels, aggravating the infection. In fact, TRPV1 knockout animals displayed better outcomes than their wild-type counterparts during <italic toggle="yes">S. aureus</italic> infection [<xref rid="B156-pathogens-14-00185" ref-type="bibr">156</xref>]. This study was preceded by the observation that Nav1.8-Cre/Diphtheria Toxin A (DTA) animals (whose Nav1.8<sup>+</sup> nociceptors were ablated) showed significantly augmented neutrophil recruitment due to the inability to release CGRP, thus demonstrating a detrimental role of nociceptive neurons in <italic toggle="yes">S. aureus</italic> infection [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>].</p><p>Molecules that serve as a chemoattractant to neutrophils also prime those cells for a more robust response upon bacterial encounter. Molecules produced by the host capable of priming neutrophils include chemokines and cytokines (e.g., TNF-&#945;, IL-1&#946;, IL-6), growth factors (e.g., GM-CSF, G-CSF), and cell-to-cell contact and adhesion, which improve cytokine production and release, phagocytic activity, production of ROS, and degranulation, resulting in more efficient bactericidal activity [<xref rid="B216-pathogens-14-00185" ref-type="bibr">216</xref>]. <italic toggle="yes">S. aureus</italic> bacterial factors able to prime neutrophils include phenol-soluble modulin peptides [<xref rid="B117-pathogens-14-00185" ref-type="bibr">117</xref>] and LTA [<xref rid="B217-pathogens-14-00185" ref-type="bibr">217</xref>,<xref rid="B218-pathogens-14-00185" ref-type="bibr">218</xref>].</p><p>Neutrophils that have been primed and/or recruited by chemoattractants exit the bloodstream to reach the site of infection, where these cells are activated by PAMPs (e.g., LTA from <italic toggle="yes">S. aureus</italic>) binding to their pattern recognition receptors (e.g., TLR-2), recognizing pathogens. Priming and chemotaxis demand a lower stimuli concentration than neutrophil activation. Besides pathogen recognition, activated neutrophils display extended life span, enhanced adhesion, phagocytic activity, and production of cytokines and granules, features that are necessary for a proper antimicrobial response [<xref rid="B216-pathogens-14-00185" ref-type="bibr">216</xref>,<xref rid="B217-pathogens-14-00185" ref-type="bibr">217</xref>,<xref rid="B219-pathogens-14-00185" ref-type="bibr">219</xref>]. Evidence suggests that TLR2 and TLR4 are the main TLRs involved in <italic toggle="yes">S. aureus</italic> immune response [<xref rid="B146-pathogens-14-00185" ref-type="bibr">146</xref>,<xref rid="B220-pathogens-14-00185" ref-type="bibr">220</xref>,<xref rid="B221-pathogens-14-00185" ref-type="bibr">221</xref>,<xref rid="B222-pathogens-14-00185" ref-type="bibr">222</xref>]. In addition, NOD-like receptors, specifically NOD2, identify muramyl dipeptide derived from <italic toggle="yes">S. aureus</italic>, inducing NF-&#954;B translocation to the nucleus [<xref rid="B223-pathogens-14-00185" ref-type="bibr">223</xref>,<xref rid="B224-pathogens-14-00185" ref-type="bibr">224</xref>]. Neutrophils also express complement receptors and mannose-binding lectin receptors. Mannose-binding lectins (MBL) are recognition molecules able to detect molecular patterns in many microorganisms, including <italic toggle="yes">S. aureus</italic>, by opsonizing them [<xref rid="B225-pathogens-14-00185" ref-type="bibr">225</xref>]. Indeed, MBL-deficient mice are susceptible to <italic toggle="yes">S. aureus</italic> infection [<xref rid="B226-pathogens-14-00185" ref-type="bibr">226</xref>]. The complement system plays an important role in microbe opsonization [<xref rid="B136-pathogens-14-00185" ref-type="bibr">136</xref>,<xref rid="B227-pathogens-14-00185" ref-type="bibr">227</xref>], as gram-positive bacteria have developed evasion mechanisms to escape this type of host defense (as reviewed by [<xref rid="B228-pathogens-14-00185" ref-type="bibr">228</xref>]).</p><p>Neutrophils are a crucial part of the immune response against <italic toggle="yes">S. aureus</italic>, as depletion of those cells increases pro-inflammatory cytokine levels and the severity of <italic toggle="yes">S. aureus</italic> infection in mice [<xref rid="B229-pathogens-14-00185" ref-type="bibr">229</xref>]. Upon pathogen recognition, neutrophils have their killing machinery activated by means of phagocytosis, releasing neutrophil extracellular traps (known as NETs), or degranulating. Phagocytosis activates the production of RNS and ROS, such as nitric oxide (NO), which are important for killing activity. Indeed, for instance, the inhibition of nitric oxide synthase (NOS) results in aggravation of sepsis and septic arthritis [<xref rid="B230-pathogens-14-00185" ref-type="bibr">230</xref>,<xref rid="B231-pathogens-14-00185" ref-type="bibr">231</xref>]. Superoxide and derived ROS are produced during a process known as respiratory or oxidative burst by NADPH oxidase [<xref rid="B232-pathogens-14-00185" ref-type="bibr">232</xref>]. The multi-subunit enzyme complex NADPH oxidase is composed of a heterodimer of gp91phox and p22phox, known as cytochrome b558, which is the catalytic core and electron transferase, and the cofactors p47phox, p40phox, p67phox, Rap1A, and a small G protein Rac2 [<xref rid="B216-pathogens-14-00185" ref-type="bibr">216</xref>,<xref rid="B232-pathogens-14-00185" ref-type="bibr">232</xref>]. Before neutrophils are activated, these subunits are disassembled: flavocytochrome b558 and Rap1A are found in membrane compartments, while p40phox, p47phox, and p67phox are located in cytosolic compartments. Even though superoxide anion by itself does not possess strong microbicidal activity, it is a precursor to other oxidants including hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), hydroxyl radical (OH<sup>&#8226;</sup>), hypochlorous acid (HOCl), peroxynitrite (ONOO<sup>&#8226;</sup>), and stronger oxidants that contribute to <italic toggle="yes">S. aureus</italic> killing [<xref rid="B233-pathogens-14-00185" ref-type="bibr">233</xref>]. In fact, as a mechanism of immune evasion, <italic toggle="yes">S. aureus</italic> induces the production of the anti-inflammatory metabolite itaconate by neutrophils, which inhibits respiratory burst and, consequently, bacterial clearance [<xref rid="B234-pathogens-14-00185" ref-type="bibr">234</xref>].</p><p>In parallel with ROS production, neutrophils generate granules that fuse with the phagosome, forming the phagolysosome. Primary granules, also called azurophilic granules, contain myeloperoxidase (MPO), an enzyme responsible for catalyzing a reaction between chloride and H<sub>2</sub>O<sub>2</sub>, resulting in HOCl, an effective antimicrobial agent that attacks microbial enzymes essential for energy production and preservation of structural integrity [<xref rid="B235-pathogens-14-00185" ref-type="bibr">235</xref>]. Patients with MPO deficiency are still able to promote microbe killing, compensating for the lack of MPO with other mechanisms, but although pathogen engulfment is efficient, killing is delayed [<xref rid="B236-pathogens-14-00185" ref-type="bibr">236</xref>]. The fusion of primary granules with the phagosome also enriches the phagosomal compartment with elastase, lysozyme, &#945;-defensins, cathepsins, proteinase-3, and azurocidin [<xref rid="B237-pathogens-14-00185" ref-type="bibr">237</xref>]. Some of the mechanisms used by antimicrobial peptides include pore-forming, restriction of the synthesis of nucleic acids and proteins, cell cycle interruption, as well as DNA, RNA, and organelle degradation (as reviewed by [<xref rid="B238-pathogens-14-00185" ref-type="bibr">238</xref>]).</p><p>Neutrophils can also release intracellular-stored granules by exocytosis, or degranulation, to the exterior of the cell, which is dependent on cytoskeleton reorganization and changes in intracellular Ca<sup>2+</sup> levels [<xref rid="B239-pathogens-14-00185" ref-type="bibr">239</xref>]. Despite their importance during extracellular bacterial clearance, uncontrolled degranulation can damage host tissue significantly. Phenol-soluble modulins secreted by <italic toggle="yes">S. aureus</italic> are known to induce neutrophil degranulation [<xref rid="B240-pathogens-14-00185" ref-type="bibr">240</xref>], and proline-rich kinase 2 (Pyk2) seems to be required for efficient clearance of <italic toggle="yes">S. aureus</italic> infection, at least in part, due to its role during the neutrophil degranulation process [<xref rid="B241-pathogens-14-00185" ref-type="bibr">241</xref>].</p><p>A third mechanism used against microorganisms, including <italic toggle="yes">S. aureus</italic>, during neutrophil defense, is the release of weblike structures called NETs. The extrusion of these structures, composed of primary granule- and cytosolic proteins, decondensed chromatin, and bound histones, is known as NETosis. NETs trap microorganisms, preventing their spread and promoting clearance [<xref rid="B242-pathogens-14-00185" ref-type="bibr">242</xref>]. Moreover, NETs are also triggered by non-infectious stimuli, such as microcrystals, immune complexes, cytokines, and alkaline pH [<xref rid="B243-pathogens-14-00185" ref-type="bibr">243</xref>,<xref rid="B244-pathogens-14-00185" ref-type="bibr">244</xref>,<xref rid="B245-pathogens-14-00185" ref-type="bibr">245</xref>]. It was previously described that neutrophils responding uniquely to <italic toggle="yes">S. aureus</italic> via NET formation did not require neutrophil lysis and are ROS independent [<xref rid="B246-pathogens-14-00185" ref-type="bibr">246</xref>], in contrast with other reports in which the release of NETs resulted in cell death [<xref rid="B247-pathogens-14-00185" ref-type="bibr">247</xref>,<xref rid="B248-pathogens-14-00185" ref-type="bibr">248</xref>]. In this pathway, when NETs culminate in neutrophil lysis (known as classical NETosis), the death process usually takes 2&#8211;4 h [<xref rid="B247-pathogens-14-00185" ref-type="bibr">247</xref>], while vital NET release takes 5&#8211;60 min, and neutrophils retain not only viability but many of their immune functions [<xref rid="B246-pathogens-14-00185" ref-type="bibr">246</xref>]. Depending on the stimuli, components of NET structures may vary&#8212;after simulation with C5a, for example, NETs contained mitochondrial DNA [<xref rid="B249-pathogens-14-00185" ref-type="bibr">249</xref>], while LPS results in lysosome-associated membrane protein 2 (LAMP2)-enriched NETs [<xref rid="B250-pathogens-14-00185" ref-type="bibr">250</xref>]. Among many <italic toggle="yes">S. aureus</italic> components capable of triggering NETs release, some studies point out Panton&#8211;Valentine leukocidin (PVL), a pore-forming toxin that promoted vital NETs extrusion [<xref rid="B246-pathogens-14-00185" ref-type="bibr">246</xref>,<xref rid="B251-pathogens-14-00185" ref-type="bibr">251</xref>]. Other <italic toggle="yes">S. aureus</italic> components, including leukotoxins GH (pore-forming cytolytic toxins) [<xref rid="B252-pathogens-14-00185" ref-type="bibr">252</xref>], AgrD (regulator of virulence factors expression) [<xref rid="B253-pathogens-14-00185" ref-type="bibr">253</xref>], and phenol-soluble modulin &#945; (membrane-disturbing peptides) [<xref rid="B254-pathogens-14-00185" ref-type="bibr">254</xref>], also can generate NETosis. In addition, <italic toggle="yes">S. aureus</italic>-induced NET formation is strictly regulated and requires both TLR2 activation and complement protein C3, as TLR2- or C3-deficient mice were unable to release nuclear DNA or histones, nor perform TLR2 or C3a receptor stimulation alone during skin infections [<xref rid="B255-pathogens-14-00185" ref-type="bibr">255</xref>].</p><p>Although essential for pathogen clearance, aberrant NET formation or dysregulation of NETosis clearance is linked to several pathologies [<xref rid="B256-pathogens-14-00185" ref-type="bibr">256</xref>]. Prolonged or excessive NET formation contributes to chronic inflammation and/or autoimmunity, important factors of diseases like atherosclerosis, psoriasis, type II diabetes, rheumatoid arthritis, psoriasis, and gout arthritis (as reviewed by [<xref rid="B257-pathogens-14-00185" ref-type="bibr">257</xref>]). As several NET components exhibit tissue destructive capacity due to cytotoxic activities [<xref rid="B258-pathogens-14-00185" ref-type="bibr">258</xref>,<xref rid="B259-pathogens-14-00185" ref-type="bibr">259</xref>], respiratory dysfunction and poor outcomes are observed in <italic toggle="yes">S. aureus</italic>-infected cystic fibrosis patients, for example, as these patients show large amounts of MPO and nitrating species in their sputum [<xref rid="B260-pathogens-14-00185" ref-type="bibr">260</xref>,<xref rid="B261-pathogens-14-00185" ref-type="bibr">261</xref>]. Similarly, exaggerated NETs production provokes intravascular coagulation and tissue damage in septic mice [<xref rid="B262-pathogens-14-00185" ref-type="bibr">262</xref>,<xref rid="B263-pathogens-14-00185" ref-type="bibr">263</xref>], increases lung injury in <italic toggle="yes">S. aureus</italic>-induced pneumonia [<xref rid="B264-pathogens-14-00185" ref-type="bibr">264</xref>], and contribute to vegetation formation in <italic toggle="yes">S. aureus</italic> endocarditis [<xref rid="B265-pathogens-14-00185" ref-type="bibr">265</xref>]. Therefore, ideally, both NET structures and apoptotic neutrophils that have promoted bacterial killing should be removed properly by macrophages through a non-phlogistic process called efferocytosis [<xref rid="B266-pathogens-14-00185" ref-type="bibr">266</xref>]. In fact, NET formation also enhances the antibacterial activity of macrophages [<xref rid="B267-pathogens-14-00185" ref-type="bibr">267</xref>], another important cell type during host defense against <italic toggle="yes">S. aureus</italic>.</p><p>Summing up, neutrophils are essential for the host innate immune response against <italic toggle="yes">S. aureus</italic> infection. Their recruitment is orchestrated by host inflammatory molecules as well as by bacterial virulence factors. Phagocytosis, degranulation, and NET formation are neutrophil mechanisms. The primary goal of neutrophils is to kill the causative bacteria, <italic toggle="yes">S. aureus</italic>, in this case; however, this cell type also causes tissue damage, thus the microbicidal mechanisms are two-way responses. Finding balance is essential to protect the host.</p></sec><sec id="sec3dot1dot4-pathogens-14-00185"><title>3.1.4. Mast Cells</title><p>Mast cells are granule-containing cells found in connective tissues and mucosa, deeply involved in allergic reactions by releasing the granules that contain proteases, cytokines, and proteoglycans, and act as antigen-presenting cells. Exacerbated or inappropriate mast cell activation is linked to several diseases, such as asthma, atopic dermatitis, and psoriasis [<xref rid="B268-pathogens-14-00185" ref-type="bibr">268</xref>].</p><p>Patients affected by atopic dermatitis and infected with <italic toggle="yes">S. aureus</italic> present a higher number of mast cells with a consequent Th1 response development and the upregulation of IFN-&#947; [<xref rid="B269-pathogens-14-00185" ref-type="bibr">269</xref>]. When mast cells sense intracellular <italic toggle="yes">S. aureus</italic>, the IFN-&#947;-mediated type 1 response promotes autocrine feedback, stimulating a cell-autonomous antimicrobial state of mast cells [<xref rid="B270-pathogens-14-00185" ref-type="bibr">270</xref>]. To control the exacerbated response, mast cells can activate Tregs via IL-2 production during chronic allergic dermatitis [<xref rid="B271-pathogens-14-00185" ref-type="bibr">271</xref>]. The staphylococcal enterotoxin B (SEB) activates TRPV1<sup>+</sup> sensory neurons, which produce substance P, that in turn stimulates mast cell degranulation in skin inflammation [<xref rid="B272-pathogens-14-00185" ref-type="bibr">272</xref>].</p><p><italic toggle="yes">S. aureus</italic> can induce mast cell activation directly. Nakamura et al. (2013) demonstrated that <italic toggle="yes">S. aureus</italic>-derived &#948;-toxin is a potent inducer of mast cell degranulation in allergic skin diseases [<xref rid="B51-pathogens-14-00185" ref-type="bibr">51</xref>]. The same toxin present on the skin increases epicutaneous sensitization to food allergens in mice [<xref rid="B273-pathogens-14-00185" ref-type="bibr">273</xref>]. In addition, LTA promotes skin mast cell proliferation and maturation via stem cell factor production from keratinocytes [<xref rid="B274-pathogens-14-00185" ref-type="bibr">274</xref>]. Moreover, PGN-stimulated mast cells (via TLR2) produce IL-6, IL-5, TNF-&#945;, IL-13, and IL-4 [<xref rid="B275-pathogens-14-00185" ref-type="bibr">275</xref>]. Biofilm-secreted factors also induce mast cell infiltration and mucosal damage in chronic rhinosinusitis [<xref rid="B276-pathogens-14-00185" ref-type="bibr">276</xref>].</p><p>In summary, mast cells and their granules are present during Th1 responses, and IFN-&#947; produced by those cells helps mount an efficient antimicrobial response against <italic toggle="yes">S. aureus</italic>. Bacterial components, such as &#948;-toxin, LTA, and peptidoglycans, stimulate mast cell activation.</p></sec><sec id="sec3dot1dot5-pathogens-14-00185"><title>3.1.5. Eosinophils</title><p>Eosinophils are classically known as effector cells primarily involved in parasite infections and hypersensitivity diseases, releasing inflammatory mediators, granule proteins, and lipids. Interestingly, studies have pointed out the physiologic role of eosinophils as well, serving as multifunctional leukocytes with immunoregulatory functions [<xref rid="B277-pathogens-14-00185" ref-type="bibr">277</xref>,<xref rid="B278-pathogens-14-00185" ref-type="bibr">278</xref>].</p><p>Patients with airway inflammation and infected with <italic toggle="yes">S. aureus</italic> recruit eosinophils to form extracellular eosinophilic traps (EETs) as part of the host immune defense [<xref rid="B279-pathogens-14-00185" ref-type="bibr">279</xref>]. Furthermore, serum IgE levels specific to SEB could contribute to eosinophil activation and IgE production in adult asthmatics [<xref rid="B280-pathogens-14-00185" ref-type="bibr">280</xref>]. Detection of SEB was confirmed in patients with different subtypes of chronic rhinosinusitis, acting as superantigens in the sinonasal mucosa [<xref rid="B281-pathogens-14-00185" ref-type="bibr">281</xref>]. The levels of enterotoxins-IgE were associated with disease severity, eosinophilic inflammation, and increased incidence of asthma comorbidity in <italic toggle="yes">S. aureus</italic>-associated chronic rhinosinusitis individuals [<xref rid="B282-pathogens-14-00185" ref-type="bibr">282</xref>]. Indeed, mice exposed to intranasal administration of SEB showed worse airway inflammation by increased eosinophil infiltration and production of chemokines and adhesion molecules that facilitate eosinophilic migration to the lungs [<xref rid="B283-pathogens-14-00185" ref-type="bibr">283</xref>]. During skin inflammation, <italic toggle="yes">S. aureus</italic> epicutaneous exposure resulted in eosinophil infiltration where these cells had a comparable contribution to the skin inflammation as T cells, in an eosinophil-derived IL-17A and IL-17F dependent manner [<xref rid="B284-pathogens-14-00185" ref-type="bibr">284</xref>]. Therefore, those studies point out eosinophils&#8217; presence as aggravating factors during some <italic toggle="yes">S. aureus</italic> infections, but their role in other disease-specific conditions remains unclear.</p></sec></sec><sec id="sec3dot2-pathogens-14-00185"><title>3.2. Adaptive Immune Response</title><sec id="sec3dot2dot1-pathogens-14-00185"><title>3.2.1. T Cells</title><p>T cells, also called T lymphocytes, express a unique receptor, T cell receptor or TCR, that detects and responds to infected cells and are divided into &#945;&#946; or &#947;&#948; TCRs [<xref rid="B285-pathogens-14-00185" ref-type="bibr">285</xref>]. T helper (Th) cells, or CD4<sup>+</sup> T cells, express membrane CD4 and recognize antigens presented by MHC class II, while cytotoxic T cells, or CD8<sup>+</sup> T cells, express CD8 and recognize antigens presented by MHC class I [<xref rid="B285-pathogens-14-00185" ref-type="bibr">285</xref>]. Na&#239;ve CD4<sup>+</sup> T cells can differentiate into subsets: Th1, Th2, Th9, Th17, Treg, and Tfh, based on the expression of signature cytokines and displaying different functions [<xref rid="B286-pathogens-14-00185" ref-type="bibr">286</xref>]. The Th1 subset induces type 1 responses to combat intracellular pathogens (e.g., bacteria, viruses, protozoa) by inducing macrophage polarization towards the M1 phenotype. Type 2 responses, marked by recruitment of eosinophils, basophils, mast cells, and macrophage polarization towards an anti-inflammatory profile, are elicited by Th2. Th9 cells, which differentiate in the presence of IL-4 and TGF-&#946;, secrete IL-9 and are involved in allergic diseases [<xref rid="B287-pathogens-14-00185" ref-type="bibr">287</xref>,<xref rid="B288-pathogens-14-00185" ref-type="bibr">288</xref>,<xref rid="B289-pathogens-14-00185" ref-type="bibr">289</xref>]. Th17 mediates type 3 response to offer protection against fungi and extracellular bacteria, recruiting neutrophils to the infection site and stimulating secretion of anti-bacterial molecules by barrier tissues [<xref rid="B290-pathogens-14-00185" ref-type="bibr">290</xref>,<xref rid="B291-pathogens-14-00185" ref-type="bibr">291</xref>]. Follicular T helper cells, Tfh, help B cells produce antibodies [<xref rid="B292-pathogens-14-00185" ref-type="bibr">292</xref>], and Tregs are regulatory T cells that have the essential role of suppressing excessive immune responses and avoiding reactions to self-antigens [<xref rid="B293-pathogens-14-00185" ref-type="bibr">293</xref>].</p><p>The role of T cells during <italic toggle="yes">S. aureus</italic> infections was investigated by several studies. Lin and colleagues report that Th1 and Th17 responses have a protective role by favoring microbial killing through IFN-&#947;, IL-17, and neutrophil chemotaxis against <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Candida albicans</italic> [<xref rid="B294-pathogens-14-00185" ref-type="bibr">294</xref>]. Furthermore, vaccinated mice that developed moderate Th1 immunity showed better survival rates [<xref rid="B295-pathogens-14-00185" ref-type="bibr">295</xref>], and Th1-inducing vaccines reduced <italic toggle="yes">S. aureus</italic> burden significantly [<xref rid="B296-pathogens-14-00185" ref-type="bibr">296</xref>]. Blocking <italic toggle="yes">S. aureus</italic>-induced IL-10 production (which impairs T cell responses) improved bacterial clearance during subsequent systemic and subcutaneous infection [<xref rid="B297-pathogens-14-00185" ref-type="bibr">297</xref>]. Production of IL-17 is also carried out by &#947;&#948; T cells, and this cell population is linked to several beneficial roles in different contexts&#8212;deficiency of &#947;&#948; T cells results in impaired neutrophil recruitment and bacterial clearance in <italic toggle="yes">S. aureus</italic>-induced pneumonia [<xref rid="B298-pathogens-14-00185" ref-type="bibr">298</xref>]; similar results were observed during skin infections [<xref rid="B299-pathogens-14-00185" ref-type="bibr">299</xref>,<xref rid="B300-pathogens-14-00185" ref-type="bibr">300</xref>,<xref rid="B301-pathogens-14-00185" ref-type="bibr">301</xref>] and peritonitis [<xref rid="B302-pathogens-14-00185" ref-type="bibr">302</xref>]. A population of IL-17-producing memory &#947;&#948; T cells expands upon the first <italic toggle="yes">S. aureus</italic> infection, which makes IL-1 signaling dispensable upon a second challenge [<xref rid="B302-pathogens-14-00185" ref-type="bibr">302</xref>]. Furthermore, during implant-associated infections, the chemokine receptor CCR2 induces &#947;&#948; T cells in draining lymph nodes, preventing <italic toggle="yes">S. aureus</italic> spread [<xref rid="B303-pathogens-14-00185" ref-type="bibr">303</xref>].</p><p>In some contexts of <italic toggle="yes">S. aureus</italic> infection, however, T cells show a detrimental role. Depletion of CD4+ cells resulted in less tissue damage in staphylococcal arthritis [<xref rid="B304-pathogens-14-00185" ref-type="bibr">304</xref>] and early MRSA pulmonary infection [<xref rid="B305-pathogens-14-00185" ref-type="bibr">305</xref>]. In a mouse model of septic arthritis, NF-&#954;B activation as a consequence of the Th17 response was correlated with augmented RANKL expression and bone resorption [<xref rid="B306-pathogens-14-00185" ref-type="bibr">306</xref>]. &#945;&#946; T cells-deficient mice exhibit fewer bacteria recovered and less inflammation in wound tissues, which appears to be explained by modulation of CXCR2 expression and subsequent neutrophil migration to the wound tissue [<xref rid="B307-pathogens-14-00185" ref-type="bibr">307</xref>].</p><p>In conclusion, each T cell subtype can show different roles in different diseases or contexts, as they influence many other cell types, inflammatory mediators, and receptor expression depending on the circumstances.</p></sec><sec id="sec3dot2dot2-pathogens-14-00185"><title>3.2.2. B Cells</title><p>The B cell-mediated immune response against <italic toggle="yes">S. aureus</italic> involves producing antibodies targeting specific antigens of the bacteria. These antibodies are crucial for opsonizing <italic toggle="yes">S. aureus</italic> and promoting its ingestion by phagocytes, such as neutrophils and macrophages, through antibody-mediated and complement-mediated mechanisms. In addition, antibodies can target virulence factors (e.g., SpA, superantigens [SAgs]), toxins (e.g., &#945;-toxin), cell wall components (e.g., wall teichoic acids [WTA]), and non-protein antigens (e.g., lipoteichoic acid, peptidoglycans) [<xref rid="B308-pathogens-14-00185" ref-type="bibr">308</xref>] and interfere with their detrimental effects.</p><p>Na&#239;ve B cells differentiate into IgM-producing plasma cells. To produce high-affinity antibodies of other classes, most B cells need assistance from T cells recognizing the same antigen. The type of memory helper T cells involved directs the immunoglobulin class switch: Th1 responses induce IgG subclasses that can bind to Fc receptors and activate complement, Tregs promote a class switch to IgA, and Th2 cells drive IgE responses (characteristic of allergic reactions) [<xref rid="B309-pathogens-14-00185" ref-type="bibr">309</xref>]. Marginal zone (MZ) B cells, which rapidly respond to bacterial invasion by producing antibodies, regulate the splenic neutrophil accumulation during the early phase of systemic <italic toggle="yes">S. aureus</italic> infection, and interaction with neutrophils aids MZ B cells in differentiating into IgM-secreting cells and helps clear systemic bacterial infections [<xref rid="B310-pathogens-14-00185" ref-type="bibr">310</xref>]. Also, evidence shows that immune memory against <italic toggle="yes">S. aureus</italic>, indicated by high titers of class-switched antibodies, protects against severe disease. Children with low serum levels of antibodies targeting &#945;-toxin are more susceptible to skin infections caused by MRSA [<xref rid="B311-pathogens-14-00185" ref-type="bibr">311</xref>] and tracking the fate of patients with <italic toggle="yes">S. aureus</italic> bacteremia, authors found that those who progressed to sepsis had lower anti-toxin antibody titers at diagnosis compared to those who recovered without complications [<xref rid="B312-pathogens-14-00185" ref-type="bibr">312</xref>]. Previous studies demonstrate that passive transfer of antibodies targeting various staphylococcal antigens (e.g., ClfA, Hla, IsdA, IsdB, FhuD2) provided protection against <italic toggle="yes">S. aureus</italic> in animal models [<xref rid="B313-pathogens-14-00185" ref-type="bibr">313</xref>,<xref rid="B314-pathogens-14-00185" ref-type="bibr">314</xref>,<xref rid="B315-pathogens-14-00185" ref-type="bibr">315</xref>]. Additionally, immunization with a peptide that mimics lipoteichoic acid induces memory B cells in BALB/c mice, increasing the percentage of plasma cells and memory B cells in the spleen and bone marrow. It also raises the levels of IL-6 and IL-21, two essential cytokines for memory B cell development [<xref rid="B316-pathogens-14-00185" ref-type="bibr">316</xref>].</p><p>The efficacy of antibody-mediated protection against <italic toggle="yes">S. aureus</italic> is, however, controversial. Vaccines that showed promising results in pre-clinical or even phase I, II, and III clinical trials have failed to promote satisfactory immunity in humans (summarized in [<xref rid="B317-pathogens-14-00185" ref-type="bibr">317</xref>]). In addition, the pathogen&#8217;s numerous immune evasion mechanisms challenge the efficacy of antibody-mediated defenses [<xref rid="B318-pathogens-14-00185" ref-type="bibr">318</xref>,<xref rid="B319-pathogens-14-00185" ref-type="bibr">319</xref>]. For example, factors like SpA and Sbi can block circulating antibodies, SpA induce B-cell depletion, or undermine downstream processes mediated by antibody binding to complement components [<xref rid="B320-pathogens-14-00185" ref-type="bibr">320</xref>]. This anti-humoral arsenal explains, in part, why natural exposure to <italic toggle="yes">S. aureus</italic> does not protect the host from infection. Therefore, the failure of some <italic toggle="yes">S. aureus</italic> vaccines may be attributed to the bacterium&#8217;s phenotypic variability, allowing it to switch off toxins, capsules, and adhesins during different growth phases, local environments, and in response to host defenses [<xref rid="B317-pathogens-14-00185" ref-type="bibr">317</xref>]. Adding suitable adjuvants to these identified epitopes can be crucial in designing an effective vaccine against <italic toggle="yes">S. aureus</italic> infection. Recently, bioinformatics tools have been used extensively to identify appropriate epitopes for vaccine formulation [<xref rid="B317-pathogens-14-00185" ref-type="bibr">317</xref>].</p></sec></sec><sec id="sec3dot3-pathogens-14-00185"><title>3.3. Other Cell Types</title><p>Besides immune cells, other cell types respond to <italic toggle="yes">S. aureus</italic>, modulating immune response and sometimes resulting in neuronal activation, pruritus, and/or pain, characteristic of some infections.</p><sec id="sec3dot3dot1-pathogens-14-00185"><title>3.3.1. Tissue Barrier Cells</title><p>Keratinocytes, the main cell type in the epidermis, accumulate <italic toggle="yes">S. aureus</italic> inside their lysosomes and produce IL-1&#945; via TLR9 during AD [<xref rid="B321-pathogens-14-00185" ref-type="bibr">321</xref>]. Furthermore, there is an increase in IL-36&#945; levels along with IL-4, which triggers B cell IgE class-switching and plasma cell differentiation [<xref rid="B322-pathogens-14-00185" ref-type="bibr">322</xref>]. Both L-1&#945; and IL-36&#945;, as well as IL-17 production by &#947;&#948; T cells and neutrophil infiltration, are elicited by the phenol-soluble modulin (PSM)&#945; virulence factor [<xref rid="B323-pathogens-14-00185" ref-type="bibr">323</xref>]. In fact, by co-culturing keratinocytes and neutrophils, Focken and Schittek (2024) [<xref rid="B324-pathogens-14-00185" ref-type="bibr">324</xref>] showed that neutrophil survival was enhanced by IL-8 signaling, as well as their priming to further antimicrobial activity against <italic toggle="yes">S. aureus</italic> [<xref rid="B324-pathogens-14-00185" ref-type="bibr">324</xref>]. Other inflammatory cytokines released by keratinocytes responding to <italic toggle="yes">S. aureus</italic> include IL-1&#946; and IL-33 [<xref rid="B325-pathogens-14-00185" ref-type="bibr">325</xref>,<xref rid="B326-pathogens-14-00185" ref-type="bibr">326</xref>], the latter being a mediator of itch [<xref rid="B327-pathogens-14-00185" ref-type="bibr">327</xref>]. Interestingly, tissue-resident Langerhans cells produce IL-1&#946; in response to <italic toggle="yes">S. aureus</italic> but not <italic toggle="yes">S</italic>. <italic toggle="yes">epidermidis,</italic> differentiating commensal from pathogenic bacteria via this specific cytokine [<xref rid="B328-pathogens-14-00185" ref-type="bibr">328</xref>]. Evidence shows that <italic toggle="yes">S. aureus</italic>-derived LTA induces damage to the skin barrier by enhancing neutrophil infiltration and IL-1 family levels and decreasing filaggrin and loricrin expression, barrier proteins required for healthy epidermis [<xref rid="B329-pathogens-14-00185" ref-type="bibr">329</xref>].</p><p>Using epithelial cells from human nasal tissue explants, authors demonstrated that IL-33 and thymic stromal lymphopoietin (TSLP) is produced during chronic rhinosinusitis with nasal polyps, perpetuating airway Th2 inflammation response [<xref rid="B330-pathogens-14-00185" ref-type="bibr">330</xref>]. Release of TSLP is induced, at least in part, by <italic toggle="yes">S. aureus</italic>-derived diacylated lipopeptide signaling through TLR2/TLR6 in keratinocytes [<xref rid="B331-pathogens-14-00185" ref-type="bibr">331</xref>]. Activation of TLR2 by peptidoglycan from <italic toggle="yes">S. aureus</italic> elicits upregulation of IL-6, TNF-&#945;, IL-31, IL-33, ST2, and CXCL1/2 in dry skin and psoriasis models in mice [<xref rid="B332-pathogens-14-00185" ref-type="bibr">332</xref>].</p><p>During <italic toggle="yes">S. aureus</italic> skin and soft tissue infection (SSTI), Hla is secreted to disrupt epithelial barriers [<xref rid="B333-pathogens-14-00185" ref-type="bibr">333</xref>]. Interestingly, there is an estrogen-specific response to Hla [<xref rid="B334-pathogens-14-00185" ref-type="bibr">334</xref>], and G protein-coupled estrogen receptor activation limits <italic toggle="yes">S. aureus</italic> pathogenesis by reducing expression of the Hla receptor, ADAM10, on keratinocytes, as well as protecting the permeability barrier by enhancing intercellular junction integrity [<xref rid="B335-pathogens-14-00185" ref-type="bibr">335</xref>].</p><p>Altogether, this body of evidence shows how epithelial cells developed different mechanisms to limit pathogen invasion and proliferation, and communication between epithelial cells and leukocytes is essential for a proper immune response.</p></sec><sec id="sec3dot3dot2-pathogens-14-00185"><title>3.3.2. Neurons and Glial Cells</title><p>As neurotransmitters and neuropeptides affect immune cells [<xref rid="B336-pathogens-14-00185" ref-type="bibr">336</xref>,<xref rid="B337-pathogens-14-00185" ref-type="bibr">337</xref>], growing evidence points out the significant role of neuroimmune communication, underlying the complex interactions in many tissues and contexts [<xref rid="B338-pathogens-14-00185" ref-type="bibr">338</xref>,<xref rid="B339-pathogens-14-00185" ref-type="bibr">339</xref>]. In response to infections, neurons produce trophic factors that recruit microglia and astrocytes which can amplify immune responses. If the inflammatory process is prolonged, persistent recruitment of effector cells builds a feedback loop that supports inflammation and may result in neuronal injury [<xref rid="B340-pathogens-14-00185" ref-type="bibr">340</xref>]. Additionally, bacteria-derived toxins can interact with the nervous system directly [<xref rid="B341-pathogens-14-00185" ref-type="bibr">341</xref>,<xref rid="B342-pathogens-14-00185" ref-type="bibr">342</xref>], and interestingly, peripheral nerve damage makes individuals more susceptible to <italic toggle="yes">S. aureus</italic> infections [<xref rid="B343-pathogens-14-00185" ref-type="bibr">343</xref>,<xref rid="B344-pathogens-14-00185" ref-type="bibr">344</xref>].</p><p>The spleen and lymph nodes are innervated by sympathetic nerve fibers [<xref rid="B345-pathogens-14-00185" ref-type="bibr">345</xref>], which control the production of proinflammatory mediators associated with type 1 responses [<xref rid="B346-pathogens-14-00185" ref-type="bibr">346</xref>,<xref rid="B347-pathogens-14-00185" ref-type="bibr">347</xref>,<xref rid="B348-pathogens-14-00185" ref-type="bibr">348</xref>]. Recently, it was demonstrated that ablation of sympathetic nerve fibers impairs the development of protective immune memory to <italic toggle="yes">S. aureus</italic> infection in mice [<xref rid="B349-pathogens-14-00185" ref-type="bibr">349</xref>], highlighting the importance of functional neural circuits for the host&#8217;s defense.</p><p>Cutaneous TRPV1<sup>+</sup> expressing neurons directly sense noxious stimuli [<xref rid="B350-pathogens-14-00185" ref-type="bibr">350</xref>] and stimulate IL-23/IL-17 production, driving Th17 response during psoriasis-like inflammation [<xref rid="B351-pathogens-14-00185" ref-type="bibr">351</xref>]. Optogenetic stimulation of TRPV1<sup>+</sup> sensory neurons can trigger an inflammatory reflex arc that augments host defense to <italic toggle="yes">S. aureus</italic> by providing Th17 immunity [<xref rid="B352-pathogens-14-00185" ref-type="bibr">352</xref>]. In the skin, <italic toggle="yes">S. aureus</italic> triggers CGRP release by TRPV1<sup>+</sup> neurons, which in turn abrogates neutrophil influx and inflammatory macrophage phenotype, favoring anti-inflammatory macrophages instead [<xref rid="B156-pathogens-14-00185" ref-type="bibr">156</xref>]. TRPV1<sup>+</sup> dorsal root ganglia (DRG) neurons respond to formyl peptides present in <italic toggle="yes">S. aureus</italic>, suggesting the direct signaling between bacteria and neurons inducing pain independently of immune cells [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>]. In addition, depletion of Nav1.8-lineage neurons abolished mechanical and thermal hyperalgesia in <italic toggle="yes">S. aureus</italic> infection, indicating that this neuronal population is essential for pain behavior induced by this microorganism in mice [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>]. Those animals also showed an increased local influx of neutrophils and monocytes as well as lymphadenopathy [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>], and signs of augmented inflammation upon Nav1.8<sup>+</sup> neuron deletion. Similarly, on a murine model of lethal <italic toggle="yes">S. aureus</italic> pneumonia, TRPV1 sensory neurons suppress neutrophil recruitment and pulmonary &#947;&#948; T cell-mediated defenses, worsening the condition. Neuron ablation increased survival rates, cytokine levels, and lung bacterial clearance [<xref rid="B353-pathogens-14-00185" ref-type="bibr">353</xref>].</p><p>The skin is also innervated by other neuronal subsets, including nonpeptidergic MrgprD-expressing sensory neurons, involved in itch sensation, inflammatory pain, and mechanical stimuli [<xref rid="B354-pathogens-14-00185" ref-type="bibr">354</xref>,<xref rid="B355-pathogens-14-00185" ref-type="bibr">355</xref>,<xref rid="B356-pathogens-14-00185" ref-type="bibr">356</xref>]. In various cutaneous inflammation models, ablation of MrgprD-expressing neurons led to mast cell degranulation and glutamate release, emphasizing the suppressive function of those neurons controlling exacerbated inflammation [<xref rid="B357-pathogens-14-00185" ref-type="bibr">357</xref>]. On the other hand, this ablation also augmented the immune defenses against <italic toggle="yes">S. aureus</italic>, underlining the double-edged sword of inflammatory milieu.</p><p><italic toggle="yes">S. aureus</italic>-associated brain abscesses develop after local infections, such as in paranasal sinuses, spread via blood circulation, or direct invasion in cases of head trauma [<xref rid="B358-pathogens-14-00185" ref-type="bibr">358</xref>,<xref rid="B359-pathogens-14-00185" ref-type="bibr">359</xref>]. In addition to leukocyte recruitment, microglia induce upregulated expression of TNF-&#945;, IL-1&#946;, IL-12, MCP-1, and macrophage inflammatory protein-2 (MIP-2) [<xref rid="B360-pathogens-14-00185" ref-type="bibr">360</xref>,<xref rid="B361-pathogens-14-00185" ref-type="bibr">361</xref>]. Again, at the same time those mediators helped control infection, surrounding tissue damage was observed [<xref rid="B362-pathogens-14-00185" ref-type="bibr">362</xref>]. In this sense, minocycline was found to reduce bacterial burden while suppressing microglial/astrocyte activation and IL-1&#946; and CCL2 levels, being an interesting therapeutic approach to treat brain abscesses [<xref rid="B363-pathogens-14-00185" ref-type="bibr">363</xref>].</p><p>Despite all those types of cells involved during <italic toggle="yes">S. aureus</italic> infection (summarized in <xref rid="pathogens-14-00185-f003" ref-type="fig">Figure 3</xref>), in chronic or severe cases bacteria persist, and this is due to virulence strategies acquired along the way&#8213;that continue to evolve. In the next Sections, we detail the main <italic toggle="yes">S. aureus</italic> virulence factors identified so far and how they manage to evade immune response.</p></sec></sec></sec><sec id="sec4-pathogens-14-00185"><title>4. Virulence Factors: General Virulence Strategies</title><p>Despite being frequently associated with human diseases, <italic toggle="yes">S. aureus</italic> colonizes humans persistently in a variety of sites such as the nose, skin, throat, axillae, groin, and intestine, establishing an intricate interplay with the human body and other commensal microorganisms [<xref rid="B364-pathogens-14-00185" ref-type="bibr">364</xref>,<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. Colonization is usually harmless, although it is a risk factor for the development of opportunistic infections that can vary from mild skin and soft tissue infections to severe invasive infections, such as osteomyelitis, septic arthritis, bacteremia, pneumonia, and endocarditis (see <xref rid="sec2-pathogens-14-00185" ref-type="sec">Section 2</xref>) [<xref rid="B13-pathogens-14-00185" ref-type="bibr">13</xref>,<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. The modulation of persistence as part of the host microbiota and the potential pathogenicity requires several mechanisms of host immune evasion and virulence strategies [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. These strategies target both innate and adaptive immune responses.</p><p>As mentioned previously, neutrophils are critical in controlling <italic toggle="yes">S. aureus</italic> infections [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. However, <italic toggle="yes">S. aureus</italic> produces factors that inhibit neutrophil chemotaxis and killing activity [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. For example, <italic toggle="yes">S. aureus</italic> can block neutrophil receptors and impair the host&#8217;s complement system [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B366-pathogens-14-00185" ref-type="bibr">366</xref>]. <italic toggle="yes">S. aureus</italic> can produce proteins that prevent opsonization and phagocytosis [<xref rid="B367-pathogens-14-00185" ref-type="bibr">367</xref>] and modify cell surface charges to repel antimicrobial peptides [<xref rid="B368-pathogens-14-00185" ref-type="bibr">368</xref>,<xref rid="B369-pathogens-14-00185" ref-type="bibr">369</xref>]. Furthermore, <italic toggle="yes">S. aureus</italic> can produce leukocidins that form pores in neutrophil membranes, leading to cell lysis [<xref rid="B370-pathogens-14-00185" ref-type="bibr">370</xref>].</p><p>Biofilm formation is another strategy that represents a challenge in managing <italic toggle="yes">S. aureus</italic> infections since it enhances antibiotic resistance and immune clearance. Within biofilms, <italic toggle="yes">S. aureus</italic> evades immune detection by masking its PAMPs [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. The biofilm matrix can also be a barrier to antibiotic penetration, contributing to chronic and recurrent infections [<xref rid="B371-pathogens-14-00185" ref-type="bibr">371</xref>].</p><p><italic toggle="yes">S. aureus</italic> is known for its diverse array of factors and mechanisms that facilitate persistence in the host. In the following section, the most important virulence factors of <italic toggle="yes">S. aureus</italic> known to date will be discussed in detail.</p><sec><title>Mechanisms of Immune Evasion</title><p><italic toggle="yes">S. aureus</italic> employs a range of tactics to evade neutrophil destruction. It prevents neutrophils from migrating from the blood to tissues, impeding their activation and movement toward infection sites [<xref rid="B372-pathogens-14-00185" ref-type="bibr">372</xref>]. Additionally, <italic toggle="yes">S. aureus</italic> obstructs phagocytosis by forming aggregates, developing protective surface structures, and creating biofilms [<xref rid="B372-pathogens-14-00185" ref-type="bibr">372</xref>]. It also blocks opsonization to avoid immune recognition and neutralizes the killing mechanisms of neutrophils [<xref rid="B372-pathogens-14-00185" ref-type="bibr">372</xref>,<xref rid="B373-pathogens-14-00185" ref-type="bibr">373</xref>]. Furthermore, <italic toggle="yes">S. aureus</italic> can directly kill neutrophils by releasing toxins or inducing apoptosis [<xref rid="B372-pathogens-14-00185" ref-type="bibr">372</xref>,<xref rid="B373-pathogens-14-00185" ref-type="bibr">373</xref>].</p><p>Neutrophils must transmigrate through a multistep cascade to finally reach the site of infection outside the circulation. These steps comprise rolling and adhesion to the endothelium, followed by diapedesis and orientation along the chemoattractant gradient [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B374-pathogens-14-00185" ref-type="bibr">374</xref>]. Neutrophils are activated by cytokines and factors of the complement system and attracted by host-derived substances such as leukotriene B4 or IL-8 and bacterial components [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>]. Gram-positive bacteria, like <italic toggle="yes">S. aureus</italic>, release activators and chemoattractants such as N-terminal lipoylated structures of lipoproteins [<xref rid="B375-pathogens-14-00185" ref-type="bibr">375</xref>], peptidoglycan [<xref rid="B376-pathogens-14-00185" ref-type="bibr">376</xref>], unmethylated CpG DNA sequences [<xref rid="B377-pathogens-14-00185" ref-type="bibr">377</xref>], and formylated peptides [<xref rid="B378-pathogens-14-00185" ref-type="bibr">378</xref>]. The former group is collectively identified as PAMPs, and they are responsible for the activation of TLRs [<xref rid="B379-pathogens-14-00185" ref-type="bibr">379</xref>].</p><p><italic toggle="yes">S. aureus</italic> blocks neutrophil extravasation, activation, and chemotaxis by numerous factors and mechanisms. <italic toggle="yes">S. aureus</italic> produces staphylococcal superantigen-like (SSL) proteins with various immunomodulatory functions, including inhibition of chemotaxis and phagocytosis (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). However, their full range of activities is unknown [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>]. SSL consists of fourteen exoproteins; eleven of these are encoded on the staphylococcal pathogenicity island 2 (SaPI 2), present in all strains of <italic toggle="yes">S. aureus</italic>, while the other three are in the immune evasion cluster [<xref rid="B380-pathogens-14-00185" ref-type="bibr">380</xref>,<xref rid="B381-pathogens-14-00185" ref-type="bibr">381</xref>]. These molecules were identified based on sequence and structural similarities to superantigens, though they lack superantigenic activity [<xref rid="B382-pathogens-14-00185" ref-type="bibr">382</xref>]. SSL family members inhibit activation and chemotaxis through diverse mechanisms. For example, staphylococcal superantigen-like 5 (SSL5) binds to P-selectin glycoprotein ligand-1 (PSGL-1), inhibiting neutrophil adhesion and extravasation [<xref rid="B383-pathogens-14-00185" ref-type="bibr">383</xref>]. SSL5 and SSL1 also inhibit matrix metalloproteinases, reducing neutrophil motility and chemotaxis [<xref rid="B384-pathogens-14-00185" ref-type="bibr">384</xref>]. More recently, it was discovered that SSL1 exhibited in vitro protease activity. Also, protease activity was observed in a rabbit ocular infection model since SSLs are not expressed in mouse infection models [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B385-pathogens-14-00185" ref-type="bibr">385</xref>]. SSL7 has been found to bind C5 and immunoglobulin A (IgA), thereby inhibiting the complement system and blocking Fc&#945;RI binding [<xref rid="B386-pathogens-14-00185" ref-type="bibr">386</xref>]. SSLs are challenging to study because they are not expressed in mouse infection models, but overexpression vectors have shown that SSL3 contributes to staphylococcal pathogenesis by inhibiting toll-like receptor 2 [<xref rid="B387-pathogens-14-00185" ref-type="bibr">387</xref>]. SSL13, however, seems to induce neutrophil responses, highlighting the complex interactions of immune-modulating molecules during <italic toggle="yes">S. aureus</italic> infection [<xref rid="B388-pathogens-14-00185" ref-type="bibr">388</xref>].</p><p>Chemotaxis inhibitory protein of <italic toggle="yes">S. aureus</italic> (CHIPS), FLIPr, FLIPr-like, and staphopain protease also inhibit chemotaxis (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). CHIPS acts as a potent and specific inhibitor of neutrophil and monocyte chemotaxis toward C5aR and formyl peptide receptor 1 (FPR1) [<xref rid="B138-pathogens-14-00185" ref-type="bibr">138</xref>,<xref rid="B389-pathogens-14-00185" ref-type="bibr">389</xref>], while FLIPr and FLIPr-like inhibit FPR1 and FPR2 [<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>,<xref rid="B391-pathogens-14-00185" ref-type="bibr">391</xref>]. This inhibition prevents neutrophil migration toward the infection site by obstructing the chemotactic signals necessary for recruitment [<xref rid="B138-pathogens-14-00185" ref-type="bibr">138</xref>,<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>]. For example, FLIPr impairs neutrophil responses to FPR1 agonists and exerts anti-inflammatory activity by inhibiting calcium mobilization and cell migration toward chemoattractants [<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>]. Specifically, it inhibits calcium mobilization in neutrophils stimulated with various molecules, including MMK-1, WKYMVM, prion-protein fragment PrP 106&#8211;126, and amyloid &#946; 1&#8211;42 [<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>]. FLIPr also prevents neutrophil-directed migration toward MMK-1 and partially toward fMLP. It binds to FPRL1 and, at higher concentrations, to FPR [<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>].</p><p>In addition to chemotaxis inhibition, <italic toggle="yes">S. aureus</italic> employs other strategies to evade the immune system, notably by interfering with phagocytosis. Effective phagocytosis requires the bacterial targets to be opsonized with antibodies or complement. <italic toggle="yes">S. aureus</italic> interferes with opsonization using proteins such as surface protein A (SpA), which binds nonspecifically to immunoglobulins (Igs) [<xref rid="B392-pathogens-14-00185" ref-type="bibr">392</xref>], creating a &#8220;camouflage&#8221; effect, or the <italic toggle="yes">S. aureus</italic> binder of IgG (Sbi), and SSL10, which prevents receptor-mediated phagocytosis [<xref rid="B320-pathogens-14-00185" ref-type="bibr">320</xref>,<xref rid="B393-pathogens-14-00185" ref-type="bibr">393</xref>,<xref rid="B394-pathogens-14-00185" ref-type="bibr">394</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). <italic toggle="yes">S. aureus</italic> also produces proteins that inhibit the complement system, such as staphylococcal complement inhibitor (SCIN), which disrupts complement pathways inhibiting C3 convertases [<xref rid="B395-pathogens-14-00185" ref-type="bibr">395</xref>], and others like extracellular fibrinogen-binding protein Efb, extracellular complement-binding protein Ecb, and SSL7, which inhibit specific complement pathways or components [<xref rid="B386-pathogens-14-00185" ref-type="bibr">386</xref>,<xref rid="B396-pathogens-14-00185" ref-type="bibr">396</xref>,<xref rid="B397-pathogens-14-00185" ref-type="bibr">397</xref>].</p><p>Another virulence factor includes superantigens (sAgs), bacterial toxins that stimulate T cell proliferation and disrupt immune regulation, thereby enhancing invasive <italic toggle="yes">S. aureus</italic> infections and colonization [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). They bind to various variable-&#946; chains in the T cell receptor. Well-known examples include toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxins B and C, but over 26 sAgs facilitate binding to many variable-&#946; chains in the T-cell receptor [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B369-pathogens-14-00185" ref-type="bibr">369</xref>,<xref rid="B398-pathogens-14-00185" ref-type="bibr">398</xref>].</p><p>Recently, staphylococcal enterotoxin-like toxin X (SElX) was found in 95% of <italic toggle="yes">S. aureus</italic> isolates examined [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. SElX stimulates T cell activation, promoting necrotizing pneumonia in a rabbit model, and hinders phagocytosis by binding to neutrophils through surface receptors [<xref rid="B399-pathogens-14-00185" ref-type="bibr">399</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). This dual role in disrupting innate and adaptive immune responses highlights its significance. Genomic studies have also identified staphylococcal sAgs SElW in 97% of the isolates [<xref rid="B398-pathogens-14-00185" ref-type="bibr">398</xref>], with the gene-encoding SElW being truncated in some staphylococcal clones but full length in others. SElW exhibits strong T cell activation in a bacteremia model, specifically driving T cell mitogenic activity in the human and livestock-adapted CC398 clone [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B398-pathogens-14-00185" ref-type="bibr">398</xref>].</p><p>A broad array of molecules helps <italic toggle="yes">S. aureus</italic> survive after being phagocytosed, where it encounters toxic products like reactive oxygen species, nitric oxide, antimicrobial peptides, and neutrophil serine proteases (NSPs) [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B400-pathogens-14-00185" ref-type="bibr">400</xref>,<xref rid="B401-pathogens-14-00185" ref-type="bibr">401</xref>]. The extracellular adherence protein (Eap) and its homologs (EapH1 and EapH2) can inhibit NSPs at low concentrations, preventing bacterial killing, regulation of neutrophil extracellular traps (NETs), and degradation of phenol-soluble modulins (PSMs) [<xref rid="B400-pathogens-14-00185" ref-type="bibr">400</xref>,<xref rid="B401-pathogens-14-00185" ref-type="bibr">401</xref>]. PSMs target the neutrophil formyl-receptor 2, causing degranulation and neutrophil lysis [<xref rid="B401-pathogens-14-00185" ref-type="bibr">401</xref>]. NSPs can degrade and inactivate various staphylococcal immune evasion factors, including CHIPS, though they act differently on homologous proteins, potentially explaining the redundancy of these factors [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B366-pathogens-14-00185" ref-type="bibr">366</xref>]. Eap proteins protect against NSP activity on staphylococcal immune evasion factors [<xref rid="B401-pathogens-14-00185" ref-type="bibr">401</xref>,<xref rid="B402-pathogens-14-00185" ref-type="bibr">402</xref>].</p><p>Inside the phagosome, myeloperoxidase (MPO) utilizes hydrogen peroxide to produce reactive oxygen species, collaborating with intracellular proteases to combat <italic toggle="yes">S. aureus</italic> [<xref rid="B403-pathogens-14-00185" ref-type="bibr">403</xref>,<xref rid="B404-pathogens-14-00185" ref-type="bibr">404</xref>]. High-throughput screening identified a factor that inhibits neutrophil killing by binding and inhibiting MPO, named staphylococcal peroxidase inhibitor [<xref rid="B405-pathogens-14-00185" ref-type="bibr">405</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). This molecule&#8217;s expression increases after phagocytosis, evading MPO-dependent killing [<xref rid="B405-pathogens-14-00185" ref-type="bibr">405</xref>]. Similar to other <italic toggle="yes">S. aureus</italic> immune evasion factors, the staphylococcal peroxidase inhibitor does not interact with or inhibit MPOs from other species [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. <italic toggle="yes">S. aureus</italic> neutralizes reactive oxygen species (ROS) using staphyloxanthin, superoxide dismutase, catalase, and alkyl hydroperoxide reductase [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B406-pathogens-14-00185" ref-type="bibr">406</xref>,<xref rid="B407-pathogens-14-00185" ref-type="bibr">407</xref>,<xref rid="B408-pathogens-14-00185" ref-type="bibr">408</xref>,<xref rid="B409-pathogens-14-00185" ref-type="bibr">409</xref>,<xref rid="B410-pathogens-14-00185" ref-type="bibr">410</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). It inhibits oxidative bursts by converting ADP and AMP to adenosine and resists copper-induced ROS production [<xref rid="B411-pathogens-14-00185" ref-type="bibr">411</xref>]. <italic toggle="yes">S. aureus</italic> also neutralizes antimicrobial peptides (AMPs) by altering the bacterial surface charge, degrading AMPs, and reducing recognition of AMPs [<xref rid="B412-pathogens-14-00185" ref-type="bibr">412</xref>].</p><p><italic toggle="yes">S. aureus</italic> expresses various cell-wall-anchored adhesins, including those in the MSCRAMM (microbial surface components recognizing adhesive matrix molecules) family [<xref rid="B413-pathogens-14-00185" ref-type="bibr">413</xref>]. The serine-aspartate repeat protein D (SdrD) is a significant MSCRAMM protein contributing to colonization, infection, and abscess formation [<xref rid="B414-pathogens-14-00185" ref-type="bibr">414</xref>,<xref rid="B415-pathogens-14-00185" ref-type="bibr">415</xref>]. It inhibits the innate immune killing of <italic toggle="yes">S. aureus</italic> and promotes bacterial survival in human blood. However, its mechanisms remain unclear [<xref rid="B416-pathogens-14-00185" ref-type="bibr">416</xref>]. Another serine&#8211;aspartate repeat protein, SdrE, binds complement factor H, aiding in complement evasion [<xref rid="B417-pathogens-14-00185" ref-type="bibr">417</xref>]. The fibronectin-binding protein FnbpB plays a critical role in binding to host ligands, activating platelets, and invading non-phagocytic cells [<xref rid="B418-pathogens-14-00185" ref-type="bibr">418</xref>]. It also binds plasminogen, which can be converted to plasmin by host activators or staphylokinase, and has a novel role in binding histones, leading to their degradation [<xref rid="B419-pathogens-14-00185" ref-type="bibr">419</xref>].</p><p>Host deployment of NETs is an effective defense against bacterial intrusions, leading to neutrophil death (NETosis) [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. <italic toggle="yes">S. aureus</italic> counters this by secreting staphylococcal nuclease (Nuc) to degrade the NETs DNA backbone and using adenosine synthase A (AdsA) to convert extracellular ATP and ADP into adenosine, an anti-inflammatory molecule [<xref rid="B420-pathogens-14-00185" ref-type="bibr">420</xref>,<xref rid="B421-pathogens-14-00185" ref-type="bibr">421</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). AdsA also converts dAMP into deoxyadenosine (dAdo), triggering apoptosis in macrophages and thereby reducing their activity at the infection site [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>).</p><p>Another crucial group of <italic toggle="yes">S. aureus</italic> immune evasion molecules is the bicomponent pore-forming toxins (leukocidins), which are primarily associated with neutrophilia but also target various immune cells [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B422-pathogens-14-00185" ref-type="bibr">422</xref>]. Leukocidins create octameric membrane-spanning pores, leading to cell lysis by binding to specific cell receptors [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. LukAB, a leukocidin, kills dendritic cells, preventing antigen presentation necessary for adaptive immunity [<xref rid="B423-pathogens-14-00185" ref-type="bibr">423</xref>]. Additionally, <italic toggle="yes">S. aureus</italic> produces toxins such as &#945;-toxin, which is significant for its cytolytic properties [<xref rid="B424-pathogens-14-00185" ref-type="bibr">424</xref>].</p><p>Biofilm formation is another factor in <italic toggle="yes">S. aureus</italic> pathogenesis, on top of the host-evasion factors previously discussed. These biofilms can form on non-living materials of indwelling medical devices and tissue surfaces, such as heart valves in endocarditis [<xref rid="B425-pathogens-14-00185" ref-type="bibr">425</xref>]. Infections linked to biofilm growth on biomedical devices like catheters and implants or host tissues such as wounds and heart valves prove challenging to treat [<xref rid="B425-pathogens-14-00185" ref-type="bibr">425</xref>]. Biofilm formation progresses through three main stages: adhesion, maturation/proliferation, and detachment [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>]. They protect the bacteria by embedding them in extracellular matrices of proteins, polysaccharides, and extracellular DNA [<xref rid="B425-pathogens-14-00185" ref-type="bibr">425</xref>]. Additionally, the secretion of factors like hemolysins, nucleases, and PSMs supports effective host evasion in the biofilm lifestyle, which might promote the shifting of the immune response toward an anti-inflammatory state [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B426-pathogens-14-00185" ref-type="bibr">426</xref>].</p><p>The primary role of biofilm formation during infection is to protect the bacteria from phagocyte attacks [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>,<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>] (<xref rid="pathogens-14-00185-f004" ref-type="fig">Figure 4</xref>). Some argue biofilm formation and abscesses share similar characteristics, but critical differences exist [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>]. For instance, biofilms are typically not surrounded by large layers of neutrophils as abscesses are, likely because <italic toggle="yes">S. aureus</italic> in biofilms exists in a less aggressive state and does not produce or shed a significant number of chemoattractant molecules through the biofilm matrix [<xref rid="B427-pathogens-14-00185" ref-type="bibr">427</xref>]. Furthermore, <italic toggle="yes">S. aureus</italic> biofilms have been demonstrated to alter the host immune response, promoting an anti-inflammatory state [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>,<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>,<xref rid="B427-pathogens-14-00185" ref-type="bibr">427</xref>].</p><p>Several mechanisms regarding the induction of an anti-inflammatory state in the human immune system by <italic toggle="yes">S. aureus</italic> biofilms can be highlighted. For example, leukocidins PVL and HlgAB help <italic toggle="yes">S. aureus</italic> survive in biofilms by triggering NET formation, which traps and kills planktonic bacteria [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B370-pathogens-14-00185" ref-type="bibr">370</xref>]. Bacterial DNase (Nuc) also digests NET DNA, aiding biofilm dispersal and increasing metastasis infection [<xref rid="B428-pathogens-14-00185" ref-type="bibr">428</xref>]. Moreover, LukAB assists in phagocyte escape within biofilms [<xref rid="B428-pathogens-14-00185" ref-type="bibr">428</xref>]. <italic toggle="yes">S. aureus</italic> biofilms modulate the host immune response to an anti-inflammatory state, recruiting myeloid-derived suppressor cells (MDSCs) and polarizing macrophages to M2-like anti-inflammatory states [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. MDSCs inhibit T-cell activation and promote bacterial persistence [<xref rid="B429-pathogens-14-00185" ref-type="bibr">429</xref>]. Activated macrophages typically promote inflammation through immunometabolism, with metabolites like succinate (pro-inflammatory) and itaconate (anti-inflammatory) [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>]. <italic toggle="yes">S. aureus</italic> biofilms, however, induce macrophages to an anti-inflammatory status, switching their metabolism to mitochondrial oxidative phosphorylation (OXPHOS) [<xref rid="B155-pathogens-14-00185" ref-type="bibr">155</xref>]. <italic toggle="yes">S. aureus</italic> biofilms produce IL-10 via staphylococcal lactate, reflecting the interaction of bacterial and host metabolism [<xref rid="B430-pathogens-14-00185" ref-type="bibr">430</xref>]. Furthermore, host itaconate inhibits bacterial glycolysis, promoting biofilm formation [<xref rid="B431-pathogens-14-00185" ref-type="bibr">431</xref>]. <xref rid="pathogens-14-00185-t006" ref-type="table">Table 6</xref> summarizes the key immune evasion mechanisms employed by <italic toggle="yes">S. aureus</italic>, highlighting the primary proteins and factors involved in targeting various aspects of the host immune response.</p><p><italic toggle="yes">S. aureus</italic> produces diverse virulence factors that enable its persistence and pathogenicity, manifesting in both mild skin infections and severe conditions like pneumonia and endocarditis. It is crucial to comprehend the mechanisms underlying these virulence factors and how the host responds to them, as this knowledge is vital for devising effective therapeutic strategies and treatments.</p><fig position="anchor" id="pathogens-14-00185-f004" orientation="portrait"><label>Figure 4</label><caption><p><italic toggle="yes">Staphylococcus aureus</italic> immune evasion strategies. (<bold>a</bold>) <italic toggle="yes">S. aureus</italic> hinders neutrophil adhesion and receptor-mediated activation, thereby blocking their migration to infection sites. This process is mediated by virulence factors such as staphylococcal superantigen-like (SSL) family proteins, chemotaxis inhibitory protein of <italic toggle="yes">S. aureus</italic> (CHIPS), FPRL1 inhibitory protein (FLIPr), FLIPr-like protein, and staphylococcal enterotoxin-like toxin X (SElX) [<xref rid="B138-pathogens-14-00185" ref-type="bibr">138</xref>,<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B384-pathogens-14-00185" ref-type="bibr">384</xref>,<xref rid="B391-pathogens-14-00185" ref-type="bibr">391</xref>]. (<bold>b</bold>) To evade phagocytosis by neutrophils, <italic toggle="yes">S. aureus</italic> utilizes surface proteins like surface protein A (SpA), <italic toggle="yes">S. aureus</italic> binder of IgG (Sbi), and SSL10, which interfere with the host immune response [<xref rid="B320-pathogens-14-00185" ref-type="bibr">320</xref>,<xref rid="B392-pathogens-14-00185" ref-type="bibr">392</xref>,<xref rid="B393-pathogens-14-00185" ref-type="bibr">393</xref>,<xref rid="B394-pathogens-14-00185" ref-type="bibr">394</xref>]. (<bold>c</bold>) Inside the phagosome, <italic toggle="yes">S. aureus</italic> neutralizes reactive oxygen species produced by myeloperoxidase (MPO) to resist neutrophil-killing mechanisms. This is achieved through enzymes such as staphyloxanthin, superoxide dismutase, catalase, and hydroperoxide reductase [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B405-pathogens-14-00185" ref-type="bibr">405</xref>,<xref rid="B406-pathogens-14-00185" ref-type="bibr">406</xref>,<xref rid="B407-pathogens-14-00185" ref-type="bibr">407</xref>,<xref rid="B408-pathogens-14-00185" ref-type="bibr">408</xref>,<xref rid="B409-pathogens-14-00185" ref-type="bibr">409</xref>,<xref rid="B410-pathogens-14-00185" ref-type="bibr">410</xref>]. (<bold>d</bold>) Superantigens produced by <italic toggle="yes">S. aureus</italic>, including toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxin B (SEB), staphylococcal enterotoxin C (SEC), and SElX, cause excessive T-cell proliferation, leading to immune dysregulation and potential tissue damage [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B398-pathogens-14-00185" ref-type="bibr">398</xref>,<xref rid="B420-pathogens-14-00185" ref-type="bibr">420</xref>]. (<bold>e</bold>) <italic toggle="yes">S. aureus</italic> forms biofilms that provide a protective matrix, enhancing resistance to the host immune system [<xref rid="B20-pathogens-14-00185" ref-type="bibr">20</xref>,<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>]. (<bold>f</bold>) <italic toggle="yes">S. aureus</italic> toxins, such as staphylococcal nuclease (Nuc), adenosine synthase A (AdsA), and leukocidin AB (LukAB), inhibit neutrophil extracellular trap (NET) formation (NETosis) [<xref rid="B420-pathogens-14-00185" ref-type="bibr">420</xref>,<xref rid="B421-pathogens-14-00185" ref-type="bibr">421</xref>]. Nuc and AdsA also induce macrophage apoptosis, impairing immune clearance of the bacteria [<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pathogens-14-00185-g004.jpg"/></fig></sec></sec><sec id="sec5-pathogens-14-00185"><title>5. Future Perspectives</title><p><italic toggle="yes">S. aureus</italic> is the leading cause of hospital-acquired infections and can cause a wide range of inflammatory diseases and pain. In this article, we present the most recent knowledge about <italic toggle="yes">S. aureus</italic>, addressing the main inflammatory diseases caused by this bacterium, its pathogenic mechanisms, and the main cell types involved in the host immune response upon an infection. A better understanding of these aspects can guide the development of new targeted therapies for treating diseases and pain induced by <italic toggle="yes">S. aureus</italic>.</p><p>Despite the fact that <italic toggle="yes">S. aureus</italic> is one of the most extensively studied microorganisms, there is still a significant gap in knowledge, unfortunately. Regarding the pathogenicity of <italic toggle="yes">S. aureus</italic>, some mechanisms remain largely unknown. Several inflammatory cells are involved in the pathogenesis of this bacterium, including Th9, Tfh, and ILC cells, whose mechanisms remain open for investigation [<xref rid="B15-pathogens-14-00185" ref-type="bibr">15</xref>]. Studies demonstrate that Th9 cells are important regulators of immunity to autoimmune diseases [<xref rid="B432-pathogens-14-00185" ref-type="bibr">432</xref>] and tumor immunity [<xref rid="B433-pathogens-14-00185" ref-type="bibr">433</xref>], in addition to acting in the pathophysiology of respiratory tract allergies, such as asthma [<xref rid="B434-pathogens-14-00185" ref-type="bibr">434</xref>] and allergic rhinitis [<xref rid="B435-pathogens-14-00185" ref-type="bibr">435</xref>]. However, despite there being data in the literature that correlate the role of these cells with the development of several diseases, little is known about the mechanisms of <italic toggle="yes">S. aureus</italic> involved in the development of a Th9-type inflammatory response. In the case of Tfh and ILC cells, some studies have associated them with the pathogenic mechanisms of <italic toggle="yes">S. aureus</italic> [<xref rid="B436-pathogens-14-00185" ref-type="bibr">436</xref>,<xref rid="B437-pathogens-14-00185" ref-type="bibr">437</xref>,<xref rid="B438-pathogens-14-00185" ref-type="bibr">438</xref>]; however, there is still a need for further investigation of the involvement of these cells in the inflammatory diseases caused by this bacterium.</p><p><italic toggle="yes">S. aureus</italic> can induce different forms of cell death, which have a significant role in the pathogenesis of several diseases [<xref rid="B15-pathogens-14-00185" ref-type="bibr">15</xref>]. However, the roles of some types of cell death, such as ferroptosis (regulated and iron-dependent cell death) [<xref rid="B439-pathogens-14-00185" ref-type="bibr">439</xref>] and cuproptosis (cell death caused by excess copper and accumulation of mitochondrial proteins) [<xref rid="B440-pathogens-14-00185" ref-type="bibr">440</xref>], remain poorly defined in the context of <italic toggle="yes">S. aureus</italic> infection. Furthermore, there are few data in the literature that investigate the pathogenic mechanisms of <italic toggle="yes">S. aureus</italic> with pain present in different types of diseases. This might be of importance considering that <italic toggle="yes">S. aureus</italic> can shape the immune response by activating nociceptor neurons [<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>]. Thus, future research may allow greater knowledge about the mechanisms involved in pain and infection by <italic toggle="yes">S. aureus</italic>, increasing the possibility of developing new therapeutic and prophylactic approaches for diseases correlated to this bacterium. Few data in the literature address the treatment of pain present in several diseases caused by <italic toggle="yes">S. aureus.</italic> Blake et. al. demonstrated that QX-314, a membrane-impermeable sodium channel blocker, relieves pain when administered to sensory neurons. They observed that QX-314 silences neuronal activity caused by the administration of pore-forming toxins and potentially blocks all major pain modalities (spontaneous pain, thermal, and mechanical hyperalgesia) during MRSA infection [<xref rid="B441-pathogens-14-00185" ref-type="bibr">441</xref>]. Another study demonstrated that systemic blockade of CXCR2, through DF2156A (an antagonist of CXCR1 and CXCR2), decreased inflammation, pain, and tissue damage caused by <italic toggle="yes">S. aureus</italic> [<xref rid="B442-pathogens-14-00185" ref-type="bibr">442</xref>]. Thus, investing in research that addresses the pain mechanisms caused by <italic toggle="yes">S. aureus</italic> and seeking therapeutic approaches that contribute to improving patients&#8217; quality of life is a current need that is open for investigation.</p><p>Treatment of infections caused by <italic toggle="yes">S. aureus</italic> is becoming increasingly difficult, mainly due to the acquisition of resistance genes, selection of antibiotic-resistant strains (e.g., methicillin-resistant <italic toggle="yes">S. aureus</italic>) [<xref rid="B1-pathogens-14-00185" ref-type="bibr">1</xref>], biofilm formation [<xref rid="B443-pathogens-14-00185" ref-type="bibr">443</xref>], and strategies to evade the host&#8217;s immune system [<xref rid="B444-pathogens-14-00185" ref-type="bibr">444</xref>]. These adversities, as well as others not reported here, make <italic toggle="yes">S. aureus</italic> a growing threat to global health. Thus, driven by the increasing antibiotic resistance and additional difficulties in finding functional treatments (e.g., vaccines), there is a growing interest in developing novel and/or adjuvant strategies for treating <italic toggle="yes">S. aureus</italic> infections. <xref rid="pathogens-14-00185-t007" ref-type="table">Table 7</xref> summarizes some clinical and preclinical studies of promising new approaches for the treatment of diseases caused by <italic toggle="yes">S. aureus</italic> that have structural components and virulence factors as targets.</p><p>Despite enormous progress in research into <italic toggle="yes">S. aureus</italic> and its related diseases, it is still difficult to find satisfactory treatments, especially for resistant strains. Regarding vaccines, many classical methods and new technologies have been tested, and even though some research reveals vaccines with potential protective effects, none have been approved for use to date [<xref rid="B479-pathogens-14-00185" ref-type="bibr">479</xref>]. Thus, future research that addresses new methodologies, such as reverse vaccinology and bioconjugates, appears promising and may be the center of future vaccine development [<xref rid="B444-pathogens-14-00185" ref-type="bibr">444</xref>,<xref rid="B480-pathogens-14-00185" ref-type="bibr">480</xref>].</p><p>Taken together, the development of new therapeutic drugs that work according to different principles than those currently available may be the solution to reduce the factors that contribute to the establishment of resistance and spread of <italic toggle="yes">S. aureus</italic> [<xref rid="B19-pathogens-14-00185" ref-type="bibr">19</xref>]. In this context, therapeutic approaches that control the release of molecules, such as methods for incorporating microparticles and nanotechnology, are also targets of interest in future research. This controlled release minimizes systemic toxicity and reduces the induction of resistance to treatments by <italic toggle="yes">S. aureus</italic>, overcoming some of the bacteria&#8217;s evasion mechanisms and helping in the combat and prophylaxis of the infection [<xref rid="B79-pathogens-14-00185" ref-type="bibr">79</xref>].</p><p>Another avenue of research of great interest is the use of new personalized methods to combat infections, such as the Clustered Regularly Spaced Short Palindromic Repeats (CRISPR/Cas9) technique [<xref rid="B79-pathogens-14-00185" ref-type="bibr">79</xref>,<xref rid="B481-pathogens-14-00185" ref-type="bibr">481</xref>]. Bikard et al. developed programmable and specific antimicrobials through CRISPR/Cas9. This reprogrammed antimicrobial was responsible for targeting MRSA virulence genes, making it susceptible to methicillin again [<xref rid="B482-pathogens-14-00185" ref-type="bibr">482</xref>].</p><p>In this same context, bioinformatics tools can be great allies in discovering the pathogenic mechanisms of <italic toggle="yes">S. aureus</italic> and in the treatment of pain and related diseases. Several studies already use these tools for genomic characterization of new strains of MSSA [<xref rid="B483-pathogens-14-00185" ref-type="bibr">483</xref>] and MRSA [<xref rid="B484-pathogens-14-00185" ref-type="bibr">484</xref>,<xref rid="B485-pathogens-14-00185" ref-type="bibr">485</xref>], which expands the knowledge about these strains. Furthermore, Abujubara et al. reported the synthesis of a series of inhibitors of Sortase A, a surface enzyme of gram-positive bacteria, through a computational analysis. Applying these inhibitors in in vitro assays, they found that three of them inhibit the growth of <italic toggle="yes">S. aureus</italic> and the formation of biofilms [<xref rid="B486-pathogens-14-00185" ref-type="bibr">486</xref>]. In addition, Muthukrishnan et al. demonstrate the feasibility of a bioinformatics approach in using a patient&#8217;s immune proteome active against <italic toggle="yes">S. aureus</italic> to diagnose <italic toggle="yes">S. aureus</italic> musculoskeletal infections (MSKI) [<xref rid="B487-pathogens-14-00185" ref-type="bibr">487</xref>].</p><p>In summary, an advanced understanding of the pathophysiology of <italic toggle="yes">S. aureus</italic> in different types of diseases and in pain and knowledge of structural pathogenic and resistance mechanisms may aid in the discovery and development of new strategies to treat <italic toggle="yes">S. aureus</italic> infections.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors wish to thank the support of the core facilities CMLP-UEL and CEPPOS-UEL.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, F.S.R.-O., J.M.R., G.M.-C., F.B.C., G.N., R.C. and W.A.V.; writing&#8212;original draft preparation, F.S.R.-O., J.M.R., G.M.-C., F.B.C., G.N., R.C. and W.A.V.; writing&#8212;review and editing, F.S.R.-O., J.M.R., G.M.-C., F.B.C., G.N., R.C. and W.A.V.; visualization, F.S.R.-O., J.M.R., G.M.-C. and F.B.C.; supervision, G.N., R.C. and W.A.V.; funding acquisition, G.N., R.C. and W.A.V. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish it.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-14-00185"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus Aureus</article-title><source>Front. Cell Infect. Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>107</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.00107</pub-id><pub-id pub-id-type="pmid">32257966</pub-id><pub-id pub-id-type="pmcid">PMC7089872</pub-id></element-citation></ref><ref id="B2-pathogens-14-00185"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>De Lencastre</surname><given-names>H.</given-names></name><name name-style="western"><surname>Garau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kluytmans</surname><given-names>J.</given-names></name><name name-style="western"><surname>Malhotra-Kumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Harbarth</surname><given-names>S.</given-names></name></person-group><article-title>Methicillin-Resistant Staphylococcus Aureus</article-title><source>Nat. Rev. Dis. Primers</source><year>2018</year><volume>4</volume><fpage>18033</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2018.33</pub-id><pub-id pub-id-type="pmid">29849094</pub-id></element-citation></ref><ref id="B3-pathogens-14-00185"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>S.Y.C.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Eichenberger</surname><given-names>E.</given-names></name><name name-style="western"><surname>Holland</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>V.G.</given-names></name></person-group><article-title>Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management</article-title><source>Clin. Microbiol. Rev.</source><year>2015</year><volume>28</volume><fpage>603</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1128/CMR.00134-14</pub-id><pub-id pub-id-type="pmid">26016486</pub-id><pub-id pub-id-type="pmcid">PMC4451395</pub-id></element-citation></ref><ref id="B4-pathogens-14-00185"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rasigade</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Dumitrescu</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lina</surname><given-names>G.</given-names></name></person-group><article-title>New Epidemiology of Staphylococcus Aureus Infections</article-title><source>Clin. Microbiol. Infect.</source><year>2014</year><volume>20</volume><fpage>587</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12718</pub-id><pub-id pub-id-type="pmid">24930666</pub-id></element-citation></ref><ref id="B5-pathogens-14-00185"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>T&#259;taru</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Canciu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Terti&#537;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cristea</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cernat</surname><given-names>A.</given-names></name></person-group><article-title>Staphylococcus Aureus&#8212;Review on Potential Targets for Sensors Development</article-title><source>Bioelectrochemistry</source><year>2023</year><volume>153</volume><elocation-id>108492</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioelechem.2023.108492</pub-id><pub-id pub-id-type="pmid">37413820</pub-id></element-citation></ref><ref id="B6-pathogens-14-00185"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#246;ffler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tuchscherr</surname><given-names>L.</given-names></name></person-group><article-title>Staphylococcus Aureus Toxins: Promoter or Handicap during Infection?</article-title><source>Toxins</source><year>2021</year><volume>13</volume><elocation-id>287</elocation-id><pub-id pub-id-type="doi">10.3390/toxins13040287</pub-id><pub-id pub-id-type="pmid">33921743</pub-id><pub-id pub-id-type="pmcid">PMC8072895</pub-id></element-citation></ref><ref id="B7-pathogens-14-00185"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laabei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uhlemann</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lowy</surname><given-names>F.D.</given-names></name><name name-style="western"><surname>Austin</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ouadi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Feil</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thorpe</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>B.</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Evolutionary Trade-Offs Underlie the Multi-Faceted Virulence of Staphylococcus Aureus</article-title><source>PLoS Biol.</source><year>2015</year><volume>13</volume><elocation-id>e1002229</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002229</pub-id><pub-id pub-id-type="pmid">26331877</pub-id><pub-id pub-id-type="pmcid">PMC4558032</pub-id></element-citation></ref><ref id="B8-pathogens-14-00185"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Lowy</surname><given-names>F.D.</given-names></name></person-group><article-title>Pathogenesis of Methicillin-Resistant Staphylococcus Aureus Infection</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>46</volume><fpage>S350</fpage><pub-id pub-id-type="doi">10.1086/533591</pub-id><pub-id pub-id-type="pmid">18462090</pub-id><pub-id pub-id-type="pmcid">PMC2474459</pub-id></element-citation></ref><ref id="B9-pathogens-14-00185"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schaumburg</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fegeler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Friedrich</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>K&#246;ck</surname><given-names>R.</given-names></name></person-group><article-title>Staphylococcus Aureus from the German General Population Is Highly Diverse</article-title><source>Int. J. Med. Microbiol.</source><year>2017</year><volume>307</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2016.11.007</pub-id><pub-id pub-id-type="pmid">28017539</pub-id></element-citation></ref><ref id="B10-pathogens-14-00185"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wertheim</surname><given-names>H.F.L.</given-names></name><name name-style="western"><surname>Melles</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Vos</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Van Leeuwen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Van Belkum</surname><given-names>A.</given-names></name><name name-style="western"><surname>Verbrugh</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Nouwen</surname><given-names>J.L.</given-names></name></person-group><article-title>The Role of Nasal Carriage in Staphylococcus Aureus Infections</article-title><source>Lancet Infect. Dis.</source><year>2005</year><volume>5</volume><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70295-4</pub-id><pub-id pub-id-type="pmid">16310147</pub-id></element-citation></ref><ref id="B11-pathogens-14-00185"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanselman</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Kruth</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Rousseau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Weese</surname><given-names>J.S.</given-names></name></person-group><article-title>Coagulase Positive Staphylococcal Colonization of Humans and Their Household Pets</article-title><source>Can. Vet. J.</source><year>2009</year><volume>50</volume><fpage>954</fpage><pub-id pub-id-type="pmid">19949556</pub-id><pub-id pub-id-type="pmcid">PMC2726022</pub-id></element-citation></ref><ref id="B12-pathogens-14-00185"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W.</given-names></name></person-group><article-title>A Pursuit of Staphylococcus Aureus Continues: A Role of Persister Cells</article-title><source>Arch. Pharm. Res.</source><year>2020</year><volume>43</volume><fpage>630</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1007/s12272-020-01246-x</pub-id><pub-id pub-id-type="pmid">32627141</pub-id></element-citation></ref><ref id="B13-pathogens-14-00185"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowy</surname><given-names>F.D.</given-names></name></person-group><article-title>Staphylococcus Aureus Infections</article-title><source>N. Engl. J. Med.</source><year>1998</year><volume>339</volume><fpage>520</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1056/NEJM199808203390806</pub-id><pub-id pub-id-type="pmid">9709046</pub-id></element-citation></ref><ref id="B14-pathogens-14-00185"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kluytmans</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Van Belkum</surname><given-names>A.</given-names></name><name name-style="western"><surname>Verbrugh</surname><given-names>H.</given-names></name></person-group><article-title>Nasal Carriage of Staphylococcus Aureus: Epidemiology, Underlying Mechanisms, and Associated Risks</article-title><source>Clin. Microbiol. Rev.</source><year>1997</year><volume>10</volume><fpage>505</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1128/CMR.10.3.505</pub-id><pub-id pub-id-type="pmid">9227864</pub-id><pub-id pub-id-type="pmcid">PMC172932</pub-id></element-citation></ref><ref id="B15-pathogens-14-00185"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Exploring the Role of Staphylococcus Aureus in Inflammatory Diseases</article-title><source>Toxins</source><year>2022</year><volume>14</volume><elocation-id>464</elocation-id><pub-id pub-id-type="doi">10.3390/toxins14070464</pub-id><pub-id pub-id-type="pmid">35878202</pub-id><pub-id pub-id-type="pmcid">PMC9318596</pub-id></element-citation></ref><ref id="B16-pathogens-14-00185"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.</given-names></name></person-group><article-title>Pathogenesis of Staphylococcus Aureus Bloodstream Infections</article-title><source>Annu. Rev. Pathol.</source><year>2016</year><volume>11</volume><fpage>343</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-012615-044351</pub-id><pub-id pub-id-type="pmid">26925499</pub-id><pub-id pub-id-type="pmcid">PMC5068359</pub-id></element-citation></ref><ref id="B17-pathogens-14-00185"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lew</surname><given-names>P.D.P.</given-names></name><name name-style="western"><surname>Waldvogel</surname><given-names>P.F.A.</given-names></name></person-group><article-title>Osteomyelitis</article-title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>369</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16727-5</pub-id><pub-id pub-id-type="pmid">15276398</pub-id></element-citation></ref><ref id="B18-pathogens-14-00185"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Widaa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Claro</surname><given-names>T.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Kerrigan</surname><given-names>S.W.</given-names></name></person-group><article-title>Staphylococcus Aureus Protein A Plays a Critical Role in Mediating Bone Destruction and Bone Loss in Osteomyelitis</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e40586</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040586</pub-id><pub-id pub-id-type="pmid">22792377</pub-id><pub-id pub-id-type="pmcid">PMC3394727</pub-id></element-citation></ref><ref id="B19-pathogens-14-00185"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad-Mansour</surname><given-names>N.</given-names></name><name name-style="western"><surname>Loubet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pouget</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dunyach-Remy</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sotto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lavigne</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Molle</surname><given-names>V.</given-names></name></person-group><article-title>Staphylococcus Aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments</article-title><source>Toxins</source><year>2021</year><volume>13</volume><elocation-id>677</elocation-id><pub-id pub-id-type="doi">10.3390/toxins13100677</pub-id><pub-id pub-id-type="pmid">34678970</pub-id><pub-id pub-id-type="pmcid">PMC8540901</pub-id></element-citation></ref><ref id="B20-pathogens-14-00185"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>G.Y.C.</given-names></name><name name-style="western"><surname>Bae</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title>Pathogenicity and Virulence of Staphylococcus Aureus</article-title><source>Virulence</source><year>2021</year><volume>12</volume><fpage>547</fpage><pub-id pub-id-type="doi">10.1080/21505594.2021.1878688</pub-id><pub-id pub-id-type="pmid">33522395</pub-id><pub-id pub-id-type="pmcid">PMC7872022</pub-id></element-citation></ref><ref id="B21-pathogens-14-00185"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>D.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sim&#245;es</surname><given-names>M.</given-names></name></person-group><article-title>Staphylococcus Aureus Toxins and Their Molecular Activity in Infectious Diseases</article-title><source>Toxins</source><year>2018</year><volume>10</volume><elocation-id>252</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10060252</pub-id><pub-id pub-id-type="pmid">29921792</pub-id><pub-id pub-id-type="pmcid">PMC6024779</pub-id></element-citation></ref><ref id="B22-pathogens-14-00185"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grumann</surname><given-names>D.</given-names></name><name name-style="western"><surname>N&#252;bel</surname><given-names>U.</given-names></name><name name-style="western"><surname>Br&#246;ker</surname><given-names>B.M.</given-names></name></person-group><article-title>Staphylococcus Aureus Toxins--Their Functions and Genetics</article-title><source>Infect. Genet. Evol.</source><year>2014</year><volume>21</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.03.013</pub-id><pub-id pub-id-type="pmid">23541411</pub-id></element-citation></ref><ref id="B23-pathogens-14-00185"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright-Fleming</surname><given-names>W.</given-names></name></person-group><article-title>Healthy carriage of staphylococcus aureus: Its prevalence and importance</article-title><source>Bacteriol. Rev.</source><year>1963</year><volume>27</volume><fpage>56</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1128/BR.27.1.56-71.1963</pub-id><pub-id pub-id-type="pmid">14000926</pub-id><pub-id pub-id-type="pmcid">PMC441169</pub-id></element-citation></ref><ref id="B24-pathogens-14-00185"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Staphylococcus Aureus Infections and Human Intestinal Microbiota</article-title><source>Pathogens</source><year>2024</year><volume>13</volume><elocation-id>276</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens13040276</pub-id><pub-id pub-id-type="pmid">38668232</pub-id><pub-id pub-id-type="pmcid">PMC11053856</pub-id></element-citation></ref><ref id="B25-pathogens-14-00185"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weidinger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Bieber</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kabashima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Irvine</surname><given-names>A.D.</given-names></name></person-group><article-title>Atopic Dermatitis</article-title><source>Nat. Rev. Dis. Primers</source><year>2018</year><volume>4</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1038/s41572-018-0001-z</pub-id><pub-id pub-id-type="pmid">29930242</pub-id></element-citation></ref><ref id="B26-pathogens-14-00185"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teufelberger</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Br&#246;ker</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Krysko</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Krysko</surname><given-names>O.</given-names></name></person-group><article-title>Staphylococcus Aureus Orchestrates Type 2 Airway Diseases</article-title><source>Trends Mol. Med.</source><year>2019</year><volume>25</volume><fpage>696</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2019.05.003</pub-id><pub-id pub-id-type="pmid">31176612</pub-id></element-citation></ref><ref id="B27-pathogens-14-00185"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jorde</surname><given-names>I.</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stegemann-Koniszewski</surname><given-names>S.</given-names></name></person-group><article-title>The Role of Staphylococcus Aureus and Its Toxins in the Pathogenesis of Allergic Asthma</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>24</volume><elocation-id>654</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24010654</pub-id><pub-id pub-id-type="pmid">36614093</pub-id><pub-id pub-id-type="pmcid">PMC9820472</pub-id></element-citation></ref><ref id="B28-pathogens-14-00185"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pullerits</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Branchu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jubelin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Personnic</surname><given-names>N.</given-names></name></person-group><article-title>Bacteria and Host Interplay in Staphylococcus Aureus Septic Arthritis and Sepsis</article-title><source>Pathogens</source><year>2021</year><volume>10</volume><elocation-id>158</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens10020158</pub-id><pub-id pub-id-type="pmid">33546401</pub-id><pub-id pub-id-type="pmcid">PMC7913561</pub-id></element-citation></ref><ref id="B29-pathogens-14-00185"><label>29.</label><element-citation publication-type="gov"><article-title>Guidelines for the Diagnosis and Management of Asthma 2007 (EPR-3)|NHLBI, NIH</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma" ext-link-type="uri">https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-22">(accessed on 22 December 2024)</date-in-citation></element-citation></ref><ref id="B30-pathogens-14-00185"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Paula Santos</surname><given-names>U.</given-names></name><name name-style="western"><surname>Arbex</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Braga</surname><given-names>A.L.F.</given-names></name><name name-style="western"><surname>Mizutani</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Can&#231;ado</surname><given-names>J.E.D.</given-names></name><name name-style="western"><surname>Terra-Filho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chatkin</surname><given-names>J.M.</given-names></name></person-group><article-title>Environmental Air Pollution: Respiratory Effects</article-title><source>J. Bras. Pneumol.</source><year>2021</year><volume>47</volume><fpage>e20200267</fpage><pub-id pub-id-type="doi">10.36416/1806-3756/e20200267</pub-id><pub-id pub-id-type="pmid">33567063</pub-id><pub-id pub-id-type="pmcid">PMC7889311</pub-id></element-citation></ref><ref id="B31-pathogens-14-00185"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toskala</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>D.W.</given-names></name></person-group><article-title>Asthma Risk Factors</article-title><source>Int. Forum Allergy Rhinol.</source><year>2015</year><volume>5</volume><fpage>S11</fpage><lpage>S16</lpage><pub-id pub-id-type="doi">10.1002/alr.21557</pub-id><pub-id pub-id-type="pmid">26335830</pub-id><pub-id pub-id-type="pmcid">PMC7159773</pub-id></element-citation></ref><ref id="B32-pathogens-14-00185"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reyes-Angel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaviany</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rastogi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Forno</surname><given-names>E.</given-names></name></person-group><article-title>Obesity-Related Asthma in Children and Adolescents</article-title><source>Lancet Child. Adolesc. Health</source><year>2022</year><volume>6</volume><fpage>713</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/S2352-4642(22)00185-7</pub-id><pub-id pub-id-type="pmid">35988550</pub-id><pub-id pub-id-type="pmcid">PMC12090466</pub-id></element-citation></ref><ref id="B33-pathogens-14-00185"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Celed&#243;n</surname><given-names>J.C.</given-names></name></person-group><article-title>Stress and Asthma: Novel Insights on Genetic, Epigenetic, and Immunologic Mechanisms</article-title><source>J. Allergy Clin. Immunol.</source><year>2014</year><volume>134</volume><fpage>1009</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2014.07.005</pub-id><pub-id pub-id-type="pmid">25129683</pub-id><pub-id pub-id-type="pmcid">PMC4252392</pub-id></element-citation></ref><ref id="B34-pathogens-14-00185"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stern</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Litonjua</surname><given-names>A.A.</given-names></name></person-group><article-title>Asthma Epidemiology and Risk Factors</article-title><source>Semin. Immunopathol.</source><year>2020</year><volume>42</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/s00281-020-00785-1</pub-id><pub-id pub-id-type="pmid">32020334</pub-id></element-citation></ref><ref id="B35-pathogens-14-00185"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>P.</given-names></name><name name-style="western"><surname>Adeloye</surname><given-names>D.</given-names></name><name name-style="western"><surname>Salim</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rudan</surname><given-names>I.</given-names></name></person-group><article-title>Global, Regional, and National Prevalence of Asthma in 2019: A Systematic Analysis and Modelling Study</article-title><source>J. Glob. Health</source><year>2022</year><volume>12</volume><fpage>4052</fpage><pub-id pub-id-type="doi">10.7189/jogh.12.04052</pub-id><pub-id pub-id-type="pmcid">PMC9239324</pub-id><pub-id pub-id-type="pmid">35765786</pub-id></element-citation></ref><ref id="B36-pathogens-14-00185"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinharoy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>P.</given-names></name></person-group><article-title>Socioeconomic and Environmental Predictors of Asthma-Related Mortality</article-title><source>J. Environ. Public Health</source><year>2018</year><volume>2018</volume><fpage>9389570</fpage><pub-id pub-id-type="doi">10.1155/2018/9389570</pub-id><pub-id pub-id-type="pmid">29853926</pub-id><pub-id pub-id-type="pmcid">PMC5941796</pub-id></element-citation></ref><ref id="B37-pathogens-14-00185"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Won</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Nasal Colonization and Asthma in Adults: Systematic Review and Meta-Analysis</article-title><source>J. Allergy Clin. Immunol. Pract.</source><year>2019</year><volume>7</volume><fpage>606</fpage><lpage>615.e9</lpage><pub-id pub-id-type="doi">10.1016/j.jaip.2018.08.020</pub-id><pub-id pub-id-type="pmid">30193937</pub-id></element-citation></ref><ref id="B38-pathogens-14-00185"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Ludwig</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brigham</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>McCormack</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Matsui</surname><given-names>E.C.</given-names></name></person-group><article-title>Effect of Home Exposure to Staphylococcus Aureus on Asthma in Adolescents</article-title><source>J. Allergy Clin. Immunol.</source><year>2018</year><volume>141</volume><fpage>402</fpage><lpage>405.e10</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.06.031</pub-id><pub-id pub-id-type="pmid">28739287</pub-id><pub-id pub-id-type="pmcid">PMC5758414</pub-id></element-citation></ref><ref id="B39-pathogens-14-00185"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomassen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jarvis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Newson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Van Ree</surname><given-names>R.</given-names></name><name name-style="western"><surname>Forsberg</surname><given-names>B.</given-names></name><name name-style="western"><surname>Howarth</surname><given-names>P.</given-names></name><name name-style="western"><surname>Janson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kowalski</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Kr&#228;mer</surname><given-names>U.</given-names></name><name name-style="western"><surname>Matricardi</surname><given-names>P.M.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Enterotoxin-Specific IgE Is Associated with Asthma in the General Population: A GA2LEN Study</article-title><source>Allergy</source><year>2013</year><volume>68</volume><fpage>1289</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1111/all.12230</pub-id><pub-id pub-id-type="pmid">24117882</pub-id></element-citation></ref><ref id="B40-pathogens-14-00185"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stentzel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Teufelberger</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nordengr&#252;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kolata</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>F.</given-names></name><name name-style="western"><surname>van Crombruggen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Michalik</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumpfm&#252;ller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tischer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schweder</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Staphylococcal Serine Protease&#8211;like Proteins Are Pacemakers of Allergic Airway Reactions to Staphylococcus Aureus</article-title><source>J. Allergy Clin. Immunol.</source><year>2017</year><volume>139</volume><fpage>492</fpage><lpage>500.e8</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2016.03.045</pub-id><pub-id pub-id-type="pmid">27315768</pub-id></element-citation></ref><ref id="B41-pathogens-14-00185"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreiber</surname><given-names>J.</given-names></name><name name-style="western"><surname>Br&#246;ker</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Ehmann</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name></person-group><article-title>Nonatopic Severe Asthma Might Still Be Atopic: Sensitization toward Staphylococcus Aureus Enterotoxins</article-title><source>J. Allergy Clin. Immunol.</source><year>2019</year><volume>143</volume><fpage>2279</fpage><lpage>2280.e2</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2019.01.018</pub-id><pub-id pub-id-type="pmid">30707972</pub-id></element-citation></ref><ref id="B42-pathogens-14-00185"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humbert</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bousquet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Palomares</surname><given-names>O.</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kottakis</surname><given-names>I.</given-names></name><name name-style="western"><surname>Jaumont</surname><given-names>X.</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Papadopoulos</surname><given-names>N.G.</given-names></name></person-group><article-title>IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy</article-title><source>J. Allergy Clin. Immunol. Pract.</source><year>2019</year><volume>7</volume><fpage>1418</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1016/j.jaip.2019.02.030</pub-id><pub-id pub-id-type="pmid">30928481</pub-id></element-citation></ref><ref id="B43-pathogens-14-00185"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jun</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Park</surname><given-names>T.I.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.C.</given-names></name></person-group><article-title>Staphylococcus Aureus-Derived Membrane Vesicles Exacerbate Skin Inflammation in Atopic Dermatitis</article-title><source>Clin. Exp. Allergy</source><year>2017</year><volume>47</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1111/cea.12851</pub-id><pub-id pub-id-type="pmid">27910159</pub-id></element-citation></ref><ref id="B44-pathogens-14-00185"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langan</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Irvine</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Weidinger</surname><given-names>S.</given-names></name></person-group><article-title>Atopic Dermatitis</article-title><source>Lancet</source><year>2020</year><volume>396</volume><fpage>345</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31286-1</pub-id><pub-id pub-id-type="pmid">32738956</pub-id></element-citation></ref><ref id="B45-pathogens-14-00185"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Deming</surname><given-names>C.</given-names></name><name name-style="western"><surname>Conlan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Grice</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Beatson</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Nomicos</surname><given-names>E.</given-names></name><name name-style="western"><surname>Polley</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Komarow</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Mullikin</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Temporal Shifts in the Skin Microbiome Associated with Disease Flares and Treatment in Children with Atopic Dermatitis</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1101/gr.131029.111</pub-id><pub-id pub-id-type="pmid">22310478</pub-id><pub-id pub-id-type="pmcid">PMC3337431</pub-id></element-citation></ref><ref id="B46-pathogens-14-00185"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrd</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Deming</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>S.K.B.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>O.J.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>W.I.</given-names></name><name name-style="western"><surname>Conlan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Segre</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>H.H.</given-names></name></person-group><article-title>Staphylococcus Aureus and Staphylococcus Epidermidis Strain Diversity Underlying Pediatric Atopic Dermatitis</article-title><source>Sci. Transl. Med.</source><year>2017</year><volume>9</volume><fpage>eaal4651</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aal4651</pub-id><pub-id pub-id-type="pmid">28679656</pub-id><pub-id pub-id-type="pmcid">PMC5706545</pub-id></element-citation></ref><ref id="B47-pathogens-14-00185"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khadka</surname><given-names>V.D.</given-names></name><name name-style="western"><surname>Key</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Romo-Gonz&#225;lez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Gayosso</surname><given-names>A.</given-names></name><name name-style="western"><surname>Campos-Cabrera</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Ger&#243;nimo-Gallegos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lynn</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Dur&#225;n-McKinster</surname><given-names>C.</given-names></name><name name-style="western"><surname>Coria-Jim&#233;nez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>T.D.</given-names></name><etal/></person-group><article-title>The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment</article-title><source>Front. Cell Infect. Microbiol.</source><year>2021</year><volume>11</volume><elocation-id>720674</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.720674</pub-id><pub-id pub-id-type="pmid">34631601</pub-id><pub-id pub-id-type="pmcid">PMC8498027</pub-id></element-citation></ref><ref id="B48-pathogens-14-00185"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LEYDEN</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>MARPLES</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>KLIGMAN</surname><given-names>A.M.</given-names></name></person-group><article-title>Staphylococcus Aureus in the Lesions of Atopic Dermatitis</article-title><source>Br. J. Dermatol.</source><year>1974</year><volume>90</volume><fpage>525</fpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.1974.tb06447.x</pub-id><pub-id pub-id-type="pmid">4601016</pub-id></element-citation></ref><ref id="B49-pathogens-14-00185"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obata</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hisatsune</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fukushima-Nomura</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ebihara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Arai</surname><given-names>C.</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kutsuno</surname><given-names>S.</given-names></name><name name-style="western"><surname>Iwao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sugai</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Comprehensive Genomic Characterization of Staphylococcus Aureus Isolated from Atopic Dermatitis Patients in Japan: Correlations with Disease Severity, Eruption Type, and Anatomical Site</article-title><source>Microbiol. Spectr.</source><year>2023</year><volume>11</volume><elocation-id>e0523922</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.05239-22</pub-id><pub-id pub-id-type="pmid">37432109</pub-id><pub-id pub-id-type="pmcid">PMC10434064</pub-id></element-citation></ref><ref id="B50-pathogens-14-00185"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hrestak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Matija&#353;i&#263;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Paljetak</surname><given-names>H.&#268;.</given-names></name><name name-style="western"><surname>Drvar</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Had&#382;avdi&#263;</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Peri&#263;</surname><given-names>M.</given-names></name></person-group><article-title>Skin Microbiota in Atopic Dermatitis</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>3503</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23073503</pub-id><pub-id pub-id-type="pmid">35408862</pub-id><pub-id pub-id-type="pmcid">PMC8998607</pub-id></element-citation></ref><ref id="B51-pathogens-14-00185"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oscherwitz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cease</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Mu&#241;oz-Planillo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hasegawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Villaruz</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>G.Y.C.</given-names></name><name name-style="western"><surname>McGavin</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Travers</surname><given-names>J.B.</given-names></name><etal/></person-group><article-title>Staphylococcus &#948;-Toxin Induces Allergic Skin Disease by Activating Mast Cells</article-title><source>Nature</source><year>2013</year><volume>503</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/nature12655</pub-id><pub-id pub-id-type="pmid">24172897</pub-id><pub-id pub-id-type="pmcid">PMC4090780</pub-id></element-citation></ref><ref id="B52-pathogens-14-00185"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Syed</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Clark</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Boles</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Kahlenberg</surname><given-names>J.M.</given-names></name></person-group><article-title>Staphlyococcus Aureus Phenol-Soluble Modulins Stimulate the Release of Proinflammatory Cytokines from Keratinocytes and Are Required for Induction of Skin Inflammation</article-title><source>Infect. Immun.</source><year>2015</year><volume>83</volume><fpage>3428</fpage><lpage>3437</lpage><pub-id pub-id-type="doi">10.1128/IAI.00401-15</pub-id><pub-id pub-id-type="pmid">26077761</pub-id><pub-id pub-id-type="pmcid">PMC4534673</pub-id></element-citation></ref><ref id="B53-pathogens-14-00185"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name></person-group><article-title>Global Epidemiology of Atopic Dermatitis: A Comprehensive Systematic Analysis and Modelling Study</article-title><source>Br. J. Dermatol.</source><year>2023</year><volume>190</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1093/bjd/ljad339</pub-id><pub-id pub-id-type="pmid">37705227</pub-id></element-citation></ref><ref id="B54-pathogens-14-00185"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudikoff</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lebwohl</surname><given-names>M.</given-names></name></person-group><article-title>Atopic Dermatitis</article-title><source>Lancet</source><year>1998</year><volume>351</volume><fpage>1715</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)12082-7</pub-id><pub-id pub-id-type="pmid">9734903</pub-id></element-citation></ref><ref id="B55-pathogens-14-00185"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>J.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>E.L.</given-names></name></person-group><article-title>The Socioeconomics of Atopic Dermatitis</article-title><source>Ann. Allergy Asthma Immunol.</source><year>2019</year><volume>122</volume><fpage>360</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.anai.2018.12.017</pub-id><pub-id pub-id-type="pmid">30597208</pub-id></element-citation></ref><ref id="B56-pathogens-14-00185"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christaki</surname><given-names>E.</given-names></name><name name-style="western"><surname>Giamarellos-Bourboulis</surname><given-names>E.J.</given-names></name></person-group><article-title>The Complex Pathogenesis of Bacteremia</article-title><source>Virulence</source><year>2014</year><volume>5</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.4161/viru.26514</pub-id><pub-id pub-id-type="pmid">24067507</pub-id><pub-id pub-id-type="pmcid">PMC3916384</pub-id></element-citation></ref><ref id="B57-pathogens-14-00185"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nutman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wullfhart</surname><given-names>L.</given-names></name><name name-style="western"><surname>Temkin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Schechner</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schwaber</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Carmeli</surname><given-names>Y.</given-names></name></person-group><article-title>Hospital-Onset Bloodstream Infections Caused by Eight Sentinel Bacteria: A Nationwide Study in Israel, 2018&#8211;2019</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><elocation-id>1009</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms10051009</pub-id><pub-id pub-id-type="pmid">35630452</pub-id><pub-id pub-id-type="pmcid">PMC9147328</pub-id></element-citation></ref><ref id="B58-pathogens-14-00185"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hung</surname><given-names>Y.P.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>W.C.</given-names></name></person-group><article-title>Age-Related Trends in Adults with Community-Onset Bacteremia</article-title><source>Antimicrob. Agents Chemother.</source><year>2017</year><volume>61</volume><pub-id pub-id-type="doi">10.1128/AAC.01050-17</pub-id><pub-id pub-id-type="pmid">28923864</pub-id><pub-id pub-id-type="pmcid">PMC5700340</pub-id></element-citation></ref><ref id="B59-pathogens-14-00185"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gatica</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fuentes</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rivera-As&#237;n</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ram&#237;rez-C&#233;spedes</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sep&#250;lveda-Alfaro</surname><given-names>J.</given-names></name><name name-style="western"><surname>Catal&#225;n</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Kalergis</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>F.</given-names></name><name name-style="western"><surname>Riedel</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>Novel Evidence on Sepsis-Inducing Pathogens: From Laboratory to Bedside</article-title><source>Front. Microbiol.</source><year>2023</year><volume>14</volume><elocation-id>1198200</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2023.1198200</pub-id><pub-id pub-id-type="pmid">37426029</pub-id><pub-id pub-id-type="pmcid">PMC10327444</pub-id></element-citation></ref><ref id="B60-pathogens-14-00185"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>C.</given-names></name></person-group><article-title>Epidemiology, Risk Factors and Outcomes of Bloodstream Infection Caused by ESKAPEEc Pathogens among Hospitalized Children</article-title><source>BMC Pediatr.</source><year>2021</year><volume>21</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.1186/s12887-021-02661-9</pub-id><pub-id pub-id-type="pmid">33882891</pub-id><pub-id pub-id-type="pmcid">PMC8059001</pub-id></element-citation></ref><ref id="B61-pathogens-14-00185"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mihara</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>J.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sawa</surname><given-names>T.</given-names></name></person-group><article-title>Relationship between Mortality and Molecular Epidemiology of Methicillin-Resistant Staphylococcus Aureus Bacteremia</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0271115</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0271115</pub-id><pub-id pub-id-type="pmid">35802589</pub-id><pub-id pub-id-type="pmcid">PMC9269358</pub-id></element-citation></ref><ref id="B62-pathogens-14-00185"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fenoll</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>P&#233;rez</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Bayo</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Mill&#225;n</surname><given-names>V.F.</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>M.C.M.</given-names></name><name name-style="western"><surname>&#193;lvarez</surname><given-names>R.M.M.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>M.P.P.</given-names></name><name name-style="western"><surname>Us&#243;n</surname><given-names>M.C.V.</given-names></name><name name-style="western"><surname>Paesa</surname><given-names>C.R.</given-names></name></person-group><article-title>Clinical Characteristics and Prognosis of Staphylococcus Aureus Bacteremia</article-title><source>Rev. Esp. De. Quimioter.</source><year>2022</year><volume>35</volume><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.37201/REQ/035.2022</pub-id><pub-id pub-id-type="pmcid">PMC9728609</pub-id><pub-id pub-id-type="pmid">36205230</pub-id></element-citation></ref><ref id="B63-pathogens-14-00185"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huttunen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Aittoniemi</surname><given-names>J.</given-names></name></person-group><article-title>New Concepts in the Pathogenesis, Diagnosis and Treatment of Bacteremia and Sepsis</article-title><source>J. Infect.</source><year>2011</year><volume>63</volume><fpage>407</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2011.08.004</pub-id><pub-id pub-id-type="pmid">21840338</pub-id></element-citation></ref><ref id="B64-pathogens-14-00185"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatli-Kis</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yildirim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bicmen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kirakli</surname><given-names>C.</given-names></name></person-group><article-title>Early Detection of Bacteremia Pathogens with Rapid Molecular Diagnostic Tests and Evaluation of Effect on Intensive Care Patient Management</article-title><source>Diagn. Microbiol. Infect. Dis.</source><year>2024</year><volume>110</volume><elocation-id>116424</elocation-id><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2024.116424</pub-id><pub-id pub-id-type="pmid">38996775</pub-id></element-citation></ref><ref id="B65-pathogens-14-00185"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#377;r&#243;d&#322;owski</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sobo&#324;ska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Salamon</surname><given-names>D.</given-names></name><name name-style="western"><surname>McFarlane</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Zi&#281;tkiewicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gosiewski</surname><given-names>T.</given-names></name></person-group><article-title>Classical Microbiological Diagnostics of Bacteremia: Are the Negative Results Really Negative? What Is the Laboratory Result Telling Us About the &#8220;Gold Standard&#8221;?</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>346</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8030346</pub-id><pub-id pub-id-type="pmid">32121353</pub-id><pub-id pub-id-type="pmcid">PMC7143506</pub-id></element-citation></ref><ref id="B66-pathogens-14-00185"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudiol</surname><given-names>F.</given-names></name><name name-style="western"><surname>Aguado</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Almirante</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bouza</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cercenado</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dom&#237;nguez</surname><given-names>M.&#193;.</given-names></name><name name-style="western"><surname>Gasch</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lora-Tamayo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mir&#243;</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Palomar</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Diagnosis and Treatment of Bacteremia and Endocarditis Due to Staphylococcus Aureus. A Clinical Guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)</article-title><source>Enferm. Infecc. Microbiol. Clin.</source><year>2015</year><volume>33</volume><fpage>625.e1</fpage><lpage>625.e23</lpage><pub-id pub-id-type="doi">10.1016/j.eimc.2015.03.015</pub-id><pub-id pub-id-type="pmid">25937457</pub-id></element-citation></ref><ref id="B67-pathogens-14-00185"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westgeest</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Buis</surname><given-names>D.T.P.</given-names></name><name name-style="western"><surname>Sigaloff</surname><given-names>K.C.E.</given-names></name><name name-style="western"><surname>Ruffin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Visser</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Schippers</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Lambregts</surname><given-names>M.M.C.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>S.Y.C.</given-names></name><name name-style="western"><surname>De Boer</surname><given-names>M.G.J.</given-names></name><etal/></person-group><article-title>Global Differences in the Management of Staphylococcus Aureus Bacteremia: No International Standard of Care</article-title><source>Clin. Infect. Dis.</source><year>2023</year><volume>77</volume><fpage>1092</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1093/cid/ciad363</pub-id><pub-id pub-id-type="pmid">37310693</pub-id><pub-id pub-id-type="pmcid">PMC10573727</pub-id></element-citation></ref><ref id="B68-pathogens-14-00185"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Hal</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Vaska</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Espedido</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Gosbell</surname><given-names>I.B.</given-names></name></person-group><article-title>Predictors of Mortality in Staphylococcus Aureus Bacteremia</article-title><source>Clin. Microbiol. Rev.</source><year>2012</year><volume>25</volume><fpage>362</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1128/CMR.05022-11</pub-id><pub-id pub-id-type="pmid">22491776</pub-id><pub-id pub-id-type="pmcid">PMC3346297</pub-id></element-citation></ref><ref id="B69-pathogens-14-00185"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonald</surname><given-names>J.R.</given-names></name></person-group><article-title>Acute Infective Endocarditis</article-title><source>Infect. Dis. Clin. N. Am.</source><year>2009</year><volume>23</volume><fpage>643</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1016/j.idc.2009.04.013</pub-id><pub-id pub-id-type="pmid">19665088</pub-id><pub-id pub-id-type="pmcid">PMC2726828</pub-id></element-citation></ref><ref id="B70-pathogens-14-00185"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Klein</surname><given-names>J.L.</given-names></name></person-group><article-title>Infective Endocarditis: A Contemporary Update</article-title><source>Clin. Med.</source><year>2020</year><volume>20</volume><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.7861/clinmed.cme.20.1.1</pub-id><pub-id pub-id-type="pmid">31941729</pub-id><pub-id pub-id-type="pmcid">PMC6964163</pub-id></element-citation></ref><ref id="B71-pathogens-14-00185"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holland</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Baddour</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Hoen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Miro</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>V.G.</given-names></name></person-group><article-title>Infective Endocarditis</article-title><source>Nat. Rev. Dis. Primers</source><year>2016</year><volume>2</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/nrdp.2016.59</pub-id><pub-id pub-id-type="pmcid">PMC5240923</pub-id><pub-id pub-id-type="pmid">27582414</pub-id></element-citation></ref><ref id="B72-pathogens-14-00185"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nappi</surname><given-names>F.</given-names></name></person-group><article-title>Native Infective Endocarditis: A State-of-the-Art-Review</article-title><source>Microorganisms</source><year>2024</year><volume>12</volume><elocation-id>1481</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms12071481</pub-id><pub-id pub-id-type="pmid">39065249</pub-id><pub-id pub-id-type="pmcid">PMC11278776</pub-id></element-citation></ref><ref id="B73-pathogens-14-00185"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunne</surname><given-names>B.</given-names></name><name name-style="western"><surname>Marr</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>D.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>M.</given-names></name><name name-style="western"><surname>Merry</surname><given-names>C.</given-names></name><name name-style="western"><surname>Larbalestier</surname><given-names>R.</given-names></name></person-group><article-title>Infective Endocarditis</article-title><source>Heart Lung Circ.</source><year>2014</year><volume>23</volume><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.hlc.2014.02.010</pub-id><pub-id pub-id-type="pmid">24717864</pub-id></element-citation></ref><ref id="B74-pathogens-14-00185"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murdoch</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Corey</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Hoen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mir&#243;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Karchmer</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Olaison</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Moreillon</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis&#8211;Prospective Cohort Study</article-title><source>Arch. Intern. Med.</source><year>2009</year><volume>169</volume><fpage>463</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1001/archinternmed.2008.603</pub-id><pub-id pub-id-type="pmid">19273776</pub-id><pub-id pub-id-type="pmcid">PMC3625651</pub-id></element-citation></ref><ref id="B75-pathogens-14-00185"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salgado-Pab&#243;n</surname><given-names>W.</given-names></name><name name-style="western"><surname>Breshears</surname><given-names>L.</given-names></name><name name-style="western"><surname>Spaulding</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Merriman</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Stach</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Schlievert</surname><given-names>P.M.</given-names></name></person-group><article-title>Superantigens Are Critical for Staphylococcus Aureus Infective Endocarditis, Sepsis, and Acute Kidney Injury</article-title><source>mBio</source><year>2013</year><volume>4</volume><fpage>e00494-13</fpage><pub-id pub-id-type="doi">10.1128/mBio.00494-13</pub-id><pub-id pub-id-type="pmid">23963178</pub-id><pub-id pub-id-type="pmcid">PMC3747586</pub-id></element-citation></ref><ref id="B76-pathogens-14-00185"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cimmino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bottino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Formisano</surname><given-names>T.</given-names></name><name name-style="western"><surname>Orlandi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Molinari</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sperlongano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Castaldo</surname><given-names>P.</given-names></name><name name-style="western"><surname>D&#8217;Elia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>A.</given-names></name><name name-style="western"><surname>Palladino</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management</article-title><source>Life</source><year>2023</year><volume>13</volume><elocation-id>377</elocation-id><pub-id pub-id-type="doi">10.3390/life13020377</pub-id><pub-id pub-id-type="pmid">36836734</pub-id><pub-id pub-id-type="pmcid">PMC9965398</pub-id></element-citation></ref><ref id="B77-pathogens-14-00185"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkhouli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>F.</given-names></name><name name-style="western"><surname>Alhajji</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berzingi</surname><given-names>C.O.</given-names></name><name name-style="western"><surname>Sohail</surname><given-names>M.R.</given-names></name></person-group><article-title>Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States</article-title><source>Mayo Clin. Proc.</source><year>2020</year><volume>95</volume><fpage>858</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2019.08.023</pub-id><pub-id pub-id-type="pmid">31902529</pub-id></element-citation></ref><ref id="B78-pathogens-14-00185"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urish</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Cassat</surname><given-names>J.E.</given-names></name></person-group><article-title>Staphylococcus Aureus Osteomyelitis: Bone, Bugs, and Surgery</article-title><source>Infect. Immun.</source><year>2020</year><volume>88</volume><pub-id pub-id-type="doi">10.1128/IAI.00932-19</pub-id><pub-id pub-id-type="pmid">32094258</pub-id><pub-id pub-id-type="pmcid">PMC7309607</pub-id></element-citation></ref><ref id="B79-pathogens-14-00185"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavanagh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Widaa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sexton</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fennell</surname><given-names>J.</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Kearney</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Kerrigan</surname><given-names>S.W.</given-names></name></person-group><article-title>Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions</article-title><source>Clin. Microbiol. Rev.</source><year>2018</year><volume>31</volume><fpage>e00084-17</fpage><pub-id pub-id-type="doi">10.1128/CMR.00084-17</pub-id><pub-id pub-id-type="pmid">29444953</pub-id><pub-id pub-id-type="pmcid">PMC5967688</pub-id></element-citation></ref><ref id="B80-pathogens-14-00185"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jorge</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Chueire</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Baptista Rossit</surname><given-names>A.R.</given-names></name></person-group><article-title>Osteomyelitis: A Current Challenge</article-title><source>Braz. J. Infect. Dis.</source><year>2010</year><volume>14</volume><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/S1413-8670(10)70063-5</pub-id><pub-id pub-id-type="pmid">20835519</pub-id></element-citation></ref><ref id="B81-pathogens-14-00185"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettencourt</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bettencourt</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>M.</given-names></name></person-group><article-title>Osteomyelitis: An Overview of Antimicrobial Therapy</article-title><source>Braz. J. Pharm. Sci.</source><year>2013</year><volume>49</volume><fpage>13</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1590/S1984-82502013000100003</pub-id></element-citation></ref><ref id="B82-pathogens-14-00185"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masters</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Ricciardi</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Bentley</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Moriarty</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Muthukrishnan</surname><given-names>G.</given-names></name></person-group><article-title>Skeletal Infections: Microbial Pathogenesis, Immunity and Clinical Management</article-title><source>Nat. Rev. Microbiol.</source><year>2022</year><volume>20</volume><fpage>385</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/s41579-022-00686-0</pub-id><pub-id pub-id-type="pmid">35169289</pub-id><pub-id pub-id-type="pmcid">PMC8852989</pub-id></element-citation></ref><ref id="B83-pathogens-14-00185"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.Q.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Z.D.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>L.</given-names></name></person-group><article-title>Current Opinions on the Mechanism, Classification, Imaging Diagnosis and Treatment of Post-Traumatic Osteomyelitis</article-title><source>Chin. J. Traumatol.</source><year>2021</year><volume>24</volume><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/j.cjtee.2021.07.006</pub-id><pub-id pub-id-type="pmid">34429227</pub-id><pub-id pub-id-type="pmcid">PMC8606609</pub-id></element-citation></ref><ref id="B84-pathogens-14-00185"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Marriott</surname><given-names>I.</given-names></name><name name-style="western"><surname>Anguita</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bost</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>M.C.</given-names></name></person-group><article-title>Staphylococcus Aureus&#8212;Induced Tumor Necrosis Factor&#8212;Related Apoptosis&#8212;Inducing Ligand Expression Mediates Apoptosis and Caspase-8 Activation in Infected Osteoblasts</article-title><source>BMC Microbiol.</source><year>2003</year><volume>3</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-3-5</pub-id><pub-id pub-id-type="pmid">12697056</pub-id><pub-id pub-id-type="pmcid">PMC154098</pub-id></element-citation></ref><ref id="B85-pathogens-14-00185"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claro</surname><given-names>T.</given-names></name><name name-style="western"><surname>Widaa</surname><given-names>A.</given-names></name><name name-style="western"><surname>McDonnell</surname><given-names>C.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Kerrigan</surname><given-names>S.W.</given-names></name></person-group><article-title>Staphylococcus Aureus Protein A Binding to Osteoblast Tumour Necrosis Factor Receptor 1 Results in Activation of Nuclear Factor Kappa B and Release of Interleukin-6 in Bone Infection</article-title><source>Microbiology</source><year>2013</year><volume>159</volume><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1099/mic.0.063016-0</pub-id><pub-id pub-id-type="pmid">23154968</pub-id></element-citation></ref><ref id="B86-pathogens-14-00185"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kremers</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Nwojo</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Ransom</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Wood-Wentz</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Joseph Melton</surname><given-names>L.</given-names></name><name name-style="western"><surname>Huddleston</surname><given-names>P.M.</given-names></name></person-group><article-title>Trends in the Epidemiology of Osteomyelitis a Population-Based Study, 1969 to 2009</article-title><source>J. Bone Jt. Surg. Am. Vol.</source><year>2014</year><volume>97</volume><fpage>837</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.2106/JBJS.N.01350</pub-id><pub-id pub-id-type="pmid">25995495</pub-id><pub-id pub-id-type="pmcid">PMC4642868</pub-id></element-citation></ref><ref id="B87-pathogens-14-00185"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>N.</given-names></name><name name-style="western"><surname>B&#228;rtl</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alt</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rupp</surname><given-names>M.</given-names></name></person-group><article-title>The Epidemiology of Osteomyelitis in Children</article-title><source>Children</source><year>2021</year><volume>8</volume><elocation-id>1000</elocation-id><pub-id pub-id-type="doi">10.3390/children8111000</pub-id><pub-id pub-id-type="pmid">34828711</pub-id><pub-id pub-id-type="pmcid">PMC8621985</pub-id></element-citation></ref><ref id="B88-pathogens-14-00185"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deutschman</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Seymour</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shankar-Hari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Annane</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bellomo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Chiche</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Coopersmith</surname><given-names>C.M.</given-names></name><etal/></person-group><article-title>The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id><pub-id pub-id-type="pmid">26903338</pub-id><pub-id pub-id-type="pmcid">PMC4968574</pub-id></element-citation></ref><ref id="B89-pathogens-14-00185"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruotsalainen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sammalkorpi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Laine</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huotari</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sarna</surname><given-names>S.</given-names></name><name name-style="western"><surname>Valtonen</surname><given-names>V.</given-names></name><name name-style="western"><surname>J&#228;rvinen</surname><given-names>A.</given-names></name></person-group><article-title>Clinical Manifestations and Outcome in Staphylococcus Aureus Endocarditis among Injection Drug Users and Nonaddicts: A Prospective Study of 74 Patients</article-title><source>BMC Infect. Dis.</source><year>2006</year><volume>6</volume><elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-6-137</pub-id><pub-id pub-id-type="pmid">16965625</pub-id><pub-id pub-id-type="pmcid">PMC1584240</pub-id></element-citation></ref><ref id="B90-pathogens-14-00185"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paulsen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mehl</surname><given-names>A.</given-names></name><name name-style="western"><surname>Askim</surname><given-names>&#197;.</given-names></name><name name-style="western"><surname>Sollig&#229;rd</surname><given-names>E.</given-names></name><name name-style="western"><surname>&#197;svold</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Dam&#229;s</surname><given-names>J.K.</given-names></name></person-group><article-title>Epidemiology and Outcome of Staphylococcus Aureus Bloodstream Infection and Sepsis in a Norwegian County 1996-2011: An Observational Study</article-title><source>BMC Infect. Dis.</source><year>2015</year><volume>15</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-015-0849-4</pub-id><pub-id pub-id-type="pmid">25887177</pub-id><pub-id pub-id-type="pmcid">PMC4351681</pub-id></element-citation></ref><ref id="B91-pathogens-14-00185"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nabera</surname><given-names>C.K.</given-names></name></person-group><article-title>Staphylococcus Aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies</article-title><source>Clin. Infect. Dis.</source><year>2009</year><volume>48</volume><fpage>S231</fpage><lpage>S237</lpage><pub-id pub-id-type="doi">10.1086/598189</pub-id><pub-id pub-id-type="pmid">19374578</pub-id></element-citation></ref><ref id="B92-pathogens-14-00185"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwiecinski</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.R.</given-names></name></person-group><article-title>Staphylococcus Aureus Bloodstream Infections: Pathogenesis and Regulatory Mechanisms</article-title><source>Curr. Opin. Microbiol.</source><year>2020</year><volume>53</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2020.02.005</pub-id><pub-id pub-id-type="pmid">32172183</pub-id><pub-id pub-id-type="pmcid">PMC7244392</pub-id></element-citation></ref><ref id="B93-pathogens-14-00185"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q.L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Sepsis-Induced Immunosuppression: Mechanisms, Diagnosis and Current Treatment Options</article-title><source>Mil. Med. Res.</source><year>2022</year><volume>9</volume><fpage>56</fpage><pub-id pub-id-type="doi">10.1186/s40779-022-00422-y</pub-id><pub-id pub-id-type="pmid">36209190</pub-id><pub-id pub-id-type="pmcid">PMC9547753</pub-id></element-citation></ref><ref id="B94-pathogens-14-00185"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fournier</surname><given-names>B.</given-names></name><name name-style="western"><surname>Philpott</surname><given-names>D.J.</given-names></name></person-group><article-title>Recognition of Staphylococcus Aureus by the Innate Immune System</article-title><source>Clin. Microbiol. Rev.</source><year>2005</year><volume>18</volume><elocation-id>521</elocation-id><pub-id pub-id-type="doi">10.1128/CMR.18.3.521-540.2005</pub-id><pub-id pub-id-type="pmid">16020688</pub-id><pub-id pub-id-type="pmcid">PMC1195972</pub-id></element-citation></ref><ref id="B95-pathogens-14-00185"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rhodes</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alhazzani</surname><given-names>W.</given-names></name><name name-style="western"><surname>Antonelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Coopersmith</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>French</surname><given-names>C.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Mcintyre</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ostermann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>H.C.</given-names></name><etal/></person-group><article-title>Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021</article-title><source>Intensive Care Med.</source><year>2021</year><volume>47</volume><fpage>1181</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1007/s00134-021-06506-y</pub-id><pub-id pub-id-type="pmid">34599691</pub-id><pub-id pub-id-type="pmcid">PMC8486643</pub-id></element-citation></ref><ref id="B96-pathogens-14-00185"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srzi&#263;</surname><given-names>I.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>V.N.</given-names></name><name name-style="western"><surname>Pejak</surname><given-names>D.T.</given-names></name></person-group><article-title>Sepsis Definition: What&#8217;s New in the Treatment Guidelines</article-title><source>Acta Clin. Croat.</source><year>2022</year><volume>61</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.20471/acc.2022.61.s1.11</pub-id><pub-id pub-id-type="pmid">36304809</pub-id><pub-id pub-id-type="pmcid">PMC9536156</pub-id></element-citation></ref><ref id="B97-pathogens-14-00185"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudd</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Agesa</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Shackelford</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Tsoi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kievlan</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Colombara</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Ikuta</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Kissoon</surname><given-names>N.</given-names></name><name name-style="western"><surname>Finfer</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Global, Regional, and National Sepsis Incidence and Mortality, 1990&#8211;2017: Analysis for the Global Burden of Disease Study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id><pub-id pub-id-type="pmid">31954465</pub-id><pub-id pub-id-type="pmcid">PMC6970225</pub-id></element-citation></ref><ref id="B98-pathogens-14-00185"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santacroce</surname><given-names>E.</given-names></name><name name-style="western"><surname>D&#8217;Angerio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ciobanu</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Masini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lo Tartaro</surname><given-names>D.</given-names></name><name name-style="western"><surname>Coloretti</surname><given-names>I.</given-names></name><name name-style="western"><surname>Busani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rubio</surname><given-names>I.</given-names></name><name name-style="western"><surname>Meschiari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Franceschini</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Advances and Challenges in Sepsis Management: Modern Tools and Future Directions</article-title><source>Cells</source><year>2024</year><volume>13</volume><elocation-id>439</elocation-id><pub-id pub-id-type="doi">10.3390/cells13050439</pub-id><pub-id pub-id-type="pmid">38474403</pub-id><pub-id pub-id-type="pmcid">PMC10931424</pub-id></element-citation></ref><ref id="B99-pathogens-14-00185"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleischmann-Struzek</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rudd</surname><given-names>K.</given-names></name></person-group><article-title>Challenges of Assessing the Burden of Sepsis</article-title><source>Med. Klin. Intensiv. Notfallmedizin</source><year>2023</year><volume>118</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s00063-023-01088-7</pub-id><pub-id pub-id-type="pmid">37975898</pub-id><pub-id pub-id-type="pmcid">PMC10733211</pub-id></element-citation></ref><ref id="B100-pathogens-14-00185"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oami</surname><given-names>T.</given-names></name><name name-style="western"><surname>Imaeda</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nakada</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Abe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yamao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ogura</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shime</surname><given-names>N.</given-names></name><name name-style="western"><surname>Umemura</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Temporal Trends of Medical Cost and Cost-Effectiveness in Sepsis Patients: A Japanese Nationwide Medical Claims Database</article-title><source>J. Intensive Care</source><year>2022</year><volume>10</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s40560-022-00624-5</pub-id><pub-id pub-id-type="pmid">35836301</pub-id><pub-id pub-id-type="pmcid">PMC9281011</pub-id></element-citation></ref><ref id="B101-pathogens-14-00185"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodgin</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Moss</surname><given-names>M.</given-names></name></person-group><article-title>The Epidemiology of Sepsis</article-title><source>Curr. Pharm. Des.</source><year>2008</year><volume>14</volume><fpage>1833</fpage><lpage>1839</lpage><pub-id pub-id-type="doi">10.2174/138161208784980590</pub-id><pub-id pub-id-type="pmid">18691094</pub-id></element-citation></ref><ref id="B102-pathogens-14-00185"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colavite</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Sartori</surname><given-names>A.</given-names></name></person-group><article-title>Septic Arthritis: Immunopathogenesis, Experimental Models and Therapy</article-title><source>J. Venom. Anim. Toxins Incl. Trop. Dis.</source><year>2014</year><volume>20</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1678-9199-20-19</pub-id><pub-id pub-id-type="pmid">24822058</pub-id><pub-id pub-id-type="pmcid">PMC4017707</pub-id></element-citation></ref><ref id="B103-pathogens-14-00185"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirtliff</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Mader</surname><given-names>J.T.</given-names></name></person-group><article-title>Acute Septic Arthritis</article-title><source>Clin. Microbiol. Rev.</source><year>2002</year><volume>15</volume><fpage>527</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1128/CMR.15.4.527-544.2002</pub-id><pub-id pub-id-type="pmid">12364368</pub-id><pub-id pub-id-type="pmcid">PMC126863</pub-id></element-citation></ref><ref id="B104-pathogens-14-00185"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Hyun</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Seong</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>Clinical Characteristics and Causative Pathogens of Infective Arthritis and Risk Factors for Gram-Negative Bacterial Infections</article-title><source>Infect. Chemother.</source><year>2020</year><volume>52</volume><fpage>503</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.3947/ic.2020.52.4.503</pub-id><pub-id pub-id-type="pmid">33377320</pub-id><pub-id pub-id-type="pmcid">PMC7779980</pub-id></element-citation></ref><ref id="B105-pathogens-14-00185"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>M.</given-names></name><name name-style="western"><surname>Arthur Vithran</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name></person-group><article-title>An Update on Recent Progress of the Epidemiology, Etiology, Diagnosis, and Treatment of Acute Septic Arthritis: A Review</article-title><source>Front. Cell Infect. Microbiol.</source><year>2023</year><volume>13</volume><elocation-id>1193645</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1193645</pub-id><pub-id pub-id-type="pmid">37249986</pub-id><pub-id pub-id-type="pmcid">PMC10214960</pub-id></element-citation></ref><ref id="B106-pathogens-14-00185"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Massey</surname><given-names>R.C.</given-names></name></person-group><article-title>How Does Staphylococcus Aureus Escape the Bloodstream?</article-title><source>Trends Microbiol.</source><year>2011</year><volume>19</volume><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2010.12.005</pub-id><pub-id pub-id-type="pmid">21227700</pub-id></element-citation></ref><ref id="B107-pathogens-14-00185"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Arias</surname><given-names>M.</given-names></name><name name-style="western"><surname>Balsa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mola</surname><given-names>E.M.</given-names></name></person-group><article-title>Septic Arthritis</article-title><source>Best. Pract. Res. Clin. Rheumatol.</source><year>2011</year><volume>25</volume><fpage>407</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2011.02.001</pub-id><pub-id pub-id-type="pmid">22100289</pub-id></element-citation></ref><ref id="B108-pathogens-14-00185"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Novel Therapeutic Interventions towards Improved Management of Septic Arthritis</article-title><source>BMC Musculoskelet. Disord.</source><year>2021</year><volume>22</volume><elocation-id>530</elocation-id><pub-id pub-id-type="doi">10.1186/s12891-021-04383-6</pub-id><pub-id pub-id-type="pmid">34107951</pub-id><pub-id pub-id-type="pmcid">PMC8191206</pub-id></element-citation></ref><ref id="B109-pathogens-14-00185"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staurengo-Ferrari</surname><given-names>L.</given-names></name><name name-style="western"><surname>Trevelin</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Fattori</surname><given-names>V.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>de Lima</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Pelayo</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Casagrande</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fukada</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>M.M.</given-names></name><etal/></person-group><article-title>Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus Aureus-Induced Septic Arthritis</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>962</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00962</pub-id><pub-id pub-id-type="pmid">29867945</pub-id><pub-id pub-id-type="pmcid">PMC5968393</pub-id></element-citation></ref><ref id="B110-pathogens-14-00185"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papathanasiou</surname><given-names>I.</given-names></name><name name-style="western"><surname>Malizos</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Poultsides</surname><given-names>L.</given-names></name><name name-style="western"><surname>Karachalios</surname><given-names>T.</given-names></name><name name-style="western"><surname>Oikonomou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tsezou</surname><given-names>A.</given-names></name></person-group><article-title>The Catabolic Role of Toll-like Receptor 2 (TLR-2) Mediated by the NF-&#922;B Pathway in Septic Arthritis</article-title><source>J. Orthop. Res.</source><year>2011</year><volume>29</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1002/jor.21239</pub-id><pub-id pub-id-type="pmid">20740673</pub-id></element-citation></ref><ref id="B111-pathogens-14-00185"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanangat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Postlethwaite</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hasty</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smeltzer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Appling</surname><given-names>W.</given-names></name><name name-style="western"><surname>Schaberg</surname><given-names>D.</given-names></name></person-group><article-title>Induction of Multiple Matrix Metalloproteinases in Human Dermal and Synovial Fibroblasts by Staphylococcus Aureus: Implications in the Pathogenesis of Septic Arthritis and Other Soft Tissue Infections</article-title><source>Arthritis Res. Ther.</source><year>2006</year><volume>8</volume><fpage>R176</fpage><pub-id pub-id-type="doi">10.1186/ar2086</pub-id><pub-id pub-id-type="pmid">17129374</pub-id><pub-id pub-id-type="pmcid">PMC1794521</pub-id></element-citation></ref><ref id="B112-pathogens-14-00185"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Kajiyama</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schurman</surname><given-names>D.J.</given-names></name></person-group><article-title>Staphylococcal Septic Arthritis: Antibiotic and Nonsteroidal Anti-Inflammatory Drug Treatment in a Rabbit Model</article-title><source>J. Orthop. Res.</source><year>1997</year><volume>15</volume><fpage>919</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1002/jor.1100150619</pub-id><pub-id pub-id-type="pmid">9497819</pub-id></element-citation></ref><ref id="B113-pathogens-14-00185"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakiniene</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bremell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>Addition of Corticosteroids to Antibiotic Treatment Ameliorates the Course of Experimental Staphylococcus Aureus Arthritis</article-title><source>Arthritis Rheum.</source><year>1996</year><volume>39</volume><fpage>1596</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1002/art.1780390921</pub-id><pub-id pub-id-type="pmid">8814072</pub-id></element-citation></ref><ref id="B114-pathogens-14-00185"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McBride</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mowbray</surname><given-names>J.</given-names></name><name name-style="western"><surname>Caughey</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>E.</given-names></name><name name-style="western"><surname>Luey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Playle</surname><given-names>V.</given-names></name><name name-style="western"><surname>Askelund</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults</article-title><source>Clin. Infect. Dis.</source><year>2020</year><volume>70</volume><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1093/cid/ciz265</pub-id><pub-id pub-id-type="pmid">30941403</pub-id></element-citation></ref><ref id="B115-pathogens-14-00185"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chassagne</surname><given-names>P.</given-names></name></person-group><article-title>Is Presentation of Bacteremia in the Elderly the Same as in Younger Patients?</article-title><source>Am. J. Med.</source><year>1996</year><volume>100</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0002-9343(96)90013-3</pub-id><pub-id pub-id-type="pmid">8579089</pub-id></element-citation></ref><ref id="B116-pathogens-14-00185"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Southgate</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>He</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Nanamori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>R.D.</given-names></name></person-group><article-title>Identification of Formyl Peptides from Listeria Monocytogenes and Staphylococcus Aureus as Potent Chemoattractants for Mouse Neutrophils</article-title><source>J. Immunol.</source><year>2008</year><volume>181</volume><fpage>1429</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.2.1429</pub-id><pub-id pub-id-type="pmid">18606697</pub-id><pub-id pub-id-type="pmcid">PMC2705627</pub-id></element-citation></ref><ref id="B117-pathogens-14-00185"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Braughton</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Kretschmer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bach</surname><given-names>T.H.L.</given-names></name><name name-style="western"><surname>Queck</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Dorward</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Klebanoff</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Identification of Novel Cytolytic Peptides as Key Virulence Determinants for Community-Associated MRSA</article-title><source>Nat. Med.</source><year>2007</year><volume>13</volume><fpage>1510</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1038/nm1656</pub-id><pub-id pub-id-type="pmid">17994102</pub-id></element-citation></ref><ref id="B118-pathogens-14-00185"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staurengo-Ferrari</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ruiz-Miyazawa</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Pinho-Ribeiro</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Domiciano</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Fattori</surname><given-names>V.</given-names></name><name name-style="western"><surname>Mizokami</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Pelayo</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Bordignon</surname><given-names>J.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Casagrande</surname><given-names>R.</given-names></name><etal/></person-group><article-title>The Nitroxyl Donor Angeli&#8217;s Salt Ameliorates Staphylococcus Aureus-Induced Septic Arthritis in Mice</article-title><source>Free Radic. Biol. Med.</source><year>2017</year><volume>108</volume><fpage>487</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.04.016</pub-id><pub-id pub-id-type="pmid">28419865</pub-id></element-citation></ref><ref id="B119-pathogens-14-00185"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keynan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rubinstein</surname><given-names>E.</given-names></name></person-group><article-title>Staphylococcus Aureus Bacteremia, Risk Factors, Complications, and Management</article-title><source>Crit. Care Clin.</source><year>2013</year><volume>29</volume><fpage>547</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.ccc.2013.03.008</pub-id><pub-id pub-id-type="pmid">23830653</pub-id></element-citation></ref><ref id="B120-pathogens-14-00185"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F.S.X.</given-names></name></person-group><article-title>Innate Immune Response of Corneal Epithelial Cells to Staphylococcus Aureus Infection: Role of Peptidoglycan in Stimulating Proinflammatory Cytokine Secretion</article-title><source>Invest. Ophthalmol. Vis. Sci.</source><year>2004</year><volume>45</volume><fpage>3513</fpage><lpage>3522</lpage><pub-id pub-id-type="doi">10.1167/iovs.04-0467</pub-id><pub-id pub-id-type="pmid">15452057</pub-id><pub-id pub-id-type="pmcid">PMC2666393</pub-id></element-citation></ref><ref id="B121-pathogens-14-00185"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#243;mez</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.</given-names></name></person-group><article-title>Airway Epithelial Cell Signaling in Response to Bacterial Pathogens</article-title><source>Pediatr. Pulmonol.</source><year>2008</year><volume>43</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1002/ppul.20735</pub-id><pub-id pub-id-type="pmid">18041080</pub-id></element-citation></ref><ref id="B122-pathogens-14-00185"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorrentino</surname><given-names>R.</given-names></name><name name-style="western"><surname>De Souza</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Sriskandan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Duffin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Paul-Clark</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>J.A.</given-names></name></person-group><article-title>Pattern Recognition Receptors and Interleukin-8 Mediate Effects of Gram-Positive and Gram-Negative Bacteria on Lung Epithelial Cell Function</article-title><source>Br. J. Pharmacol.</source><year>2008</year><volume>154</volume><fpage>864</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1038/bjp.2008.139</pub-id><pub-id pub-id-type="pmid">18536738</pub-id><pub-id pub-id-type="pmcid">PMC2439843</pub-id></element-citation></ref><ref id="B123-pathogens-14-00185"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ning</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name></person-group><article-title>Staphylococcus Aureus Regulates Secretion of Interleukin-6 and Monocyte Chemoattractant Protein-1 through Activation of Nuclear Factor KappaB Signaling Pathway in Human Osteoblasts</article-title><source>Braz. J. Infect. Dis.</source><year>2011</year><volume>15</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/S1413-8670(11)70173-8</pub-id><pub-id pub-id-type="pmid">21670915</pub-id></element-citation></ref><ref id="B124-pathogens-14-00185"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Allen</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>P.R.</given-names></name></person-group><article-title>Tissue-Resident Macrophages</article-title><source>Nat. Immunol.</source><year>2013</year><volume>14</volume><fpage>986</fpage><pub-id pub-id-type="doi">10.1038/ni.2705</pub-id><pub-id pub-id-type="pmid">24048120</pub-id><pub-id pub-id-type="pmcid">PMC4045180</pub-id></element-citation></ref><ref id="B125-pathogens-14-00185"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pamer</surname><given-names>E.G.</given-names></name></person-group><article-title>Monocyte Recruitment during Infection and Inflammation</article-title><source>Nat. Rev. Immunol.</source><year>2011</year><volume>11</volume><fpage>762</fpage><pub-id pub-id-type="doi">10.1038/nri3070</pub-id><pub-id pub-id-type="pmid">21984070</pub-id><pub-id pub-id-type="pmcid">PMC3947780</pub-id></element-citation></ref><ref id="B126-pathogens-14-00185"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auffray</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sieweke</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Geissmann</surname><given-names>F.</given-names></name></person-group><article-title>Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells</article-title><source>Annu. Rev. Immunol.</source><year>2009</year><volume>27</volume><fpage>669</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132557</pub-id><pub-id pub-id-type="pmid">19132917</pub-id></element-citation></ref><ref id="B127-pathogens-14-00185"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Italiani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boraschi</surname><given-names>D.</given-names></name></person-group><article-title>From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><elocation-id>514</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2014.00514</pub-id><pub-id pub-id-type="pmid">25368618</pub-id><pub-id pub-id-type="pmcid">PMC4201108</pub-id></element-citation></ref><ref id="B128-pathogens-14-00185"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surewaard</surname><given-names>B.G.J.</given-names></name><name name-style="western"><surname>Deniset</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Zemp</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Amrein</surname><given-names>M.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Conly</surname><given-names>J.</given-names></name><name name-style="western"><surname>Omri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yates</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P.</given-names></name></person-group><article-title>Identification and Treatment of the Staphylococcus Aureus Reservoir In Vivo</article-title><source>J. Exp. Med.</source><year>2016</year><volume>213</volume><fpage>1141</fpage><pub-id pub-id-type="doi">10.1084/jem.20160334</pub-id><pub-id pub-id-type="pmid">27325887</pub-id><pub-id pub-id-type="pmcid">PMC4925027</pub-id></element-citation></ref><ref id="B129-pathogens-14-00185"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitur</surname><given-names>K.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nieto</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wachtel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.</given-names></name></person-group><article-title>Toxin-Induced Necroptosis Is a Major Mechanism of Staphylococcus Aureus Lung Damage</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><elocation-id>1004820</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004820</pub-id><pub-id pub-id-type="pmid">25880560</pub-id><pub-id pub-id-type="pmcid">PMC4399879</pub-id></element-citation></ref><ref id="B130-pathogens-14-00185"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Harfenist</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Soong</surname><given-names>G.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.</given-names></name></person-group><article-title>Participation of CD11c+ Leukocytes in Methicillin-Resistant Staphylococcus Aureus Clearance from the Lung</article-title><source>Infect. Immun.</source><year>2011</year><volume>79</volume><fpage>1898</fpage><pub-id pub-id-type="doi">10.1128/IAI.01299-10</pub-id><pub-id pub-id-type="pmid">21402768</pub-id><pub-id pub-id-type="pmcid">PMC3088152</pub-id></element-citation></ref><ref id="B131-pathogens-14-00185"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yajjala</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>V.C.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Scherr</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Fey</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Bayles</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K.</given-names></name></person-group><article-title>Resistance to Acute Macrophage Killing Promotes Airway Fitness of Prevalent Community-Acquired Staphylococcus Aureus Strains</article-title><source>J. Immunol.</source><year>2016</year><volume>196</volume><fpage>4196</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600081</pub-id><pub-id pub-id-type="pmid">27053759</pub-id><pub-id pub-id-type="pmcid">PMC4868659</pub-id></element-citation></ref><ref id="B132-pathogens-14-00185"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bearden</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Esen</surname><given-names>N.</given-names></name></person-group><article-title>IL-1 and TNF-Alpha Play a Pivotal Role in the Host Immune Response in a Mouse Model of Staphylococcus Aureus-Induced Experimental Brain Abscess</article-title><source>J. Neuropathol. Exp. Neurol.</source><year>2004</year><volume>63</volume><fpage>381</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1093/jnen/63.4.381</pub-id><pub-id pub-id-type="pmid">15099027</pub-id></element-citation></ref><ref id="B133-pathogens-14-00185"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nandi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name></person-group><article-title>Murine Macrophage Response from Peritoneal Cavity Requires Signals Mediated by Chemokine Receptor CCR-2 during Staphylococcus Aureus Infection</article-title><source>Immunol. Res.</source><year>2016</year><volume>64</volume><fpage>213</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1007/s12026-015-8739-9</pub-id><pub-id pub-id-type="pmid">26616292</pub-id></element-citation></ref><ref id="B134-pathogens-14-00185"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandt</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Klopfenstein</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Winfree</surname><given-names>S.</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Territo</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>L.</given-names></name><name name-style="western"><surname>Serezani</surname><given-names>C.H.</given-names></name></person-group><article-title>Macrophage-Derived LTB4 Promotes Abscess Formation and Clearance of Staphylococcus Aureus Skin Infection in Mice</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><elocation-id>e1007244</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007244</pub-id><pub-id pub-id-type="pmid">30102746</pub-id><pub-id pub-id-type="pmcid">PMC6107286</pub-id></element-citation></ref><ref id="B135-pathogens-14-00185"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Quie</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Michael</surname><given-names>A.F.</given-names></name></person-group><article-title>Activation of Complement by Cell Surface Components of Staphylococcus Aureus</article-title><source>Infect. Immun.</source><year>1978</year><volume>20</volume><fpage>388</fpage><pub-id pub-id-type="doi">10.1128/iai.20.2.388-392.1978</pub-id><pub-id pub-id-type="pmid">669803</pub-id><pub-id pub-id-type="pmcid">PMC421867</pub-id></element-citation></ref><ref id="B136-pathogens-14-00185"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>K.O.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>D.K.</given-names></name></person-group><article-title>Lipoteichoic Acid from Staphylococcus Aureus Activates the Complement System via C3 Induction and Cd55 Inhibition</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>1135</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9061135</pub-id><pub-id pub-id-type="pmid">34074052</pub-id><pub-id pub-id-type="pmcid">PMC8225101</pub-id></element-citation></ref><ref id="B137-pathogens-14-00185"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei&#223;</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schlatterer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>C.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kretschmer</surname><given-names>D.</given-names></name></person-group><article-title>Formyl-Peptide Receptor Activation Enhances Phagocytosis of Community-Acquired Methicillin-Resistant Staphylococcus Aureus</article-title><source>J. Infect. Dis.</source><year>2020</year><volume>221</volume><fpage>668</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz498</pub-id><pub-id pub-id-type="pmid">31573600</pub-id></element-citation></ref><ref id="B138-pathogens-14-00185"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Postma</surname><given-names>B.</given-names></name><name name-style="western"><surname>Poppelier</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>van Galen</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Prossnitz</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name></person-group><article-title>Chemotaxis Inhibitory Protein of Staphylococcus Aureus Binds Specifically to the C5a and Formylated Peptide Receptor</article-title><source>J. Immunol.</source><year>2004</year><volume>172</volume><fpage>6994</fpage><lpage>7001</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.11.6994</pub-id><pub-id pub-id-type="pmid">15153520</pub-id></element-citation></ref><ref id="B139-pathogens-14-00185"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pidwill</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Cole</surname><given-names>J.</given-names></name><name name-style="western"><surname>Renshaw</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>S.J.</given-names></name></person-group><article-title>The Role of Macrophages in Staphylococcus Aureus Infection</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>620339</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.620339</pub-id><pub-id pub-id-type="pmid">33542723</pub-id><pub-id pub-id-type="pmcid">PMC7850989</pub-id></element-citation></ref><ref id="B140-pathogens-14-00185"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Winter</surname><given-names>D.</given-names></name><name name-style="western"><surname>Blecher-Gonen</surname><given-names>R.</given-names></name><name name-style="western"><surname>David</surname><given-names>E.</given-names></name><name name-style="western"><surname>Keren-Shaul</surname><given-names>H.</given-names></name><name name-style="western"><surname>Merad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S.</given-names></name><name name-style="western"><surname>Amit</surname><given-names>I.</given-names></name></person-group><article-title>Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment</article-title><source>Cell</source><year>2014</year><volume>159</volume><fpage>1312</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.018</pub-id><pub-id pub-id-type="pmid">25480296</pub-id><pub-id pub-id-type="pmcid">PMC4437213</pub-id></element-citation></ref><ref id="B141-pathogens-14-00185"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>BoseDasgupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pieters</surname><given-names>J.</given-names></name></person-group><article-title>Inflammatory Stimuli Reprogram Macrophage Phagocytosis to Macropinocytosis for the Rapid Elimination of Pathogens</article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1003879</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003879</pub-id><pub-id pub-id-type="pmid">24497827</pub-id><pub-id pub-id-type="pmcid">PMC3907376</pub-id></element-citation></ref><ref id="B142-pathogens-14-00185"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashimoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tawaratsumida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kariya</surname><given-names>H.</given-names></name><name name-style="western"><surname>Aoyama</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tamura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Suda</surname><given-names>Y.</given-names></name></person-group><article-title>Lipoprotein Is a Predominant Toll-like Receptor 2 Ligand in Staphylococcus Aureus Cell Wall Components</article-title><source>Int. Immunol.</source><year>2006</year><volume>18</volume><fpage>355</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh374</pub-id><pub-id pub-id-type="pmid">16373361</pub-id></element-citation></ref><ref id="B143-pathogens-14-00185"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sanjo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Takada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall Components</article-title><source>Immunity</source><year>1999</year><volume>11</volume><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80119-3</pub-id><pub-id pub-id-type="pmid">10549626</pub-id></element-citation></ref><ref id="B144-pathogens-14-00185"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bandyopadhyay</surname><given-names>D.</given-names></name><name name-style="western"><surname>Majhi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Adhikary</surname><given-names>R.</given-names></name></person-group><article-title>Possible Role of Toll-like Receptor-2 in the Intracellular Survival of Staphylococcus Aureus in Murine Peritoneal Macrophages: Involvement of Cytokines and Anti-Oxidant Enzymes</article-title><source>Scand. J. Immunol.</source><year>2014</year><volume>80</volume><fpage>127</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1111/sji.12195</pub-id><pub-id pub-id-type="pmid">24846691</pub-id></element-citation></ref><ref id="B145-pathogens-14-00185"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Cellular Responses to Bacterial Cell Wall Components Are Mediated through MyD88-Dependent Signaling Cascades</article-title><source>Int. Immunol.</source><year>2000</year><volume>12</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1093/intimm/12.1.113</pub-id><pub-id pub-id-type="pmid">10607756</pub-id></element-citation></ref><ref id="B146-pathogens-14-00185"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus Aureus Infection</article-title><source>J. Immunol.</source><year>2000</year><volume>165</volume><fpage>5392</fpage><lpage>5396</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.165.10.5392</pub-id><pub-id pub-id-type="pmid">11067888</pub-id></element-citation></ref><ref id="B147-pathogens-14-00185"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>The Nuclear Factor Kappa B (NF-&#922;B) Activation Is Required for Phagocytosis of Staphylococcus Aureus by RAW 264.7 Cells</article-title><source>Exp. Cell Res.</source><year>2014</year><volume>327</volume><fpage>256</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2014.04.018</pub-id><pub-id pub-id-type="pmid">24798100</pub-id></element-citation></ref><ref id="B148-pathogens-14-00185"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q.Z.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q.H.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gershwin</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Z.X.</given-names></name></person-group><article-title>Forkhead Box O1 Regulates Macrophage Polarization Following Staphylococcus Aureus Infection: Experimental Murine Data and Review of the Literature</article-title><source>Clin. Rev. Allergy Immunol.</source><year>2016</year><volume>51</volume><fpage>353</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s12016-016-8531-1</pub-id><pub-id pub-id-type="pmid">26924010</pub-id></element-citation></ref><ref id="B149-pathogens-14-00185"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izquierdo Gonzalez</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Hossain</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Neef</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zwack</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Raafat</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fechtner</surname><given-names>K.</given-names></name><name name-style="western"><surname>Herzog</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Schl&#252;ter</surname><given-names>R.</given-names></name><etal/></person-group><article-title>TLR4 Sensing of IsdB of Staphylococcus Aureus Induces a Proinflammatory Cytokine Response via the NLRP3-Caspase-1 Inflammasome Cascade</article-title><source>mBio</source><year>2024</year><volume>15</volume><elocation-id>e0022523</elocation-id><pub-id pub-id-type="doi">10.1128/MBIO.00225-23</pub-id><pub-id pub-id-type="pmid">38112465</pub-id><pub-id pub-id-type="pmcid">PMC10790753</pub-id></element-citation></ref><ref id="B150-pathogens-14-00185"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krysko</surname><given-names>O.</given-names></name><name name-style="western"><surname>Holtappels</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kubica</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deswarte</surname><given-names>K.</given-names></name><name name-style="western"><surname>Derycke</surname><given-names>L.</given-names></name><name name-style="western"><surname>Claeys</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Brusselle</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Vandenabeele</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Alternatively Activated Macrophages and Impaired Phagocytosis of <italic toggle="yes">S. Aureus</italic> in Chronic Rhinosinusitis</article-title><source>Allergy</source><year>2011</year><volume>66</volume><fpage>396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.2010.02498.x</pub-id><pub-id pub-id-type="pmid">20973804</pub-id></element-citation></ref><ref id="B151-pathogens-14-00185"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Shih</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>P.J.</given-names></name></person-group><article-title>Staphylococcus Aureus Biofilm Elicits the Expansion, Activation and Polarization of Myeloid-Derived Suppressor Cells in Vivo and in Vitro</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0183271</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0183271</pub-id><pub-id pub-id-type="pmid">28813499</pub-id><pub-id pub-id-type="pmcid">PMC5559065</pub-id></element-citation></ref><ref id="B152-pathogens-14-00185"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thurlow</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Hanke</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Angle</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aldrich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Engebretsen</surname><given-names>I.L.</given-names></name><name name-style="western"><surname>Bayles</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name></person-group><article-title>Staphylococcus Aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation in Vivo</article-title><source>J. Immunol.</source><year>2011</year><volume>186</volume><fpage>6585</fpage><lpage>6596</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002794</pub-id><pub-id pub-id-type="pmid">21525381</pub-id><pub-id pub-id-type="pmcid">PMC3110737</pub-id></element-citation></ref><ref id="B153-pathogens-14-00185"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLaughlin</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Hoogewerf</surname><given-names>A.J.</given-names></name></person-group><article-title>Interleukin-1beta-Induced Growth Enhancement of Staphylococcus Aureus Occurs in Biofilm but Not Planktonic Cultures</article-title><source>Microb. Pathog.</source><year>2006</year><volume>41</volume><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2006.04.005</pub-id><pub-id pub-id-type="pmid">16769197</pub-id></element-citation></ref><ref id="B154-pathogens-14-00185"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanke</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Angle</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name></person-group><article-title>MyD88-Dependent Signaling Influences Fibrosis and Alternative Macrophage Activation during Staphylococcus Aureus Biofilm Infection</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e42476</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0042476</pub-id><pub-id pub-id-type="pmid">22879997</pub-id><pub-id pub-id-type="pmcid">PMC3411753</pub-id></element-citation></ref><ref id="B155-pathogens-14-00185"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Heim</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Attri</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Bronich</surname><given-names>T.K.</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name></person-group><article-title>Monocyte Metabolic Reprogramming Promotes Pro-Inflammatory Activity and Staphylococcus Aureus Biofilm Clearance</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008354</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008354</pub-id><pub-id pub-id-type="pmid">32142554</pub-id><pub-id pub-id-type="pmcid">PMC7080272</pub-id></element-citation></ref><ref id="B156-pathogens-14-00185"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>J.</given-names></name><name name-style="western"><surname>You</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>TRPV1+ Neurons Alter Staphylococcus Aureus Skin Infection Outcomes by Affecting Macrophage Polarization and Neutrophil Recruitment</article-title><source>BMC Immunol.</source><year>2023</year><volume>24</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.1186/s12865-023-00584-x</pub-id><pub-id pub-id-type="pmid">38129779</pub-id><pub-id pub-id-type="pmcid">PMC10740264</pub-id></element-citation></ref><ref id="B157-pathogens-14-00185"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiu</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Heesters</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Ghasemlou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Von Hehn</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wainger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Strominger</surname><given-names>A.</given-names></name><name name-style="western"><surname>Muralidharan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.R.</given-names></name><etal/></person-group><article-title>Bacteria Activate Sensory Neurons That Modulate Pain and Inflammation</article-title><source>Nature</source><year>2013</year><volume>501</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nature12479</pub-id><pub-id pub-id-type="pmid">23965627</pub-id><pub-id pub-id-type="pmcid">PMC3773968</pub-id></element-citation></ref><ref id="B158-pathogens-14-00185"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flannagan</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Heit</surname><given-names>B.</given-names></name><name name-style="western"><surname>Heinrichs</surname><given-names>D.E.</given-names></name></person-group><article-title>Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus Aureus</article-title><source>Pathogens</source><year>2015</year><volume>4</volume><elocation-id>826</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens4040826</pub-id><pub-id pub-id-type="pmid">26633519</pub-id><pub-id pub-id-type="pmcid">PMC4693167</pub-id></element-citation></ref><ref id="B159-pathogens-14-00185"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hackam</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Rotstein</surname><given-names>O.D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Demaurex</surname><given-names>N.</given-names></name><name name-style="western"><surname>Woodside</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>O.</given-names></name><name name-style="western"><surname>Grinstein</surname><given-names>S.</given-names></name></person-group><article-title>Regulation of Phagosomal Acidification. Differential Targeting of Na+/H+ Exchangers, Na+/K+-ATPases, and Vacuolar-Type H+-Atpases</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>29810</fpage><lpage>29820</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.47.29810</pub-id><pub-id pub-id-type="pmid">9368053</pub-id></element-citation></ref><ref id="B160-pathogens-14-00185"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bore</surname><given-names>E.</given-names></name><name name-style="western"><surname>Langsrud</surname><given-names>S.</given-names></name><name name-style="western"><surname>Langsrud</surname><given-names>&#216;.</given-names></name><name name-style="western"><surname>Rode</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Holck</surname><given-names>A.</given-names></name></person-group><article-title>Acid-Shock Responses in Staphylococcus Aureus Investigated by Global Gene Expression Analysis</article-title><source>Microbiology</source><year>2007</year><volume>153</volume><fpage>2289</fpage><lpage>2303</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2007/005942-0</pub-id><pub-id pub-id-type="pmid">17600073</pub-id></element-citation></ref><ref id="B161-pathogens-14-00185"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadati</surname><given-names>T.</given-names></name><name name-style="western"><surname>Houben</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bitorina</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shiri-Sverdlov</surname><given-names>R.</given-names></name></person-group><article-title>The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management</article-title><source>Cells</source><year>2020</year><volume>9</volume><elocation-id>1679</elocation-id><pub-id pub-id-type="doi">10.3390/cells9071679</pub-id><pub-id pub-id-type="pmid">32668602</pub-id><pub-id pub-id-type="pmcid">PMC7407943</pub-id></element-citation></ref><ref id="B162-pathogens-14-00185"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>G.Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brumell</surname><given-names>J.H.</given-names></name></person-group><article-title>The Many Roles of NOX2 NADPH Oxidase-Derived ROS in Immunity</article-title><source>Semin. Immunopathol.</source><year>2010</year><volume>32</volume><fpage>415</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1007/s00281-010-0221-0</pub-id><pub-id pub-id-type="pmid">20803017</pub-id></element-citation></ref><ref id="B163-pathogens-14-00185"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra</surname><given-names>F.E.</given-names></name><name name-style="western"><surname>Borgogna</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Sward</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>J.M.</given-names></name></person-group><article-title>Epic Immune Battles of History: Neutrophils vs. Staphylococcus Aureus</article-title><source>Front. Cell Infect. Microbiol.</source><year>2017</year><volume>7</volume><elocation-id>286</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00286</pub-id><pub-id pub-id-type="pmid">28713774</pub-id><pub-id pub-id-type="pmcid">PMC5491559</pub-id></element-citation></ref><ref id="B164-pathogens-14-00185"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldblatt</surname><given-names>D.</given-names></name></person-group><article-title>Recent Advances in Chronic Granulomatous Disease</article-title><source>J. Infect.</source><year>2014</year><volume>69</volume><issue>(Suppl. S1)</issue><fpage>S32</fpage><lpage>S35</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2014.07.013</pub-id><pub-id pub-id-type="pmid">25264161</pub-id></element-citation></ref><ref id="B165-pathogens-14-00185"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bogdan</surname><given-names>C.</given-names></name><name name-style="western"><surname>R&#246;llinghoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diefenbach</surname><given-names>A.</given-names></name></person-group><article-title>The Role of Nitric Oxide in Innate Immunity</article-title><source>Immunol. Rev.</source><year>2000</year><volume>173</volume><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1034/j.1600-065X.2000.917307.x</pub-id><pub-id pub-id-type="pmid">10719664</pub-id></element-citation></ref><ref id="B166-pathogens-14-00185"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinberg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Misukonis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shami</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mason</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sauls</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dittman</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>E.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bachus</surname><given-names>K.</given-names></name></person-group><article-title>Human Mononuclear Phagocyte Inducible Nitric Oxide Synthase (INOS): Analysis of INOS MRNA, INOS Protein, Biopterin, and Nitric Oxide Production by Blood Monocytes and Peritoneal Macrophages</article-title><source>Blood</source><year>1995</year><volume>86</volume><fpage>1184</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1182/blood.V86.3.1184.1184</pub-id><pub-id pub-id-type="pmid">7542498</pub-id></element-citation></ref><ref id="B167-pathogens-14-00185"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#252;ller</surname><given-names>S.</given-names></name><name name-style="western"><surname>Faulhaber</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sieber</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pfeifer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gansz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Deshmukh</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Dauth</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brix</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saftig</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The Endolysosomal Cysteine Cathepsins L and K Are Involved in Macrophage-Mediated Clearance of Staphylococcus Aureus and the Concomitant Cytokine Induction</article-title><source>FASEB J.</source><year>2014</year><volume>28</volume><fpage>162</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1096/fj.13-232272</pub-id><pub-id pub-id-type="pmid">24036885</pub-id></element-citation></ref><ref id="B168-pathogens-14-00185"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlk&#246;nig</surname><given-names>A.</given-names></name><name name-style="western"><surname>Huet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Looze</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wintjens</surname><given-names>R.</given-names></name></person-group><article-title>Structural Relationships in the Lysozyme Superfamily: Significant Evidence for Glycoside Hydrolase Signature Motifs</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e15388</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015388</pub-id><pub-id pub-id-type="pmid">21085702</pub-id><pub-id pub-id-type="pmcid">PMC2976769</pub-id></element-citation></ref><ref id="B169-pathogens-14-00185"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pushkaran</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Nataraj</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nair</surname><given-names>N.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mohan</surname><given-names>C.G.</given-names></name></person-group><article-title>Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus Aureus by Peptidoglycan o-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay</article-title><source>J. Chem. Inf. Model.</source><year>2015</year><volume>55</volume><fpage>760</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1021/ci500734k</pub-id><pub-id pub-id-type="pmid">25774564</pub-id></element-citation></ref><ref id="B170-pathogens-14-00185"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimada</surname><given-names>T.</given-names></name><name name-style="western"><surname>Park</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Brikos</surname><given-names>C.</given-names></name><name name-style="western"><surname>Goodridge</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Becker</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Reyes</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Aderem</surname><given-names>A.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Evades the Lysozyme-Based Digestion of Peptidoglycan That Links Phagocytosis and Macrophage IL-1&#946; Secretion</article-title><source>Cell Host Microbe</source><year>2010</year><volume>7</volume><fpage>38</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.12.008</pub-id><pub-id pub-id-type="pmid">20114027</pub-id><pub-id pub-id-type="pmcid">PMC2818986</pub-id></element-citation></ref><ref id="B171-pathogens-14-00185"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z.Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.J.</given-names></name></person-group><article-title>Stimulator of Interferon Genes (STING) Promotes Staphylococcus Aureus-Induced Extracellular Traps Formation via the ROS-ERK Signaling Pathway</article-title><source>Front. Cell Dev. Biol.</source><year>2022</year><volume>10</volume><elocation-id>836880</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2022.836880</pub-id><pub-id pub-id-type="pmid">35399524</pub-id><pub-id pub-id-type="pmcid">PMC8984202</pub-id></element-citation></ref><ref id="B172-pathogens-14-00185"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boe</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Ippolito</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kovacs</surname><given-names>E.J.</given-names></name></person-group><article-title>Extracellular Traps and Macrophages: New Roles for the Versatile Phagocyte</article-title><source>J. Leukoc. Biol.</source><year>2015</year><volume>97</volume><elocation-id>1023</elocation-id><pub-id pub-id-type="doi">10.1189/jlb.4RI1014-521R</pub-id><pub-id pub-id-type="pmid">25877927</pub-id><pub-id pub-id-type="pmcid">PMC4763879</pub-id></element-citation></ref><ref id="B173-pathogens-14-00185"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>O.A.</given-names></name><name name-style="western"><surname>Von K&#246;ckritz-Blickwede</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bright</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Hensler</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Zinkernagel</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Cogen</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Monestier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Glass</surname><given-names>C.K.</given-names></name><etal/></person-group><article-title>Statins Enhance Formation of Phagocyte Extracellular Traps</article-title><source>Cell Host Microbe</source><year>2010</year><volume>8</volume><fpage>445</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.10.005</pub-id><pub-id pub-id-type="pmid">21075355</pub-id><pub-id pub-id-type="pmcid">PMC3008410</pub-id></element-citation></ref><ref id="B174-pathogens-14-00185"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>K.</given-names></name><name name-style="western"><surname>Werno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Browne</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stamp</surname><given-names>L.K.</given-names></name></person-group><article-title>Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population</article-title><source>J. Rheumatol.</source><year>2015</year><volume>42</volume><fpage>2392</fpage><lpage>2397</lpage><pub-id pub-id-type="doi">10.3899/jrheum.150434</pub-id><pub-id pub-id-type="pmid">26523022</pub-id></element-citation></ref><ref id="B175-pathogens-14-00185"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duque</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Descoteaux</surname><given-names>A.</given-names></name></person-group><article-title>Macrophage Cytokines: Involvement in Immunity and Infectious Diseases</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><elocation-id>491</elocation-id><pub-id pub-id-type="doi">10.3389/FIMMU.2014.00491</pub-id><pub-id pub-id-type="pmid">25339958</pub-id><pub-id pub-id-type="pmcid">PMC4188125</pub-id></element-citation></ref><ref id="B176-pathogens-14-00185"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wojdasiewicz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Poniatowski</surname><given-names>&#321;.A.</given-names></name><name name-style="western"><surname>Szukiewicz</surname><given-names>D.</given-names></name></person-group><article-title>The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis</article-title><source>Mediat. Inflamm.</source><year>2014</year><volume>2014</volume><fpage>561459</fpage><pub-id pub-id-type="doi">10.1155/2014/561459</pub-id><pub-id pub-id-type="pmid">24876674</pub-id><pub-id pub-id-type="pmcid">PMC4021678</pub-id></element-citation></ref><ref id="B177-pathogens-14-00185"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brylka</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Schinke</surname><given-names>T.</given-names></name></person-group><article-title>Chemokines in Physiological and Pathological Bone Remodeling</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><elocation-id>2182</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02182</pub-id><pub-id pub-id-type="pmid">31572390</pub-id><pub-id pub-id-type="pmcid">PMC6753917</pub-id></element-citation></ref><ref id="B178-pathogens-14-00185"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dey</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sawoo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name></person-group><article-title>Simultaneous Neutralization of TGF-&#946; and IL-6 Attenuates Staphylococcus Aureus-Induced Arthritic Inflammation through Differential Modulation of Splenic and Synovial Macrophages</article-title><source>Scand. J. Immunol.</source><year>2023</year><volume>97</volume><fpage>e13252</fpage><pub-id pub-id-type="doi">10.1111/sji.13252</pub-id><pub-id pub-id-type="pmid">36597222</pub-id></element-citation></ref><ref id="B179-pathogens-14-00185"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name></person-group><article-title>Endogenous Blocking of TLR2 along with TNF-&#945; and IL-1&#946; Ameliorates the Severity of the <italic toggle="yes">S. Aureus</italic> Arthritis via Modulating STAT3/SOCS3 Expressions in Tissue Resident Macrophages</article-title><source>Microb. Pathog.</source><year>2024</year><volume>187</volume><fpage>106518</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2023.106518</pub-id><pub-id pub-id-type="pmid">38160988</pub-id></element-citation></ref><ref id="B180-pathogens-14-00185"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sultana</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name></person-group><article-title>Etoposide-Mediated Depletion of Peripheral Blood Monocytes Post s.Aureus Infection Attenuates Septic Arthritis by Modulating Macrophage-Derived Factors Responsible for Inflammatory Destruction</article-title><source>Immunol. Lett.</source><year>2020</year><volume>220</volume><fpage>51</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2020.02.001</pub-id><pub-id pub-id-type="pmid">32032616</pub-id></element-citation></ref><ref id="B181-pathogens-14-00185"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardenburg</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.</given-names></name></person-group><article-title>Host Defenses against Staphylococcus Aureus Infection Require Recognition of Bacterial Lipoproteins</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>13831</fpage><pub-id pub-id-type="doi">10.1073/pnas.0603072103</pub-id><pub-id pub-id-type="pmid">16954184</pub-id><pub-id pub-id-type="pmcid">PMC1564215</pub-id></element-citation></ref><ref id="B182-pathogens-14-00185"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Yun</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Finlay</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.H.</given-names></name></person-group><article-title>Lipoprotein in the Cell Wall of Staphylococcus Aureus Is a Major Inducer of Nitric Oxide Production in Murine Macrophages</article-title><source>Mol. Immunol.</source><year>2015</year><volume>65</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2014.12.016</pub-id><pub-id pub-id-type="pmid">25600878</pub-id></element-citation></ref><ref id="B183-pathogens-14-00185"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Engdahl</surname><given-names>C.</given-names></name><name name-style="western"><surname>Na</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jarneborn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Karlsson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pullerits</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name><etal/></person-group><article-title>The YIN and YANG of Lipoproteins in Developing and Preventing Infectious Arthritis by Staphylococcus Aureus</article-title><source>PLoS Pathog.</source><year>2019</year><volume>15</volume><elocation-id>e1007877</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007877</pub-id><pub-id pub-id-type="pmid">31226163</pub-id><pub-id pub-id-type="pmcid">PMC6608979</pub-id></element-citation></ref><ref id="B184-pathogens-14-00185"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schultz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jarneborn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wienken</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Froning</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pullerits</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hayen</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Lipoproteins Cause Bone Resorption in a Mouse Model of Staphylococcus Aureus Septic Arthritis</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>843799</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.843799</pub-id><pub-id pub-id-type="pmid">35356518</pub-id><pub-id pub-id-type="pmcid">PMC8959583</pub-id></element-citation></ref><ref id="B185-pathogens-14-00185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>M.-T.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sch&#246;ttler</surname><given-names>H.</given-names></name><name name-style="western"><surname>Niemann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schultz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barczyk-Kahlert</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hayen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Herrmann</surname><given-names>M.</given-names></name></person-group><article-title>Bacterial Lipoproteins Shift Cellular Metabolism to Glycolysis in Macrophages Causing Bone Erosion</article-title><source>Microbiol. Spectr.</source><year>2023</year><volume>11</volume><elocation-id>e0429322</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.04293-22</pub-id><pub-id pub-id-type="pmid">37191536</pub-id><pub-id pub-id-type="pmcid">PMC10269925</pub-id></element-citation></ref><ref id="B186-pathogens-14-00185"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodoen</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>Natural Killer Cells as an Initial Defense against Pathogens</article-title><source>Curr. Opin. Immunol.</source><year>2006</year><volume>18</volume><fpage>391</fpage><pub-id pub-id-type="doi">10.1016/j.coi.2006.05.002</pub-id><pub-id pub-id-type="pmid">16765573</pub-id><pub-id pub-id-type="pmcid">PMC7127478</pub-id></element-citation></ref><ref id="B187-pathogens-14-00185"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerwenka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><article-title>Natural Killer Cells, Viruses and Cancer</article-title><source>Nat. Rev. Immunol.</source><year>2001</year><volume>1</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/35095564</pub-id><pub-id pub-id-type="pmid">11905813</pub-id></element-citation></ref><ref id="B188-pathogens-14-00185"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>B.</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Z.</given-names></name></person-group><article-title>Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection</article-title><source>Immunity</source><year>2016</year><volume>45</volume><fpage>131</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.019</pub-id><pub-id pub-id-type="pmid">27421702</pub-id></element-citation></ref><ref id="B189-pathogens-14-00185"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosser</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J.P.</given-names></name></person-group><article-title>Exploring the Full Spectrum of Macrophage Activation</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>958</fpage><pub-id pub-id-type="doi">10.1038/nri2448</pub-id><pub-id pub-id-type="pmid">19029990</pub-id><pub-id pub-id-type="pmcid">PMC2724991</pub-id></element-citation></ref><ref id="B190-pathogens-14-00185"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mata Forsberg</surname><given-names>M.</given-names></name><name name-style="western"><surname>Arasa</surname><given-names>C.</given-names></name><name name-style="western"><surname>van Zwol</surname><given-names>W.</given-names></name><name name-style="western"><surname>Uzun&#231;ayir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sch&#246;nbichler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Regenthal</surname><given-names>P.</given-names></name><name name-style="western"><surname>Schelin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lindkvist-Petersson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bj&#246;rkander</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sverremark-Ekstr&#246;m</surname><given-names>E.</given-names></name></person-group><article-title>Activation of Human &#915;&#948; T Cells and NK Cells by Staphylococcal Enterotoxins Requires Both Monocytes and Conventional T Cells</article-title><source>J. Leukoc. Biol.</source><year>2022</year><volume>111</volume><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1002/JLB.3A1020-630RR</pub-id><pub-id pub-id-type="pmid">34114693</pub-id></element-citation></ref><ref id="B191-pathogens-14-00185"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nilsson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bremell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tarkowskt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carlsten</surname><given-names>H.</given-names></name></person-group><article-title>Protective Role of NK1.1+ Cells in Experimental Staphylococcus Aureus Arthritis</article-title><source>Clin. Exp. Immunol.</source><year>2001</year><volume>117</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.1999.00922.x</pub-id><pub-id pub-id-type="pmid">10403917</pub-id><pub-id pub-id-type="pmcid">PMC1905466</pub-id></element-citation></ref><ref id="B192-pathogens-14-00185"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Small</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gill</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kugathasan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Santosuosso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Heinrichs</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Ashkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name></person-group><article-title>NK Cells Play a Critical Protective Role in Host Defense against Acute Extracellular Staphylococcus Aureus Bacterial Infection in the Lung</article-title><source>J. Immunol.</source><year>2008</year><volume>180</volume><fpage>5558</fpage><lpage>5568</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.8.5558</pub-id><pub-id pub-id-type="pmid">18390740</pub-id></element-citation></ref><ref id="B193-pathogens-14-00185"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genardi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Visvabharathy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Morgun</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Gapin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Berdyshev</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.R.</given-names></name></person-group><article-title>Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant Staphylococcus Aureus Infection</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>610010</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.610010</pub-id><pub-id pub-id-type="pmid">33312179</pub-id><pub-id pub-id-type="pmcid">PMC7708336</pub-id></element-citation></ref><ref id="B194-pathogens-14-00185"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torcellan</surname><given-names>T.</given-names></name><name name-style="western"><surname>Friedrich</surname><given-names>C.</given-names></name><name name-style="western"><surname>Doucet-Ladev&#232;ze</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ossner</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sol&#233;</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Riedmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ugur</surname><given-names>M.</given-names></name><name name-style="western"><surname>Imdahl</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rosshart</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>Circulating NK Cells Establish Tissue Residency upon Acute Infection of Skin and Mediate Accelerated Effector Responses to Secondary Infection</article-title><source>Immunity</source><year>2024</year><volume>57</volume><fpage>124</fpage><lpage>140.e7</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2023.11.018</pub-id><pub-id pub-id-type="pmid">38157853</pub-id><pub-id pub-id-type="pmcid">PMC10783803</pub-id></element-citation></ref><ref id="B195-pathogens-14-00185"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakane</surname><given-names>A.</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Asano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kohanawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Minagawa</surname><given-names>T.</given-names></name></person-group><article-title>Endogenous Gamma Interferon, Tumor Necrosis Factor, and Interleukin-6 in Staphylococcus Aureus Infection in Mice</article-title><source>Infect. Immun.</source><year>1995</year><volume>63</volume><fpage>1165</fpage><lpage>1172</lpage><pub-id pub-id-type="doi">10.1128/iai.63.4.1165-1172.1995</pub-id><pub-id pub-id-type="pmid">7890367</pub-id><pub-id pub-id-type="pmcid">PMC173129</pub-id></element-citation></ref><ref id="B196-pathogens-14-00185"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasaki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nishikawa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mizuki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Madarame</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tagawa</surname><given-names>Y.I.</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nakane</surname><given-names>A.</given-names></name></person-group><article-title>Interleukin-4 and Interleukin-10 Are Involved in Host Resistance to Staphylococcus Aureus Infection through Regulation of Gamma Interferon</article-title><source>Infect. Immun.</source><year>2000</year><volume>68</volume><fpage>2424</fpage><pub-id pub-id-type="doi">10.1128/IAI.68.5.2424-2430.2000</pub-id><pub-id pub-id-type="pmid">10768926</pub-id><pub-id pub-id-type="pmcid">PMC97441</pub-id></element-citation></ref><ref id="B197-pathogens-14-00185"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G.</given-names></name></person-group><article-title>Staphylococcus Aureus &#946;-Hemolysin Up-Regulates the Expression of IFN-&#947; by Human CD56bright NK Cells</article-title><source>Front. Cell Infect. Microbiol.</source><year>2021</year><volume>11</volume><elocation-id>658141</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.658141</pub-id><pub-id pub-id-type="pmid">33854984</pub-id><pub-id pub-id-type="pmcid">PMC8039520</pub-id></element-citation></ref><ref id="B198-pathogens-14-00185"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y.X.</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>The Dual Role of Interferon-Gamma in Experimental Staphylococcus Aureus Septicaemia versus Arthritis</article-title><source>Immunology</source><year>1998</year><volume>93</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.1998.00407.x</pub-id><pub-id pub-id-type="pmid">9536122</pub-id><pub-id pub-id-type="pmcid">PMC1364109</pub-id></element-citation></ref><ref id="B199-pathogens-14-00185"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Kasper</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Tzianabos</surname><given-names>A.O.</given-names></name></person-group><article-title>IFN-Gamma Regulated Chemokine Production Determines the Outcome of Staphylococcus Aureus Infection</article-title><source>J. Immunol.</source><year>2008</year><volume>181</volume><fpage>1323</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.2.1323</pub-id><pub-id pub-id-type="pmid">18606687</pub-id></element-citation></ref><ref id="B200-pathogens-14-00185"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hidalgo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chilvers</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Summers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Koenderman</surname><given-names>L.</given-names></name></person-group><article-title>The Neutrophil Life Cycle</article-title><source>Trends Immunol.</source><year>2019</year><volume>40</volume><fpage>584</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1016/j.it.2019.04.013</pub-id><pub-id pub-id-type="pmid">31153737</pub-id></element-citation></ref><ref id="B201-pathogens-14-00185"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Metzemaekers</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gouwy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Proost</surname><given-names>P.</given-names></name></person-group><article-title>Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords</article-title><source>Cell Mol. Immunol.</source><year>2020</year><volume>17</volume><fpage>433</fpage><pub-id pub-id-type="doi">10.1038/s41423-020-0412-0</pub-id><pub-id pub-id-type="pmid">32238918</pub-id><pub-id pub-id-type="pmcid">PMC7192912</pub-id></element-citation></ref><ref id="B202-pathogens-14-00185"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Pinho</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Souza</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nicoli</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>M.M.</given-names></name></person-group><article-title>Role of the Platelet-Activating Factor (PAF) Receptor during Pulmonary Infection with Gram Negative Bacteria</article-title><source>Br. J. Pharmacol.</source><year>2002</year><volume>137</volume><fpage>621</fpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0704918</pub-id><pub-id pub-id-type="pmid">12381675</pub-id><pub-id pub-id-type="pmcid">PMC1573539</pub-id></element-citation></ref><ref id="B203-pathogens-14-00185"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swamydas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Break</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Jaeger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Green</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Collar</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>B.G.</given-names></name><etal/></person-group><article-title>CXCR1-Mediated Neutrophil Degranulation and Fungal Killing Promotes Candida Clearance and Host Survival</article-title><source>Sci. Transl. Med.</source><year>2016</year><volume>8</volume><fpage>322ra10</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aac7718</pub-id><pub-id pub-id-type="pmid">26791948</pub-id><pub-id pub-id-type="pmcid">PMC4938152</pub-id></element-citation></ref><ref id="B204-pathogens-14-00185"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rouse</surname><given-names>B.T.</given-names></name></person-group><article-title>CXCR2-/- Mice Show Enhanced Susceptibility to Herpetic Stromal Keratitis: A Role for IL-6-Induced Neovascularization</article-title><source>J. Immunol.</source><year>2004</year><volume>172</volume><fpage>1237</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.2.1237</pub-id><pub-id pub-id-type="pmid">14707102</pub-id></element-citation></ref><ref id="B205-pathogens-14-00185"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tateda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Newstead</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Standiford</surname><given-names>T.J.</given-names></name></person-group><article-title>Chemokine-Dependent Neutrophil Recruitment in a Murine Model of Legionella Pneumonia: Potential Role of Neutrophils as Immunoregulatory Cells</article-title><source>Infect. Immun.</source><year>2001</year><volume>69</volume><fpage>2017</fpage><pub-id pub-id-type="doi">10.1128/IAI.69.4.2017-2024.2001</pub-id><pub-id pub-id-type="pmid">11254553</pub-id><pub-id pub-id-type="pmcid">PMC98125</pub-id></element-citation></ref><ref id="B206-pathogens-14-00185"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#244;nego</surname><given-names>F.</given-names></name><name name-style="western"><surname>Castanheira</surname><given-names>F.V.e.S.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Kanashiro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leite</surname><given-names>C.A.V.G.</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Col&#243;n</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>V.d.F.</given-names></name><name name-style="western"><surname>Alves-Filho</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>F.Q.</given-names></name></person-group><article-title>Paradoxical Roles of the Neutrophil in Sepsis: Protective and Deleterious</article-title><source>Front. Immunol.</source><year>2016</year><volume>7</volume><elocation-id>155</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00155</pub-id><pub-id pub-id-type="pmid">27199981</pub-id><pub-id pub-id-type="pmcid">PMC4844928</pub-id></element-citation></ref><ref id="B207-pathogens-14-00185"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Albright</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Caswell</surname><given-names>J.L.</given-names></name></person-group><article-title>Effect of Interleukin-8 and Granulocyte Colony-Stimulating Factor on Priming and Activation of Bovine Neutrophils</article-title><source>Infect. Immun.</source><year>2003</year><volume>71</volume><fpage>1643</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.4.1643-1649.2003</pub-id><pub-id pub-id-type="pmid">12654776</pub-id><pub-id pub-id-type="pmcid">PMC152050</pub-id></element-citation></ref><ref id="B208-pathogens-14-00185"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Donato</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Effner</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nordengr&#252;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lechner</surname><given-names>A.</given-names></name><name name-style="western"><surname>Darisipudi</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Volz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hagl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Br&#246;ker</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Renner</surname><given-names>E.D.</given-names></name></person-group><article-title>Staphylococcus Aureus Serine Protease-like Protein A (SplA) Induces IL-8 by Keratinocytes and Synergizes with IL-17A</article-title><source>Cytokine</source><year>2024</year><volume>180</volume><fpage>156634</fpage><pub-id pub-id-type="doi">10.1016/j.cyto.2024.156634</pub-id><pub-id pub-id-type="pmid">38810500</pub-id></element-citation></ref><ref id="B209-pathogens-14-00185"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Aulock</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morath</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hareng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Knapp</surname><given-names>S.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>T.</given-names></name></person-group><article-title>Lipoteichoic Acid from Staphylococcus Aureus Is a Potent Stimulus for Neutrophil Recruitment</article-title><source>Immunobiology</source><year>2003</year><volume>208</volume><fpage>413</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1078/0171-2985-00285</pub-id><pub-id pub-id-type="pmid">14748514</pub-id></element-citation></ref><ref id="B210-pathogens-14-00185"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sipprell</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Leach</surname><given-names>W.</given-names></name><name name-style="western"><surname>Suptela</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Marriott</surname><given-names>I.</given-names></name></person-group><article-title>Staphylococcus Aureus Infection Induces the Production of the Neutrophil Chemoattractants CXCL1, CXCL2, CXCL3, CXCL5, CCL3, and CCL7 by Murine Osteoblasts</article-title><source>Infect. Immun.</source><year>2023</year><volume>91</volume><fpage>e0001423</fpage><pub-id pub-id-type="doi">10.1128/iai.00014-23</pub-id><pub-id pub-id-type="pmid">36880752</pub-id><pub-id pub-id-type="pmcid">PMC10112169</pub-id></element-citation></ref><ref id="B211-pathogens-14-00185"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Youn</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pontaza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dikeman</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Alphonse</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Anany</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ahmadi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Neutrophil-Intrinsic TNF Receptor Signaling Orchestrates Host Defense against Staphylococcus Aureus</article-title><source>Sci. Adv.</source><year>2023</year><volume>9</volume><fpage>eadf8748</fpage><pub-id pub-id-type="doi">10.1126/sciadv.adf8748</pub-id><pub-id pub-id-type="pmid">37327341</pub-id><pub-id pub-id-type="pmcid">PMC10275602</pub-id></element-citation></ref><ref id="B212-pathogens-14-00185"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#252;rr</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Kristian</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matteoli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Margolis</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Trias</surname><given-names>J.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Bohn</surname><given-names>E.</given-names></name><name name-style="western"><surname>Landmann</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Neutrophil Chemotaxis by Pathogen-Associated Molecular Patterns--Formylated Peptides Are Crucial but Not the Sole Neutrophil Attractants Produced by Staphylococcus Aureus</article-title><source>Cell Microbiol.</source><year>2006</year><volume>8</volume><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00610.x</pub-id><pub-id pub-id-type="pmid">16441432</pub-id></element-citation></ref><ref id="B213-pathogens-14-00185"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Payne</surname><given-names>J.A.E.</given-names></name><name name-style="western"><surname>Tailhades</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ellett</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kostoulias</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fulcher</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>R.</given-names></name><name name-style="western"><surname>Louch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Weber</surname><given-names>S.A.</given-names></name><etal/></person-group><article-title>Antibiotic-Chemoattractants Enhance Neutrophil Clearance of Staphylococcus Aureus</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>6157</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-26244-5</pub-id><pub-id pub-id-type="pmid">34697316</pub-id><pub-id pub-id-type="pmcid">PMC8546149</pub-id></element-citation></ref><ref id="B214-pathogens-14-00185"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghimire</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pettygrove</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Pallister</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Stangeland</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stanhope</surname><given-names>S.</given-names></name><name name-style="western"><surname>Klapper</surname><given-names>I.</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>P.S.</given-names></name></person-group><article-title>Direct Microscopic Observation of Human Neutrophil-Staphylococcus Aureus Interaction In Vitro Suggests a Potential Mechanism for Initiation of Biofilm Infection on an Implanted Medical Device</article-title><source>Infect. Immun.</source><year>2019</year><volume>87</volume><pub-id pub-id-type="doi">10.1128/IAI.00745-19</pub-id><pub-id pub-id-type="pmid">31548325</pub-id><pub-id pub-id-type="pmcid">PMC6867845</pub-id></element-citation></ref><ref id="B215-pathogens-14-00185"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pettygrove</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Kratofil</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Alhede</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Newton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Qvortrup</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pallister</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Bjarnsholt</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P.</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Delayed Neutrophil Recruitment Allows Nascent Staphylococcus Aureus Biofilm Formation and Immune Evasion</article-title><source>Biomaterials</source><year>2021</year><volume>275</volume><elocation-id>120775</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.120775</pub-id><pub-id pub-id-type="pmid">34243039</pub-id><pub-id pub-id-type="pmcid">PMC8325624</pub-id></element-citation></ref><ref id="B216-pathogens-14-00185"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Burlak</surname><given-names>C.</given-names></name><name name-style="western"><surname>Deleo</surname><given-names>F.R.</given-names></name></person-group><article-title>Neutrophils in the Innate Immune Response</article-title><source>Arch. Immunol. Ther. Exp.</source><year>2005</year><volume>53</volume><fpage>505</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">16407783</pub-id></element-citation></ref><ref id="B217-pathogens-14-00185"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lotz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Aga</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wilde</surname><given-names>I.</given-names></name><name name-style="western"><surname>van Zandbergen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>T.</given-names></name><name name-style="western"><surname>Solbach</surname><given-names>W.</given-names></name><name name-style="western"><surname>Laskay</surname><given-names>T.</given-names></name></person-group><article-title>Highly Purified Lipoteichoic Acid Activates Neutrophil Granulocytes and Delays Their Spontaneous Apoptosis via CD14 and TLR2</article-title><source>J. Leukoc. Biol.</source><year>2004</year><volume>75</volume><fpage>467</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1189/jlb.0803360</pub-id><pub-id pub-id-type="pmid">14673018</pub-id></element-citation></ref><ref id="B218-pathogens-14-00185"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lajqi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Frommhold</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gille</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hudalla</surname><given-names>H.</given-names></name></person-group><article-title>Gram-Positive Staphylococcus Aureus LTA Promotes Distinct Memory-like Effects in Murine Bone Marrow Neutrophils</article-title><source>Cell Immunol.</source><year>2022</year><volume>376</volume><fpage>104535</fpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2022.104535</pub-id><pub-id pub-id-type="pmid">35537323</pub-id></element-citation></ref><ref id="B219-pathogens-14-00185"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabroe</surname><given-names>I.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Horsburgh</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Dower</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Whyte</surname><given-names>M.K.B.</given-names></name></person-group><article-title>Selective Roles for Toll-like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span</article-title><source>J. Immunol.</source><year>2003</year><volume>170</volume><fpage>5268</fpage><lpage>5275</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.10.5268</pub-id><pub-id pub-id-type="pmid">12734376</pub-id></element-citation></ref><ref id="B220-pathogens-14-00185"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name><etal/></person-group><article-title>TLR2, TLR4, and NLRP3 Mediated the Balance between Host Immune-Driven Resistance and Tolerance in Staphylococcus Aureus-Infected Mice</article-title><source>Microb. Pathog.</source><year>2022</year><volume>169</volume><fpage>105671</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2022.105671</pub-id><pub-id pub-id-type="pmid">35811022</pub-id></element-citation></ref><ref id="B221-pathogens-14-00185"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>W.</given-names></name></person-group><article-title>Staphylococcus Aureus Increases Prostaglandin E2 Secretion in Cow Neutrophils by Activating TLR2, TLR4, and NLRP3 Inflammasome Signaling Pathways</article-title><source>Front. Microbiol.</source><year>2023</year><volume>14</volume><elocation-id>1163261</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2023.1163261</pub-id><pub-id pub-id-type="pmid">37168122</pub-id><pub-id pub-id-type="pmcid">PMC10165004</pub-id></element-citation></ref><ref id="B222-pathogens-14-00185"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenzel</surname><given-names>W.</given-names></name><name name-style="western"><surname>Soltek</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sanchez-Ruiz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miletic</surname><given-names>H.</given-names></name><name name-style="western"><surname>Schl&#252;ter</surname><given-names>D.</given-names></name><name name-style="western"><surname>Deckert</surname><given-names>M.</given-names></name></person-group><article-title>Both TLR2 and TLR4 Are Required for the Effective Immune Response in Staphylococcus Aureus-Induced Experimental Murine Brain Abscess</article-title><source>Am. J. Pathol.</source><year>2008</year><volume>172</volume><fpage>132</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2008.070567</pub-id><pub-id pub-id-type="pmid">18165267</pub-id><pub-id pub-id-type="pmcid">PMC2189630</pub-id></element-citation></ref><ref id="B223-pathogens-14-00185"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#252;ller-Anstett</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>P.</given-names></name><name name-style="western"><surname>Albrecht</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nega</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wagener</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Kaesler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schaller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Biedermann</surname><given-names>T.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group><article-title>Staphylococcal Peptidoglycan Co-Localizes with Nod2 and TLR2 and Activates Innate Immune Response via Both Receptors in Primary Murine Keratinocytes</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e13153</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0013153</pub-id><pub-id pub-id-type="pmid">20949035</pub-id><pub-id pub-id-type="pmcid">PMC2951902</pub-id></element-citation></ref><ref id="B224-pathogens-14-00185"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#228;ffler</surname><given-names>H.</given-names></name><name name-style="western"><surname>Demircioglu</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>K&#252;hner</surname><given-names>D.</given-names></name><name name-style="western"><surname>Menz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bender</surname><given-names>A.</given-names></name><name name-style="western"><surname>Autenrieth</surname><given-names>I.B.</given-names></name><name name-style="western"><surname>Bodammer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lamprecht</surname><given-names>G.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Frick</surname><given-names>J.S.</given-names></name></person-group><article-title>NOD2 Stimulation by Staphylococcus Aureus-Derived Peptidoglycan Is Boosted by Toll-like Receptor 2 Costimulation with Lipoproteins in Dendritic Cells</article-title><source>Infect. Immun.</source><year>2014</year><volume>82</volume><fpage>4681</fpage><lpage>4688</lpage><pub-id pub-id-type="doi">10.1128/IAI.02043-14</pub-id><pub-id pub-id-type="pmid">25156723</pub-id><pub-id pub-id-type="pmcid">PMC4249339</pub-id></element-citation></ref><ref id="B225-pathogens-14-00185"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fraser</surname><given-names>I.P.</given-names></name><name name-style="western"><surname>Koziel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ezekowitz</surname><given-names>R.A.B.</given-names></name></person-group><article-title>The Serum Mannose-Binding Protein and the Macrophage Mannose Receptor Are Pattern Recognition Molecules That Link Innate and Adaptive Immunity</article-title><source>Semin. Immunol.</source><year>1998</year><volume>10</volume><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1006/smim.1998.0141</pub-id><pub-id pub-id-type="pmid">9799711</pub-id></element-citation></ref><ref id="B226-pathogens-14-00185"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dundee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shahroor-Karni</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thiel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jensenius</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gad</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hamblin</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sastry</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Ezekowitz</surname><given-names>R.A.B.</given-names></name></person-group><article-title>Mannose-Binding Lectin-Deficient Mice Are Susceptible to Infection with Staphylococcus Aureus</article-title><source>J. Exp. Med.</source><year>2004</year><volume>199</volume><fpage>1379</fpage><pub-id pub-id-type="doi">10.1084/jem.20032207</pub-id><pub-id pub-id-type="pmid">15148336</pub-id><pub-id pub-id-type="pmcid">PMC2211809</pub-id></element-citation></ref><ref id="B227-pathogens-14-00185"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boero</surname><given-names>E.</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Juliet</surname><given-names>T.</given-names></name><name name-style="western"><surname>van Yperen</surname><given-names>E.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name></person-group><article-title>Use of Flow Cytometry to Evaluate Phagocytosis of Staphylococcus Aureus by Human Neutrophils</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>635825</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.635825</pub-id><pub-id pub-id-type="pmid">33679791</pub-id><pub-id pub-id-type="pmcid">PMC7934835</pub-id></element-citation></ref><ref id="B228-pathogens-14-00185"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loh</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Aghababa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Proft</surname><given-names>T.</given-names></name></person-group><article-title>Eluding the Immune System&#8217;s Frontline Defense: Secreted Complement Evasion Factors of Pathogenic Gram-Positive Cocci</article-title><source>Microbiol. Res.</source><year>2023</year><volume>277</volume><elocation-id>127512</elocation-id><pub-id pub-id-type="doi">10.1016/j.micres.2023.127512</pub-id><pub-id pub-id-type="pmid">37826985</pub-id></element-citation></ref><ref id="B229-pathogens-14-00185"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verdrengh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>Role of Neutrophils in Experimental Septicemia and Septic Arthritis Induced by Staphylococcus Aureus</article-title><source>Infect. Immun.</source><year>1997</year><volume>65</volume><fpage>2517</fpage><lpage>2521</lpage><pub-id pub-id-type="doi">10.1128/iai.65.7.2517-2521.1997</pub-id><pub-id pub-id-type="pmid">9199413</pub-id><pub-id pub-id-type="pmcid">PMC175355</pub-id></element-citation></ref><ref id="B230-pathogens-14-00185"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farias Benjamim</surname><given-names>C.</given-names></name><name name-style="western"><surname>Santana Silva</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bruno Fortes</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Aparecida Oliveira</surname><given-names>M.</given-names></name><name name-style="western"><surname>Henrique Ferreira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Queiroz Cunha</surname><given-names>F.</given-names></name></person-group><article-title>Inhibition of Leukocyte Rolling by Nitric Oxide during Sepsis Leads to Reduced Migration of Active Microbicidal Neutrophils</article-title><source>Infect. Immun.</source><year>2002</year><volume>70</volume><fpage>3602</fpage><pub-id pub-id-type="doi">10.1128/IAI.70.7.3602-3610.2002</pub-id><pub-id pub-id-type="pmid">12065501</pub-id><pub-id pub-id-type="pmcid">PMC128083</pub-id></element-citation></ref><ref id="B231-pathogens-14-00185"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakiniene</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bremell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>Inhibition of Nitric Oxide Synthase (NOS) Aggravates Staphylococcus Aureus Septicaemia and Septic Arthritis</article-title><source>Clin. Exp. Immunol.</source><year>2003</year><volume>110</volume><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.1997.4431456.x</pub-id><pub-id pub-id-type="pmid">9409638</pub-id><pub-id pub-id-type="pmcid">PMC1904816</pub-id></element-citation></ref><ref id="B232-pathogens-14-00185"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Ammons</surname><given-names>M.C.B.</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name></person-group><article-title>The Expanding Role of NADPH Oxidases in Health and Disease: No Longer Just Agents of Death and Destruction</article-title><source>Clin. Sci.</source><year>2006</year><volume>111</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1042/CS20060059</pub-id><pub-id pub-id-type="pmid">16764554</pub-id></element-citation></ref><ref id="B233-pathogens-14-00185"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beavers</surname><given-names>W.N.</given-names></name><name name-style="western"><surname>Skaar</surname><given-names>E.P.</given-names></name></person-group><article-title>Neutrophil-Generated Oxidative Stress and Protein Damage in Staphylococcus Aureus</article-title><source>Pathog. Dis.</source><year>2016</year><volume>74</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1093/femspd/ftw060</pub-id><pub-id pub-id-type="pmid">27354296</pub-id><pub-id pub-id-type="pmcid">PMC5975594</pub-id></element-citation></ref><ref id="B234-pathogens-14-00185"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Riquelme</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Baskota</surname><given-names>S.U.</given-names></name><name name-style="western"><surname>Drikic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Monk</surname><given-names>I.R.</given-names></name><name name-style="western"><surname>Stinear</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.S.</given-names></name></person-group><article-title>Staphylococcus Aureus Stimulates Neutrophil Itaconate Production That Suppresses the Oxidative Burst</article-title><source>Cell Rep.</source><year>2023</year><volume>42</volume><fpage>112064</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112064</pub-id><pub-id pub-id-type="pmid">36724077</pub-id><pub-id pub-id-type="pmcid">PMC10387506</pub-id></element-citation></ref><ref id="B235-pathogens-14-00185"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nauseef</surname><given-names>W.M.</given-names></name></person-group><article-title>Salt, Chloride, Bleach, and Innate Host Defense</article-title><source>J. Leukoc. Biol.</source><year>2015</year><volume>98</volume><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1189/jlb.4RU0315-109R</pub-id><pub-id pub-id-type="pmid">26048979</pub-id><pub-id pub-id-type="pmcid">PMC4763953</pub-id></element-citation></ref><ref id="B236-pathogens-14-00185"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nauseef</surname><given-names>W.M.</given-names></name></person-group><article-title>How Human Neutrophils Kill and Degrade Microbes: An Integrated View</article-title><source>Immunol. Rev.</source><year>2007</year><volume>219</volume><fpage>88</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00550.x</pub-id><pub-id pub-id-type="pmid">17850484</pub-id></element-citation></ref><ref id="B237-pathogens-14-00185"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Diep</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title>Host Defense and Pathogenesis in Staphylococcus Aureus Infections</article-title><source>Infect. Dis. Clin. N. Am.</source><year>2009</year><volume>23</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1016/j.idc.2008.10.003</pub-id><pub-id pub-id-type="pmid">19135914</pub-id><pub-id pub-id-type="pmcid">PMC2748223</pub-id></element-citation></ref><ref id="B238-pathogens-14-00185"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name></person-group><article-title>Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>11401</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222111401</pub-id><pub-id pub-id-type="pmid">34768832</pub-id><pub-id pub-id-type="pmcid">PMC8584040</pub-id></element-citation></ref><ref id="B239-pathogens-14-00185"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacy</surname><given-names>P.</given-names></name></person-group><article-title>Mechanisms of Degranulation in Neutrophils</article-title><source>Allergy Asthma Clin. Immunol.</source><year>2006</year><volume>2</volume><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1186/1710-1492-2-3-98</pub-id><pub-id pub-id-type="pmid">20525154</pub-id><pub-id pub-id-type="pmcid">PMC2876182</pub-id></element-citation></ref><ref id="B240-pathogens-14-00185"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Phenol-Soluble Modulin A4 Mediates Staphylococcus Aureus-Associated Vascular Leakage by Stimulating Heparin-Binding Protein Release from Neutrophils</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><elocation-id>29373</elocation-id><pub-id pub-id-type="doi">10.1038/srep29373</pub-id><pub-id pub-id-type="pmid">27383625</pub-id><pub-id pub-id-type="pmcid">PMC4935938</pub-id></element-citation></ref><ref id="B241-pathogens-14-00185"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamen</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Schlessinger</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lowell</surname><given-names>C.A.</given-names></name></person-group><article-title>Pyk2 Is Required for Neutrophil Degranulation and Host Defense Responses to Bacterial Infection</article-title><source>J. Immunol.</source><year>2010</year><volume>186</volume><fpage>1656</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002093</pub-id><pub-id pub-id-type="pmid">21187437</pub-id><pub-id pub-id-type="pmcid">PMC3248398</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="expression-of-concern" ext-link-type="pubmed" xlink:href="38709995"/></element-citation></ref><ref id="B242-pathogens-14-00185"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkmann</surname><given-names>V.</given-names></name><name name-style="western"><surname>Reichard</surname><given-names>U.</given-names></name><name name-style="western"><surname>Goosmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fauler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Uhlemann</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Weinrauch</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps Kill Bacteria</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1532</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1126/science.1092385</pub-id><pub-id pub-id-type="pmid">15001782</pub-id></element-citation></ref><ref id="B243-pathogens-14-00185"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rada</surname><given-names>B.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps and Microcrystals</article-title><source>J. Immunol. Res.</source><year>2017</year><volume>2017</volume><fpage>2896380</fpage><pub-id pub-id-type="doi">10.1155/2017/2896380</pub-id><pub-id pub-id-type="pmid">28373994</pub-id><pub-id pub-id-type="pmcid">PMC5361057</pub-id></element-citation></ref><ref id="B244-pathogens-14-00185"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kenny</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Herzig</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kr&#252;ger</surname><given-names>R.</given-names></name><name name-style="western"><surname>Muth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>V.</given-names></name><name name-style="western"><surname>von Bernuth</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A.</given-names></name></person-group><article-title>Diverse Stimuli Engage Different Neutrophil Extracellular Trap Pathways</article-title><source>eLife</source><year>2017</year><volume>6</volume><fpage>e24437</fpage><pub-id pub-id-type="doi">10.7554/eLife.24437</pub-id><pub-id pub-id-type="pmid">28574339</pub-id><pub-id pub-id-type="pmcid">PMC5496738</pub-id></element-citation></ref><ref id="B245-pathogens-14-00185"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Souza</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Breda</surname><given-names>L.C.D.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>de Almeida</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>C&#226;mara</surname><given-names>N.O.S.</given-names></name><name name-style="western"><surname>Sweezey</surname><given-names>N.</given-names></name><name name-style="western"><surname>Palaniyar</surname><given-names>N.</given-names></name></person-group><article-title>Alkaline PH Promotes NADPH Oxidase-Independent Neutrophil Extracellular Trap Formation: A Matter of Mitochondrial Reactive Oxygen Species Generation and Citrullination and Cleavage of Histone</article-title><source>Front. Immunol.</source><year>2018</year><volume>8</volume><elocation-id>1849</elocation-id><pub-id pub-id-type="doi">10.3389/FIMMU.2017.01849</pub-id><pub-id pub-id-type="pmid">29375550</pub-id><pub-id pub-id-type="pmcid">PMC5767187</pub-id></element-citation></ref><ref id="B246-pathogens-14-00185"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilsczek</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Salina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>K.K.H.</given-names></name><name name-style="western"><surname>Fahey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yipp</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Sibley</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Green</surname><given-names>F.H.Y.</given-names></name><name name-style="western"><surname>Surette</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Sugai</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus Aureus</article-title><source>J. Immunol.</source><year>2010</year><volume>185</volume><fpage>7413</fpage><lpage>7425</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000675</pub-id><pub-id pub-id-type="pmid">21098229</pub-id></element-citation></ref><ref id="B247-pathogens-14-00185"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Abed</surname><given-names>U.</given-names></name><name name-style="western"><surname>Goosmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hurwitz</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>I.</given-names></name><name name-style="western"><surname>Wahn</surname><given-names>V.</given-names></name><name name-style="western"><surname>Weinrauch</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>V.</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A.</given-names></name></person-group><article-title>Novel Cell Death Program Leads to Neutrophil Extracellular Traps</article-title><source>J. Cell Biol.</source><year>2007</year><volume>176</volume><fpage>231</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1083/jcb.200606027</pub-id><pub-id pub-id-type="pmid">17210947</pub-id><pub-id pub-id-type="pmcid">PMC2063942</pub-id></element-citation></ref><ref id="B248-pathogens-14-00185"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papayannopoulos</surname><given-names>V.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps in Immunity and Disease</article-title><source>Nat. Rev. Immunol.</source><year>2018</year><volume>18</volume><fpage>134</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.105</pub-id><pub-id pub-id-type="pmid">28990587</pub-id></element-citation></ref><ref id="B249-pathogens-14-00185"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yousefi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mihalache</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kozlowski</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>I.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>H.U.</given-names></name></person-group><article-title>Viable Neutrophils Release Mitochondrial DNA to Form Neutrophil Extracellular Traps</article-title><source>Cell Death Differ.</source><year>2009</year><volume>16</volume><fpage>1438</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.96</pub-id><pub-id pub-id-type="pmid">19609275</pub-id></element-citation></ref><ref id="B250-pathogens-14-00185"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petretto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bruschi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pratesi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Croia</surname><given-names>C.</given-names></name><name name-style="western"><surname>Candiano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ghiggeri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Migliorini</surname><given-names>P.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps (NET) Induced by Different Stimuli: A Comparative Proteomic Analysis</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0218946</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0218946</pub-id><pub-id pub-id-type="pmid">31283757</pub-id><pub-id pub-id-type="pmcid">PMC6613696</pub-id></element-citation></ref><ref id="B251-pathogens-14-00185"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazzoleni</surname><given-names>V.</given-names></name><name name-style="western"><surname>Zimmermann-Meisse</surname><given-names>G.</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tarassov</surname><given-names>I.</given-names></name><name name-style="western"><surname>Pr&#233;vost</surname><given-names>G.</given-names></name></person-group><article-title>Staphylococcus Aureus Panton-Valentine Leukocidin Triggers an Alternative NETosis Process Targeting Mitochondria</article-title><source>FASEB J.</source><year>2021</year><volume>35</volume><fpage>e21167</fpage><pub-id pub-id-type="doi">10.1096/fj.201902981R</pub-id><pub-id pub-id-type="pmid">33241563</pub-id></element-citation></ref><ref id="B252-pathogens-14-00185"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malachowa</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dorward</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name></person-group><article-title>Staphylococcus Aureus LukGH Promotes Formation of Neutrophil Extracellular Traps</article-title><source>J. Immunol.</source><year>2013</year><volume>191</volume><fpage>6022</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301821</pub-id><pub-id pub-id-type="pmid">24190656</pub-id><pub-id pub-id-type="pmcid">PMC3903389</pub-id></element-citation></ref><ref id="B253-pathogens-14-00185"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Corriden</surname><given-names>R.</given-names></name><name name-style="western"><surname>Akong-Moore</surname><given-names>K.</given-names></name><name name-style="western"><surname>Olson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dorrestein</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name></person-group><article-title>N-Terminal ArgD Peptides from the Classical Staphylococcus Aureus Agr System Have Cytotoxic and Proinflammatory Activities</article-title><source>Chem. Biol.</source><year>2014</year><volume>21</volume><elocation-id>1457</elocation-id><pub-id pub-id-type="doi">10.1016/j.chembiol.2014.09.015</pub-id><pub-id pub-id-type="pmid">25457179</pub-id><pub-id pub-id-type="pmcid">PMC4304878</pub-id></element-citation></ref><ref id="B254-pathogens-14-00185"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bj&#246;rnsdottir</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rudin</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Klose</surname><given-names>F.P.</given-names></name><name name-style="western"><surname>Elmwall</surname><given-names>J.</given-names></name><name name-style="western"><surname>Welin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stylianou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Christenson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Urban</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Forsman</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dahlgren</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Phenol-Soluble Modulin a Peptide Toxins from Aggressive Staphylococcus Aureus Induce Rapid Formation of Neutrophil Extracellular Traps through a Reactive Oxygen Species-Independent Pathway</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><elocation-id>257</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00257</pub-id><pub-id pub-id-type="pmid">28337204</pub-id><pub-id pub-id-type="pmcid">PMC5343011</pub-id></element-citation></ref><ref id="B255-pathogens-14-00185"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yipp</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Petri</surname><given-names>B.</given-names></name><name name-style="western"><surname>Salina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jenne</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>B.N.V.</given-names></name><name name-style="western"><surname>Zbytnuik</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Pittman</surname><given-names>K.</given-names></name><name name-style="western"><surname>Asaduzzaman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Meijndert</surname><given-names>H.C.</given-names></name><etal/></person-group><article-title>Dynamic NETosis Is Carried Out by Live Neutrophils in Human and Mouse Bacterial Abscesses and During Severe Gram-Positive Infection</article-title><source>Nat. Med.</source><year>2012</year><volume>18</volume><fpage>1386</fpage><pub-id pub-id-type="doi">10.1038/nm.2847</pub-id><pub-id pub-id-type="pmid">22922410</pub-id><pub-id pub-id-type="pmcid">PMC4529131</pub-id></element-citation></ref><ref id="B256-pathogens-14-00185"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cahilog</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Weng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>D.</given-names></name></person-group><article-title>The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms</article-title><source>Inflammation</source><year>2020</year><volume>43</volume><fpage>2021</fpage><pub-id pub-id-type="doi">10.1007/s10753-020-01294-x</pub-id><pub-id pub-id-type="pmid">32830308</pub-id><pub-id pub-id-type="pmcid">PMC7443373</pub-id></element-citation></ref><ref id="B257-pathogens-14-00185"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinegin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Vorobjeva</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pinegin</surname><given-names>V.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps and Their Role in the Development of Chronic Inflammation and Autoimmunity</article-title><source>Autoimmun. Rev.</source><year>2015</year><volume>14</volume><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2015.03.002</pub-id><pub-id pub-id-type="pmid">25797532</pub-id></element-citation></ref><ref id="B258-pathogens-14-00185"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawabata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hagio</surname><given-names>T.</given-names></name><name name-style="western"><surname>Matsuoka</surname><given-names>S.</given-names></name></person-group><article-title>The Role of Neutrophil Elastase in Acute Lung Injury</article-title><source>Eur. J. Pharmacol.</source><year>2002</year><volume>451</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(02)02182-9</pub-id><pub-id pub-id-type="pmid">12223222</pub-id></element-citation></ref><ref id="B259-pathogens-14-00185"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saffarzadeh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Juenemann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Queisser</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Lochnit</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barreto</surname><given-names>G.</given-names></name><name name-style="western"><surname>Galuska</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Lohmeyer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Preissner</surname><given-names>K.T.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>32366</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0032366</pub-id><pub-id pub-id-type="pmcid">PMC3289648</pub-id><pub-id pub-id-type="pmid">22389696</pub-id></element-citation></ref><ref id="B260-pathogens-14-00185"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Der Vliet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Shigenaga</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Eiserich</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Marelich</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Cross</surname><given-names>C.E.</given-names></name></person-group><article-title>Myeloperoxidase and Protein Oxidation in Cystic Fibrosis</article-title><source>Am. J. Physiol. Lung Cell Mol. Physiol.</source><year>2000</year><volume>279</volume><fpage>L537</fpage><lpage>L546</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2000.279.3.L537</pub-id><pub-id pub-id-type="pmid">10956629</pub-id></element-citation></ref><ref id="B261-pathogens-14-00185"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papayannopoulos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Staab</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A.</given-names></name></person-group><article-title>Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e28526</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028526</pub-id><pub-id pub-id-type="pmid">22174830</pub-id><pub-id pub-id-type="pmcid">PMC3235130</pub-id></element-citation></ref><ref id="B262-pathogens-14-00185"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolaczkowska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Jenne</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Surewaard</surname><given-names>B.G.J.</given-names></name><name name-style="western"><surname>Thanabalasuriar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W.Y.</given-names></name><name name-style="western"><surname>Sanz</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Mowen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Opdenakker</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P.</given-names></name></person-group><article-title>Molecular Mechanisms of NET Formation and Degradation Revealed by Intravital Imaging in the Liver Vasculature</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>6673</fpage><pub-id pub-id-type="doi">10.1038/ncomms7673</pub-id><pub-id pub-id-type="pmid">25809117</pub-id><pub-id pub-id-type="pmcid">PMC4389265</pub-id></element-citation></ref><ref id="B263-pathogens-14-00185"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonald</surname><given-names>B.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Tse</surname><given-names>M.</given-names></name><name name-style="western"><surname>Esmon</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Kolaczkowska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Jenne</surname><given-names>C.N.</given-names></name></person-group><article-title>Platelets and Neutrophil Extracellular Traps Collaborate to Promote Intravascular Coagulation during Sepsis in Mice</article-title><source>Blood</source><year>2017</year><volume>129</volume><fpage>1357</fpage><pub-id pub-id-type="doi">10.1182/blood-2016-09-741298</pub-id><pub-id pub-id-type="pmid">28073784</pub-id><pub-id pub-id-type="pmcid">PMC5345735</pub-id></element-citation></ref><ref id="B264-pathogens-14-00185"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefran&#231;ais</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mallavia</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhuo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Calfee</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Looney</surname><given-names>M.R.</given-names></name></person-group><article-title>Maladaptive Role of Neutrophil Extracellular Traps in Pathogen-Induced Lung Injury</article-title><source>JCI Insight</source><year>2018</year><volume>3</volume><fpage>e98178</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.98178</pub-id><pub-id pub-id-type="pmid">29415887</pub-id><pub-id pub-id-type="pmcid">PMC5821185</pub-id></element-citation></ref><ref id="B265-pathogens-14-00185"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Ohniwa</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Chia</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>C.J.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps Enhance Staphylococcus Aureus Vegetation Formation through Interaction with Platelets in Infective Endocarditis</article-title><source>Thromb. Haemost.</source><year>2019</year><volume>119</volume><fpage>786</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1055/s-0039-1678665</pub-id><pub-id pub-id-type="pmid">30731490</pub-id></element-citation></ref><ref id="B266-pathogens-14-00185"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singhal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>Neutrophil and Remnant Clearance in Immunity and Inflammation</article-title><source>Immunology</source><year>2022</year><volume>165</volume><fpage>22</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1111/imm.13423</pub-id><pub-id pub-id-type="pmid">34704249</pub-id></element-citation></ref><ref id="B267-pathogens-14-00185"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monteith</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Chazin</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Skaar</surname><given-names>E.P.</given-names></name></person-group><article-title>Neutrophil Extracellular Traps Enhance Macrophage Killing of Bacterial Pathogens</article-title><source>Sci. Adv.</source><year>2021</year><volume>7</volume><fpage>eabj2101</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abj2101</pub-id><pub-id pub-id-type="pmid">34516771</pub-id><pub-id pub-id-type="pmcid">PMC8442908</pub-id></element-citation></ref><ref id="B268-pathogens-14-00185"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Numata</surname><given-names>T.</given-names></name><name name-style="western"><surname>Harada</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nakae</surname><given-names>S.</given-names></name></person-group><article-title>Roles of Mast Cells in Cutaneous Diseases</article-title><source>Front. Immunol.</source><year>2022</year><volume>13</volume><elocation-id>923495</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.923495</pub-id><pub-id pub-id-type="pmid">35874756</pub-id><pub-id pub-id-type="pmcid">PMC9298983</pub-id></element-citation></ref><ref id="B269-pathogens-14-00185"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsui</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kanai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ikuta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Horikawa</surname><given-names>S.</given-names></name></person-group><article-title>Mast Cells Stimulated with Peptidoglycan from Staphylococcus Aureus Augment the Development of Th1 Cells</article-title><source>J. Pharm. Pharm. Sci.</source><year>2018</year><volume>21</volume><fpage>296</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.18433/jpps29951</pub-id><pub-id pub-id-type="pmid">30012242</pub-id></element-citation></ref><ref id="B270-pathogens-14-00185"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldmann</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sauerwein</surname><given-names>T.</given-names></name><name name-style="western"><surname>Molinari</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rohde</surname><given-names>M.</given-names></name><name name-style="western"><surname>F&#246;rstner</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Medina</surname><given-names>E.</given-names></name></person-group><article-title>Cytosolic Sensing of Intracellular Staphylococcus Aureus by Mast Cells Elicits a Type I IFN Response That Enhances Cell-Autonomous Immunity</article-title><source>J. Immunol.</source><year>2022</year><volume>208</volume><fpage>1675</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2100622</pub-id><pub-id pub-id-type="pmid">35321877</pub-id></element-citation></ref><ref id="B271-pathogens-14-00185"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hershko</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>R.</given-names></name><name name-style="western"><surname>Charles</surname><given-names>N.</given-names></name><name name-style="western"><surname>Alvarez-Errico</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sargent</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Laurence</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>J.</given-names></name></person-group><article-title>Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>562</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.07.013</pub-id><pub-id pub-id-type="pmid">21982597</pub-id><pub-id pub-id-type="pmcid">PMC3432919</pub-id></element-citation></ref><ref id="B272-pathogens-14-00185"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serhan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Basso</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sibilano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Petitfils</surname><given-names>C.</given-names></name><name name-style="western"><surname>Meixiong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bonnart</surname><given-names>C.</given-names></name><name name-style="western"><surname>Reber</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Marichal</surname><given-names>T.</given-names></name><name name-style="western"><surname>Starkl</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cenac</surname><given-names>N.</given-names></name><etal/></person-group><article-title>House Dust Mites Activate Nociceptor-Mast Cell Clusters to Drive Type Skin Inflammation</article-title><source>Nat. Immunol.</source><year>2019</year><volume>20</volume><fpage>1435</fpage><pub-id pub-id-type="doi">10.1038/s41590-019-0493-z</pub-id><pub-id pub-id-type="pmid">31591569</pub-id><pub-id pub-id-type="pmcid">PMC6858877</pub-id></element-citation></ref><ref id="B273-pathogens-14-00185"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kaitani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Izawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ando</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kamei</surname><given-names>A.</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>S.</given-names></name><name name-style="western"><surname>Maehara</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kojima</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus &#948;-Toxin Present on Skin Promotes the Development of Food Allergy in a Murine Model</article-title><source>Front. Immunol.</source><year>2023</year><volume>14</volume><elocation-id>1173069</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1173069</pub-id><pub-id pub-id-type="pmid">37275864</pub-id><pub-id pub-id-type="pmcid">PMC10235538</pub-id></element-citation></ref><ref id="B274-pathogens-14-00185"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mascarenhas</surname><given-names>N.</given-names></name><name name-style="western"><surname>Eckmann</surname><given-names>L.</given-names></name><name name-style="western"><surname>Miyamoto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>T.</given-names></name><name name-style="western"><surname>Di Nardo</surname><given-names>A.</given-names></name></person-group><article-title>Skin Microbiome Promotes Mast Cell Maturation by Triggering Stem Cell Factor Production in Keratinocytes</article-title><source>J. Allergy Clin. Immunol.</source><year>2017</year><volume>139</volume><fpage>1205</fpage><lpage>1216.e6</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2016.09.019</pub-id><pub-id pub-id-type="pmid">27746235</pub-id><pub-id pub-id-type="pmcid">PMC5385284</pub-id></element-citation></ref><ref id="B275-pathogens-14-00185"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Supajatura</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ushio</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nakao</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name><name name-style="western"><surname>Okumura</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ra</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>H.</given-names></name></person-group><article-title>Differential Responses of Mast Cell Toll-like Receptors 2 and 4 in Allergy and Innate Immunity</article-title><source>J. Clin. Invest.</source><year>2002</year><volume>109</volume><fpage>1351</fpage><pub-id pub-id-type="doi">10.1172/JCI0214704</pub-id><pub-id pub-id-type="pmid">12021251</pub-id><pub-id pub-id-type="pmcid">PMC150977</pub-id></element-citation></ref><ref id="B276-pathogens-14-00185"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houtak</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nepal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bouras</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shaghayegh</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>C.</given-names></name><name name-style="western"><surname>Finnie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fenix</surname><given-names>K.</given-names></name><name name-style="western"><surname>Psaltis</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Wormald</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Vreugde</surname><given-names>S.</given-names></name></person-group><article-title>Staphylococcus Aureus Biofilm-Secreted Factors Cause Mucosal Damage, Mast Cell Infiltration, and Goblet Cell Hyperplasia in a Rat Rhinosinusitis Model</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>3402</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25063402</pub-id><pub-id pub-id-type="pmid">38542379</pub-id><pub-id pub-id-type="pmcid">PMC10970533</pub-id></element-citation></ref><ref id="B277-pathogens-14-00185"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kita</surname><given-names>H.</given-names></name></person-group><article-title>Eosinophils: Multifaceted Biological Properties and Roles in Health and Disease</article-title><source>Immunol. Rev.</source><year>2011</year><volume>242</volume><fpage>161</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01026.x</pub-id><pub-id pub-id-type="pmid">21682744</pub-id><pub-id pub-id-type="pmcid">PMC3139217</pub-id></element-citation></ref><ref id="B278-pathogens-14-00185"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobsen</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Taranova</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.J.</given-names></name></person-group><article-title>Eosinophils: Singularly Destructive Effector Cells or Purveyors of Immunoregulation?</article-title><source>J. Allergy Clin. Immunol.</source><year>2007</year><volume>119</volume><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2007.03.043</pub-id><pub-id pub-id-type="pmid">17481717</pub-id></element-citation></ref><ref id="B279-pathogens-14-00185"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gevaert</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Krysko</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Holtappels</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Ruyck</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nauwynck</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yousefi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>H.U.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name></person-group><article-title>Extracellular Eosinophilic Traps in Association with Staphylococcus Aureus at the Site of Epithelial Barrier Defects in Patients with Severe Airway Inflammation</article-title><source>J. Allergy Clin. Immunol.</source><year>2017</year><volume>139</volume><fpage>1849</fpage><lpage>1860.e6</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2017.01.019</pub-id><pub-id pub-id-type="pmid">28216437</pub-id></element-citation></ref><ref id="B280-pathogens-14-00185"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>E.-M.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.-S.</given-names></name></person-group><article-title>Association between Specific IgE to Staphylococcal Enterotoxin B and the Eosinophilic Phenotype of Asthma</article-title><source>Korean J. Intern. Med.</source><year>2024</year><volume>39</volume><fpage>659</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.3904/kjim.2024.003</pub-id><pub-id pub-id-type="pmid">38986495</pub-id><pub-id pub-id-type="pmcid">PMC11236811</pub-id></element-citation></ref><ref id="B281-pathogens-14-00185"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.Q.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.Y.</given-names></name></person-group><article-title>Different Roles of Staphylococcus Aureus Enterotoxin in Different Subtypes of Nasal Polyps</article-title><source>Exp. Ther. Med.</source><year>2017</year><volume>13</volume><fpage>321</fpage><pub-id pub-id-type="doi">10.3892/etm.2016.3951</pub-id><pub-id pub-id-type="pmid">28123509</pub-id><pub-id pub-id-type="pmcid">PMC5244894</pub-id></element-citation></ref><ref id="B282-pathogens-14-00185"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rha</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Khalmuratova</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Eun</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S.N.</given-names></name><etal/></person-group><article-title>Superantigen-Related TH2 CD4+ T Cells in Nonasthmatic Chronic Rhinosinusitis with Nasal Polyps</article-title><source>J. Allergy Clin. Immunol.</source><year>2020</year><volume>145</volume><fpage>1378</fpage><lpage>1388.e10</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2019.12.915</pub-id><pub-id pub-id-type="pmid">31987845</pub-id></element-citation></ref><ref id="B283-pathogens-14-00185"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinheiro-Torres</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Ferreira-Duarte</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Takeshita</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Gushiken</surname><given-names>V.O.</given-names></name><name name-style="western"><surname>Roncalho-Buck</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Anh&#234;</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>E.</given-names></name><name name-style="western"><surname>DeSouza</surname><given-names>I.A.</given-names></name></person-group><article-title>Airways Exposure of Bacterial Superantigen SEB Enhances Bone Marrow Eosinophil Population and Facilitates Its Egress to Blood and Lung Tissue</article-title><source>Life Sci.</source><year>2021</year><volume>264</volume><fpage>118685</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.118685</pub-id><pub-id pub-id-type="pmid">33137369</pub-id></element-citation></ref><ref id="B284-pathogens-14-00185"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kline</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Orlando</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Youn</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feller</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Pontaza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dikeman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Limjunyawong</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Proteases Trigger Eosinophil-Mediated Skin Inflammation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2024</year><volume>121</volume><fpage>e2309243121</fpage><pub-id pub-id-type="doi">10.1073/pnas.2309243121</pub-id><pub-id pub-id-type="pmid">38289950</pub-id><pub-id pub-id-type="pmcid">PMC10861893</pub-id></element-citation></ref><ref id="B285-pathogens-14-00185"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shepherd</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>McLaren</surname><given-names>J.E.</given-names></name></person-group><article-title>T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>6144</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21176144</pub-id><pub-id pub-id-type="pmid">32858901</pub-id><pub-id pub-id-type="pmcid">PMC7504484</pub-id></element-citation></ref><ref id="B286-pathogens-14-00185"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>CD4 T Helper Cell Subsets and Related Human Immunological Disorders</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>8011</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21218011</pub-id><pub-id pub-id-type="pmid">33126494</pub-id><pub-id pub-id-type="pmcid">PMC7663252</pub-id></element-citation></ref><ref id="B287-pathogens-14-00185"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dardalhon</surname><given-names>V.</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Galileos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Mitsdoerffer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Strom</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Elyaman</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>I.C.</given-names></name><etal/></person-group><article-title>IL-4 Inhibits TGF-Beta-Induced Foxp3+ T Cells and, Together with TGF-Beta, Generates IL-9+ IL-10+ Foxp3(-) Effector T Cells</article-title><source>Nat. Immunol.</source><year>2008</year><volume>9</volume><fpage>1347</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1038/ni.1677</pub-id><pub-id pub-id-type="pmid">18997793</pub-id><pub-id pub-id-type="pmcid">PMC2999006</pub-id></element-citation></ref><ref id="B288-pathogens-14-00185"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sehra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Glosson-Byers</surname><given-names>N.L.</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>M.H.</given-names></name></person-group><article-title>TH9 Cells Are Required for Tissue Mast Cell Accumulation during Allergic Inflammation</article-title><source>J. Allergy Clin. Immunol.</source><year>2015</year><volume>136</volume><fpage>433</fpage><lpage>440.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2015.01.021</pub-id><pub-id pub-id-type="pmid">25746972</pub-id><pub-id pub-id-type="pmcid">PMC4530056</pub-id></element-citation></ref><ref id="B289-pathogens-14-00185"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veldhoen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uyttenhove</surname><given-names>C.</given-names></name><name name-style="western"><surname>van Snick</surname><given-names>J.</given-names></name><name name-style="western"><surname>Helmby</surname><given-names>H.</given-names></name><name name-style="western"><surname>Westendorf</surname><given-names>A.</given-names></name><name name-style="western"><surname>Buer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>C.</given-names></name><name name-style="western"><surname>Stockinger</surname><given-names>B.</given-names></name></person-group><article-title>Transforming Growth Factor-Beta &#8220;reprograms&#8221; the Differentiation of T Helper 2 Cells and Promotes an Interleukin 9-Producing Subset</article-title><source>Nat. Immunol.</source><year>2008</year><volume>9</volume><fpage>1341</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1038/ni.1659</pub-id><pub-id pub-id-type="pmid">18931678</pub-id></element-citation></ref><ref id="B290-pathogens-14-00185"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stockinger</surname><given-names>B.</given-names></name><name name-style="western"><surname>Omenetti</surname><given-names>S.</given-names></name></person-group><article-title>The Dichotomous Nature of T Helper 17 Cells</article-title><source>Nat. Rev. Immunol.</source><year>2017</year><volume>17</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.50</pub-id><pub-id pub-id-type="pmid">28555673</pub-id></element-citation></ref><ref id="B291-pathogens-14-00185"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paroli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Caccavale</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fiorillo</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Spadea</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gumina</surname><given-names>S.</given-names></name><name name-style="western"><surname>Candela</surname><given-names>V.</given-names></name><name name-style="western"><surname>Paroli</surname><given-names>M.P.</given-names></name></person-group><article-title>The Double Game Played by Th17 Cells in Infection: Host Defense and Immunopathology</article-title><source>Pathogens</source><year>2022</year><volume>11</volume><elocation-id>1547</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens11121547</pub-id><pub-id pub-id-type="pmid">36558881</pub-id><pub-id pub-id-type="pmcid">PMC9781511</pub-id></element-citation></ref><ref id="B292-pathogens-14-00185"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S.</given-names></name></person-group><article-title>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</article-title><source>Immunity</source><year>2019</year><volume>50</volume><fpage>1132</fpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.04.011</pub-id><pub-id pub-id-type="pmid">31117010</pub-id><pub-id pub-id-type="pmcid">PMC6532429</pub-id></element-citation></ref><ref id="B293-pathogens-14-00185"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakaguchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nomura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ono</surname><given-names>M.</given-names></name></person-group><article-title>Regulatory T Cells and Immune Tolerance</article-title><source>Cell</source><year>2008</year><volume>133</volume><fpage>775</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.05.009</pub-id><pub-id pub-id-type="pmid">18510923</pub-id></element-citation></ref><ref id="B294-pathogens-14-00185"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Farber</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Avanesian</surname><given-names>V.</given-names></name><name name-style="western"><surname>Baquir</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>French</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Spellberg</surname><given-names>B.</given-names></name></person-group><article-title>Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus Aureus and Candida Albicans Infection in Mice</article-title><source>PLoS Pathog.</source><year>2009</year><volume>5</volume><elocation-id>e1000703</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000703</pub-id><pub-id pub-id-type="pmid">20041174</pub-id><pub-id pub-id-type="pmcid">PMC2792038</pub-id></element-citation></ref><ref id="B295-pathogens-14-00185"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spellberg</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Yeaman</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Avanesian</surname><given-names>V.</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Filler</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Lipke</surname><given-names>P.</given-names></name><name name-style="western"><surname>Otoo</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus Aureus</article-title><source>Infect. Immun.</source><year>2008</year><volume>76</volume><fpage>4574</fpage><pub-id pub-id-type="doi">10.1128/IAI.00700-08</pub-id><pub-id pub-id-type="pmid">18644876</pub-id><pub-id pub-id-type="pmcid">PMC2546811</pub-id></element-citation></ref><ref id="B296-pathogens-14-00185"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Lalor</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Leech</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>O&#8217;Keeffe</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Mac Aog&#225;in</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Halloran</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Lacey</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Tavakol</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hearnden</surname><given-names>C.H.</given-names></name><etal/></person-group><article-title>Memory Th1 Cells Are Protective in Invasive Staphylococcus Aureus Infection</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><elocation-id>1005226</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005226</pub-id><pub-id pub-id-type="pmid">26539822</pub-id><pub-id pub-id-type="pmcid">PMC4634925</pub-id></element-citation></ref><ref id="B297-pathogens-14-00185"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Claxton</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Carlile</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Vozza</surname><given-names>E.G.</given-names></name><name name-style="western"><surname>Mills</surname><given-names>K.H.G.</given-names></name><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name></person-group><article-title>IL-10 Inhibition during Immunization Improves Vaccine-Induced Protection against Staphylococcus Aureus Infection</article-title><source>JCI Insight</source><year>2024</year><volume>9</volume><fpage>e178216</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.178216</pub-id><pub-id pub-id-type="pmid">38973612</pub-id><pub-id pub-id-type="pmcid">PMC11383370</pub-id></element-citation></ref><ref id="B298-pathogens-14-00185"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.Y.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Z.N.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>X.H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Role of Gamma-Delta T Cells in Host Response against Staphylococcus Aureus-Induced Pneumonia</article-title><source>BMC Immunol.</source><year>2012</year><volume>13</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-13-38</pub-id><pub-id pub-id-type="pmid">22776294</pub-id><pub-id pub-id-type="pmcid">PMC3524664</pub-id></element-citation></ref><ref id="B299-pathogens-14-00185"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Pietras</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>R.I.</given-names></name><name name-style="western"><surname>Farzam</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Monroe</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Magorien</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Blauvelt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>IL-17 Is Essential for Host Defense against Cutaneous Staphylococcus Aureus Infection in Mice</article-title><source>J. Clin. Investig.</source><year>2010</year><volume>120</volume><fpage>1762</fpage><pub-id pub-id-type="doi">10.1172/JCI40891</pub-id><pub-id pub-id-type="pmid">20364087</pub-id><pub-id pub-id-type="pmcid">PMC2860944</pub-id></element-citation></ref><ref id="B300-pathogens-14-00185"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#246;lne</surname><given-names>L.</given-names></name><name name-style="western"><surname>Corthay</surname><given-names>A.</given-names></name><name name-style="western"><surname>Holmdahl</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>Role of Gamma/Delta T Cell Receptor-Expressing Lymphocytes in Cutaneous Infection Caused by Staphylococcus Aureus</article-title><source>Clin. Exp. Immunol.</source><year>2003</year><volume>132</volume><fpage>209</fpage><pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02151.x</pub-id><pub-id pub-id-type="pmid">12699407</pub-id><pub-id pub-id-type="pmcid">PMC1808706</pub-id></element-citation></ref><ref id="B301-pathogens-14-00185"><label>301.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Mulcahy</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;Keeffe</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Geoghegan</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name></person-group><article-title>Nlrp-3-Driven Interleukin 17 Production by &#915;&#948;T Cells Controls Infection Outcomes during Staphylococcus Aureus Surgical Site Infection</article-title><source>Infect. Immun.</source><year>2013</year><volume>81</volume><fpage>4478</fpage><lpage>4489</lpage><pub-id pub-id-type="doi">10.1128/IAI.01026-13</pub-id><pub-id pub-id-type="pmid">24082072</pub-id><pub-id pub-id-type="pmcid">PMC3837970</pub-id></element-citation></ref><ref id="B302-pathogens-14-00185"><label>302.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>O&#8217;Keeffe</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Lalor</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Maher</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Mills</surname><given-names>K.H.G.</given-names></name><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name></person-group><article-title>Staphylococcus Aureus Infection of Mice Expands a Population of Memory &#915;&#948; T Cells That Are Protective against Subsequent Infection</article-title><source>J. Immunol.</source><year>2014</year><volume>192</volume><fpage>3697</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.1303420</pub-id><pub-id pub-id-type="pmid">24623128</pub-id><pub-id pub-id-type="pmcid">PMC3979672</pub-id></element-citation></ref><ref id="B303-pathogens-14-00185"><label>303.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dikeman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alphonse</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Ortines</surname><given-names>R.V.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Dillen</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>CCR2 Contributes to Host Defense against Staphylococcus Orthopedic Implant-Associated Infections In Mice</article-title><source>J. Orthop. Res.</source><year>2022</year><volume>40</volume><fpage>409</fpage><pub-id pub-id-type="doi">10.1002/jor.25027</pub-id><pub-id pub-id-type="pmid">33713394</pub-id><pub-id pub-id-type="pmcid">PMC8435538</pub-id></element-citation></ref><ref id="B304-pathogens-14-00185"><label>304.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelnour</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bremell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Holmdahl</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name></person-group><article-title>Role of T Lymphocytes in Experimental Staphylococcus Aureus Arthritis</article-title><source>Scand. J. Immunol.</source><year>1994</year><volume>39</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3083.1994.tb03392.x</pub-id><pub-id pub-id-type="pmid">8146600</pub-id></element-citation></ref><ref id="B305-pathogens-14-00185"><label>305.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Alonzo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Planet</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Prince</surname><given-names>A.S.</given-names></name></person-group><article-title>CD4+ T Cells Promote the Pathogenesis of Staphylococcus Aureus Pneumonia</article-title><source>J. Infect. Dis.</source><year>2015</year><volume>211</volume><fpage>835</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu525</pub-id><pub-id pub-id-type="pmid">25240171</pub-id><pub-id pub-id-type="pmcid">PMC4402374</pub-id></element-citation></ref><ref id="B306-pathogens-14-00185"><label>306.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B.</given-names></name></person-group><article-title>Role of Different Th17 and Treg Downstream Signalling Pathways in the Pathogenesis of Staphylococcus Aureus Infection Induced Septic Arthritis in Mice</article-title><source>Exp. Mol. Pathol.</source><year>2020</year><volume>116</volume><fpage>104485</fpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2020.104485</pub-id><pub-id pub-id-type="pmid">32574668</pub-id></element-citation></ref><ref id="B307-pathogens-14-00185"><label>307.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Solinga</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Rich</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zaleski</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Cocchiaro</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Risley</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tzianabos</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.C.</given-names></name></person-group><article-title>CD4+ T Cells and CXC Chemokines Modulate the Pathogenesis of Staphylococcus Aureus Wound Infections</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>10408</fpage><pub-id pub-id-type="doi">10.1073/pnas.0508961103</pub-id><pub-id pub-id-type="pmid">16801559</pub-id><pub-id pub-id-type="pmcid">PMC1502471</pub-id></element-citation></ref><ref id="B308-pathogens-14-00185"><label>308.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holtfreter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kolata</surname><given-names>J.</given-names></name><name name-style="western"><surname>Br&#246;ker</surname><given-names>B.M.</given-names></name></person-group><article-title>Towards the Immune Proteome of Staphylococcus Aureus&#8212;The Anti-<italic toggle="yes">S. Aureus</italic> Antibody Response</article-title><source>Int. J. Med. Microbiol.</source><year>2010</year><volume>300</volume><fpage>176</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2009.10.002</pub-id><pub-id pub-id-type="pmid">19889576</pub-id></element-citation></ref><ref id="B309-pathogens-14-00185"><label>309.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stavnezer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Guikema</surname><given-names>J.E.J.</given-names></name><name name-style="western"><surname>Schrader</surname><given-names>C.E.</given-names></name></person-group><article-title>Mechanism and Regulation of Class Switch Recombination</article-title><source>Annu. Rev. Immunol.</source><year>2008</year><volume>26</volume><fpage>261</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090248</pub-id><pub-id pub-id-type="pmid">18370922</pub-id><pub-id pub-id-type="pmcid">PMC2707252</pub-id></element-citation></ref><ref id="B310-pathogens-14-00185"><label>310.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>L.W.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>I.Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>K.I.</given-names></name></person-group><article-title>Marginal Zone B Cells Assist With Neutrophil Accumulation to Fight Against Systemic Staphylococcus Aureus Infection</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>636818</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.636818</pub-id><pub-id pub-id-type="pmid">34040603</pub-id><pub-id pub-id-type="pmcid">PMC8141640</pub-id></element-citation></ref><ref id="B311-pathogens-14-00185"><label>311.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fritz</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Tiemann</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Epplin</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Al-Zubeidi</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Bubeck Wardenburg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hunstad</surname><given-names>D.A.</given-names></name></person-group><article-title>A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus Aureus Infection</article-title><source>Clin. Infect. Dis.</source><year>2013</year><volume>56</volume><fpage>1554</fpage><lpage>1561</lpage><pub-id pub-id-type="doi">10.1093/cid/cit123</pub-id><pub-id pub-id-type="pmid">23446627</pub-id><pub-id pub-id-type="pmcid">PMC3641868</pub-id></element-citation></ref><ref id="B312-pathogens-14-00185"><label>312.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adhikari</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Ajao</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Aman</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Karauzum</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sarwar</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lydecker</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Roghmann</surname><given-names>M.C.</given-names></name></person-group><article-title>Lower Antibody Levels to Staphylococcus Aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive <italic toggle="yes">S. Aureus</italic> Infections</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>915</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis462</pub-id><pub-id pub-id-type="pmid">22807524</pub-id></element-citation></ref><ref id="B313-pathogens-14-00185"><label>313.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>R.P.N.</given-names></name><name name-style="western"><surname>Mariotti</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fiaschi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nosari</surname><given-names>S.</given-names></name><name name-style="western"><surname>MacCari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liberatori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Pezzicoli</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Falco</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Falugi</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus FhuD2 Is Involved in the Early Phase of Staphylococcal Dissemination and Generates Protective Immunity in Mice</article-title><source>J. Infect. Dis.</source><year>2012</year><volume>206</volume><fpage>1041</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis463</pub-id><pub-id pub-id-type="pmid">22829645</pub-id></element-citation></ref><ref id="B314-pathogens-14-00185"><label>314.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>DeDent</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>McAdow</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bagnoli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>IsdA and IsdB Antibodies Protect Mice against Staphylococcus Aureus Abscess Formation and Lethal Challenge</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>6382</fpage><lpage>6392</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.02.097</pub-id><pub-id pub-id-type="pmid">20226248</pub-id><pub-id pub-id-type="pmcid">PMC3095377</pub-id></element-citation></ref><ref id="B315-pathogens-14-00185"><label>315.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardenburg</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Vaccine Protection against Staphylococcus Aureus Pneumonia</article-title><source>J. Exp. Med.</source><year>2008</year><volume>205</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1084/jem.20072208</pub-id><pub-id pub-id-type="pmid">18268041</pub-id><pub-id pub-id-type="pmcid">PMC2271014</pub-id></element-citation></ref><ref id="B316-pathogens-14-00185"><label>316.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X.R.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.Y.</given-names></name></person-group><article-title>Immunization with a Peptide Mimicking Lipoteichoic Acid Induces Memory B Cells in BALB/c Mice</article-title><source>BMC Infect. Dis.</source><year>2024</year><volume>24</volume><elocation-id>371</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-024-09262-8</pub-id><pub-id pub-id-type="pmid">38566017</pub-id><pub-id pub-id-type="pmcid">PMC10986077</pub-id></element-citation></ref><ref id="B317-pathogens-14-00185"><label>317.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chand</surname><given-names>U.</given-names></name><name name-style="western"><surname>Priyambada</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kushawaha</surname><given-names>P.K.</given-names></name></person-group><article-title>Staphylococcus Aureus Vaccine Strategy: Promise and Challenges</article-title><source>Microbiol. Res.</source><year>2023</year><volume>271</volume><elocation-id>127362</elocation-id><pub-id pub-id-type="doi">10.1016/j.micres.2023.127362</pub-id><pub-id pub-id-type="pmid">36958134</pub-id></element-citation></ref><ref id="B318-pathogens-14-00185"><label>318.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Thammavongsa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.</given-names></name></person-group><article-title>Recurrent Infections and Immune Evasion Strategies of Staphylococcus Aureus</article-title><source>Curr. Opin. Microbiol.</source><year>2012</year><volume>15</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2011.10.012</pub-id><pub-id pub-id-type="pmid">22088393</pub-id><pub-id pub-id-type="pmcid">PMC3538788</pub-id></element-citation></ref><ref id="B319-pathogens-14-00185"><label>319.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serruto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Scarselli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gros</surname><given-names>P.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Molecular Mechanisms of Complement Evasion: Learning from Staphylococci and Meningococci</article-title><source>Nat. Rev. Microbiol.</source><year>2010</year><volume>8</volume><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2366</pub-id><pub-id pub-id-type="pmid">20467445</pub-id></element-citation></ref><ref id="B320-pathogens-14-00185"><label>320.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atkins</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Burman</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Chamberlain</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Poutrel</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bagby</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>A.T.A.</given-names></name><name name-style="western"><surname>Feil</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>van den Elsen</surname><given-names>J.M.H.</given-names></name></person-group><article-title><italic toggle="yes">S. Aureus</italic> IgG-Binding Proteins SpA and Sbi: Host Specificity and Mechanisms of Immune Complex Formation</article-title><source>Mol. Immunol.</source><year>2008</year><volume>45</volume><fpage>1600</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2007.10.021</pub-id><pub-id pub-id-type="pmid">18061675</pub-id></element-citation></ref><ref id="B321-pathogens-14-00185"><label>321.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriwaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Niitsu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yanase</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hisatsune</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sugai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hide</surname><given-names>M.</given-names></name></person-group><article-title>Staphylococcus Aureus from Atopic Dermatitis Skin Accumulates in the Lysosomes of Keratinocytes with Induction of IL-1&#945; Secretion via TLR9</article-title><source>Allergy</source><year>2019</year><volume>74</volume><fpage>560</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1111/all.13622</pub-id><pub-id pub-id-type="pmid">30269350</pub-id></element-citation></ref><ref id="B322-pathogens-14-00185"><label>322.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrick</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alphonse</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Dikeman</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Youn</surname><given-names>C.</given-names></name><name name-style="western"><surname>Otterson</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ravipati</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mazhar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Denny</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Epicutaneous Staphylococcus Aureus Induces IL-36 to Enhance IgE Production and Ensuing Allergic Disease</article-title><source>J. Clin. Invest.</source><year>2021</year><volume>131</volume><fpage>e143334</fpage><pub-id pub-id-type="doi">10.1172/JCI143334</pub-id><pub-id pub-id-type="pmid">33645549</pub-id><pub-id pub-id-type="pmcid">PMC7919715</pub-id></element-citation></ref><ref id="B323-pathogens-14-00185"><label>323.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oguma</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wakabayashi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nygaard</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Inohara</surname><given-names>N.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Matsue</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Virulent PSM&#945; Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation</article-title><source>Cell Host Microbe</source><year>2017</year><volume>22</volume><fpage>667</fpage><lpage>677.e5</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.10.008</pub-id><pub-id pub-id-type="pmid">29120744</pub-id><pub-id pub-id-type="pmcid">PMC5728420</pub-id></element-citation></ref><ref id="B324-pathogens-14-00185"><label>324.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Focken</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schittek</surname><given-names>B.</given-names></name></person-group><article-title>Crosstalk between Keratinocytes and Neutrophils Shapes Skin Immunity against <italic toggle="yes">S. Aureus</italic> Infection</article-title><source>Front. Immunol.</source><year>2024</year><volume>15</volume><elocation-id>1275153</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1275153</pub-id><pub-id pub-id-type="pmid">38440739</pub-id><pub-id pub-id-type="pmcid">PMC10911042</pub-id></element-citation></ref><ref id="B325-pathogens-14-00185"><label>325.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sweren</surname><given-names>E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Alphonse</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Islam</surname><given-names>N.</given-names></name><name name-style="western"><surname>Li</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Bacteria Induce Skin Regeneration via IL-1&#946; Signaling</article-title><source>Cell Host Microbe</source><year>2021</year><volume>29</volume><fpage>777</fpage><pub-id pub-id-type="doi">10.1016/j.chom.2021.03.003</pub-id><pub-id pub-id-type="pmid">33798492</pub-id><pub-id pub-id-type="pmcid">PMC8122070</pub-id></element-citation></ref><ref id="B326-pathogens-14-00185"><label>326.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Kindi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Alkahtani</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Saville</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alshammari</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>O&#8217;Neill</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Second Immunoglobulin-Binding Protein Drives Atopic Dermatitis via IL-33</article-title><source>J. Allergy Clin. Immunol.</source><year>2021</year><volume>147</volume><fpage>1354</fpage><lpage>1368.e3</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2020.09.023</pub-id><pub-id pub-id-type="pmid">33011245</pub-id></element-citation></ref><ref id="B327-pathogens-14-00185"><label>327.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Achanta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kaelberer</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Caceres</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jordt</surname><given-names>S.E.</given-names></name></person-group><article-title>IL-33/ST2 Signaling Excites Sensory Neurons and Mediates Itch Response in a Mouse Model of Poison Ivy Contact Allergy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>E7572</fpage><lpage>E7579</lpage><pub-id pub-id-type="doi">10.1073/pnas.1606608113</pub-id><pub-id pub-id-type="pmid">27821781</pub-id><pub-id pub-id-type="pmcid">PMC5127381</pub-id></element-citation></ref><ref id="B328-pathogens-14-00185"><label>328.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Brutscher</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ehrstr&#246;m</surname><given-names>M.</given-names></name><name name-style="western"><surname>Melican</surname><given-names>K.</given-names></name></person-group><article-title>Tissue Resident Cells Differentiate <italic toggle="yes">S. Aureus</italic> from S. Epidermidis via IL-1&#946; Following Barrier Disruption in Healthy Human Skin</article-title><source>PLoS Pathog.</source><year>2024</year><volume>20</volume><elocation-id>e1012056</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1012056</pub-id><pub-id pub-id-type="pmid">39208402</pub-id><pub-id pub-id-type="pmcid">PMC11389914</pub-id></element-citation></ref><ref id="B329-pathogens-14-00185"><label>329.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brauweiler</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Goleva</surname><given-names>E.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>D.Y.M.</given-names></name></person-group><article-title>Staphylococcus Aureus Lipoteichoic Acid Damages the Skin Barrier through an IL-1 Mediated Pathway</article-title><source>J. Investig. Dermatol.</source><year>2019</year><volume>139</volume><fpage>1753</fpage><pub-id pub-id-type="doi">10.1016/j.jid.2019.02.006</pub-id><pub-id pub-id-type="pmid">30779913</pub-id><pub-id pub-id-type="pmcid">PMC6650368</pub-id></element-citation></ref><ref id="B330-pathogens-14-00185"><label>330.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Holtappels</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Ruyck</surname><given-names>N.</given-names></name><name name-style="western"><surname>Krysko</surname><given-names>O.</given-names></name><name name-style="western"><surname>Van Crombruggen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Braun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Papadopoulos</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell-Derived Cytokines</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2018</year><volume>198</volume><fpage>452</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1164/rccm.201710-2112OC</pub-id><pub-id pub-id-type="pmid">29768034</pub-id><pub-id pub-id-type="pmcid">PMC6118025</pub-id></element-citation></ref><ref id="B331-pathogens-14-00185"><label>331.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vu</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Baba</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Le</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kamijo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hiramatsu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ogawa</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Membrane and Diacylated Lipopeptide Induce Thymic Stromal Lymphopoietin in Keratinocytes through the Toll-like Receptor 2-Toll-like Receptor 6 Pathway</article-title><source>J. Allergy Clin. Immunol.</source><year>2010</year><volume>126</volume><fpage>985</fpage><lpage>993.e3</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2010.09.002</pub-id><pub-id pub-id-type="pmid">21050945</pub-id></element-citation></ref><ref id="B332-pathogens-14-00185"><label>332.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z.H.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Q.Y.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>D.N.</given-names></name><etal/></person-group><article-title>Keratinocyte TLR2 and TLR7 Contribute to Chronic Itch through Pruritic Cytokines and Chemokines in Mice</article-title><source>J. Cell. Physiol.</source><year>2023</year><volume>238</volume><fpage>257</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1002/jcp.30923</pub-id><pub-id pub-id-type="pmid">36436135</pub-id></element-citation></ref><ref id="B333-pathogens-14-00185"><label>333.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diep</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Villaruz</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Braughton</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title>Evolution of Virulence in Epidemic Community-Associated Methicillin-Resistant Staphylococcus Aureus</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>5883</fpage><pub-id pub-id-type="doi">10.1073/pnas.0900743106</pub-id><pub-id pub-id-type="pmid">19293374</pub-id><pub-id pub-id-type="pmcid">PMC2667066</pub-id></element-citation></ref><ref id="B334-pathogens-14-00185"><label>334.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castleman</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Pokhrel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Triplett</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Kusewitt</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Elmore</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Joyner</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Femling</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hathaway</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Prossnitz</surname><given-names>E.R.</given-names></name><etal/></person-group><article-title>Innate Sex Bias of Staphylococcus Aureus Skin Infection Is Driven by Alpha-Hemolysin</article-title><source>J. Immunol.</source><year>2017</year><volume>200</volume><fpage>657</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700810</pub-id><pub-id pub-id-type="pmid">29222165</pub-id><pub-id pub-id-type="pmcid">PMC5760295</pub-id></element-citation></ref><ref id="B335-pathogens-14-00185"><label>335.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Triplett</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Pokhrel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Castleman</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Daly</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Elmore</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Joyner</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>G.</given-names></name><name name-style="western"><surname>Herbert</surname><given-names>G.</given-names></name><name name-style="western"><surname>Campen</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Hathaway</surname><given-names>H.J.</given-names></name><etal/></person-group><article-title>GPER Activation Protects against Epithelial Barrier Disruption by Staphylococcusaureus &#945;-Toxin</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><elocation-id>1343</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-37951-3</pub-id><pub-id pub-id-type="pmid">30718654</pub-id><pub-id pub-id-type="pmcid">PMC6362070</pub-id></element-citation></ref><ref id="B336-pathogens-14-00185"><label>336.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veiga-Fernandes</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mucida</surname><given-names>D.</given-names></name></person-group><article-title>Neuro-Immune Interactions at Barrier Surfaces</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>801</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.041</pub-id><pub-id pub-id-type="pmid">27153494</pub-id><pub-id pub-id-type="pmcid">PMC4871617</pub-id></element-citation></ref><ref id="B337-pathogens-14-00185"><label>337.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baral</surname><given-names>P.</given-names></name><name name-style="western"><surname>Udit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>I.M.</given-names></name></person-group><article-title>Pain and Immunity: Implications for Host Defence</article-title><source>Nat. Rev. Immunol.</source><year>2019</year><volume>19</volume><fpage>433</fpage><pub-id pub-id-type="doi">10.1038/s41577-019-0147-2</pub-id><pub-id pub-id-type="pmid">30874629</pub-id><pub-id pub-id-type="pmcid">PMC6700742</pub-id></element-citation></ref><ref id="B338-pathogens-14-00185"><label>338.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Artis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>I.M.</given-names></name></person-group><article-title>Neuro-Immune Interactions in the Tissues</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>464</fpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.02.017</pub-id><pub-id pub-id-type="pmid">32187517</pub-id><pub-id pub-id-type="pmcid">PMC10710744</pub-id></element-citation></ref><ref id="B339-pathogens-14-00185"><label>339.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fattori</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ferraz</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Rasquel-Oliveira</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Verri</surname><given-names>W.A.</given-names></name></person-group><article-title>Neuroimmune Communication in Infection and Pain: Friends or Foes?</article-title><source>Immunol. Lett.</source><year>2021</year><volume>229</volume><fpage>32</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2020.11.009</pub-id><pub-id pub-id-type="pmid">33248166</pub-id></element-citation></ref><ref id="B340-pathogens-14-00185"><label>340.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramesh</surname><given-names>G.</given-names></name><name name-style="western"><surname>Maclean</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Philipp</surname><given-names>M.T.</given-names></name></person-group><article-title>Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain</article-title><source>Mediat. Inflamm.</source><year>2013</year><volume>2013</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1155/2013/480739</pub-id><pub-id pub-id-type="pmcid">PMC3753746</pub-id><pub-id pub-id-type="pmid">23997430</pub-id></element-citation></ref><ref id="B341-pathogens-14-00185"><label>341.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popoff</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Poulain</surname><given-names>B.</given-names></name></person-group><article-title>Bacterial Toxins and the Nervous System: Neurotoxins and Multipotential Toxins Interacting with Neuronal Cells</article-title><source>Toxins</source><year>2010</year><volume>2</volume><elocation-id>683</elocation-id><pub-id pub-id-type="doi">10.3390/toxins2040683</pub-id><pub-id pub-id-type="pmid">22069606</pub-id><pub-id pub-id-type="pmcid">PMC3153206</pub-id></element-citation></ref><ref id="B342-pathogens-14-00185"><label>342.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>I.M.</given-names></name></person-group><article-title>Bacterial Signaling to the Nervous System via Toxins and Metabolites</article-title><source>J. Mol. Biol.</source><year>2017</year><volume>429</volume><elocation-id>587</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2016.12.023</pub-id><pub-id pub-id-type="pmid">28065740</pub-id><pub-id pub-id-type="pmcid">PMC5325782</pub-id></element-citation></ref><ref id="B343-pathogens-14-00185"><label>343.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomerie</surname><given-names>J.Z.</given-names></name></person-group><article-title>Infections in Patients with Spinal Cord Injuries</article-title><source>Clin. Infect. Dis.</source><year>1997</year><volume>25</volume><fpage>1285</fpage><lpage>1292</lpage><pub-id pub-id-type="doi">10.1086/516144</pub-id><pub-id pub-id-type="pmid">9431366</pub-id></element-citation></ref><ref id="B344-pathogens-14-00185"><label>344.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hatipoglu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mutluoglu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Turhan</surname><given-names>V.</given-names></name><name name-style="western"><surname>Uzun</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lipsky</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Sevim</surname><given-names>E.</given-names></name><name name-style="western"><surname>Demiraslan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Eryilmaz</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ozuguz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Memis</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Causative Pathogens and Antibiotic Resistance in Diabetic Foot Infections: A Prospective Multi-Center Study</article-title><source>J. Diabetes Complicat.</source><year>2016</year><volume>30</volume><fpage>910</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1016/j.jdiacomp.2016.02.013</pub-id><pub-id pub-id-type="pmid">26965794</pub-id></element-citation></ref><ref id="B345-pathogens-14-00185"><label>345.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felten</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Felten</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Bellinger</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Madden</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Olschowka</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Livnat</surname><given-names>S.</given-names></name></person-group><article-title>Noradrenergic Sympathetic Innervation of Lymphoid Organs</article-title><source>Prog. Allergy</source><year>1988</year><volume>43</volume><fpage>14</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1159/000416168</pub-id><pub-id pub-id-type="pmid">3059356</pub-id></element-citation></ref><ref id="B346-pathogens-14-00185"><label>346.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Weber</surname><given-names>J.</given-names></name><name name-style="western"><surname>Holtkamp</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Ince</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>de Juan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lutes</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barnoud</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kizil</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hergenhan</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Loss of Direct Adrenergic Innervation after Peripheral Nerve Injury Causes Lymph Node Expansion through IFN-&#947;</article-title><source>J. Exp. Med.</source><year>2021</year><volume>218</volume><fpage>e20202377</fpage><pub-id pub-id-type="doi">10.1084/jem.20202377</pub-id><pub-id pub-id-type="pmid">34086056</pub-id><pub-id pub-id-type="pmcid">PMC8185988</pub-id></element-citation></ref><ref id="B347-pathogens-14-00185"><label>347.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breivik</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gundersen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Opstad</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Fonnum</surname><given-names>F.</given-names></name></person-group><article-title>Chemical Sympathectomy Inhibits Periodontal Disease in Fischer 344 Rats</article-title><source>J. Periodontal Res.</source><year>2005</year><volume>40</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.2005.00803.x</pub-id><pub-id pub-id-type="pmid">15966910</pub-id></element-citation></ref><ref id="B348-pathogens-14-00185"><label>348.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kudo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Matsuki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sekikawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tagawa</surname><given-names>Y.I.</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nakane</surname><given-names>A.</given-names></name></person-group><article-title>Effect of 6-Hydroxydopamine on Host Resistance against Listeria Monocytogenes Infection</article-title><source>Infect. Immun.</source><year>2001</year><volume>69</volume><fpage>7234</fpage><pub-id pub-id-type="doi">10.1128/IAI.69.12.7234-7241.2001</pub-id><pub-id pub-id-type="pmid">11705892</pub-id><pub-id pub-id-type="pmcid">PMC98806</pub-id></element-citation></ref><ref id="B349-pathogens-14-00185"><label>349.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reel</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Abbadi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Cizio</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pippin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Mortan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bose</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Cox</surname><given-names>M.A.</given-names></name></person-group><article-title>The Sympathetic Nervous System Is Necessary for Development of CD4+ T-Cell Memory Following Staphylococcus Aureus Infection</article-title><source>J. Infect. Dis.</source><year>2023</year><volume>228</volume><fpage>966</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiad154</pub-id><pub-id pub-id-type="pmid">37163747</pub-id><pub-id pub-id-type="pmcid">PMC10547460</pub-id></element-citation></ref><ref id="B350-pathogens-14-00185"><label>350.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szallasi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cortright</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Blum</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Eid</surname><given-names>S.R.</given-names></name></person-group><article-title>The Vanilloid Receptor TRPV1: 10 Years from Channel Cloning to Antagonist Proof-of-Concept</article-title><source>Nat. Rev. Drug Discov.</source><year>2007</year><volume>6</volume><fpage>357</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1038/nrd2280</pub-id><pub-id pub-id-type="pmid">17464295</pub-id></element-citation></ref><ref id="B351-pathogens-14-00185"><label>351.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riol-Blanco</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ordovas-Montanes</surname><given-names>J.</given-names></name><name name-style="western"><surname>Perro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Naval</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thiriot</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Paust</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Von Andrian</surname><given-names>U.H.</given-names></name></person-group><article-title>Nociceptive Sensory Neurons Drive Interleukin-23 Mediated Psoriasiform Skin Inflammation</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>157</fpage><pub-id pub-id-type="doi">10.1038/nature13199</pub-id><pub-id pub-id-type="pmid">24759321</pub-id><pub-id pub-id-type="pmcid">PMC4127885</pub-id></element-citation></ref><ref id="B352-pathogens-14-00185"><label>352.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Hirai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>J.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>B.M.</given-names></name><etal/></person-group><article-title>Cutaneous TRPV1+ Neurons Trigger Protective Innate Type-17 Anticipatory Immunity</article-title><source>Cell</source><year>2019</year><volume>178</volume><fpage>919</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.06.022</pub-id><pub-id pub-id-type="pmid">31353219</pub-id><pub-id pub-id-type="pmcid">PMC6788801</pub-id></element-citation></ref><ref id="B353-pathogens-14-00185"><label>353.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baral</surname><given-names>P.</given-names></name><name name-style="western"><surname>Umans</surname><given-names>B.D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wallrapp</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bist</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kirschbaum</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Burkett</surname><given-names>P.R.</given-names></name><etal/></person-group><article-title>Nociceptor Sensory Neurons Suppress Neutrophil and &#915;&#948; T Cell Responses in Bacterial Lung Infections and Lethal Pneumonia</article-title><source>Nat. Med.</source><year>2018</year><volume>24</volume><fpage>417</fpage><pub-id pub-id-type="doi">10.1038/nm.4501</pub-id><pub-id pub-id-type="pmid">29505031</pub-id><pub-id pub-id-type="pmcid">PMC6263165</pub-id></element-citation></ref><ref id="B354-pathogens-14-00185"><label>354.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Han</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lamotte</surname><given-names>R.H.</given-names></name></person-group><article-title>Enhanced Excitability of MRGPRA3- and MRGPRD-Positive Nociceptors in a Model of Inflammatory Itch and Pain</article-title><source>Brain</source><year>2014</year><volume>137</volume><fpage>1039</fpage><pub-id pub-id-type="doi">10.1093/brain/awu007</pub-id><pub-id pub-id-type="pmid">24549959</pub-id><pub-id pub-id-type="pmcid">PMC3959553</pub-id></element-citation></ref><ref id="B355-pathogens-14-00185"><label>355.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rau</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>McIlwrath</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Jankowski</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Zylka</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Koerber</surname><given-names>H.R.</given-names></name></person-group><article-title>Mrgprd Enhances Excitability in Specific Populations of Cutaneous Murine Polymodal Nociceptors</article-title><source>J. Neurosci.</source><year>2009</year><volume>29</volume><fpage>8612</fpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1057-09.2009</pub-id><pub-id pub-id-type="pmid">19571152</pub-id><pub-id pub-id-type="pmcid">PMC2756673</pub-id></element-citation></ref><ref id="B356-pathogens-14-00185"><label>356.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavanaugh</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shields</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Zylka</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Basbaum</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>D.J.</given-names></name></person-group><article-title>Distinct Subsets of Unmyelinated Primary Sensory Fibers Mediate Behavioral Responses to Noxious Thermal and Mechanical Stimuli</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>9075</fpage><pub-id pub-id-type="doi">10.1073/pnas.0901507106</pub-id><pub-id pub-id-type="pmid">19451647</pub-id><pub-id pub-id-type="pmcid">PMC2683885</pub-id></element-citation></ref><ref id="B357-pathogens-14-00185"><label>357.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Chaudhri</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hirai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Rittenhouse</surname><given-names>N.</given-names></name><name name-style="western"><surname>Schmitz</surname><given-names>E.G.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>McNeil</surname><given-names>B.D.</given-names></name><etal/></person-group><article-title>Nonpeptidergic Neurons Suppress Mast Cells via Glutamate to Maintain Skin Homeostasis</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>2151</fpage><lpage>2166.e16</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.002</pub-id><pub-id pub-id-type="pmid">33765440</pub-id><pub-id pub-id-type="pmcid">PMC8052305</pub-id></element-citation></ref><ref id="B358-pathogens-14-00185"><label>358.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Husain</surname><given-names>N.</given-names></name><name name-style="western"><surname>Husain</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.K.</given-names></name></person-group><article-title>Analysis of Microbial Etiology and Mortality in Patients with Brain Abscess</article-title><source>J. Infect.</source><year>2006</year><volume>53</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2005.12.002</pub-id><pub-id pub-id-type="pmid">16436297</pub-id></element-citation></ref><ref id="B359-pathogens-14-00185"><label>359.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathisen</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Patrick Johnson</surname><given-names>J.</given-names></name></person-group><article-title>Brain Abscess</article-title><source>Clin. Infect. Dis.</source><year>1997</year><volume>25</volume><fpage>763</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1086/515541</pub-id><pub-id pub-id-type="pmid">9356788</pub-id></element-citation></ref><ref id="B360-pathogens-14-00185"><label>360.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Phulwani</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Esen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Syed</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Haney</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>McCastlain</surname><given-names>K.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>J.</given-names></name></person-group><article-title>MyD88-Dependent Signals Are Essential for the Host Immune Response in Experimental Brain Abscess</article-title><source>J. Immunol.</source><year>2007</year><volume>178</volume><fpage>4528</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.7.4528</pub-id><pub-id pub-id-type="pmid">17372011</pub-id><pub-id pub-id-type="pmcid">PMC2094730</pub-id></element-citation></ref><ref id="B361-pathogens-14-00185"><label>361.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Esen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bearden</surname><given-names>E.D.</given-names></name></person-group><article-title>Toll-like Receptor 2 (TLR2) Is Pivotal for Recognition of <italic toggle="yes">S. Aureus</italic> Peptidoglycan But Not Intact Bacteria by Microglia</article-title><source>Glia</source><year>2005</year><volume>49</volume><fpage>567</fpage><pub-id pub-id-type="doi">10.1002/glia.20144</pub-id><pub-id pub-id-type="pmid">15593098</pub-id><pub-id pub-id-type="pmcid">PMC2394509</pub-id></element-citation></ref><ref id="B362-pathogens-14-00185"><label>362.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldwin</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name></person-group><article-title>Persistent Immune Activation Associated with a Mouse Model of Staphylococcus Aureus-Induced Experimental Brain Abscess</article-title><source>J. Neuroimmunol.</source><year>2004</year><volume>151</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2004.02.002</pub-id><pub-id pub-id-type="pmid">15145600</pub-id></element-citation></ref><ref id="B363-pathogens-14-00185"><label>363.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kielian</surname><given-names>T.</given-names></name><name name-style="western"><surname>Esen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Phulwani</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Syed</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nishina</surname><given-names>K.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Schwartzman</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Ruhe</surname><given-names>J.J.</given-names></name></person-group><article-title>Minocycline Modulates Neuroinflammation Independently of Its Antimicrobial Activity in Staphylococcus Aureus-Induced Brain Abscess</article-title><source>Am. J. Pathol.</source><year>2007</year><volume>171</volume><fpage>1199</fpage><pub-id pub-id-type="doi">10.2353/ajpath.2007.070231</pub-id><pub-id pub-id-type="pmid">17717149</pub-id><pub-id pub-id-type="pmcid">PMC1988870</pub-id></element-citation></ref><ref id="B364-pathogens-14-00185"><label>364.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krismer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Weidenmaier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zipperer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name></person-group><article-title>The Commensal Lifestyle of Staphylococcus Aureus and Its Interactions with the Nasal Microbiota</article-title><source>Nat. Rev. Microbiol.</source><year>2017</year><volume>15</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.104</pub-id><pub-id pub-id-type="pmid">29021598</pub-id></element-citation></ref><ref id="B365-pathogens-14-00185"><label>365.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howden</surname><given-names>B.P.</given-names></name><name name-style="western"><surname>Giulieri</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Wong Fok Lung</surname><given-names>T.</given-names></name><name name-style="western"><surname>Baines</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Sharkey</surname><given-names>L.K.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.Y.H.</given-names></name><name name-style="western"><surname>Hachani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Monk</surname><given-names>I.R.</given-names></name><name name-style="western"><surname>Stinear</surname><given-names>T.P.</given-names></name></person-group><article-title>Staphylococcus Aureus Host Interactions and Adaptation</article-title><source>Nat. Rev. Microbiol.</source><year>2023</year><volume>21</volume><fpage>380</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/s41579-023-00852-y</pub-id><pub-id pub-id-type="pmid">36707725</pub-id><pub-id pub-id-type="pmcid">PMC9882747</pub-id></element-citation></ref><ref id="B366-pathogens-14-00185"><label>366.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapels</surname><given-names>D.A.C.</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>A.</given-names></name><name name-style="western"><surname>Von K&#246;ckritz-Blickwede</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tromp</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Horsburgh</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name></person-group><article-title>Staphylococcus Aureus Protects Its Immune-Evasion Proteins against Degradation by Neutrophil Serine Proteases</article-title><source>Cell Microbiol.</source><year>2016</year><volume>18</volume><fpage>536</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1111/cmi.12528</pub-id><pub-id pub-id-type="pmid">26418545</pub-id></element-citation></ref><ref id="B367-pathogens-14-00185"><label>367.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dasari</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nordengr&#252;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vilhena</surname><given-names>C.</given-names></name><name name-style="western"><surname>Steil</surname><given-names>L.</given-names></name><name name-style="western"><surname>Abdurrahman</surname><given-names>G.</given-names></name><name name-style="western"><surname>Surmann</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dhople</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lahrberg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Skerka</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The Protease SplB of Staphylococcus Aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis</article-title><source>J. Bacteriol.</source><year>2022</year><volume>204</volume><fpage>e0018421</fpage><pub-id pub-id-type="doi">10.1128/JB.00184-21</pub-id><pub-id pub-id-type="pmid">34633872</pub-id><pub-id pub-id-type="pmcid">PMC8765433</pub-id></element-citation></ref><ref id="B368-pathogens-14-00185"><label>368.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falugi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Role of Protein A in the Evasion of Host Adaptive Immune Responses by Staphylococcus Aureus</article-title><source>mBio</source><year>2013</year><volume>4</volume><fpage>e00575-13</fpage><pub-id pub-id-type="doi">10.1128/mBio.00575-13</pub-id><pub-id pub-id-type="pmid">23982075</pub-id><pub-id pub-id-type="pmcid">PMC3760252</pub-id></element-citation></ref><ref id="B369-pathogens-14-00185"><label>369.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thammavongsa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Staphylococcal Manipulation of Host Immune Responses</article-title><source>Nat. Rev. Microbiol.</source><year>2015</year><volume>13</volume><fpage>529</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3521</pub-id><pub-id pub-id-type="pmid">26272408</pub-id><pub-id pub-id-type="pmcid">PMC4625792</pub-id></element-citation></ref><ref id="B370-pathogens-14-00185"><label>370.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berends</surname><given-names>E.T.M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>E.</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sen</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Wozniak</surname><given-names>D.J.</given-names></name></person-group><article-title>Staphylococcus Aureus Biofilms Release Leukocidins to Elicit Extracellular Trap Formation and Evade Neutrophil-Mediated Killing</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>7416</fpage><lpage>7421</lpage><pub-id pub-id-type="doi">10.1073/pnas.1721949115</pub-id><pub-id pub-id-type="pmid">29941565</pub-id><pub-id pub-id-type="pmcid">PMC6048508</pub-id></element-citation></ref><ref id="B371-pathogens-14-00185"><label>371.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Archer</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Mazaitis</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>William Costerton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Leid</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Powers</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Shirtliff</surname><given-names>M.E.</given-names></name></person-group><article-title>Staphylococcus Aureus Biofilms: Properties, Regulation, and Roles in Human Disease</article-title><source>Virulence</source><year>2011</year><volume>2</volume><fpage>445</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.4161/viru.2.5.17724</pub-id><pub-id pub-id-type="pmid">21921685</pub-id><pub-id pub-id-type="pmcid">PMC3322633</pub-id></element-citation></ref><ref id="B372-pathogens-14-00185"><label>372.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Jong</surname><given-names>N.W.M.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Immune Evasion by Staphylococcus Aureus</article-title><source>Microbiol. Spectr.</source><year>2019</year><volume>7</volume><pub-id pub-id-type="doi">10.1128/microbiolspec.GPP3-0061-2019</pub-id><pub-id pub-id-type="pmid">30927347</pub-id><pub-id pub-id-type="pmcid">PMC11590434</pub-id></element-citation></ref><ref id="B373-pathogens-14-00185"><label>373.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rigby</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>F.R.</given-names></name></person-group><article-title>Neutrophils in Innate Host Defense against Staphylococcus Aureus Infections</article-title><source>Semin. Immunopathol.</source><year>2012</year><volume>34</volume><fpage>237</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1007/s00281-011-0295-3</pub-id><pub-id pub-id-type="pmid">22080185</pub-id><pub-id pub-id-type="pmcid">PMC3271231</pub-id></element-citation></ref><ref id="B374-pathogens-14-00185"><label>374.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolaczkowska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P.</given-names></name></person-group><article-title>Neutrophil Recruitment and Function in Health and Inflammation</article-title><source>Nat. Rev. Immunol.</source><year>2013</year><volume>13</volume><fpage>159</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/nri3399</pub-id><pub-id pub-id-type="pmid">23435331</pub-id></element-citation></ref><ref id="B375-pathogens-14-00185"><label>375.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group><article-title>Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2016</year><volume>80</volume><elocation-id>891</elocation-id><pub-id pub-id-type="doi">10.1128/MMBR.00028-16</pub-id><pub-id pub-id-type="pmid">27512100</pub-id><pub-id pub-id-type="pmcid">PMC4981669</pub-id></element-citation></ref><ref id="B376-pathogens-14-00185"><label>376.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dziarski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>D.</given-names></name></person-group><article-title>Peptidoglycan Recognition in Innate Immunity</article-title><source>J. Endotoxin Res.</source><year>2005</year><volume>11</volume><fpage>304</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1177/09680519050110050801</pub-id><pub-id pub-id-type="pmid">16263004</pub-id></element-citation></ref><ref id="B377-pathogens-14-00185"><label>377.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hemmi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kaisho</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sato</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sanjo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>H.</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K.</given-names></name><etal/></person-group><article-title>A Toll-like Receptor Recognizes Bacterial DNA</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1038/35047123</pub-id><pub-id pub-id-type="pmid">11130078</pub-id></element-citation></ref><ref id="B378-pathogens-14-00185"><label>378.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krepel</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.M.</given-names></name></person-group><article-title>Chemotactic Ligands That Activate G-Protein-Coupled Formylpeptide Receptors</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>3426</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20143426</pub-id><pub-id pub-id-type="pmid">31336833</pub-id><pub-id pub-id-type="pmcid">PMC6678346</pub-id></element-citation></ref><ref id="B379-pathogens-14-00185"><label>379.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Pathogen Recognition by the Innate Immune System</article-title><source>Int. Rev. Immunol.</source><year>2011</year><volume>30</volume><fpage>16</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.3109/08830185.2010.529976</pub-id><pub-id pub-id-type="pmid">21235323</pub-id></element-citation></ref><ref id="B380-pathogens-14-00185"><label>380.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bestebroer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Azouagh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Walenkamp</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Boer</surname><given-names>I.G.J.</given-names></name><name name-style="western"><surname>Romijn</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>De Haas</surname><given-names>C.J.C.</given-names></name></person-group><article-title>Staphylococcal SSL5 Inhibits Leukocyte Activation by Chemokines and Anaphylatoxins</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>328</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-04-153882</pub-id><pub-id pub-id-type="pmid">18941109</pub-id></element-citation></ref><ref id="B381-pathogens-14-00185"><label>381.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jongerius</surname><given-names>I.</given-names></name><name name-style="western"><surname>K&#246;hl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name></person-group><article-title>Staphylococcal Complement Evasion by Various Convertase-Blocking Molecules</article-title><source>J. Exp. Med.</source><year>2007</year><volume>204</volume><fpage>2461</fpage><lpage>2471</lpage><pub-id pub-id-type="doi">10.1084/jem.20070818</pub-id><pub-id pub-id-type="pmid">17893203</pub-id><pub-id pub-id-type="pmcid">PMC2118443</pub-id></element-citation></ref><ref id="B382-pathogens-14-00185"><label>382.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arcus</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Langley</surname><given-names>R.</given-names></name><name name-style="western"><surname>Proft</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>E.N.</given-names></name></person-group><article-title>The Three-Dimensional Structure of a Superantigen-like Protein, SET3, from a Pathogenicity Island of the Staphylococcus Aureus Genome</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>32274</fpage><lpage>32281</lpage><pub-id pub-id-type="doi">10.1074/jbc.M203914200</pub-id><pub-id pub-id-type="pmid">12082105</pub-id></element-citation></ref><ref id="B383-pathogens-14-00185"><label>383.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bestebroer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Poppelier</surname><given-names>M.J.J.G.</given-names></name><name name-style="western"><surname>Ulfman</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Lenting</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Denis</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>De Haas</surname><given-names>C.J.C.</given-names></name></person-group><article-title>Staphylococcal Superantigen-like 5 Binds PSGL-1 and Inhibits P-Selectin&#8211;Mediated Neutrophil Rolling</article-title><source>Blood</source><year>2007</year><volume>109</volume><fpage>2936</fpage><lpage>2943</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-06-015461</pub-id><pub-id pub-id-type="pmid">17132726</pub-id></element-citation></ref><ref id="B384-pathogens-14-00185"><label>384.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koymans</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Bisschop</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vughs</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 &amp; SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>1072</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17071072</pub-id><pub-id pub-id-type="pmid">27399672</pub-id><pub-id pub-id-type="pmcid">PMC4964448</pub-id></element-citation></ref><ref id="B385-pathogens-14-00185"><label>385.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Caballero</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Bierdeman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Marquart</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Monk</surname><given-names>I.R.</given-names></name><name name-style="western"><surname>O&#8217;callaghan</surname><given-names>R.J.</given-names></name></person-group><article-title>Staphylococcus Aureus Superantigen-Like Protein SSL1: A Toxic Protease</article-title><source>Pathogens</source><year>2019</year><volume>8</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens8010002</pub-id><pub-id pub-id-type="pmid">30609641</pub-id><pub-id pub-id-type="pmcid">PMC6471365</pub-id></element-citation></ref><ref id="B386-pathogens-14-00185"><label>386.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langley</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wines</surname><given-names>B.</given-names></name><name name-style="western"><surname>Willoughby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Basu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Proft</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>J.D.</given-names></name></person-group><article-title>The Staphylococcal Superantigen-Like Protein 7 Binds IgA and Complement C5 and Inhibits IgA-Fc&#945;RI Binding and Serum Killing of Bacteria</article-title><source>J. Immunol.</source><year>2005</year><volume>174</volume><fpage>2926</fpage><lpage>2933</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.5.2926</pub-id><pub-id pub-id-type="pmid">15728504</pub-id></element-citation></ref><ref id="B387-pathogens-14-00185"><label>387.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koymans</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Goldmann</surname><given-names>O.</given-names></name><name name-style="western"><surname>Karlsson</surname><given-names>C.A.Q.</given-names></name><name name-style="western"><surname>Sital</surname><given-names>W.</given-names></name><name name-style="western"><surname>Th&#228;nert</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bisschop</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vrieling</surname><given-names>M.</given-names></name><name name-style="western"><surname>Malmstr&#246;m</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>De Haas</surname><given-names>C.J.C.</given-names></name><etal/></person-group><article-title>The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in Vivo</article-title><source>J. Innate Immun.</source><year>2017</year><volume>9</volume><fpage>561</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1159/000479100</pub-id><pub-id pub-id-type="pmid">28858870</pub-id></element-citation></ref><ref id="B388-pathogens-14-00185"><label>388.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>M.R.C.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>P.J.A.</given-names></name></person-group><article-title>Staphylococcal Superantigen-like Protein 13 Activates Neutrophils via Formyl Peptide Receptor 2</article-title><source>Cell Microbiol.</source><year>2018</year><volume>20</volume><elocation-id>e12941</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.12941</pub-id><pub-id pub-id-type="pmid">30098280</pub-id><pub-id pub-id-type="pmcid">PMC6220968</pub-id></element-citation></ref><ref id="B389-pathogens-14-00185"><label>389.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>Veldkamp</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Weerkamp</surname><given-names>F.</given-names></name><name name-style="western"><surname>Van Wamel</surname><given-names>W.J.B.</given-names></name><name name-style="western"><surname>Heezius</surname><given-names>E.C.J.M.</given-names></name><name name-style="western"><surname>Poppelier</surname><given-names>M.J.J.G.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Chemotaxis Inhibitory Protein of Staphylococcus Aureus, a Bacterial Antiinflammatory Agent</article-title><source>J. Exp. Med.</source><year>2004</year><volume>199</volume><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1084/jem.20031636</pub-id><pub-id pub-id-type="pmid">14993252</pub-id><pub-id pub-id-type="pmcid">PMC2213298</pub-id></element-citation></ref><ref id="B390-pathogens-14-00185"><label>390.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prat</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bestebroer</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name></person-group><article-title>A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-like 1</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>8017</fpage><lpage>8026</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.11.8017</pub-id><pub-id pub-id-type="pmid">17114475</pub-id></element-citation></ref><ref id="B391-pathogens-14-00185"><label>391.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prat</surname><given-names>C.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>P.-J.</given-names></name><name name-style="western"><surname>Bestebroer</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>C.J.C.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name></person-group><article-title>A Homolog of Formyl Peptide Receptor-like 1 (FPRL1) Inhibitor from Staphylococcus Aureus (FPRL1 Inhibitory Protein) That Inhibits FPRL1 and FPR</article-title><source>J. Immunol.</source><year>2009</year><volume>183</volume><fpage>6569</fpage><lpage>6578</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0801523</pub-id><pub-id pub-id-type="pmid">19846866</pub-id></element-citation></ref><ref id="B392-pathogens-14-00185"><label>392.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forsgren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sj&#246;quist</surname><given-names>J.</given-names></name></person-group><article-title>&#8220;Protein A&#8221; from <italic toggle="yes">S. Aureus</italic> I. Pseudo-Immune Reaction with Human &#947;-Globulin</article-title><source>J. Immunol.</source><year>1966</year><volume>97</volume><fpage>822</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.97.6.822</pub-id><pub-id pub-id-type="pmid">4163007</pub-id></element-citation></ref><ref id="B393-pathogens-14-00185"><label>393.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jacobsson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vasi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>M.</given-names></name><name name-style="western"><surname>Frykberg</surname><given-names>L.</given-names></name></person-group><article-title>A Second IgG-Binding Protein in Staphylococcus Aureus</article-title><source>Microbiology</source><year>1998</year><volume>144</volume><fpage>985</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1099/00221287-144-4-985</pub-id><pub-id pub-id-type="pmid">9579072</pub-id></element-citation></ref><ref id="B394-pathogens-14-00185"><label>394.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kamoshida</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>R.</given-names></name><name name-style="western"><surname>Takii</surname><given-names>T.</given-names></name><name name-style="western"><surname>Onozaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tsuji</surname><given-names>T.</given-names></name></person-group><article-title>Staphylococcal Superantigen-like Protein 10 (SSL10) Binds to Human Immunoglobulin G (IgG) and Inhibits Complement Activation via the Classical Pathway</article-title><source>Mol. Immunol.</source><year>2010</year><volume>47</volume><fpage>932</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2009.09.027</pub-id><pub-id pub-id-type="pmid">19913916</pub-id></element-citation></ref><ref id="B395-pathogens-14-00185"><label>395.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Daha</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Presanis</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Sim</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>van Wamel</surname><given-names>W.J.B.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Immune Evasion by a Staphylococcal Complement Inhibitor That Acts on C3 Convertases</article-title><source>Nat. Immunol.</source><year>2005</year><volume>6</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/ni1235</pub-id><pub-id pub-id-type="pmid">16086019</pub-id></element-citation></ref><ref id="B396-pathogens-14-00185"><label>396.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>Y.P.</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>A.</given-names></name><name name-style="western"><surname>Freitag</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Jongerius</surname><given-names>I.</given-names></name><name name-style="western"><surname>Medina</surname><given-names>E.</given-names></name><name name-style="western"><surname>van Rooijen</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Spaan</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>H&#246;&#246;k</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name></person-group><article-title>Phagocytosis Escape by a Staphylococcus Aureus Protein That Connects Complement and Coagulation Proteins at the Bacterial Surface</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003816</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003816</pub-id><pub-id pub-id-type="pmid">24348255</pub-id><pub-id pub-id-type="pmcid">PMC3861539</pub-id></element-citation></ref><ref id="B397-pathogens-14-00185"><label>397.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jongerius</surname><given-names>I.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Geisbrecht</surname><given-names>B.V.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.H.M.</given-names></name></person-group><article-title>Convertase Inhibitory Properties of Staphylococcal Extracellular Complement-Binding Protein</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>14973</fpage><lpage>14979</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.091975</pub-id><pub-id pub-id-type="pmid">20304920</pub-id><pub-id pub-id-type="pmcid">PMC2865291</pub-id></element-citation></ref><ref id="B398-pathogens-14-00185"><label>398.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vrieling</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tuffs</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Yebra</surname><given-names>G.</given-names></name><name name-style="western"><surname>van Smoorenburg</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pickering</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>N.</given-names></name><name name-style="western"><surname>Heinrichs</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Benedictus</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Population Analysis of Staphylococcus Aureus Reveals a Cryptic, Highly Prevalent Superantigen SElW That Contributes to the Pathogenesis of Bacteremia</article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1128/mBio.02082-20</pub-id><pub-id pub-id-type="pmid">33109757</pub-id><pub-id pub-id-type="pmcid">PMC7593966</pub-id></element-citation></ref><ref id="B399-pathogens-14-00185"><label>399.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Seo</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Cartwright</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Connelley</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chuang-Smith</surname><given-names>O.N.</given-names></name><name name-style="western"><surname>Merriman</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Guinane</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Bohach</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Schlievert</surname><given-names>P.M.</given-names></name><etal/></person-group><article-title>A Novel Core Genome-Encoded Superantigen Contributes to Lethality of Community-Associated MRSA Necrotizing Pneumonia</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><elocation-id>e1002271</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002271</pub-id><pub-id pub-id-type="pmid">22022262</pub-id><pub-id pub-id-type="pmcid">PMC3192841</pub-id></element-citation></ref><ref id="B400-pathogens-14-00185"><label>400.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spaan</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Surewaard</surname><given-names>B.G.J.</given-names></name><name name-style="western"><surname>Nijland</surname><given-names>R.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name></person-group><article-title>Neutrophils versus Staphylococcus Aureus: A Biological Tug of War</article-title><source>Annu. Rev. Microbiol.</source><year>2013</year><volume>67</volume><fpage>629</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-092412-155746</pub-id><pub-id pub-id-type="pmid">23834243</pub-id></element-citation></ref><ref id="B401-pathogens-14-00185"><label>401.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapels</surname><given-names>D.A.C.</given-names></name><name name-style="western"><surname>Ramyar</surname><given-names>K.X.</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Von K&#246;ckritz-Blickwede</surname><given-names>M.</given-names></name><name name-style="western"><surname>Milder</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eisenbeis</surname><given-names>J.</given-names></name><name name-style="western"><surname>McWhorter</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Herrmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Secretes a Unique Class of Neutrophil Serine Protease Inhibitors</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>13187</fpage><lpage>13192</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407616111</pub-id><pub-id pub-id-type="pmid">25161283</pub-id><pub-id pub-id-type="pmcid">PMC4246989</pub-id></element-citation></ref><ref id="B402-pathogens-14-00185"><label>402.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kretschmer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Breitmeyer</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gekeler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lebtig</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schlatterer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nega</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stahl</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stapels</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name></person-group><article-title>Staphylococcus Aureus Depends on Eap Proteins for Preventing Degradation of Its Phenol-Soluble Modulin Toxins by Neutrophil Serine Proteases</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>701093</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.701093</pub-id><pub-id pub-id-type="pmid">34552584</pub-id><pub-id pub-id-type="pmcid">PMC8451722</pub-id></element-citation></ref><ref id="B403-pathogens-14-00185"><label>403.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malech</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Deleo</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>M.T.</given-names></name></person-group><article-title>The Role of Neutrophils in the Immune System: An Overview</article-title><source>Methods Mol. Biol.</source><year>2014</year><volume>1124</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1007/978-1-62703-845-4_1</pub-id><pub-id pub-id-type="pmid">24504942</pub-id><pub-id pub-id-type="pmcid">PMC6777345</pub-id></element-citation></ref><ref id="B404-pathogens-14-00185"><label>404.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ploscariu</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>N.W.M.</given-names></name><name name-style="western"><surname>van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Geisbrecht</surname><given-names>B.V.</given-names></name></person-group><article-title>Identification and Structural Characterization of a Novel Myeloperoxidase Inhibitor from Staphylococcus Delphini</article-title><source>Arch. Biochem. Biophys.</source><year>2018</year><volume>645</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2018.03.007</pub-id><pub-id pub-id-type="pmid">29524428</pub-id><pub-id pub-id-type="pmcid">PMC5899673</pub-id></element-citation></ref><ref id="B405-pathogens-14-00185"><label>405.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Jong</surname><given-names>N.W.M.</given-names></name><name name-style="western"><surname>Ramyar</surname><given-names>K.X.</given-names></name><name name-style="western"><surname>Guerra</surname><given-names>F.E.</given-names></name><name name-style="western"><surname>Nijland</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fevre</surname><given-names>C.</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Van Kessel</surname><given-names>K.P.M.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><etal/></person-group><article-title>Immune Evasion by a Staphylococcal Inhibitor of Myeloperoxidase</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>9439</fpage><lpage>9444</lpage><pub-id pub-id-type="doi">10.1073/pnas.1707032114</pub-id><pub-id pub-id-type="pmid">28808028</pub-id><pub-id pub-id-type="pmcid">PMC5584439</pub-id></element-citation></ref><ref id="B406-pathogens-14-00185"><label>406.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cosgrove</surname><given-names>K.</given-names></name><name name-style="western"><surname>Coutts</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jonsson</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Tarkowski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kokai-Kun</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Mond</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>S.J.</given-names></name></person-group><article-title>Catalase (KatA) and Alkyl Hydroperoxide Reductase (AhpC) Have Compensatory Roles in Peroxide Stress Resistance and Are Required for Survival, Persistence, and Nasal Colonization in Staphylococcus Aureus</article-title><source>J. Bacteriol.</source><year>2007</year><volume>189</volume><fpage>1025</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1128/JB.01524-06</pub-id><pub-id pub-id-type="pmid">17114262</pub-id><pub-id pub-id-type="pmcid">PMC1797328</pub-id></element-citation></ref><ref id="B407-pathogens-14-00185"><label>407.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandell</surname><given-names>G.L.</given-names></name></person-group><article-title>Catalase, Superoxide Dismutase, and Virulence of Staphylococcus Aureus. In Vitro and in Vivo Studies with Emphasis on Staphylococcal--Leukocyte Interaction</article-title><source>J. Clin. Investig.</source><year>1975</year><volume>55</volume><fpage>561</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1172/JCI107963</pub-id><pub-id pub-id-type="pmid">1117067</pub-id><pub-id pub-id-type="pmcid">PMC301784</pub-id></element-citation></ref><ref id="B408-pathogens-14-00185"><label>408.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clements</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>Watson</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>S.J.</given-names></name></person-group><article-title>Characterization of the Major Superoxide Dismutase of Staphylococcus Aureus and Its Role in Starvation Survival, Stress Resistance, and Pathogenicity</article-title><source>J. Bacteriol.</source><year>1999</year><volume>181</volume><fpage>3898</fpage><lpage>3903</lpage><pub-id pub-id-type="doi">10.1128/JB.181.13.3898-3903.1999</pub-id><pub-id pub-id-type="pmid">10383955</pub-id><pub-id pub-id-type="pmcid">PMC93877</pub-id></element-citation></ref><ref id="B409-pathogens-14-00185"><label>409.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wieland</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Putzbach</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hentschel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>K.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group><article-title>Structure and Biosynthesis of Staphyloxanthin from Staphylococcus Aureus</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>32493</fpage><lpage>32498</lpage><pub-id pub-id-type="doi">10.1074/jbc.M505070200</pub-id><pub-id pub-id-type="pmid">16020541</pub-id></element-citation></ref><ref id="B410-pathogens-14-00185"><label>410.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clauditz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Resch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wieland</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group><article-title>Staphyloxanthin Plays a Role in the Fitness of Staphylococcus Aureus and Its Ability to Cope with Oxidative Stress</article-title><source>Infect. Immun.</source><year>2006</year><volume>74</volume><fpage>4950</fpage><lpage>4953</lpage><pub-id pub-id-type="doi">10.1128/IAI.00204-06</pub-id><pub-id pub-id-type="pmid">16861688</pub-id><pub-id pub-id-type="pmcid">PMC1539600</pub-id></element-citation></ref><ref id="B411-pathogens-14-00185"><label>411.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thammavongsa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kern</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Staphylococcus Aureus Synthesizes Adenosine to Escape Host Immune Responses</article-title><source>J. Exp. Med.</source><year>2009</year><volume>206</volume><fpage>2417</fpage><lpage>2427</lpage><pub-id pub-id-type="doi">10.1084/jem.20090097</pub-id><pub-id pub-id-type="pmid">19808256</pub-id><pub-id pub-id-type="pmcid">PMC2768845</pub-id></element-citation></ref><ref id="B412-pathogens-14-00185"><label>412.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Villaruz</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cha</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Sturdevant</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name></person-group><article-title>The Human Anionic Antimicrobial Peptide Dermcidin Induces Proteolytic Defence Mechanisms in Staphylococci</article-title><source>Mol. Microbiol.</source><year>2007</year><volume>63</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05540.x</pub-id><pub-id pub-id-type="pmid">17176256</pub-id></element-citation></ref><ref id="B413-pathogens-14-00185"><label>413.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name></person-group><article-title>The MSCRAMM Family of Cell-Wall-Anchored Surface Proteins of Gram-Positive Cocci</article-title><source>Trends Microbiol.</source><year>2019</year><volume>27</volume><fpage>927</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.06.007</pub-id><pub-id pub-id-type="pmid">31375310</pub-id></element-citation></ref><ref id="B414-pathogens-14-00185"><label>414.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Hwan</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Burts</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Krausz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.M.</given-names></name></person-group><article-title>Genetic Requirements for Staphylococcus Aureus Abscess Formation and Persistence in Host Tissues</article-title><source>FASEB J.</source><year>2009</year><volume>23</volume><fpage>3393</fpage><lpage>3404</lpage><pub-id pub-id-type="doi">10.1096/fj.09-135467</pub-id><pub-id pub-id-type="pmid">19525403</pub-id><pub-id pub-id-type="pmcid">PMC2747682</pub-id></element-citation></ref><ref id="B415-pathogens-14-00185"><label>415.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrigan</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Miajlovic</surname><given-names>H.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name></person-group><article-title>Surface Proteins That Promote Adherence of Staphylococcus Aureus to Human Desquamated Nasal Epithelial Cells</article-title><source>BMC Microbiol.</source><year>2009</year><volume>9</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-9-22</pub-id><pub-id pub-id-type="pmid">19183486</pub-id><pub-id pub-id-type="pmcid">PMC2642834</pub-id></element-citation></ref><ref id="B416-pathogens-14-00185"><label>416.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Askarian</surname><given-names>F.</given-names></name><name name-style="western"><surname>Uchiyama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Valderrama</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Ajayi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sollid</surname><given-names>J.U.E.</given-names></name><name name-style="western"><surname>van Sorge</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Johannessen</surname><given-names>M.</given-names></name></person-group><article-title>Serine-Aspartate Repeat Protein D Increases Staphylococcus Aureus Virulence and Survival in Blood</article-title><source>Infect. Immun.</source><year>2016</year><volume>85</volume><fpage>e00559-16</fpage><pub-id pub-id-type="doi">10.1128/IAI.00559-16</pub-id><pub-id pub-id-type="pmid">27795358</pub-id><pub-id pub-id-type="pmcid">PMC5203653</pub-id></element-citation></ref><ref id="B417-pathogens-14-00185"><label>417.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Staphylococcus Aureus SdrE Captures Complement Factor H&#8217;s C-Terminus via a Novel &#8220;close, Dock, Lock and Latch&#8221; Mechanism for Complement Evasion</article-title><source>Biochem. J.</source><year>2017</year><volume>474</volume><fpage>1619</fpage><lpage>1631</lpage><pub-id pub-id-type="doi">10.1042/BCJ20170085</pub-id><pub-id pub-id-type="pmid">28258151</pub-id><pub-id pub-id-type="pmcid">PMC5415847</pub-id></element-citation></ref><ref id="B418-pathogens-14-00185"><label>418.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speziale</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pietrocola</surname><given-names>G.</given-names></name></person-group><article-title>The Multivalent Role of Fibronectin-Binding Proteins A and B (FnBPA and FnBPB) of Staphylococcus Aureus in Host Infections</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><elocation-id>2054</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.02054</pub-id><pub-id pub-id-type="pmid">32983039</pub-id><pub-id pub-id-type="pmcid">PMC7480013</pub-id></element-citation></ref><ref id="B419-pathogens-14-00185"><label>419.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietrocola</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nobile</surname><given-names>G.</given-names></name><name name-style="western"><surname>Alfeo</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Geoghegan</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>De Filippis</surname><given-names>V.</given-names></name><name name-style="western"><surname>Speziale</surname><given-names>P.</given-names></name></person-group><article-title>Fibronectin-Binding Protein B (FnBPB) from Staphylococcus Aureus Protects against the Antimicrobial Activity of Histones</article-title><source>J. Biol. Chem.</source><year>2019</year><volume>294</volume><fpage>3588</fpage><lpage>3602</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.005707</pub-id><pub-id pub-id-type="pmid">30622139</pub-id><pub-id pub-id-type="pmcid">PMC6416437</pub-id></element-citation></ref><ref id="B420-pathogens-14-00185"><label>420.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thammavongsa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Staphylococcus Aureus Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death</article-title><source>Science</source><year>2013</year><volume>342</volume><fpage>863</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1126/science.1242255</pub-id><pub-id pub-id-type="pmid">24233725</pub-id><pub-id pub-id-type="pmcid">PMC4026193</pub-id></element-citation></ref><ref id="B421-pathogens-14-00185"><label>421.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soh</surname><given-names>K.Y.</given-names></name><name name-style="western"><surname>Loh</surname><given-names>J.M.S.</given-names></name><name name-style="western"><surname>Proft</surname><given-names>T.</given-names></name></person-group><article-title>Cell Wall-Anchored 5&#8217;-Nucleotidases in Gram-Positive Cocci</article-title><source>Mol. Microbiol.</source><year>2020</year><volume>113</volume><fpage>691</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1111/mmi.14442</pub-id><pub-id pub-id-type="pmid">31872460</pub-id></element-citation></ref><ref id="B422-pathogens-14-00185"><label>422.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spaan</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Van Strijp</surname><given-names>J.A.G.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>V.J.</given-names></name></person-group><article-title>Leukocidins: Staphylococcal Bi-Component Pore-Forming Toxins Find Their Receptors</article-title><source>Nat. Rev. Microbiol.</source><year>2017</year><volume>15</volume><fpage>435</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.27</pub-id><pub-id pub-id-type="pmid">28420883</pub-id><pub-id pub-id-type="pmcid">PMC5621924</pub-id></element-citation></ref><ref id="B423-pathogens-14-00185"><label>423.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berends</surname><given-names>E.T.M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zwack</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>M&#233;nager</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Cammer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shopsin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>V.J.</given-names></name></person-group><article-title>Staphylococcus Aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin</article-title><source>mBio</source><year>2019</year><volume>10</volume><fpage>e01918-18</fpage><pub-id pub-id-type="doi">10.1128/mBio.01918-18</pub-id><pub-id pub-id-type="pmid">30602580</pub-id><pub-id pub-id-type="pmcid">PMC6315100</pub-id></element-citation></ref><ref id="B424-pathogens-14-00185"><label>424.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berube</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Wardenburg</surname><given-names>J.B.</given-names></name></person-group><article-title>Staphylococcus Aureus &#945;-Toxin: Nearly a Century of Intrigue</article-title><source>Toxins</source><year>2013</year><volume>5</volume><fpage>1140</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.3390/toxins5061140</pub-id><pub-id pub-id-type="pmid">23888516</pub-id><pub-id pub-id-type="pmcid">PMC3717774</pub-id></element-citation></ref><ref id="B425-pathogens-14-00185"><label>425.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schilcher</surname><given-names>K.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.R.</given-names></name></person-group><article-title>Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2020</year><volume>84</volume><fpage>e00026-19</fpage><pub-id pub-id-type="doi">10.1128/MMBR.00026-19</pub-id><pub-id pub-id-type="pmid">32792334</pub-id><pub-id pub-id-type="pmcid">PMC7430342</pub-id></element-citation></ref><ref id="B426-pathogens-14-00185"><label>426.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ricciardi</surname><given-names>B.F.</given-names></name><name name-style="western"><surname>Muthukrishnan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Masters</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ninomiya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>E.M.</given-names></name></person-group><article-title>Staphylococcus Aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond</article-title><source>Curr. Rev. Musculoskelet. Med.</source><year>2018</year><volume>11</volume><fpage>389</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1007/s12178-018-9501-4</pub-id><pub-id pub-id-type="pmid">29987645</pub-id><pub-id pub-id-type="pmcid">PMC6105484</pub-id></element-citation></ref><ref id="B427-pathogens-14-00185"><label>427.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beenken</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Dunman</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>McAleese</surname><given-names>F.</given-names></name><name name-style="western"><surname>Macapagal</surname><given-names>D.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Projan</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Blevins</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Smeltzer</surname><given-names>M.S.</given-names></name></person-group><article-title>Global Gene Expression in Staphylococcus Aureus Biofilms</article-title><source>J. Bacteriol.</source><year>2004</year><volume>186</volume><fpage>4665</fpage><lpage>4684</lpage><pub-id pub-id-type="doi">10.1128/JB.186.14.4665-4684.2004</pub-id><pub-id pub-id-type="pmid">15231800</pub-id><pub-id pub-id-type="pmcid">PMC438561</pub-id></element-citation></ref><ref id="B428-pathogens-14-00185"><label>428.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berends</surname><given-names>E.T.M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hill</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Wozniak</surname><given-names>D.J.</given-names></name></person-group><article-title>Leukocidins and the Nuclease Nuc Prevent Neutrophil-Mediated Killing of Staphylococcus Aureus Biofilms</article-title><source>Infect. Immun.</source><year>2020</year><volume>88</volume><pub-id pub-id-type="doi">10.1128/IAI.00372-20</pub-id><pub-id pub-id-type="pmid">32719153</pub-id><pub-id pub-id-type="pmcid">PMC7504955</pub-id></element-citation></ref><ref id="B429-pathogens-14-00185"><label>429.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabrilovich</surname><given-names>D.I.</given-names></name><name name-style="western"><surname>Nagaraj</surname><given-names>S.</given-names></name></person-group><article-title>Myeloid-Derived Suppressor Cells as Regulators of the Immune System</article-title><source>Nat. Rev. Immunol.</source><year>2009</year><volume>9</volume><fpage>162</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1038/nri2506</pub-id><pub-id pub-id-type="pmid">19197294</pub-id><pub-id pub-id-type="pmcid">PMC2828349</pub-id></element-citation></ref><ref id="B430-pathogens-14-00185"><label>430.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heim</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Aldrich</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Chaudhari</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Klinkebiel</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gries</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Alqarzaee</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>V.C.</given-names></name><etal/></person-group><article-title>Lactate Production by Staphylococcus Aureus Biofilm Inhibits HDAC11 to Reprogramme the Host Immune Response during Persistent Infection</article-title><source>Nat. Microbiol.</source><year>2020</year><volume>5</volume><fpage>1271</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-0756-3</pub-id><pub-id pub-id-type="pmid">32661313</pub-id><pub-id pub-id-type="pmcid">PMC7529909</pub-id></element-citation></ref><ref id="B431-pathogens-14-00185"><label>431.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Lung</surname><given-names>T.W.F.</given-names></name><name name-style="western"><surname>Dach</surname><given-names>F.</given-names></name><name name-style="western"><surname>Annavajhala</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Gabryszewski</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Groves</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Drikic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Francoeur</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Induces an Itaconate-Dominated Immunometabolic Response That Drives Biofilm Formation</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1399</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21718-y</pub-id><pub-id pub-id-type="pmid">33658521</pub-id><pub-id pub-id-type="pmcid">PMC7930111</pub-id></element-citation></ref><ref id="B432-pathogens-14-00185"><label>432.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nourbakhsh</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cullimore</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G.X.</given-names></name><name name-style="western"><surname>Rostami</surname><given-names>A.</given-names></name></person-group><article-title>IL-9 Is Important for T Cell Activation and Differentiation in Autoimmune Inflammation of the Central Nervous System</article-title><source>Eur. J. Immunol.</source><year>2011</year><volume>41</volume><fpage>2197</fpage><pub-id pub-id-type="doi">10.1002/eji.201041125</pub-id><pub-id pub-id-type="pmid">21674475</pub-id><pub-id pub-id-type="pmcid">PMC3517123</pub-id></element-citation></ref><ref id="B433-pathogens-14-00185"><label>433.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purwar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schlapbach</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Elyaman</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jetten</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Khoury</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Fuhlbrigge</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>V.K.</given-names></name><etal/></person-group><article-title>Robust Tumor Immunity to Melanoma Mediated by Interleukin 9</article-title><source>Nat. Med.</source><year>2012</year><volume>18</volume><fpage>1248</fpage><pub-id pub-id-type="doi">10.1038/nm.2856</pub-id><pub-id pub-id-type="pmid">22772464</pub-id><pub-id pub-id-type="pmcid">PMC3518666</pub-id></element-citation></ref><ref id="B434-pathogens-14-00185"><label>434.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soussi-Gounni</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kontolemos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hamid</surname><given-names>Q.</given-names></name></person-group><article-title>Role of IL-9 in the Pathophysiology of Allergic Diseases</article-title><source>J. Allergy Clin. Immunol.</source><year>2001</year><volume>107</volume><fpage>575</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1067/mai.2001.114238</pub-id><pub-id pub-id-type="pmid">11295641</pub-id></element-citation></ref><ref id="B435-pathogens-14-00185"><label>435.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palomares</surname><given-names>F.</given-names></name><name name-style="western"><surname>Testera-Montes</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aranda</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Alba-Linero</surname><given-names>C.</given-names></name><name name-style="western"><surname>S&#225;enz de Santa Mar&#237;a-Garc&#237;a</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bentabol-Ramos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mayorga</surname><given-names>C.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Rondon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Eguiluz-Gracia</surname><given-names>I.</given-names></name></person-group><article-title>Allergen Exposure Boosts Peripheral Th9 Responses in Patients with Local Allergic Rhinitis</article-title><source>Int. Forum Allergy Rhinol.</source><year>2023</year><volume>13</volume><fpage>2086</fpage><lpage>2091</lpage><pub-id pub-id-type="doi">10.1002/alr.23175</pub-id><pub-id pub-id-type="pmid">37150905</pub-id></element-citation></ref><ref id="B436-pathogens-14-00185"><label>436.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dupont</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Scully</surname><given-names>I.L.</given-names></name><name name-style="western"><surname>Zimnisky</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Monian</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rossitto</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>O&#8217;Connell</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Love</surname><given-names>J.C.</given-names></name></person-group><article-title>Two Vaccines for Staphylococcus Aureus Induce a B-Cell-Mediated Immune Response</article-title><source>mSphere</source><year>2018</year><volume>3</volume><fpage>e00217-18</fpage><pub-id pub-id-type="doi">10.1128/mSphere.00217-18</pub-id><pub-id pub-id-type="pmid">30135219</pub-id><pub-id pub-id-type="pmcid">PMC6106056</pub-id></element-citation></ref><ref id="B437-pathogens-14-00185"><label>437.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardman</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.L.</given-names></name><name name-style="western"><surname>Salimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nahler</surname><given-names>J.</given-names></name><name name-style="western"><surname>Corridoni</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jagielowicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fonseka</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>D.</given-names></name><name name-style="western"><surname>Repapi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cousins</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>IL-6 Effector Function of Group-2 Innate Lymphoid Cells (ILC2) Is NOD2 Dependent</article-title><source>Sci. Immunol.</source><year>2021</year><volume>6</volume><fpage>eabe5084</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.abe5084</pub-id><pub-id pub-id-type="pmid">34021026</pub-id><pub-id pub-id-type="pmcid">PMC7611333</pub-id></element-citation></ref><ref id="B438-pathogens-14-00185"><label>438.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calus</surname><given-names>L.</given-names></name><name name-style="western"><surname>Derycke</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dullaers</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van Zele</surname><given-names>T.</given-names></name><name name-style="western"><surname>De Ruyck</surname><given-names>N.</given-names></name><name name-style="western"><surname>P&#233;rez-Novo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Holtappels</surname><given-names>G.</given-names></name><name name-style="western"><surname>De Vos</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Bachert</surname><given-names>C.</given-names></name><etal/></person-group><article-title>IL-21 Is Increased in Nasal Polyposis and after Stimulation with Staphylococcus Aureus Enterotoxin B</article-title><source>Int. Arch. Allergy Immunol.</source><year>2017</year><volume>174</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1159/000481435</pub-id><pub-id pub-id-type="pmid">29131072</pub-id></element-citation></ref><ref id="B439-pathogens-14-00185"><label>439.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Ferroptosis</article-title><source>Curr. Biol.</source><year>2020</year><volume>30</volume><fpage>R1292</fpage><lpage>R1297</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.09.068</pub-id><pub-id pub-id-type="pmid">33142092</pub-id></element-citation></ref><ref id="B440-pathogens-14-00185"><label>440.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahlson</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>S.J.</given-names></name></person-group><article-title>Copper-Induced Cell Death</article-title><source>Science</source><year>2022</year><volume>375</volume><fpage>1231</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1126/science.abo3959</pub-id><pub-id pub-id-type="pmid">35298241</pub-id></element-citation></ref><ref id="B441-pathogens-14-00185"><label>441.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blake</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Baral</surname><given-names>P.</given-names></name><name name-style="western"><surname>Voisin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lubkin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pinho-Ribeiro</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Roberson</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.C.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Woolf</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Produces Pain through Pore-Forming Toxins and Neuronal TRPV1 That Is Silenced by QX-314</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-02448-6</pub-id><pub-id pub-id-type="pmid">29295977</pub-id><pub-id pub-id-type="pmcid">PMC5750211</pub-id></element-citation></ref><ref id="B442-pathogens-14-00185"><label>442.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boff</surname><given-names>D.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>V.L.S.</given-names></name><name name-style="western"><surname>Queiroz Junior</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Allegretti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Verri</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Proost</surname><given-names>P.</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Amaral</surname><given-names>F.A.</given-names></name></person-group><article-title>CXCR2 Is Critical for Bacterial Control and Development of Joint Damage and Pain in Staphylococcus Aureus-Induced Septic Arthritis in Mouse</article-title><source>Eur. J. Immunol.</source><year>2018</year><volume>48</volume><fpage>454</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1002/eji.201747198</pub-id><pub-id pub-id-type="pmid">29168180</pub-id></element-citation></ref><ref id="B443-pathogens-14-00185"><label>443.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Misba</surname><given-names>L.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.U.</given-names></name></person-group><article-title>Antibiotics versus Biofilm: An Emerging Battleground in Microbial Communities</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2019</year><volume>8</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s13756-019-0533-3</pub-id><pub-id pub-id-type="pmid">31131107</pub-id><pub-id pub-id-type="pmcid">PMC6524306</pub-id></element-citation></ref><ref id="B444-pathogens-14-00185"><label>444.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>W&#243;jcik-Bojek</surname><given-names>U.</given-names></name><name name-style="western"><surname>R&#243;&#380;alska</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sadowska</surname><given-names>B.</given-names></name></person-group><article-title>Staphylococcus Aureus&#8212;A Known Opponent against Host Defense Mechanisms and Vaccine Development&#8212;Do We Still Have a Chance to Win?</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>948</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23020948</pub-id><pub-id pub-id-type="pmid">35055134</pub-id><pub-id pub-id-type="pmcid">PMC8781139</pub-id></element-citation></ref><ref id="B445-pathogens-14-00185"><label>445.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Begier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Seiden</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Patton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zito</surname><given-names>E.</given-names></name><name name-style="western"><surname>Severs</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>D.</given-names></name><name name-style="western"><surname>Eiden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>K.U.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>A.S.</given-names></name><etal/></person-group><article-title>SA4Ag, a 4-Antigen Staphylococcus Aureus Vaccine, Rapidly Induces High Levels of Bacteria-Killing Antibodies</article-title><source>Vaccine</source><year>2017</year><volume>35</volume><fpage>1132</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2017.01.024</pub-id><pub-id pub-id-type="pmid">28143674</pub-id></element-citation></ref><ref id="B446-pathogens-14-00185"><label>446.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>White</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Filler</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yeaman</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Hennessey</surname><given-names>J.P.</given-names></name></person-group><article-title>NDV-3, a Recombinant Alum-Adjuvanted Vaccine for Candida and Staphylococcus Aureus, Is Safe and Immunogenic in Healthy Adults</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>7594</fpage><lpage>7600</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.10.038</pub-id><pub-id pub-id-type="pmid">23099329</pub-id><pub-id pub-id-type="pmcid">PMC3513491</pub-id></element-citation></ref><ref id="B447-pathogens-14-00185"><label>447.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeaman</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Filler</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Chaili</surname><given-names>S.</given-names></name><name name-style="western"><surname>Barr</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kupferwasser</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hennessey</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>Mechanisms of NDV-3 Vaccine Efficacy in MRSA Skin versus Invasive Infection</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>E5555</fpage><lpage>E5563</lpage><pub-id pub-id-type="doi">10.1073/pnas.1415610111</pub-id><pub-id pub-id-type="pmid">25489065</pub-id><pub-id pub-id-type="pmcid">PMC4280579</pub-id></element-citation></ref><ref id="B448-pathogens-14-00185"><label>448.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Pasetti</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Adhikari</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Baughman</surname><given-names>H.</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>R.</given-names></name><name name-style="western"><surname>El-Khorazaty</surname><given-names>J.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Holtsberg</surname><given-names>F.W.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Reymann</surname><given-names>M.K.</given-names></name><etal/></person-group><article-title>Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax</article-title><source>Clin. Vaccine Immunol.</source><year>2016</year><volume>23</volume><fpage>918</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1128/CVI.00399-16</pub-id><pub-id pub-id-type="pmid">27707765</pub-id><pub-id pub-id-type="pmcid">PMC5139602</pub-id></element-citation></ref><ref id="B449-pathogens-14-00185"><label>449.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>P.Y.</given-names></name></person-group><article-title>Immunotherapies for the Prevention and Treatment of Staphylococcus Aureus Infections: Updates and Challenges</article-title><source>Pathog. Dis.</source><year>2023</year><volume>81</volume><fpage>ftad016</fpage><pub-id pub-id-type="doi">10.1093/femspd/ftad016</pub-id><pub-id pub-id-type="pmid">37422444</pub-id></element-citation></ref><ref id="B450-pathogens-14-00185"><label>450.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aman</surname><given-names>M.J.</given-names></name></person-group><article-title>Integrated BioTherapeutics</article-title><source>Hum. Vaccines Immunother.</source><year>2018</year><volume>14</volume><fpage>1308</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1080/21645515.2018.1440105</pub-id><pub-id pub-id-type="pmid">29641293</pub-id><pub-id pub-id-type="pmcid">PMC6037449</pub-id></element-citation></ref><ref id="B451-pathogens-14-00185"><label>451.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levy</surname><given-names>J.</given-names></name><name name-style="western"><surname>Licini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Haelterman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Moris</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lestrate</surname><given-names>P.</given-names></name><name name-style="western"><surname>Damaso</surname><given-names>S.</given-names></name><name name-style="western"><surname>Van Belle</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boutriau</surname><given-names>D.</given-names></name></person-group><article-title>Safety and Immunogenicity of an Investigational 4-Component Staphylococcus Aureus Vaccine with or without AS03B Adjuvant: Results of a Randomized Phase I Trial</article-title><source>Hum. Vaccin. Immunother.</source><year>2015</year><volume>11</volume><fpage>620</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1080/21645515.2015.1011021</pub-id><pub-id pub-id-type="pmid">25715157</pub-id><pub-id pub-id-type="pmcid">PMC4514337</pub-id></element-citation></ref><ref id="B452-pathogens-14-00185"><label>452.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinod</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Koo</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.C.</given-names></name></person-group><article-title>Generation of a Novel Staphylococcus Aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats</article-title><source>Infect. Immun.</source><year>2015</year><volume>83</volume><fpage>2957</fpage><lpage>2965</lpage><pub-id pub-id-type="doi">10.1128/IAI.00009-15</pub-id><pub-id pub-id-type="pmid">25964469</pub-id><pub-id pub-id-type="pmcid">PMC4468543</pub-id></element-citation></ref><ref id="B453-pathogens-14-00185"><label>453.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ledue</surname><given-names>O.</given-names></name><name name-style="western"><surname>Jun</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goulart</surname><given-names>C.</given-names></name><name name-style="western"><surname>Malley</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.J.</given-names></name></person-group><article-title>Protection against Staphylococcus Aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms</article-title><source>mBio</source><year>2018</year><volume>9</volume><fpage>e01949-18</fpage><pub-id pub-id-type="doi">10.1128/mBio.01949-18</pub-id><pub-id pub-id-type="pmid">30327437</pub-id><pub-id pub-id-type="pmcid">PMC6191547</pub-id></element-citation></ref><ref id="B454-pathogens-14-00185"><label>454.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sim</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>N.</given-names></name><name name-style="western"><surname>Son</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J.</given-names></name></person-group><article-title>Identification of Toxicity and Efficacy against New Staphylococcal Enterotoxin B Subunit Vaccine</article-title><source>J. Immunol.</source><year>2020</year><volume>204</volume><fpage>168.17</fpage><pub-id pub-id-type="doi">10.4049/jimmunol.204.Supp.168.17</pub-id></element-citation></ref><ref id="B455-pathogens-14-00185"><label>455.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mancini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Monaci</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lofano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Torre</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bacconi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tavarini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sammicheli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Arcidiacono</surname><given-names>L.</given-names></name><name name-style="western"><surname>Galletti</surname><given-names>B.</given-names></name><name name-style="western"><surname>Laera</surname><given-names>D.</given-names></name><etal/></person-group><article-title>One Dose of Staphylococcus Aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0147767</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0147767</pub-id><pub-id pub-id-type="pmid">26812180</pub-id><pub-id pub-id-type="pmcid">PMC4727907</pub-id></element-citation></ref><ref id="B456-pathogens-14-00185"><label>456.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Talyansky</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Slarve</surname><given-names>M.</given-names></name><name name-style="western"><surname>Reza</surname><given-names>H.</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Netea</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Warren</surname><given-names>T.</given-names></name><etal/></person-group><article-title>A Protein-Free Vaccine Stimulates Innate Immunity and Protects against Nosocomial Pathogens</article-title><source>Sci. Transl. Med.</source><year>2023</year><volume>15</volume><fpage>eadf9556</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.adf9556</pub-id><pub-id pub-id-type="pmid">37792959</pub-id><pub-id pub-id-type="pmcid">PMC10947341</pub-id></element-citation></ref><ref id="B457-pathogens-14-00185"><label>457.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>H.</given-names></name><name name-style="western"><surname>Henn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Malone</surname><given-names>D.</given-names></name><name name-style="western"><surname>Buoninfante</surname><given-names>A.</given-names></name><name name-style="western"><surname>Willms</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dumont</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>McLahan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Vaccination With Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus Aureus Minipig Deep Surgical Wound Infection Model</article-title><source>J. Infect. Dis.</source><year>2022</year><volume>225</volume><fpage>1460</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiab219</pub-id><pub-id pub-id-type="pmid">33895843</pub-id><pub-id pub-id-type="pmcid">PMC9016470</pub-id></element-citation></ref><ref id="B458-pathogens-14-00185"><label>458.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tkaczyk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L.I.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Datta</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>S.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zinsou</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus Aureus-Induced Pneumonia</article-title><source>Antimicrob. Agents Chemother.</source><year>2014</year><volume>58</volume><fpage>1108</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1128/AAC.02190-13</pub-id><pub-id pub-id-type="pmid">24295977</pub-id><pub-id pub-id-type="pmcid">PMC3910899</pub-id></element-citation></ref><ref id="B459-pathogens-14-00185"><label>459.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fran&#231;ois</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mercier</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Asehnoune</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nseir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fiancette</surname><given-names>M.</given-names></name><name name-style="western"><surname>Desachy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Plantef&#232;ve</surname><given-names>G.</given-names></name><name name-style="western"><surname>Meziani</surname><given-names>F.</given-names></name><name name-style="western"><surname>de Lame</surname><given-names>P.A.</given-names></name><etal/></person-group><article-title>Safety and Tolerability of a Single Administration of AR-301, a Human Monoclonal Antibody, in ICU Patients with Severe Pneumonia Caused by Staphylococcus Aureus: First-in-Human Trial</article-title><source>Intensive Care Med.</source><year>2018</year><volume>44</volume><fpage>1787</fpage><lpage>1796</lpage><pub-id pub-id-type="doi">10.1007/s00134-018-5229-2</pub-id><pub-id pub-id-type="pmid">30343314</pub-id></element-citation></ref><ref id="B460-pathogens-14-00185"><label>460.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X.Q.</given-names></name><name name-style="western"><surname>Robbie</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Esser</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>H.I.</given-names></name><name name-style="western"><surname>Bellamy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hernandez-Illas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jafri</surname><given-names>H.S.</given-names></name></person-group><article-title>Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus Aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>61</volume><pub-id pub-id-type="doi">10.1128/AAC.01020-16</pub-id><pub-id pub-id-type="pmcid">PMC5192133</pub-id><pub-id pub-id-type="pmid">27795368</pub-id></element-citation></ref><ref id="B461-pathogens-14-00185"><label>461.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fran&#231;ois</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jafri</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Chastre</surname><given-names>J.</given-names></name><name name-style="western"><surname>S&#225;nchez-Garc&#237;a</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eggimann</surname><given-names>P.</given-names></name><name name-style="western"><surname>Dequin</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Huberlant</surname><given-names>V.</given-names></name><name name-style="western"><surname>Vi&#241;a Soria</surname><given-names>L.</given-names></name><name name-style="western"><surname>Boulain</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bretonni&#232;re</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Efficacy and Safety of Suvratoxumab for Prevention of Staphylococcus Aureus Ventilator-Associated Pneumonia (SAATELLITE): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Pilot Trial</article-title><source>Lancet Infect. Dis.</source><year>2021</year><volume>21</volume><fpage>1313</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30995-6</pub-id><pub-id pub-id-type="pmid">33894131</pub-id></element-citation></ref><ref id="B462-pathogens-14-00185"><label>462.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Datta</surname><given-names>V.</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Tkaczyk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Suzich</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stover</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Sellman</surname><given-names>B.R.</given-names></name></person-group><article-title>MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus Aureus Immunocompromised Pneumonia Model</article-title><source>Antimicrob. Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>4526</fpage><lpage>4532</lpage><pub-id pub-id-type="doi">10.1128/AAC.00510-15</pub-id><pub-id pub-id-type="pmid">25987629</pub-id><pub-id pub-id-type="pmcid">PMC4505239</pub-id></element-citation></ref><ref id="B463-pathogens-14-00185"><label>463.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruzin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.Q.</given-names></name><name name-style="western"><surname>Tabor</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Mok</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tkaczyk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bellamy</surname><given-names>T.</given-names></name><name name-style="western"><surname>Roskos</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Characterisation of Anti-Alpha Toxin Antibody Levels and Colonisation Status after Administration of an Investigational Human Monoclonal Antibody, MEDI4893, against Staphylococcus Aureus Alpha Toxin</article-title><source>Clin. Transl. Immunol.</source><year>2018</year><volume>7</volume><fpage>e1009</fpage><pub-id pub-id-type="doi">10.1002/cti2.1009</pub-id><pub-id pub-id-type="pmid">29484186</pub-id><pub-id pub-id-type="pmcid">PMC5822409</pub-id></element-citation></ref><ref id="B464-pathogens-14-00185"><label>464.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peck</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rothenberg</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lewin-Koh</surname><given-names>N.</given-names></name><name name-style="western"><surname>She</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kamath</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Carrasco-Triguero</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>O.</given-names></name><name name-style="western"><surname>Castro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Teufel</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti- Staphylococcus Aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers</article-title><source>Antimicrob. Agents Chemother.</source><year>2019</year><volume>63</volume><pub-id pub-id-type="doi">10.1128/AAC.02588-18</pub-id><pub-id pub-id-type="pmid">30910894</pub-id><pub-id pub-id-type="pmcid">PMC6535527</pub-id></element-citation></ref><ref id="B465-pathogens-14-00185"><label>465.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehar</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Pillow</surname><given-names>T.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Staben</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kajihara</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Vandlen</surname><given-names>R.</given-names></name><name name-style="western"><surname>DePalatis</surname><given-names>L.</given-names></name><name name-style="western"><surname>Raab</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hazenbos</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Hiroshi Morisaki</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Novel Antibody-Antibiotic Conjugate Eliminates Intracellular <italic toggle="yes">S. aureus</italic></article-title><source>Nature</source><year>2015</year><volume>527</volume><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/nature16057</pub-id><pub-id pub-id-type="pmid">26536114</pub-id></element-citation></ref><ref id="B466-pathogens-14-00185"><label>466.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O.</given-names></name></person-group><article-title>Staphylococcus Aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A</article-title><source>J. Infect. Dis.</source><year>2019</year><volume>219</volume><fpage>884</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy597</pub-id><pub-id pub-id-type="pmid">30551184</pub-id><pub-id pub-id-type="pmcid">PMC7184913</pub-id></element-citation></ref><ref id="B467-pathogens-14-00185"><label>467.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>John</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Filler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Baddley</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Corey</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Sampathkumar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Winston</surname><given-names>L.</given-names></name><name name-style="western"><surname>John</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Kubin</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Talwani</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus Aureus Bacteremia</article-title><source>Antimicrob. Agents Chemother.</source><year>2006</year><volume>50</volume><fpage>2751</fpage><lpage>2755</lpage><pub-id pub-id-type="doi">10.1128/AAC.00096-06</pub-id><pub-id pub-id-type="pmid">16870768</pub-id><pub-id pub-id-type="pmcid">PMC1538656</pub-id></element-citation></ref><ref id="B468-pathogens-14-00185"><label>468.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karau</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Tilahun</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Krogman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Goldsby</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>David</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Mandrekar</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rajagopalan</surname><given-names>G.</given-names></name></person-group><article-title>Passive Therapy with Humanized Anti-Staphylococcal Enterotoxin B Antibodies Attenuates Systemic Inflammatory Response and Protects from Lethal Pneumonia Caused by Staphylococcal Enterotoxin B-Producing Staphylococcus Aureus</article-title><source>Virulence</source><year>2017</year><volume>8</volume><fpage>1148</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1080/21505594.2016.1267894</pub-id><pub-id pub-id-type="pmid">27925510</pub-id><pub-id pub-id-type="pmcid">PMC5711449</pub-id></element-citation></ref><ref id="B469-pathogens-14-00185"><label>469.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tha&#231;i</surname><given-names>D.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Bieber</surname><given-names>T.</given-names></name><name name-style="western"><surname>Blauvelt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Papp</surname><given-names>K.</given-names></name><name name-style="western"><surname>Soong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Worm</surname><given-names>M.</given-names></name><name name-style="western"><surname>Szepietowski</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Sofen</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Efficacy and Safety of Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments: A Randomised, Placebo-Controlled, Dose-Ranging Phase 2b Trial</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>40</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)00388-8</pub-id><pub-id pub-id-type="pmid">26454361</pub-id></element-citation></ref><ref id="B470-pathogens-14-00185"><label>470.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Bieber</surname><given-names>T.</given-names></name><name name-style="western"><surname>Guttman-Yassky</surname><given-names>E.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Blauvelt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cork</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Silverberg</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Deleuran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kataoka</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lacour</surname><given-names>J.-P.</given-names></name><etal/></person-group><article-title>Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis</article-title><source>N. Engl. J. Med.</source><year>2016</year><volume>375</volume><fpage>2335</fpage><lpage>2348</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1610020</pub-id><pub-id pub-id-type="pmid">27690741</pub-id></element-citation></ref><ref id="B471-pathogens-14-00185"><label>471.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Schlievert</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lussier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Boguniewicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hata</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fuxench</surname><given-names>Z.</given-names></name><name name-style="western"><surname>De Benedetto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ong</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Rapid Reduction in Staphylococcus Aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment</article-title><source>J. Allergy Clin. Immunol.</source><year>2023</year><volume>152</volume><fpage>1179</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2023.05.026</pub-id><pub-id pub-id-type="pmid">37315812</pub-id><pub-id pub-id-type="pmcid">PMC10716365</pub-id></element-citation></ref><ref id="B472-pathogens-14-00185"><label>472.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klimka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mertins</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nicolai</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Rummler</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Tosetti</surname><given-names>B.</given-names></name><name name-style="western"><surname>Krut</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kr&#246;nke</surname><given-names>M.</given-names></name></person-group><article-title>Epitope-Specific Immunity against Staphylococcus Aureus Coproporphyrinogen III Oxidase</article-title><source>NPJ Vaccines</source><year>2021</year><volume>6</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1038/s41541-020-00268-2</pub-id><pub-id pub-id-type="pmid">33462229</pub-id><pub-id pub-id-type="pmcid">PMC7813823</pub-id></element-citation></ref><ref id="B473-pathogens-14-00185"><label>473.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abd El-Hamid</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>D.</given-names></name><name name-style="western"><surname>Elazab</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Gad</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Shalaby</surname><given-names>M.</given-names></name><name name-style="western"><surname>El-Neshwy</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Alshahrani</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Saif</surname><given-names>A.</given-names></name><name name-style="western"><surname>Algendy</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>AlHarbi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Tackling Strong Biofilm and Multi-Virulent Vancomycin-Resistant Staphylococcus Aureus via Natural Alkaloid-Based Porous Nanoparticles: Perspective towards near Future Eradication</article-title><source>Front. Cell Infect. Microbiol.</source><year>2024</year><volume>13</volume><elocation-id>1287426</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1287426</pub-id><pub-id pub-id-type="pmid">38282617</pub-id><pub-id pub-id-type="pmcid">PMC10811083</pub-id></element-citation></ref><ref id="B474-pathogens-14-00185"><label>474.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name></person-group><article-title>Antibacterial and Anti-Inflammatory Effects of Genistein in Staphylococcus Aureus Induced Osteomyelitis in Rats</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2023</year><volume>37</volume><elocation-id>e23298</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.23298</pub-id><pub-id pub-id-type="pmid">36727417</pub-id></element-citation></ref><ref id="B475-pathogens-14-00185"><label>475.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>A.C.Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.J.</given-names></name></person-group><article-title>Butyrate Inhibits Staphylococcus Aureus-Aggravated Dermal IL-33 Expression and Skin Inflammation through Histone Deacetylase Inhibition</article-title><source>Front. Immunol.</source><year>2023</year><volume>14</volume><elocation-id>1114699</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1114699</pub-id><pub-id pub-id-type="pmid">37261337</pub-id><pub-id pub-id-type="pmcid">PMC10228744</pub-id></element-citation></ref><ref id="B476-pathogens-14-00185"><label>476.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G.</given-names></name><name name-style="western"><surname>An</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus Aureus</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><elocation-id>104</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2020.00104</pub-id><pub-id pub-id-type="pmid">32153410</pub-id><pub-id pub-id-type="pmcid">PMC7047170</pub-id></element-citation></ref><ref id="B477-pathogens-14-00185"><label>477.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfmeier</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Pletzer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Draeger</surname><given-names>A.</given-names></name><name name-style="western"><surname>Babiychuk</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>R.E.W.</given-names></name></person-group><article-title>Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus Aureus by Targeting &#945;-Type Phenol-Soluble Modulins and &#945;-Hemolysin</article-title><source>EBioMedicine</source><year>2018</year><volume>33</volume><elocation-id>211</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.06.016</pub-id><pub-id pub-id-type="pmid">29936135</pub-id><pub-id pub-id-type="pmcid">PMC6085503</pub-id></element-citation></ref><ref id="B478-pathogens-14-00185"><label>478.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Raheem</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Abd El-Hamid</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>D.</given-names></name><name name-style="western"><surname>El-Malt</surname><given-names>R.M.S.</given-names></name><name name-style="western"><surname>El-Ghareeb</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Al-Sultan</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Meligy</surname><given-names>A.M.A.</given-names></name><name name-style="western"><surname>ELTarabili</surname><given-names>R.M.</given-names></name></person-group><article-title>Future Scope of Plant-Derived Bioactive Compounds in the Management of Methicillin-Resistant Staphylococcus Aureus: In Vitro Antimicrobial and Antivirulence Prospects to Combat MRSA</article-title><source>Microb. Pathog.</source><year>2023</year><volume>183</volume><fpage>106301</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2023.106301</pub-id><pub-id pub-id-type="pmid">37579824</pub-id></element-citation></ref><ref id="B479-pathogens-14-00185"><label>479.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clegg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Soldaini</surname><given-names>E.</given-names></name><name name-style="western"><surname>McLoughlin</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Rittenhouse</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bagnoli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Phogat</surname><given-names>S.</given-names></name></person-group><article-title>Staphylococcus Aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>705360</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.705360</pub-id><pub-id pub-id-type="pmid">34305945</pub-id><pub-id pub-id-type="pmcid">PMC8294057</pub-id></element-citation></ref><ref id="B480-pathogens-14-00185"><label>480.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bidmos</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Siris</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gladstone</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Langford</surname><given-names>P.R.</given-names></name></person-group><article-title>Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>2315</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02315</pub-id><pub-id pub-id-type="pmid">30349542</pub-id><pub-id pub-id-type="pmcid">PMC6187972</pub-id></element-citation></ref><ref id="B481-pathogens-14-00185"><label>481.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doerflinger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Forsyth</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Herold</surname><given-names>M.J.</given-names></name></person-group><article-title>CRISPR/Cas9-The Ultimate Weapon to Battle Infectious Diseases?</article-title><source>Cell Microbiol.</source><year>2017</year><volume>19</volume><elocation-id>e12693</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.12693</pub-id><pub-id pub-id-type="pmid">27860197</pub-id></element-citation></ref><ref id="B482-pathogens-14-00185"><label>482.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bikard</surname><given-names>D.</given-names></name><name name-style="western"><surname>Euler</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Duportet</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fischetti</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Marraffini</surname><given-names>L.A.</given-names></name></person-group><article-title>Development of Sequence-Specific Antimicrobials Based on Programmable CRISPR-Cas Nucleases</article-title><source>Nat. Biotechnol.</source><year>2014</year><volume>32</volume><elocation-id>1146</elocation-id><pub-id pub-id-type="doi">10.1038/nbt.3043</pub-id><pub-id pub-id-type="pmid">25282355</pub-id><pub-id pub-id-type="pmcid">PMC4317352</pub-id></element-citation></ref><ref id="B483-pathogens-14-00185"><label>483.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cafiso</surname><given-names>V.</given-names></name><name name-style="western"><surname>Verde</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Zega</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pigola</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rostagno</surname><given-names>R.</given-names></name><name name-style="western"><surname>Borr&#232;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Stefani</surname><given-names>S.</given-names></name></person-group><article-title>Genomic Characterization of a New Biofilm-Forming and Adhesive ST398 Human-Adapted MSSA Lineage Causing Septic Knee Arthritis Following Surgical Reconstruction</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><elocation-id>305</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms9020305</pub-id><pub-id pub-id-type="pmid">33540689</pub-id><pub-id pub-id-type="pmcid">PMC7913009</pub-id></element-citation></ref><ref id="B484-pathogens-14-00185"><label>484.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexyuk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bogoyavlenskiy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Moldakhanov</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Akanova</surname><given-names>K.</given-names></name><name name-style="western"><surname>Manakbayeva</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alexyuk</surname><given-names>P.</given-names></name></person-group><article-title>Draft Genome Sequence Data of Methicillin-Resistant Staphylococcus Aureus, Strain 4233</article-title><source>Data Brief</source><year>2024</year><volume>54</volume><fpage>110492</fpage><pub-id pub-id-type="doi">10.1016/j.dib.2024.110492</pub-id><pub-id pub-id-type="pmid">38799713</pub-id><pub-id pub-id-type="pmcid">PMC11127097</pub-id></element-citation></ref><ref id="B485-pathogens-14-00185"><label>485.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name></person-group><article-title>The Fingerprint Mapping and Genotyping Systems Application on Methicillin-Resistant Staphylococcus Aureus</article-title><source>Microb. Pathog.</source><year>2018</year><volume>125</volume><fpage>246</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.09.031</pub-id><pub-id pub-id-type="pmid">30243550</pub-id></element-citation></ref><ref id="B486-pathogens-14-00185"><label>486.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abujubara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hintzen</surname><given-names>J.C.J.</given-names></name><name name-style="western"><surname>Rahimi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mijakovic</surname><given-names>I.</given-names></name><name name-style="western"><surname>Tietze</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tietze</surname><given-names>A.A.</given-names></name></person-group><article-title>Substrate-Derived Sortase A Inhibitors: Targeting an Essential Virulence Factor of Gram-Positive Pathogenic Bacteria</article-title><source>Chem. Sci.</source><year>2023</year><volume>14</volume><fpage>6975</fpage><lpage>6985</lpage><pub-id pub-id-type="doi">10.1039/D3SC01209C</pub-id><pub-id pub-id-type="pmid">37389257</pub-id><pub-id pub-id-type="pmcid">PMC10306101</pub-id></element-citation></ref><ref id="B487-pathogens-14-00185"><label>487.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muthukrishnan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Soin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Grier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brodell</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Ackert-Bicknell</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>F.E.-H.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Daiss</surname><given-names>J.L.</given-names></name></person-group><article-title>A Bioinformatic Approach to Utilize a Patient&#8217;s Antibody-Secreting Cells against Staphylococcus Aureus to Detect Challenging Musculoskeletal Infections</article-title><source>Immunohorizons</source><year>2020</year><volume>4</volume><fpage>339</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.4049/immunohorizons.2000024</pub-id><pub-id pub-id-type="pmid">32571786</pub-id><pub-id pub-id-type="pmcid">PMC7737182</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pathogens-14-00185-f001" orientation="portrait"><label>Figure 1</label><caption><p><italic toggle="yes">Staphylococcus aureus</italic>: Inflammatory Diseases, Immunopathogenesis, and Immune Evasion Mechanisms. <italic toggle="yes">Staphylococcus aureus</italic> (<italic toggle="yes">S. aureus</italic>) is an opportunistic pathogen that causes various inflammatory diseases (<bold>1</bold>), including asthma (<bold>1a</bold>), atopic dermatitis (<bold>1b</bold>), infective endocarditis (<bold>1c</bold>), bacteremia and sepsis (<bold>1d</bold>), and osteomyelitis and septic arthritis (<bold>1e</bold>). Following host invasion and bacterial colonization by <italic toggle="yes">S. aureus</italic>, an immune response (<bold>2</bold>) is initiated, involving the innate immune system (<bold>2.1</bold>), the adaptive immune system (<bold>2.2</bold>), and the activation of non-immune host cells (<bold>2.3</bold>). In the innate immune response, cells such as macrophages (<bold>2.1a</bold>), NK cells (<bold>2.1b</bold>), neutrophils (<bold>2.1c</bold>), mast cells (<bold>2.1d</bold>), and eosinophils (<bold>2.1e</bold>) are activated. The adaptive immune response involves the activation of T cells (<bold>2.2a</bold>) and B cells (<bold>2.2b</bold>). Additionally, during immunopathogenesis, other cell types may also become involved, including tissue barrier cells (<bold>2.3a</bold>), neurons (<bold>2.3b</bold>), and glial cells (<bold>2.3c</bold>). All of these contribute to the development of the host&#8217;s response against <italic toggle="yes">S. aureus</italic> infection. However, this pathogen has developed mechanisms to evade the host&#8217;s immune defenses (<bold>3</bold>), including the inhibition of phagocytosis and neutrophil recruitment (<bold>3a</bold>); superantigen activity and biofilm formation (<bold>3b</bold>); evasion of the complement system and neutrophil extracellular traps (<bold>3c</bold>); neutralization of reactive oxygen species, promotion of an anti-inflammatory state, and resistance to antimicrobial peptides (<bold>3d</bold>); as well as adhesion to host cells and tissues (<bold>3e</bold>). Acronyms: TGF-&#946;&#8212;Transforming Growth Factor Beta; IL&#8212;Interleukin; TNF-&#945;&#8212;Tumor Necrosis Factor Alpha; ROS: Reactive Oxygen Species; RNS&#8212;Reactive Nitrogen Species; IFN-&#947;&#8212;Interferon Gamma; AMPs&#8212;Antimicrobial Peptides; NETs&#8212;Neutrophil Extracellular Traps; CGRP&#8212;Calcitonin Gene-Related Peptide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pathogens-14-00185-g001.jpg"/></fig><fig position="float" id="pathogens-14-00185-f003" orientation="portrait"><label>Figure 3</label><caption><p>How different immune and non-immune cells respond to <italic toggle="yes">S. aureus</italic> infection. (<bold>A</bold>) Neutrophils are attracted (chemotaxis) by IL-8, CXCL1, CXCL2, CXCL3, CXCL5, CCL3, CCL7, TNF&#945;, and formylated peptides to the site of infection [<xref rid="B207-pathogens-14-00185" ref-type="bibr">207</xref>,<xref rid="B208-pathogens-14-00185" ref-type="bibr">208</xref>,<xref rid="B209-pathogens-14-00185" ref-type="bibr">209</xref>,<xref rid="B210-pathogens-14-00185" ref-type="bibr">210</xref>,<xref rid="B211-pathogens-14-00185" ref-type="bibr">211</xref>,<xref rid="B212-pathogens-14-00185" ref-type="bibr">212</xref>]. Neutrophils recognize <italic toggle="yes">S. aureus</italic> through their pattern recognition receptors (e.g., TLR-2), NOD-like receptors (NOD2), complement receptors, and Mannose-binding lectin receptors (MBLR), favoring opsonization and phagocytosis [<xref rid="B220-pathogens-14-00185" ref-type="bibr">220</xref>,<xref rid="B221-pathogens-14-00185" ref-type="bibr">221</xref>,<xref rid="B222-pathogens-14-00185" ref-type="bibr">222</xref>,<xref rid="B223-pathogens-14-00185" ref-type="bibr">223</xref>,<xref rid="B224-pathogens-14-00185" ref-type="bibr">224</xref>,<xref rid="B225-pathogens-14-00185" ref-type="bibr">225</xref>,<xref rid="B227-pathogens-14-00185" ref-type="bibr">227</xref>]. Besides phagocytosis, neutrophilic killing machinery includes ROS production, release of NETs, and degranulation [<xref rid="B233-pathogens-14-00185" ref-type="bibr">233</xref>,<xref rid="B235-pathogens-14-00185" ref-type="bibr">235</xref>,<xref rid="B237-pathogens-14-00185" ref-type="bibr">237</xref>,<xref rid="B239-pathogens-14-00185" ref-type="bibr">239</xref>,<xref rid="B242-pathogens-14-00185" ref-type="bibr">242</xref>,<xref rid="B251-pathogens-14-00185" ref-type="bibr">251</xref>,<xref rid="B252-pathogens-14-00185" ref-type="bibr">252</xref>,<xref rid="B253-pathogens-14-00185" ref-type="bibr">253</xref>,<xref rid="B254-pathogens-14-00185" ref-type="bibr">254</xref>]. (<bold>B</bold>) Macrophages chemotaxis molecules include CCL9, MCP-1, and fMLP [<xref rid="B132-pathogens-14-00185" ref-type="bibr">132</xref>,<xref rid="B133-pathogens-14-00185" ref-type="bibr">133</xref>,<xref rid="B138-pathogens-14-00185" ref-type="bibr">138</xref>], and upon bacterial encounter and recognition through TLR2/4 [<xref rid="B142-pathogens-14-00185" ref-type="bibr">142</xref>,<xref rid="B143-pathogens-14-00185" ref-type="bibr">143</xref>,<xref rid="B149-pathogens-14-00185" ref-type="bibr">149</xref>] those cells are polarized to either pro-inflammatory (to enhance antimicrobial activities) or anti-inflammatory (as an immune evasion mechanism exerted by S. aureus) [<xref rid="B141-pathogens-14-00185" ref-type="bibr">141</xref>,<xref rid="B150-pathogens-14-00185" ref-type="bibr">150</xref>,<xref rid="B151-pathogens-14-00185" ref-type="bibr">151</xref>,<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>,<xref rid="B153-pathogens-14-00185" ref-type="bibr">153</xref>,<xref rid="B154-pathogens-14-00185" ref-type="bibr">154</xref>,<xref rid="B155-pathogens-14-00185" ref-type="bibr">155</xref>]. Downstream antimicrobial mechanisms of macrophages include NF-&#954;B activation, ROS generation, release of cytokines, antimicrobial peptides and lysozymes, and METs [<xref rid="B167-pathogens-14-00185" ref-type="bibr">167</xref>,<xref rid="B168-pathogens-14-00185" ref-type="bibr">168</xref>,<xref rid="B171-pathogens-14-00185" ref-type="bibr">171</xref>,<xref rid="B172-pathogens-14-00185" ref-type="bibr">172</xref>,<xref rid="B173-pathogens-14-00185" ref-type="bibr">173</xref>,<xref rid="B175-pathogens-14-00185" ref-type="bibr">175</xref>,<xref rid="B183-pathogens-14-00185" ref-type="bibr">183</xref>]. (<bold>C</bold>) Natural killers (NKs) produce IFN-&#947; to activate macrophages for a robust antimicrobial response [<xref rid="B189-pathogens-14-00185" ref-type="bibr">189</xref>], play a critical protective role through IL-15 signaling [<xref rid="B192-pathogens-14-00185" ref-type="bibr">192</xref>], and turn into long-lived memory-like cells for faster response in the future [<xref rid="B194-pathogens-14-00185" ref-type="bibr">194</xref>]. (<bold>D</bold>) Mast cells promote IFN-&#947;-mediated type 1 response via autocrine feedback [<xref rid="B270-pathogens-14-00185" ref-type="bibr">270</xref>], activate Tregs via IL-2 [<xref rid="B271-pathogens-14-00185" ref-type="bibr">271</xref>], and produce IL-6, IL-5, TNF-&#945;, IL-13, and IL-4 during <italic toggle="yes">S. aureus</italic> infections [<xref rid="B275-pathogens-14-00185" ref-type="bibr">275</xref>]. (<bold>E</bold>) Eosinophils form EETs and contribute to skin inflammation in an IL-17-dependent manner [<xref rid="B279-pathogens-14-00185" ref-type="bibr">279</xref>,<xref rid="B284-pathogens-14-00185" ref-type="bibr">284</xref>]. <bold>(F</bold>) T cells differentiate into Th1 and Th17, which elicit type 1 (against intracellular bacteria) and type 3 (to kill extracellular bacteria) responses, respectively. They favor microbial killing through IFN-&#947;, IL-17, and neutrophil chemotaxis [<xref rid="B294-pathogens-14-00185" ref-type="bibr">294</xref>,<xref rid="B295-pathogens-14-00185" ref-type="bibr">295</xref>]. (<bold>G</bold>) B cells produce antibodies to opsonize <italic toggle="yes">S. aureus</italic> [<xref rid="B308-pathogens-14-00185" ref-type="bibr">308</xref>] and secrete IL-6 and IL-21, two essential cytokines for memory B cell development [<xref rid="B316-pathogens-14-00185" ref-type="bibr">316</xref>]. (<bold>H</bold>) Epithelial cells sense <italic toggle="yes">S. aureus</italic> through TLR2/6/9 and secrete several cytokines and chemokines to trigger and maintain an immune response [<xref rid="B321-pathogens-14-00185" ref-type="bibr">321</xref>,<xref rid="B322-pathogens-14-00185" ref-type="bibr">322</xref>,<xref rid="B324-pathogens-14-00185" ref-type="bibr">324</xref>,<xref rid="B325-pathogens-14-00185" ref-type="bibr">325</xref>,<xref rid="B326-pathogens-14-00185" ref-type="bibr">326</xref>,<xref rid="B328-pathogens-14-00185" ref-type="bibr">328</xref>,<xref rid="B329-pathogens-14-00185" ref-type="bibr">329</xref>,<xref rid="B330-pathogens-14-00185" ref-type="bibr">330</xref>,<xref rid="B331-pathogens-14-00185" ref-type="bibr">331</xref>]. (<bold>I</bold>) Neurons and glial cells can interact with bacteria directly, and specifically, TRPV1<sup>+</sup> and Nav1.8<sup>+</sup> neurons abrogate neutrophil influx, &#947;&#948; T cell-mediated defenses, and inflammatory macrophage phenotype [<xref rid="B156-pathogens-14-00185" ref-type="bibr">156</xref>,<xref rid="B157-pathogens-14-00185" ref-type="bibr">157</xref>,<xref rid="B350-pathogens-14-00185" ref-type="bibr">350</xref>,<xref rid="B353-pathogens-14-00185" ref-type="bibr">353</xref>]. In turn, microglia induce upregulated expression of TNF-&#945;, IL-1&#946;, IL-12, MCP-1, MIP-2, and leukocyte recruitment [<xref rid="B360-pathogens-14-00185" ref-type="bibr">360</xref>,<xref rid="B361-pathogens-14-00185" ref-type="bibr">361</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pathogens-14-00185-g003.jpg"/></fig><table-wrap position="float" id="pathogens-14-00185-t001" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t001_Table 1</object-id><label>Table 1</label><caption><p>Skin microbiome of patients with atopic dermatitis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Skin Colonization in AD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Relative Abundance in the Skin in AD (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">Staphylococcus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30%</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B47-pathogens-14-00185" ref-type="bibr">47</xref>,<xref rid="B50-pathogens-14-00185" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">capitis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">epidermidis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Acinetobacter</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Bacteroidetes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.3</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Corynebacterium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Cutibacterium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.2</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Micrococcus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Paracoccus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.8</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pathogens-14-00185-t002" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t002_Table 2</object-id><label>Table 2</label><caption><p>Main causative agents of bacteremia and sepsis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Prevalence in Hospitalized Children (&lt;14 Years)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Prevalence of Hospital-Onset (&#8805;18 Years)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Prevalence of Community-Onset (18&#8211;44 Years)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.0</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B57-pathogens-14-00185" ref-type="bibr">57</xref>,<xref rid="B58-pathogens-14-00185" ref-type="bibr">58</xref>,<xref rid="B59-pathogens-14-00185" ref-type="bibr">59</xref>,<xref rid="B60-pathogens-14-00185" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Acinetobacter baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Salmonella</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus agalactiae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus</italic>
<italic toggle="yes">viridans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pathogens-14-00185-t003" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t003_Table 3</object-id><label>Table 3</label><caption><p>Causative agents of infective endocarditis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of IE Cases</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Prevalence in South America</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">35&#8211;40%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17%</td><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B71-pathogens-14-00185" ref-type="bibr">71</xref>,<xref rid="B72-pathogens-14-00185" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coagulase-negative <italic toggle="yes">staphylococcus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HACEK</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polymicrobial (&#8805;2 microorganisms)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus bovis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus</italic>
<italic toggle="yes">viridans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6%</td></tr></tbody></table><table-wrap-foot><fn><p>HACEK: <italic toggle="yes">Haemophilus</italic> spp., <italic toggle="yes">Aggregatibacter</italic> spp., <italic toggle="yes">Cardiobacterium hominis</italic>, <italic toggle="yes">Eikenella corrodens e Kingella</italic> spp.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pathogens-14-00185-t004" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t004_Table 4</object-id><label>Table 4</label><caption><p>Main causative agents of osteomyelitis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Susceptibility Factors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tropism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Incidence in Skeletal Infections (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Injectable drug users, immunocompromised, spinal column surgery, orthopedic fixation devices, diabetes mellitus, vascular insufficiency, contaminated open fracture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower extremity prosthetic joint</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20&#8211;30</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Adults and children</td><td rowspan="20" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B80-pathogens-14-00185" ref-type="bibr">80</xref>,<xref rid="B81-pathogens-14-00185" ref-type="bibr">81</xref>,<xref rid="B82-pathogens-14-00185" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trauma or fracture-related</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20&#8211;40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haematogenous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foot and ankle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45&#8211;55</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">Enterobacteriaceae</italic> spp.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hospitalization (nosocomial source)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower extremity prosthetic joint</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;5</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Newborn babies</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trauma or fracture-related</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;20</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haematogenous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foot and ankle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#8211;15</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">Pseudomonas</italic> spp.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Injectable drug users, urinary infection, hospitalization (nosocomial source)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower extremity prosthetic joint</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;5</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Adults</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trauma or fracture-related</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haematogenous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foot and ankle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#8211;20</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">Staphylococcus epidermidis</italic>
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Spinal column surgery, orthopedic fixation devices, diabetes mellitus, vascular insufficiency, contaminated open fracture</td><td align="center" valign="middle" rowspan="1" colspan="1">Lower extremity prosthetic joint</td><td align="center" valign="middle" rowspan="1" colspan="1">20&#8211;25</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Adults and children</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Trauma or fracture-related</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">5&#8211;15</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Haematogenous</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&lt;5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foot and ankle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;5</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic toggle="yes">Streptococcus</italic> spp.</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Diabetes mellitus, vascular insufficiency, contaminated open fracture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower extremity prosthetic joint</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;5</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Adults, children, and newborn babies</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trauma or fracture-related</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Haematogenous</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foot and ankle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5&#8211;20</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pathogens-14-00185-t005" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t005_Table 5</object-id><label>Table 5</label><caption><p>Main causative agents of septic arthritis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Prevalence</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Involved Joints</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRCNS</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">8.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B104-pathogens-14-00185" ref-type="bibr">104</xref>,<xref rid="B105-pathogens-14-00185" ref-type="bibr">105</xref>] </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MSCNS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee and shoulder</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children and adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee, hip, and shoulder</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MSSA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children and adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee, hip, and shoulder</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Enterobacteriaceae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee and hip</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Pseudomonas</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children and adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee and hip</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic toggle="yes">Streptococcus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children and adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Knee, hip, and shoulder</td></tr></tbody></table><table-wrap-foot><fn><p>MRCNS: methicillin-resistant coagulase-negative <italic toggle="yes">Staphylococci</italic>; MSCNS: methicillin-sensitive coagulase-negative <italic toggle="yes">Staphylococci</italic>; MRSA: methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>; MSSA: methicillin-sensitive <italic toggle="yes">Staphylococcus aureus</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pathogens-14-00185-t006" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t006_Table 6</object-id><label>Table 6</label><caption><p>Immune evasion mechanisms of Staphylococcus aureus and the main proteins involved.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Immune Evasion Mechanism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Function/Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Proteins/Factors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Inhibition of Neutrophil Migration and Chemotaxis<break/>Inhibition of Phagocytosis<break/>Complement System Evasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevents neutrophils from reaching infection sites</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphylococcal superantigen-like proteins (SSL5 and SSL1), CHIPS, FLIPr, FLIPr-like</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B383-pathogens-14-00185" ref-type="bibr">383</xref>,<xref rid="B384-pathogens-14-00185" ref-type="bibr">384</xref>,<xref rid="B389-pathogens-14-00185" ref-type="bibr">389</xref>,<xref rid="B390-pathogens-14-00185" ref-type="bibr">390</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevents bacteria from being engulfed by immune cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphylococcal protein A (SpA), <italic toggle="yes">S. aureus</italic> binder of IgG (Sbi), SSL10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B320-pathogens-14-00185" ref-type="bibr">320</xref>,<xref rid="B392-pathogens-14-00185" ref-type="bibr">392</xref>,<xref rid="B394-pathogens-14-00185" ref-type="bibr">394</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocks complement activation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphylococcal complement inhibitor (SCIN), Extracellular fibrinogen-binding protein (Efb), Extracellular complement-binding protein (Ecb), SSL7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B386-pathogens-14-00185" ref-type="bibr">386</xref>,<xref rid="B395-pathogens-14-00185" ref-type="bibr">395</xref>,<xref rid="B396-pathogens-14-00185" ref-type="bibr">396</xref>,<xref rid="B397-pathogens-14-00185" ref-type="bibr">397</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Superantigen Activity<break/>Interference with Reactive Oxygen Species (ROS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulates T cell proliferation and disrupts immune regulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic shock syndrome toxin-1 (TSST-1), Staphylococcal enterotoxins B and C (SEB, SEC), Staphylococcal enterotoxin-like X (SElX)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B369-pathogens-14-00185" ref-type="bibr">369</xref>,<xref rid="B398-pathogens-14-00185" ref-type="bibr">398</xref>,<xref rid="B399-pathogens-14-00185" ref-type="bibr">399</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutralizes ROS produced by immune cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphyloxanthin, Superoxide dismutase, Catalase, Alkyl hydroperoxide reductase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B406-pathogens-14-00185" ref-type="bibr">406</xref>,<xref rid="B408-pathogens-14-00185" ref-type="bibr">408</xref>,<xref rid="B409-pathogens-14-00185" ref-type="bibr">409</xref>,<xref rid="B410-pathogens-14-00185" ref-type="bibr">410</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antimicrobial Peptide Resistance<break/>Adhesion to Host Cells and Tissues<break/>NETs Evasion<break/>Biofilm Formation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resists AMP-mediated bacterial killing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surface charge alteration, AMP degradation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B412-pathogens-14-00185" ref-type="bibr">412</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promotes bacterial adhesion and evasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MSCRAMMs, Serine-aspartate repeat protein D (SdrD), Serine-aspartate repeat protein E (SdrE), Fibronectin-binding protein B (FnbpB)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B414-pathogens-14-00185" ref-type="bibr">414</xref>,<xref rid="B417-pathogens-14-00185" ref-type="bibr">417</xref>,<xref rid="B418-pathogens-14-00185" ref-type="bibr">418</xref>,<xref rid="B419-pathogens-14-00185" ref-type="bibr">419</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Destroys neutrophil extracellular traps (NETs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphylococcal nuclease (Nuc), Adenosine synthase A (AdsA), Leukocidins (LukAB)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B420-pathogens-14-00185" ref-type="bibr">420</xref>,<xref rid="B421-pathogens-14-00185" ref-type="bibr">421</xref>,<xref rid="B428-pathogens-14-00185" ref-type="bibr">428</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protects bacteria from immune attacks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biofilm matrix (proteins, polysaccharides, extracellular DNA), Leukocidins (PVL, HlgAB), Bacterial DNase (Nuc), AdsA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B152-pathogens-14-00185" ref-type="bibr">152</xref>,<xref rid="B365-pathogens-14-00185" ref-type="bibr">365</xref>,<xref rid="B425-pathogens-14-00185" ref-type="bibr">425</xref>,<xref rid="B426-pathogens-14-00185" ref-type="bibr">426</xref>,<xref rid="B428-pathogens-14-00185" ref-type="bibr">428</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Promotion of Anti-inflammatory State</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shifts immune response to an anti-inflammatory state</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Staphylococcal biofilm components, Leukocidins (PVL, HlgAB), Adenosine, IL-10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B370-pathogens-14-00185" ref-type="bibr">370</xref>,<xref rid="B429-pathogens-14-00185" ref-type="bibr">429</xref>,<xref rid="B430-pathogens-14-00185" ref-type="bibr">430</xref>,<xref rid="B431-pathogens-14-00185" ref-type="bibr">431</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>CHIPS: Chemotaxis inhibitory protein of <italic toggle="yes">S. aureus</italic>; MSCRAMMs: microbial surface components recognizing adhesive matrix molecules; IL: Interleukin.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pathogens-14-00185-t007" orientation="portrait"><object-id pub-id-type="pii">pathogens-14-00185-t007_Table 7</object-id><label>Table 7</label><caption><p>Promising treatments against <italic toggle="yes">S. aureus</italic> infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Agent (Type)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name<break/>(Compound)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Research Stage</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recommendation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Vaccine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SA4Ag (composed of CP5 and CP8 conjugated with rmClfA and rMntC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the capsular polysaccharides of <italic toggle="yes">S. aureus</italic>. Induces high levels of antibodies that kill bacteria in adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical Stage. Phase 1 study completed. Phase 2B study in progress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Postoperative infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B445-pathogens-14-00185" ref-type="bibr">445</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01364571">NCT01364571</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02364596">NCT02364596</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02388165">NCT02388165</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NDV-3 and NDV-A (composed of a recombinant form of the Als3 protein from <italic toggle="yes">Candida albicans</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the Als3 protein. Induces rapid antibody and T cell responses. In preclinical studies, increased neutrophil infiltration and expression of IL-17 and IL-22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 and 2 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic>, <italic toggle="yes">MRSA</italic>, and <italic toggle="yes">Candida albicans infections</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B446-pathogens-14-00185" ref-type="bibr">446</xref>,<xref rid="B447-pathogens-14-00185" ref-type="bibr">447</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01926028">NCT01926028</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03455309">NCT03455309</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">STEBVax (composed of a mutated recombinant form of SEB)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interrupts the interaction of enterotoxin B with MHC class II receptors. Induces the production of toxin-neutralizing antibodies</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic shock syndrome and protection against a wide range of staphylococcal superantigens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B448-pathogens-14-00185" ref-type="bibr">448</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IBT-V02 (composed of seven toxoids of <italic toggle="yes">S. aureus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targeted against &#945;-toxin, LukS, LukF, LukAB, SEA, SEB and TSST-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 studies underway</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Postoperative MRSA infections, skin and soft tissue infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B449-pathogens-14-00185" ref-type="bibr">449</xref>,<xref rid="B450-pathogens-14-00185" ref-type="bibr">450</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSK2392103A (composed of CP5 and CP8 conjugated to tetanus toxoid, a mutated &#945;-toxin, and ClfA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the capsular polysaccharides of <italic toggle="yes">S. aureus</italic>, &#945;-toxin, and ClfA. Induces robust humoral immune responses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B451-pathogens-14-00185" ref-type="bibr">451</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01160172">NCT01160172</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSK3878858A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against recombinant proteins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 in progress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin and soft tissue infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B449-pathogens-14-00185" ref-type="bibr">449</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GAS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the cell completely. Induces increased antibody production, increased T cell population, and decreased bacterial load</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Septicemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B452-pathogens-14-00185" ref-type="bibr">452</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus vaccine</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Induces multifaceted B and T cell responses to <italic toggle="yes">S. aureus</italic> antigens. Induces the production of antibodies, Th1 or Th17 response</td><td align="center" valign="middle" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" rowspan="1" colspan="1">Bacteremia, dermonecrosis, skin abscess, and gastrointestinal colonization</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B453-pathogens-14-00185" ref-type="bibr">453</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ABN-701<break/>(composed by the modified SEB)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Directed against <italic toggle="yes">S. aureus</italic> enterotoxin B. It induces neutralization of antigen activity and elicits cellular and humoral immune responses</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Septicemia</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B454-pathogens-14-00185" ref-type="bibr">454</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4C-Staph/T7-alum </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protects against bacterial spread. It induces an increase in &#945;-hemolysin neutralizing antibody levels and Th1 and Th17 profile responses. Induces the action of T CD4<sup>+</sup> cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal abscess and peritonitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B455-pathogens-14-00185" ref-type="bibr">455</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combination Al(OH)<sub>3</sub>, MPL, and WGP vaccine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increases survival rate. Stimulates the innate immune system and induces epigenetic changes in macrophages that modulate phagocytosis and the inflammatory response to infection </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bacteremia and septicemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B456-pathogens-14-00185" ref-type="bibr">456</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LukAB Toxoid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against LukAB. Induces reduction of bacterial load at the surgical site and dissemination of <italic toggle="yes">S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Post-surgical infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B457-pathogens-14-00185" ref-type="bibr">457</xref>]</td></tr><tr><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">mAbs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salvecin (AR-301&#8212;human anti-staphylococcal IgG mAb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against &#945;-hemolysin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1, 2, and 3 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pneumonia (caused by MRSA and MSSA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B458-pathogens-14-00185" ref-type="bibr">458</xref>,<xref rid="B459-pathogens-14-00185" ref-type="bibr">459</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suvratoxumab (MEDI4893&#8212;human anti-&#945;-toxin neutralizing mAb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against &#945;-toxin, inhibiting its interaction with metalloprotease ADAM10 and its auto-oligomerization. Induces an increase in antibodies. In preclinical studies, it was responsible for increasing survival rates and reducing the bacterial load in the lungs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 and 2 studies completed, and phase 3 studies in progress.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nosocomial pneumonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B460-pathogens-14-00185" ref-type="bibr">460</xref>,<xref rid="B461-pathogens-14-00185" ref-type="bibr">461</xref>,<xref rid="B462-pathogens-14-00185" ref-type="bibr">462</xref>,<xref rid="B463-pathogens-14-00185" ref-type="bibr">463</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02296320">NCT02296320</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT05331885">NCT05331885</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DSTA4637S (anti-GlcNAc IgG mAb conjugated to a rifamycin class antibiotic)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the GlcNAc portion of teichoic acid from the cell wall of <italic toggle="yes">S. aureus</italic>. Targets intracellular <italic toggle="yes">S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B464-pathogens-14-00185" ref-type="bibr">464</xref>,<xref rid="B465-pathogens-14-00185" ref-type="bibr">465</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02596399">NCT02596399</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">514G3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against SpA. In preclinical studies it has been shown to stimulate IgG and IgA antibacterial responses and promote the decolonization of <italic toggle="yes">S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 2 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA bacteremia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B466-pathogens-14-00185" ref-type="bibr">466</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tefibazumab (Aurexis&#8212;humanized mAb that binds to the ClfA protein)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the adhesion protein ClfA expressed on the surface of <italic toggle="yes">S. aureus</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 2 studies completed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bacteremia and cystic fibrosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B467-pathogens-14-00185" ref-type="bibr">467</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT00198289">NCT00198289</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TRL1068</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targeted against highly conserved epitopes in the DNABII family of bacterial DNA-binding proteins (HU and IHF proteins).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 1 studies in progress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Joint infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT04763759">NCT04763759</ext-link>)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linezolid (humanized anti-SEB neutralizing mAb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against SEB. Attenuates the systemic inflammatory response, protects against mortality, and inhibits the production of superantigens. Induces the production of antibodies</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pneumonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B468-pathogens-14-00185" ref-type="bibr">468</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dupilumab (humanized mAb anti-IL4R&#945;)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against IL-4R&#945;. Significantly reduces bacterial load, serum CCL17, and disease severity. Reduces <italic toggle="yes">S. aureus</italic> cytotoxins and increases expression of genes relevant to Th17 responses, neutrophils, and complement pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical stage. Phase 2 and 3 studies in progress</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Atopic dermatitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([<xref rid="B469-pathogens-14-00185" ref-type="bibr">469</xref>,<xref rid="B470-pathogens-14-00185" ref-type="bibr">470</xref>,<xref rid="B471-pathogens-14-00185" ref-type="bibr">471</xref>]; <uri>ClinicalTrials.gov</uri>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT03389893">NCT03389893</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02277743">NCT02277743</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT02277769">NCT02277769</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:clinical-trial" xlink:href="NCT01859988">NCT01859988</ext-link>)</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Vaccines with mAb (epitope-focused immunization)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CgoX-D3 (anti-CgoX mAb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the CgoX enzyme. It causes a strong and protective immune response against <italic toggle="yes">S. aureus</italic>. It has a wide effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Septicemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B472-pathogens-14-00185" ref-type="bibr">472</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TPI-H8 (anti-TPI mAb)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against the TPI enzyme. It causes a strong and protective immune response against <italic toggle="yes">S. aureus</italic>. It has a wide effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Septicemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B472-pathogens-14-00185" ref-type="bibr">472</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Other</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Free-BR with MPS-NP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed against several virulence factors of <italic toggle="yes">S. aureus</italic>. It has antibacterial, anti-biofilm, anti-quorum sensing, and anti-virulence properties. Attenuates the expression of pro-inflammatory cytokines and pro-apoptotic genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multivirulent VRSA infections</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B473-pathogens-14-00185" ref-type="bibr">473</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein Isoflavone </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significantly suppresses bacterial growth and reduces the production of pro-inflammatory cytokines, such as TNF-&#945; and IL-6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA-induced osteomyelitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B474-pathogens-14-00185" ref-type="bibr">474</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Butyrate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Attenuates skin inflammation aggravated by <italic toggle="yes">S. aureus</italic> by reducing IL-13 and leukocyte infiltration in the skin. Suppressed IL-33 expression and improved inflammation by inhibiting HDAC3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Atopic dermatitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B475-pathogens-14-00185" ref-type="bibr">475</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xuebijing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">It improves survival and downregulates the expression of pro-inflammatory cytokines, such as IL-6, TNF-&#945;, and IL-10. Reduces bacterial load and tissue damage. Downregulates the activation of NF-&#954;B, MAPK, and PI3K/Akt in macrophages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Septicemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B476-pathogens-14-00185" ref-type="bibr">476</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sphingomyelin liposomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sequesters cytolytic toxins (phenol and &#945;-hemolysin-soluble modulins) and prevents hemolysis and cell necrosis </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA Infections </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B477-pathogens-14-00185" ref-type="bibr">477</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angeli Salt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">It inhibits mechanical hyperalgesia, edema, leukocyte migration, cytokine release, NF-&#954;B activation, and oxidative stress. It reduces the severity of the disease and decreases the bacterial load </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Septic arthritis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B118-pathogens-14-00185" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oils (trans-cinnamaldehyde, thymol, and carvacrol)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">They have antimicrobial and antivirulence activities. They inhibit the growth of multivirulent <italic toggle="yes">S. aureus</italic> and MRSA. Downregulate the transcription of virulence genes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical stage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B478-pathogens-14-00185" ref-type="bibr">478</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>SA4Ag: <italic toggle="yes">S. aureus</italic> 4-antigen vaccine; CP5: capsular polysaccharide 5; CP8: capsular polysaccharide 8; rmClfA: recombinant surface protein clumping factor A; rMntC: recombinant manganese transport protein C; Als3: agglutinin-like sequence 3 surface protein; IL: interleukin; MRSA: methicillin-resistant <italic toggle="yes">S. aureus</italic>; SEB: staphylococcal enterotoxin B; MHC: major histocompatibility complex; LukS: S-subunit of Panton-Valentine Leucocidin; LukF: F-subunit of Panton-Valentine Leucocidin; LukAB: Leucocidin A/B; SEA: staphylococcal enterotoxin A; TSST-1: toxic shock syndrome toxin 1; GAS: ghosts of <italic toggle="yes">S. aureus</italic>; Al(OH)<sub>3</sub>: aluminum hydroxide; MPL: monophosphoryl lipid A; WGP: whole glucan particles; mAbs: monoclonal antibodies; MSSA: methicillin-sensitive <italic toggle="yes">S. aureus</italic>; ADAM10: disintegrin and metalloproteinase domain-containing protein 10; GlcNAc: N-acetyl-glucosamine; SpA: staphylococcal protein A; HU: histone-like proteins; IHF: integration host factor; IL-4R&#945;: interleukin-4 receptor; CCL17: Chemokine (C-C) ligand 17; CgoX: coproporphyrinogen III oxidase; TPI: triose phosphate isomerase; Free-BR: berberine free; MPS-NP: mesoporous silica nanoparticles; VRSA: vancomycin-resistant <italic toggle="yes">S. aureus</italic>; TNF-&#945;: tumor necrosis factor-alpha; HDAC3: histone deacetylase 3; NF-&#954;B: nuclear factor kappa B; MAPK: mitogen-activated protein kinase; PI3K/Akt: phosphoinositide 3-kinase/protein kinase B.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>